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Metabolomics is a relatively new field that involves the study of metabolic
responses that are occurring within a biological system. Metabolite profiles of an
organism, tissue extract, and biofluids are important indicators to determine the
physiological state of a biological profile. Comparison of such profiles from different
phenotypes can be used to identify specific metabolic changes leading to the
understanding of metabolic pathways, disease progression, drug toxicity and efficacy,
and cellular responses to different intracellular and extracellular conditions.
Metabolomics investigations often use sophisticated analytical techniques such as NMR
spectroscopy to provide an unbiased and comprehensive approach to evaluate metabolic
perturbation in different cell lysates.
This dissertation will focus on the development and applications of NMR-based
metabolomics methodologies to generate reliable and reproducible results. The protocol
has been expanded greatly, optimizing all aspects of the metabolomics process including
cell growth, sample preparation, sample handling, data collection, data processing, and
data analysis. There are two main approaches in the protocol to decipher NMR
metabolomics data: pattern recognition, such as PCA and OPLS-DA, comparing
numerous 1-dimensional 1H NMR datasets to analyze biofluids at a global scale, and
quantitative profiling of 13C-labeled metabolites using 2-dimensional 1H-13C HSQC. As a

result, our protocol provides a comprehensive analysis, describing unique characteristics
and relationships between various samples that differ in their source or treatment.
We applied our protocol to predict the in vivo mechanism of action for drug leads
from NMR metabolomics data. The NMR analysis resulted in distinct clustering which
would be classified by an in vivo mechanism. Also, we demonstrated the similarity of
Staphylococcus epidermidis metabolomes resulting from exposure to divergent
environmental stressors that are known to facilitate biofilm formation. Our results
suggest that the tricarboxlic acid cycle acts as a metabolic signaling mechanism for the
activation of biofilm formation. Also investigated was the mechanism of action of Dcycloserine in M. smegmatis and M. tuberculosis. Our findings proved that D-alanine-Dalanine ligase is the primary target as cell growth is inhibited when the production of Dalanyl-D-alanine is halted. Furthermore, we were able to identify an alternate path for the
production of D-alanine via a possible transaminase mechanism.
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CHAPTER 1
INTRODUCTION

1.1 Introduction
Cells are complex systems involving numerous chemical, electrochemical, and
mechanical processes which govern basic cellular activities and coordinate cell actions.
It was once thought that the many processes occurring in cells display a hierarchal level
of organization, transferring information from DNA to RNA to proteins [1-3]. However,
a cell’s behavior is a result of the complex interactions and regulations between these
chemical entities (e.g., DNA, RNA, proteins, small molecules). For example,
transcription factors, which are products of gene transcription, can inhibit or activate the
transcription of mRNAs [4-7]. Proteins can interact with other proteins, forming new and
larger complexes with different functions [8, 9]. Biochemical reactions in cellular
metabolism can be integrated as large networks that are regulated by enzymes. Likewise,
small molecule interactions can also regulate gene transcription and protein function [1012]. It is important to note that biomolecular interactions and regulations are not at all
static. Instead, they change dynamically in response to changes in the environment and
intercellular state. The main aspect of these functional responses concerns perturbations
in metabolic regulations where enzymes, which catalyze metabolite conversions, are
subjected to multiple levels of regulations [13]. Also, transcriptional regulations may
play important roles in metabolic responses [13]. This is where using genomic,
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proteomic, and metabolomics approaches are beneficial to understand biological behavior
with different conditional perturbations (Figure 1.1a) [14-18].
A key aspect to understanding a biological system is to study metabolism, as the
concentration of the metabolites is sensitive to environmental and genetic changes [19].
Furthermore, a complete set of metabolites, which are products (molecular weight, less
than 1,500 daltons) of enzyme-catalyzed reactions in a cell, is referred to as the
metabolome [20-22]. A comprehensive list of metabolites can be used to generate
multiple metabolic networks (e.g., Glycolysis, TCA cycle, urea cycle, etc.), which can be
visualized by databases such as KEGG and Metacyc [23, 24]. Since many metabolites
are found in a wide range of organisms while others are family or species specific, it is
likely that some metabolites will fulfill important biological functions [20]. Hence,
analyzing the metabolome is well suited to determine perturbed network patterns or
metabolite changes to address important biomarkers for specific diseases, mutation, or
determining the function of drug candidates (Figure 1.1b) [18]. To understand the
different set of conditions perturbing a biological system, a comprehensive analysis in
which all metabolites are identified and quantified is performed. This comprehensive
approach is known as “ metabolomics” [20].
Metabolomics is one of the newest disciplines of the –omics cascade (genomics,
transcriptomics, proteomics) that revolutionized the strategy of modern research.
Hypothesis-based research has remained the golden rule of research [25]. However,
devising a hypothesis can be difficult with the ever increasing complexity of a problem.
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Figure 1.1. a) Schematic describing the downstream processes of the omics cascade. b)
A schematic of a metabolic pathway. Metabolites are represented as circles. An alteration
in a single enzyme can lead to a cascade of metabolic perturbations. Here, metabolites
whose levels are altered in each of three theoretical genotypes are shown by colored
circles. Orange, light blue, and green circles represent metabolites altered in genotype 1,
genotype 2 and genotype 3, respectively. Metabolites whose levels are similarly altered in
multiple genotypes are represented by multi-colored circles. Reprinted with permission
from [18] © MacMillan Publishers Limited, 2012.
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Instead, metabolomics can be performed without any prior knowledge of the system. This
means unique metabolic patterns and perturbed metabolites can be used toformulate a
new hypothesis. Hypothesis-based approaches and metabolomics are complementary in
that the analysis of both approaches can lead to similar findings, thus strengthening our
knowledge in the field [26]. Sometimes metabolomics can address unexpected findings
that are not related to the original problems being investigated. This can lead to new areas
to explore and a new hypothesis to be developed.
Metabolomics offers collaborative opportunities, connecting biology centric
research with high throughput analytical platforms and interpretation while applying
computer generated models to answer specific questions or concerns [27]. Collaborative
efforts using metabolomics have been advantageous for all aspects of science, where
groups of researchers can work together with similar interests from the same or different
institution. It also brings together researchers with different viewpoints and approaches
to solve a problem. Diversity of experience and skill sets may increase the likelihood of
a breakthrough or of successful research. Collaborations have become a popular trend,
where national centers and international projects have been developed to understand and
characterize different metabolomes [27]. It has been advantageous from a graduate
student’s perspective as it can expand our horizons in multiple disciplines.
Although, metabolomics has been around for about a decade, it has grown quite
rapidly and has become a widely-used approach with a broad field of applications,
including plants [28-30], bacteria [31-33], eukaryotic cells [34], medicinal [35], and
veterinary sciences [36]. For example, metabolomics research has been heavily used in
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the discovery of biomarkers or patterns associated with diseases [37, 38]. Metabolomics
has been applied in the study of drug toxicity and efficacy, which can lead to novel and
potent drugs [39-41]. Metabolomics, along with the genomics and proteomics has the
capability of providing diagnostics and prognostics of drug discovery clinical trials [42].
Instead, metabolomics is able to identify biomarkers that are associated with
hepatotoxicity and nephrotoxicity, which are the two major reason most drug candidates
fail [43]. New metabolomics technologies can be developed to create non-invasive
techniques that can be used to diagnose and monitor disease progression, recognize
response to treatments, and identify the development of resistance to treatments.
Metabolomics methodologies usually involve information rich analytical
platforms including: nuclear magnetic resonance spectroscopy (NMR); mass
spectroscopy (MS) coupled with separation techniques such as gas chromatography (GC)
or liquid chromatography (LC); and Fourier transform-infrared spectroscopy (FT-IR)
[44]. NMR is a popular tool because it provides a rapid, non-destructive, highthroughput method that requires minimal sample-handling. Typically, metabolites are
detectable by 1H-NMR because they usually contain one or more protons in their
molecular structure, and each proton produces one or more peaks. However, a metabolite
mixture from a given biological system may consist of thousands of metabolites, thereby
producing thousands of proton signals in a given spectrum and providing a wealth of
information on the nature of the biological system (Figure 1.2).
NMR is somewhat of a universal platform as it can capture a wide range of
metabolites with different chemical characteristics, such as aromatic compounds,
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Figure 1.2. A 1D 1H NMR spectrum, displaying hundreds of metabolites found in an
E.coli metabolomics sample. The NMR spectrum can be divided into three regions
describing the type of metabolites: aromatic, carbohydrates, and aliphatics.
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carbohydrates, amino acids, and aliphatic compounds. Unfortunately, analysis of every
peak can be very challenging due to the limitation of the proton spectral width, leading to
peak overlap.
An accurate but qualitative approach involves the use of statistical analysis and
pattern recognition. Pattern recognition techniques such as principle component analysis
(PCA) and orthogonal projection to latent structure discriminant analysis (OPLS-DA) are
currently being employed to capture the global perturbations in a metabolome [45, 46].
PCA is an unsupervised method that reduces a multivariate dataset to a single point and
projects the major variations in the dataset into a few axes called principal components.
In this way, spectral variations are captured in a model that can be easily visualized. The
overall underlying assumption is that similar metabolomic profiles will cluster closely
together in PCA or OPLS-DA scores plots and that differing metabolomics profiles will
cluster away from each other [47].
OPLS-DA is a supervised method used to determine the variations within the data
set that are correlated to classification labels (e.g., treatment, control, disease state) set by
the investigators. If the variations within the data set are not correlated with the
classification label, then the variations are filtered out, resulting in a single latent vector
[46]. This is analogous to PCA because PCA captures all the intrinsic variations within
the data set. Since the classification labels are defined in OPLS-DA, the scores plot will
create distinct clusters between classes regardless of their similarities. A separation
between classes will even occur for randomly generated data [48]. Thus, it is essential
that OPLS-DA models are properly validated. However, with proper validation using

8
both PCA and OPLS-DA methodologies, these tools are extremely powerful tools used to
organize and classify different strains, drug treatments, or diseases. This also allows for
the determination of the mechanisms of drugs with unknown actions, by comparing the
results to those for classes of drugs with known mechanisms of action [49].
A major problem with 1D-NMR metabolomics techniques is the inability to
accurately quantitate metabolic perturbation due to overlapping peaks. In addition,
attempts to identify these metabolites present a great challenge. Therefore, the use of a
two-dimensional (2D) 1H-13C HSQC experiment leads to a dispersion of peaks along the
1

H and 13C axes, increasing the resolution of the spectrum (Figure 1.3). More

importantly, a 2D 1H-13C HSQC spectrum offers useful information for the identification
of individual metabolites, since, multiple peaks comprising coupled 1H and 13C chemical
shifts may be attributed to a single metabolite, providing several redundant data points for
confirming an assignment. A number of databases have been developed to enable
metabolite identification by matching the chemical shifts from a 2D 1H-13C HSQC
spectrum obtained for a metabolomics sample to a collection of reference NMR spectra
for numerous known metabolites. Such databases include the Human Metabolome
Database (HMDB) [50], Madison Metabolomics Database (MMCD) [51], and Platform
for Riken Metabolomics (PRIMe) [52]. These databases consist of hundreds to
thousands of metabolites from a broad range of organisms; therefore, metabolite
identification should be verified with KEGG and Metacyc databases [23, 24, 40].
Metabolites can be quantified using time-zero 2D 1H-13C HSQC [53] or by quantitating
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Figure 1.3. An example of a typical 2D 1H-13C HSQC spectrum obtained for a M.
smegmatis culture grown in MADC media containing 13C-glycerol. The metabolites were
identified using HMDB, MMCD, and Prime databases.
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the relative difference in peak height [54]. Heat-maps, bar graphs or metabolic pathways
can then be generated to compare concentrations or relative peak heights of different
metabolites to identifying major perturbations associated with genetic or environmental
changes.

1.2 Overview of Thesis
1.2.1

Development of Metabolomics Methodologies
Metabolomics is a relatively new field, but it has evolved into a powerful tool for

understanding the global physiological and pathological states of a biological system.
This dissertation will focus on the development of NMR-based metabolomics
methodologies to ensure that the required information is obtained in a high throughput
and reliable manner. These NMR-based metabolomics methods were developed while
applying the techniques to different organisms, such as Aspergillus nidulans,
Mycobacterium tuberculosis, Mycobacterium smegmatis, Staphylococcus aureus,
Staphylococcus epidermidis; biofluids (urine), and human cell lines (pancreatic cancer
cells) were also examined [47, 54-58].
Chapter 2 will address the application of pattern recognition tools, such as PCA
and OPLS-DA, which can be used to decipher global changes in large NMR datasets of
cell lysates or biofluids. The chapter will explain the importance of the validation
process and the development of statistically meaningful plots. Statistical tools such as
PCAtoTree [59] and PCA/PLS-DA utilities [60] have been developed to quantify the
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differential relationship between clustering patterns. S-Plots are then used to identify
metabolite changes that are responsible for class separation.
Chapters 3 outlines the overall metabolomics protocol that was optimized in
order to generate reliable and reproducible data. Initially, the protocol was limited to
only the use of PCA and the comparison of a control, mutant, and drug treated cell lines
[47]. The protocol has been expanded greatly, optimizing all aspects of the
metabolomics processes including cell growth, sample preparation, sample handling, data
collection, data processing, and data analysis. The protocol now includes the qualitative
and quantitative analysis of 2D 1H-13C HSQC spectra. Peak intensities and volumes
within a 2D 1H-13C HSQC spectrum are directly proportional to the concentration of a
given metabolite. However, conventional HSQCs are difficult to quantify because
different spin dynamic properties, J-coupling, translational relaxation, and transverse
relaxation for each atom in a metabolite also affect peak intensities and volumes [53].
Therefore, the protocol incorporates two methods: quantifying metabolic perturbations
comparing relative peak heights, and quantifying the concentrations of metabolites using
time-zero HSQC [53].
Chapter 4 discusses a new methodology to predict the in vivo mechanism of
action for drug leads from NMR metabolomics data. Initially, drugs were compared with
mutant knockout strains to determine the mechanism of action. Drugs that clustered
similar to the mutant strains in PCA or OPLS-DA scores plots were said to have a similar
impact on the metabolome as the genetically inactivated protein and, therefore, the
genetically inactivated protein was identified as the likely drug target [47]. However, this
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requires some general knowledge of the potential drug target in order to select an
appropriate mutant knockout strain. Thus, this approach was further developed by
comparing chemical leads with unknown mechanisms to reference drugs with known
protein targets. We postulated that drugs targeting the same protein would likely cluster
together in a PCA or OPLS-DA scores plot. Three chemical leads shown to inhibit M.
tuberculosis and M. smegmatis, but with an unknown mechanism of action, were
compared with known mycobacterial drugs. The NMR analysis resulted in multiple drugs
with similar mechanisms of action clustering closely together in an OPLS-DA scores
plot, allowing for the prediction of a mechanism of action for the three chemical leads
with activity against M. tuberculosis and M. smegmatis.

1.2.2 Biofilm Formation
Staphylococcus epidermidis and Staphylococcus aureus are the most prevalent
bacteria found colonizing human skin and mucous membranes [61]. Despite their low
virulence, they have been the leading causes of infections during medical care [62].
These infections are most frequently a result of cuts, medical implants, dialysis catheters,
and many other medical procedures. The virulence and survivability of these bacterial
species is associated with their ability to attach to surfaces and form a sticky residue
called a biofilm, in which larger colonies of cells can be formed (Figure 1.4a) [63]. At a
molecular level, polysaccharide intercellular adhesion (PIA) plays an essential role in
bacterial adherence. PIA is primarily composed of a mixture N-acetylglucosamine in β1,6-glycosidic linkages containing deacetylated amino groups, succinate, and phosphate
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a)

b)

Figure 1.4. a) The process of biofilm formation. The cells first attached to a polymer
surface. As more cells are attached to the surface, they secrete out more PIA. The
biofilm matrix matures and then overtime, parts of the biofilm detaches forming new
colonies. b) Molecular structure of PIA. Reprinted with permission from [63] © Annual
Review of Medicine, 2013.
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substitutions (Figure 1.4b) [64, 65]. Overtime, more bacterial cells adhere to the complex,
secreting more PIA. Channels are formed through the complex which allows for
nutrients to flow deep within the complex community [66]. Parts of the complex colony
can then break off and form new colonies [63]. Overall, biofilms allow bacterial cells to
survive and grow through harsh environmental conditions. Numerous antibiotics are
ineffective or have diminished activity against a biofilm, because of the inability to
penetrate through the sticky mass [65, 67]. Therefore, studies are being performed to find
drugs that can detach biofilms from surfaces or prevent biofilm formation [68].
In this study, we demonstrated for the first time that a metabolic response, TCA
cycle repression, can act as a signaling mechanism for the activation of PIA and biofilm
formation. In Chapter 5, S. epidermidis TCA cycle mutants were constructed, and the
function of central metabolism was analyzed. The results showed that TCA cycle
inactivation altered the metabolic status of S. epidermidis, resulting in a derepression of
PIA biosynthetic genes and a redirection of carbon from growth into PIA biosynthesis.
In Chapter 6, we demonstrate that environmental stressors (iron limitation and
addition of ethanol) decrease TCA activity resulting in metabolic changes. These
metabolic changes are sensed by a metabolite-response regulator (catabolite control
protein; CcpA) that affect PIA production.
Chapter 7 describes a detailed NMR metabolomics analysis to investigate a
diverse array of environmental stress factors associated with biofilm formation, such as
5% NaCl, 2% glucose, 0.06 ug/ml tetracyclin, 400 nM autoinducer-2, 4% ethanol, and
iron limitation. A detailed quantitative NMR analysis describing the changes in
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metabolite concentration using 2D 1H-13C HSQC and 2D 1H-1H TOCSY spectra was
used to describe the perturbation of the metabolome associated with the environmental
stresses. The results further demonstrate that different environmental stress conditions
induce inactivation of the TCA cycle. Moreover, the TCA cycle inactivation plays a
central role in the proposed signaling pathway that also involves the perturbation of other
metabolites associated with PIA formations. Furthermore, our metabolomics analysis has
shown that some environmental stresses such as the addition of NaCl and autoinducer-2
did not affect the TCA cycle demonstrating that these factors may perturb other distant
processes.
Chapter 8 illustrates through genetic and biochemical approaches that S. aureus
ccpA can synthesize arginine from proline via the urea cycle. This is the first report of
bacteria utilizing proline for arginine biosynthesis. Ccpa is a known gene regulator for
carbon catabolite repression, and can de-repress arginine biosynthesis via glutamate [56,
69]. Ccpa can also repress TCA cycle activity which is important in biofilm formation
[70].

1.2.3 Mechanism of action of DCS on Mycobacterium tuberculosis and Mycobacterium
smegmatis
D-Cycloserine (DCS) is an effective second line antibiotic used to treat
Mycobacterium tuberculosis. DCS is a cyclic analogue of D-alanine and interferes with
the formation of peptidoglycan biosynthesis by the competitive inhibition of alanine
racemase and D-alanyl-D-alanine ligase. Both enzymes are unique to bacteria and
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valuable drug discovery targets for developing selective antibacterial agents [71].
However, DCS is rarely used due to serious neurological side effects that result from an
interaction with neuronal N-methyl aspartate receptors [72-74]. Therefore, understanding
the in vivo mechanism of action for DCS and determining if alanine racemase or Dalanine-D-alanine ligase is the lethal target of DCS could aid in the development of
effective and safe antitubercular agents.
Although it is known that DCS can competitively bind to both alanine racemase
and D-alanine ligase, it is unclear which enzyme is the lethal target of DCS [75]. Recent
studies have shown that mutations leading to the overproduction of alanine racemase
increased resistance to DCS [76]. Similarly, alanine racemase null mutants are
susceptible to DCS [76]. Overall, the sensitivity of DCS to both overproduction strain
and null mutants may suggest that alanine racemase plays an important role in the in vivo
mechanism of DCS. However, the overproduction of D-alanine-D-alanine ligase has been
shown to reduce susceptibility of DCS, suggesting that D-alanine-D-alanine ligase may
also play an important role in DCS activity [75]. Moreover, DCS mediated inhibition
can be reversed by the presence of D-alanine in the medium, suggesting DCS might
inhibit growth by alanine racemase alone [77]. However, our NMR metabolomics
experiments show that the in vivo mechanism of inactivation of alanine racemase by
mutation does not match the in vivo mechanism of action for DCS (Figure 1.5) [55]. This
suggests that another enzyme, possibly D-alanine-D-alanine ligase, may be the lethal
target.
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Figure 1.5. a) PCA scores plot comparing wild-type mc2155( ), alanine racemase null
mutant (TAM23) (●), alanine racemase over producing mutant (GPM14) ( ), DCS
resistant strain unrelated to alanine racemase mutations (GPM 16) ( ), TAM23
complemented with wild-type alanine racemase gene (TAM23 pTAMU3) ( ), mc2155
with DCS ( ), TAM23 with DCS (●), GPM14 with DCS ( ), GPM16 with DCS ( ) and
TAM23pTAMu3 with DCS ( ). Cultures that are clustered together displays similar
metabolomes while distant clustering patterns have different metabolomes. Reprinted
with permission [55] © American Chemical Society, 2007.
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The essentiality of alanine racemase in mycobacteria is also a point of discussion
because it is important in determining whether alanine racemase or D-alanine-D-alanine
ligase is the lethal target of DCS [78, 79]. For example, if alanine racemase is essential,
then it would be assumed that the inhibition of alanine racemase by DCS would be lethal.
Therefore, developing effective and safer antibiotics would focus on alanine racemase as
a drug target. On the other hand, if alanine racemase in not essential, meaning there is an
alternate path for the production of D-alanine, then D-alanine-D-alanine ligase may
assume the role as the potential lethal target of DCS. In our previous study using NMR
metabolomics, we were able to verify that there is a potential alternate pathway for the
production of D-alanine, where an alanine racemase null mutant, an alanine racemase
overproduction mutants, and wild type cells were all able to grow in the absence of Dalanine [55]. Furthermore, our 1D 1H NMR metabolomics analysis showed a decrease in
glutamate in the alanine racemase null mutant cell lysate samples, suggesting glutamate
is being utilized to produce D-alanine via a transaminase mechanism [55].
A previous NMR metabolomics study provided substantial insights regarding the
role of alanine racemase to DCS activity [55]. Nevertheless, further studies were needed
to determine the essentiality of alanine racemase and for defining the role of D-alanineD-alanine ligase in DCS activity. Chapter 9 describes further investigations of the
essentiality of alanine racemase to M. smegmatis, and provides additional evidence for a
possible alternate route for the production of D-alanine. It also illustrates the importance
of media selection in cell cultures, since the use of different media may generate
contradictory results.
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Chapter 10 describes further investigations into the identification of the M.
tuberculosis and M. smegmatis in vivo lethal target of DCS. A detailed NMR
metabolomics analysis identified D-alanine-D-alanine ligase as the lethal target of DCS.
Inhibition of cell growth by DCS was correlated with a halt in the production of Dalanyl-D-alanine. Also, increasing the cellular pool of D-alanine was identified as a
mechanism of DCS resistance. Thus, inhibition of alanine racemase may contribute
indirectly to DCS activity by lowering the levels of D-alanine and allowing DCS to
outcompete D-alanine for D-alanine-D-alanine ligase binding.
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CHAPTER 2
TOOLS FOR INTERPRETTING NMR MULTIVARIATE DATA

2.1 Introduction
The use of pattern recognition to analyze complex data sets has been one of the
most important developments in the application of NMR to metabolomics. NMR data are
generally large and complex, consisting of thousands of signals corresponding to
numerous metabolites in a biological sample. Thus, the aim of multivariate statistical
techniques is to maximize the interpretation of NMR datasets by identifying and
quantifying all the metabolites that are perturbed by genetic alterations, disease
processes, or drug treatment [1]. However, the numerous metabolite signals tend to result
in a congested NMR spectrum, which hinders manual interpretation of the data.
Pattern recognition tools, such as principal component analysis (PCA) and
orthogonal projection of latent structures discriminant analysis (OPLS-DA), are routinely
used to analyze NMR datasets collected on metabolomes extracted from various cell
cultures. The resulting PCA or OPLS-DA scores plots provide a means to identify
biological relationships between the different cell cultures based on global differences or
similarities between the cellular metabolomes [2, 3]. In general, pattern recognition tools
are used to identify the spectral features that significantly contribute to a differentiation
between the classes in an attempt to discover biomarkers or to construct a model to
determine class membership [4, 5]. PCA is an unsupervised technique, which means that
class designations are not used to generate a model [6]. Instead the model and the class
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discrimination is based on identifying the largest variations in the data [6]. However,
PCA is only applicable if variations in the experimental dataset are a consequence of
differences in an underling biological process. In effect, differences in the NMR spectra
must result from biologically relevant changes in the cellular metabolomes.
Alternatively, a supervised technique, such as OPLS-DA, requires class
designations in order to generate a model. Similar to unsupervised techniques, supervised
methods only generate a validated model if a difference in the metabolome and
associated NMR spectra actually exist. Unlike unsupervised techniques, supervised
methods can also generate the appearance of class separation even for completely random
data [7]. Thus, it is essential that the model generated by a supervised technique is
properly validated [7]. Despite these added challenges, the advantage of supervised
techniques is the ease of identifying the key spectral features (metabolites) that define the
class separation.
In this chapter, I present an overview, and describe the general application of
PCA and OPLS-DA for the analysis of NMR metabolomics data as a tool for systems
biology. I will also highlight the importance of generating statistically meaningful
OPLS-DA models using validations protocols. In addition, I will briefly describe the
statistical tools PCAtoTree and PCA/PLS-DA utilities (http://bionmr.unl.edu/pcautils.php) that have been developed by Prof. Mark Werth and Bradley Worley,
respectively, with the assistance of my NMR metabolomics datasets, to quantify the
statistical significance of class separation in PCA and OPLS-DA scores plots. Finally, I

28
will describe the application of OPLS-DA S-plots to identify the significant metabolite
changes that are responsible for class separation.

2.2 Principal Component Analysis
PCA is a well-established unsupervised statistical method for interpreting large
multivariable datasets. PCA results in the reduction of an NMR spectrum into a single
point in a Cartesian coordinate system in a K-dimensional space, where each dimension
represents a chemical shift bin from the NMR spectra (Figure 2.1) [8]. The NMR data
matrix X consists of n samples and m variables (chemical shift bins) which can be
represented as an ensemble of n points in an m dimensional space. PCA transforms the
NMR data matrix X by a partial linear least squares fit to a principal component vector
( PC1 ) corresponding to the largest variation in the dataset. The data is then fit to a
second orthogonal vector ( PC2 ) corresponding to the second largest variation in the
dataset. Each successive principal component vector describes a decreasing amount of the
variability in the NMR data matrix X. A “weights” or “loadings” matrix (P) maps the
NMR data matrix X onto these principal component vectors. Thus, the new transformed
data will have a new set of axes which relates to each principal component through a
scores matrix (T). In essence, PCA performs an orthogonal linear transformation of a
multivariate dataset into the latent (PC) coordinate space while maintaining most of the
variability of the original data (Equation 2.1)[9].
(2.1)
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Figure 2.1. Diagram of 1D 1H NMR data being reduced into a PCA scores plot. Each
spectrum is reduced to a single point along the k-dimensional variable space. Each
dimensional variable represents a chemical shift bin. PC1 account for the largest
variation, and PC2 is orthogonal to PC1 and describes the second largest variation.
Reprinted with permission [8] © Future Medicinal Chemistry, 2012.
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PCA can also be generally described as a method that decomposes the NMR data matrix
(X) into two smaller matrices corresponding to the scores matrix (T) and a transposed
loading matrix (PT) (Equation 2.2) [10, 11],
(2.2)
The scores matrix captures the systematic variation in the dataset with respect to the
samples and variables. The loadings matrix captures the relative contribution of each
chemical shift bin to this variance. The E matrix contains the residuals, the data in X that
is not explained by the PCA model. The principal components (PC) are a series of partial
linear least squares fits of the original set of samples in X that captures the maximum
amount of variance in the dataset. Therefore equation 2.2 can be expanded as shown
below [10, 11],
(2.3)
where tK and

represent the scores vector and loadings vector for each successive

principal component. The first principal component (
variance in the data. The second component (

) explains the largest amount of

) is orthogonal to the first component

and explains the second largest amount of variance in the data. Each subsequent PCK will
capture a decreasing amount of variance.

2.3 Orthogonal Projection of Latent Structure
PCA can be advantageous for detecting outliers, finding patterns or trends, or the
separation of groups that are not similar [12, 13]. This means PCA can be performed
with little to no knowledge about the samples being studied. However, PCA based
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approaches are limited, because the unsupervised approach results in a separation based
only on the maximum variations [3]. Thus, the principal components may not necessarily
reflect differences between classes [14]. On the other hand, OPLS-DA is a supervised
technique where the results in an OPLS-DA scores plot is driven by the class assignments
[3, 15]. This means that the model is rotated based on the class assignments instead of the
maximum variations in the data set (Figure 2.2). More specifically, the first (predictive)
component of the OPLS-DA scores spectra contains information that distinguishes
between class separations, while the second (orthogonal) component contains information
relative to within class membership.
OPLS-DA is a supervised algorithm that uses an orthogonal signal correction
(OSC) filter to remove any variation in data matrix X that is not correlated with a
response matrix Y [3, 16]. The data matrix Y contains discrete classifications, such as
wild-type, mutant, drugs, or disease. As an illustrative example, the wild-type cultures
can be assigned a value of 0, whereas the mutant, drugs, or disease can be designated a
value of 1. However, the class designation can be used to compare any class
combinations such as comparison between different mutants or drug treatments. Overall,
OPLS-DA uses information of data matrix Y to decompose data matrix X into blocks of
structured variations that are correlated to and orthogonal to Y, respectively using the
following equation [3, 11],
(2.4)
where Tp and

are the predictive scores and loadings that are correlated with Y. To and

are the scores and loadings, respectively, that are orthogonal to Y. E is the residuals
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Figure 2.2. Diagram of 1D 1H NMR data being reduced into an OPLSA-DA scores plot.
The OPLS-DA scores plot is rotated based on the classification assignment where the
predictive component (tp) represent between class variations and the orthogonal
component (to) represents within class variation.
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or variations in X that are not explained in the model. Also in the above expression, the
Tp

block (predictive components) represents variations between class memberships.

To

(orthogonal components) represents the within class variations.

2.4 Interpretation of PCA and OPLS-DA models
The use of PCA in NMR metabolomics is an effective strategy for obtaining
useful information about efficacy, toxicity, and selectivity of chemical leads in the drug
discovery process [17-19]. One simple approach to determine the selectivity and toxicity
of a drug is through the comparison of the metabolome from a wild-type strain, a mutant
strain, and wild-type and mutant strains treated with a chemical lead [18]. The mutant
strain must consist of an inactivated or diminished activity for the protein hypothesized to
be the target of the chemical lead. Also, the metabolome from the mutant strain must
show good separation from the metabolome of the wild type cells in a PCA scores plot.
The mutant and wild-type cultures are then treated with the chemical lead, resulting in a
total of four groups (wild-type cells, drug-treated wild-type cells, mutant cells, and drugtreated mutant cells). Depending on the drugs in vivo activity, four outcomes in the PCA
scores plot are possible (Figure 2.3). If the PCA scores plot results in two separate
clusters where the metabolomes from the drug-treated cells do not separate from the
wild-type or mutant metabolomes, then the chemical lead is said to be inactive (Figure
2.3a). Conversely, the chemical lead is predicted to be active and selective if the
metabolomes from both sets of drug-treated cultures are clustered together with the
mutant metabolome in the PCA scores plot (Figure 2.3b). This means genetically or
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Figure 2.3. Illustration demonstrating the hypothetical PCA scores plot for the following
scenarios a) inactive compound, b) active and selective inhibitor, c) active, nonselective
inhibition of target and secondary protein, and d) active, nonselective preferential
inhibition of secondary protein. Reprinted with permission [18] © Journal of Proteome
Research, 2006.
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chemically inhibiting the same protein target leads to an essentially identical change in
the metabolome. If the PCA scores plots yields three sets of clusters where the
metabolomes from both drug-treated cultures are clustered together but are separated
from the metabolomes from both the mutant and wild-type cells (Figure 2.3c), the
chemical lead is predicted to inhibit two or more protein targets. The drug is active, but
not selective. Lastly, if four distinct clustering patterns are formed in the PCA scores plot,
then the chemical lead is inhibiting a protein not related to the original, hypothesized
protein target (Figure 2.3d).
As an example, Figure 2.4 demonstrates the use of NMR metabolomics
methodology to monitor the in vivo activity of 8-azaxanthine [18]. 8-Azaxanthine is a
well-known inhibitor of urate oxidase in Aspergillus nidulans [20, 21]. A comparison was
made between the metabolome from uaZ14 mutant with an inactive urate oxidase, and
the wild-type metabolome [22]. Both strains were also treated with 8-azaxanthine,
where the resulting PCA scores plot shows two distinct clustering patterns. Both
metabolomes from wild-type and uaZ14 mutant mycelia treated with 8-azaxanthine
cluster together with the metabolome from the untreated uaZ14 mutant mycelia. The
metabolome from the untreated wild-type mycelia form a separate cluster in the PCA
scores plots. This demonstrates that 8-azaxanthine is a selective inhibitor targeting urate
oxidase. Importantly, the PCA can be related back to phenotype, where the wild type
mycelia showed hyphal growth that was lacking in uaZ14 mutant mycelia or 8azaxanthine treated mycelia [18].
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Figure 2.4. PCA scores plot comparing A. nidulans uaz14 mutant (x), wild-type with 8azaxanthine ( ), uaZ14 mutant with 8-azaxanthine (●), and wild-type cells ( ). The
scores plot is then used to compare lectin stains of untreated A. nidulans fungus (left) vs.
the fungus treated with 8-azaxanthine (right). The lectin stains, which bind to growing
chitin cell was, indicates the amount of hyphal growth that occurred after the stain.
Reprinted with permission [18] © Journal of Proteome Research, 2006.
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A common problem with the evaluation of a PCA model is the identification of
classes or groups, such as the separation between a control group and a group being
observed to have a specific disease or origin. Replicate metabolomics samples tend to
exhibit a significant variation between each sample due to differences in sample growth,
sample handling, data collection, and the inherent variability in nature. Although it is
important to minimize these variations, it is impractical to maintain perfect consistency.
Instead, OPLS-DA is able to improve class separation, because variations not correlated
with a class separation are simply removed. As an illustration, Figure 2.5 displays a
comparison between PCA and OPLS-DA scores plot used to discriminate between
strains of Scutellana baicalensis bacteria isolated from different locales [23]. The PCA
scores plot showed some class differences, but there is noticeable overlap due to within
group variations. This makes classification a challenge because it is not clear if the two
groups are statistically different. The separation of the NMR metabolomics data into
predictive and orthogonal components in OPLS-DA scores plot allows for the
identification of class discrimination (Figure 2.5b). This would enable verification of the
statistical model by predicting the origins of other S. baicalensis isolates. However,
extreme care must be taken because OPLS-DA has a tendency to over-fit the data [24].
As a result, OPLS-DA can generate scores plots with an apparent class separation even
for randomly generated data [7]. Thus, the validation of every OPLS-DA model is
essential.
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Figure 2.5. a) PCA and b) OPLS-DA scores plot comparing the metabolic fingerprints of
Korean ( ) and Chinese S. baicalensis groups ( ). Reprinted with permission [23] ©
Journal of Agricultural and Food Chemistry, 2008.
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2.5 Validation of PCA and OPLS-DA models
One of the main objectives for PCA and OPLS-DA is to select a model that best
represents the data. Since the model is heavily simplified for the ease of visual
inspection, the model might give rise to an unclear or false positive result [25]. Therefore,
statistical analysis is needed in order to establish a valid and meaningful model. For both
PCA and OPLS-DA, a quantitative measure of the goodness of fit is given by the
contribution score or the variance that is being explained by each component and is
represented as R2. The goodness of fit is calculated as follows [26, 27],
(2.5)
where RSS is residual sum of squares and SSXTOT is the total variation in the data. A R2
of 1.0 represents a complete explanation of the model while a R2 of 0.0 represents no
explanation of the model. Typically, a good model is represented by high contribution
scores for a few components, and lower contribution scores are usually attributed to noisy
data. R2 is a good way of quantifying variables being explained for each component. For
example, some variables can be explained well by either the first, second, or third
component, while some variables may only be explained by multiple component. This
allows for a qualitative determination of the variables important for each component.
The goodness of prediction (Q2) is an estimate of the predictive ability of the
model based on cross validation [27]. Cross validation is a predictive strategy of
evaluating and comparing the models generated by dividing data into two parts, a training
set and validation set [28]. More specifically a certain number of observations are
removed from the original dataset and moved into a validation set while the remaining
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observations are left in the training set. During the process, a number of successive
rounds are performed where the training set and validation set must cross-over so that
each point has a chance to be evaluated. There are multiple strategies for cross validation
including resubstitution validation, hold-out validation, k-fold cross validation, and leaveone-out cross-validation, and repeated k-fold fold cross-validation [29]. The Simca P+
package uses a type of leave-n-out cross-validation, where 1/7th of the data is left out and
then examined [27]. The quality of the model can then be estimated using equation 2.6
[26, 27]:
(2.6)
where PRESS is the predictive residual sum of squares determined using the crossvalidation models. Overall Q2 renders a measure of the final model’s predictive
capabilities. If the Q2 of each successive component is roughly equal to its R2, then the
components are said to be useful and predictive in the model. A Q2 score that is “small”
compared to the R2 indicates the component is not predictable and is comparable to
fitting a line through randomly generated data or noise.
It is easy to get a relatively high R2-value in a model by simply adding more
components until the value approaches one, since the R2 of the model is a summation of
the R2 values for each component. However, this leads to an over-fitting of the model.
Therefore, it raises the general question: how many components are relevant? In
contrast, the Q2 value for a model will reach a plateau and then begin to decrease for each
successive additional component (Figure 2.6) [30]. The decrease in Q2 indicates that the
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Figure 2.6. The relation between R2 (goodness of fit) and Q2 (goodness of prediction)
when adding new components in a model. Reprinted with permission [30] ©
Scandinavian Journal of Psychology, 2001.
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additional components are not predictive and are not used [30]. Hence, it is important to
determine the optimal number of components by the relationship of the R2 and Q2 values.
Although the R2 and Q2 values display the overall quality of the model, they do
not validate if the class prediction between different groups used in an OPLS-DA model
are statistically different. OPLS-DA has a tendency to over-fit the data, where randomly
generated groups can generate separate clusters in a scores plot [7]. A permutation test
could be used to examine the degree of over-fitting [7]. The method scrambles the
classification matrix Y while the original data matrix X remains intact. A new model is
then calculated based on the permuted Y matrix, and the permuted model is examined
based on the R2 and Q2 values. This procedure is repeated multiple times (generally more
than 100 times), creating models with different correlations to the original model.
Normally the R2 and Q2 values for the permuted models are lower than the
original model as a consequence of the reduce correlation to the original Y matrix. The
degree of reduction of these values can be used to validate the significance of the group
classification. For example, Figure 2.7 is the permutation plot of the OPLS-DA scores
plot shown in Figure 2.5b [23]. When examining the R2 and Q2 values, the models have
been permuted so much that the values can be extrapolated to a zero correlation. The R2
value at zero correlation in the plot is lower, but does not approach zero, meaning that it
is mathematically possible to reproduce any possible combinations of Y with an R2 of
0.4. The Q2 value, on the other hand, ended up with a negative value, meaning the
predictive quality is extremely poor at a zero correlation. Thus, the original model is well
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Figure 2.7. Permutation plot describing the results for 200 permutations. The solid line
represents the regression line for R2. The dashed line represents the regression line for Q2.
Reprinted with permission [23] © Journal of Agricultural and Food Chemistry, 2008.
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fit and the two groups are significantly different due to the loss of predictive power when
the classification is randomly assigned.
Cross Validated-Analysis of Variance (CV-ANOVA) is another method to test the
significance between groups [31]. It is based on the cross-validated predictive residuals
and predictive scores values, where the model is used to compare the variances of the
residuals based on the F-test. The CV-ANOVA provides a wealth of information about
the model including the corresponding mean squares, sum of squares, F-values, and
p-values. A common practice is to interpret a p-value lower than 0.05 to designated
statistically different groups.

2.6 Identifying metabolite perturbations using S-Plots
One of the common goals in metabolomics is to pinpoint metabolite perturbations
that are related to drug toxicity, diseases, genetic modifications, or environmental
variations. However, it is extremely difficult to summarize and interpret them by visually
inspecting complex 1D-NMR data. The S-plot provides an easier way to interpret the
data by combining the covariance and correlation loadings resulting from the predictive
component in an OPLS-DA scores plot. The covariance loadings correspond to the
magnitude or contribution to the scores. The correlation loadings represent the
consistency of the model variables. The two vectors can be calculated as shown below
[15]:
(
(

)
)

(2.7)
(

)

(2.8)
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Figure 2.8. Diagram of an S-plot for a given OPLS-DA scores plot. Each point in the Splot represents a chemical shift bin in a 1D NMR data set. The blue box represents points
of interest as they highly contribute to class separation. The red box represents data
contributing very little to class separation.
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where t is the scores vector in the OPLS-DA model, k is the centered variable in data
matrix X, and s is the estimated standard deviations. These two vectors are plotted as a
scatter plot and usually form an “S” shape (Figure 2.8). The selection of potentially
biochemical interesting compounds is dependent on the location of the point on the Splot, where each point represents a chemical shift bin, which in turn, can specify a
specific or set of metabolites. Points that show high correlation and covariance (blue
box) are of interest as they are responsible for class separation. Points that show low
correlation are unreliable. Points showing low covariance contribute little to no
class separation (red box). One issue with the S-plot is that the magnitude of the
contribution is relative, so there is no defined absolute value that designates a significant
contribution to class separation. As a conservative approach, points at the extreme
regions along the covariance axis are considered points of interest. As an example, in
Figure 2.8 points with a covariance greater than 0.1 or less than -0.1 would be of interest.
However, identifying points within the high risk region (high correlation, low covariance)
can be a daunting task as these metabolites may or may not be important. Therefore, the
use of loadings plots from PCA and quantitative analysis of 13C-metabolites using 2D 1H13

C HSQC’s is a good complement to identifying important metabolites.

2.7 PCAtoTree and PCA Utilities
PCA and OPLS-DA are able to decompose high-throughput data into qualitative
visual representation, showing clustering patterns of biological samples into either similar
or different groups. In some cases, the clustering patterns in a scores plot are distinct and
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well separated. In other cases, the scores plot clustering patterns are not very well
defined. Also, as the number of different groups increases (i.e., different drug treatments
or mutations) the scores plot becomes more complex and it becomes difficult to
determine if the groups are significantly different. The simple visual inspection of a PCA
and OPLS-DA scores plot does not imply the statistical significance of group separation.
In turn, a visual inspection of a scores plot does not always provide a reliable
interpretation of the biological significance of the group separation. OPLS-DA model
validation methods, such as the permutation plot or CV-ANOVA, can only determine if
two groups are significantly different. Therefore, PCAtoTree was designed to analyze
clusters in a scores plot by generating tree diagrams with corresponding bootstrap
numbers to provide a statistical significance to each group separation [32].
PCAtoTree [32] is an awk-based script written by Prof. Mark Werth that uses the
data generated by the PCA scores plot and determines the average distance and standard
deviation for each assigned group. The program uses a bootstrapping method that
generates 100 distance matrices based on the average position of each cluster. The Phylip
software package (http://evolution.genetics.washington.edu) utilizes the 100 distance
matrices to generate a consensus tree diagram with the corresponding bootstrap values for
each node. Bootstrap values below 50% indicate the separation between clusters is
insignificant. Figure 2.9 is an example of a 2D PCA scores plot and associated
metabolomics tree diagram, showing the relative similarities between the metabolomes
from different Mycobacterium smegmatis mutants and wild type cells in the presence and
absence of D-cycloserine treatment.
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Figure 2.9. a) PCA scores plot comparing mc2155( ), TAM23 (●), GPM14 ( ), GPM
16 ( ) TAM23 pTAMU3 ( ), mc2155 with DCS ( ), TAM23 with DCS (●), GPM14
with DCS ( ), GPM16 with DCS ( ) and TAM23pTAMu3 with DCS ( ). Tree diagram
corresponding to the PCA scores plot. Bootstrapping numbers less than 50 are not
displayed indicating similar clustering. Reprinted with permission [32] © Analytical
Biochemistry, 2010.
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Figure 2.10. (a) 2D OPLS-DA scores plot illustrating 95% conﬁdence ellipses for data
having one predictive and one orthogonal PLS component. The symbol shape and color
of each point correspond to the groups in (b). Discrimination in the ﬁrst component is
between wild-type and antibiotic-treated Mycobacterium smegmatis, and separations
along the second component indicate metabolic differences between various antibiotic
treatments. The antibiotics cluster together based on a shared biological target (cell wall
synthesis, mycolic acid biosynthesis, or transcription, translation and DNA supercoiling).
Three compounds of unknown in vivo activity were shown to cluster together with
inhibitors of cell wall synthesis, implying a potential biological target. Interestingly, the
M. smegmatis strain is resistant to ampicillin resulting in the ampicillin-treated cells
clustering closer to untreated cells. The ellipses deﬁne the statistical signiﬁcance of class
separation and provide an illustration where two groups actually belong to the same
biological classiﬁcation. (b) Dendrogram generated from scores in (a) using Mahalanobis
distances, with p values for the null hypothesis reported at each branch. Reprinted with
permission [33] © Analytical Biochemistry, 2013.
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PCAtoTree has been recently updated to the PCA/PLS-DA utilities written by
Bradley Worley [33]. In addition to using the bootstrapping, the program now uses a
Mahalanobis distance matrix to generate a T2 Hotelling and F statistical values.
Therefore, the statistical separations between clusters in a scores plot can now be
quantified using a p-value. The PCA/PLS-DA utilities can now apply 95% confidence
ellipses or ellipsoids around each cluster in a scores plot. Ellipses were previously hand
drawn to show visual representations for each cluster, but did not have any statistical
meaning and may lead to inaccurate interpretation. Figure 2.10 is an example of the 2D
OPLS-DA scores plot illustrating the 95% confidence ellipses defining the different
mechanism of actions of 15 different drugs. The associated tree diagrams quantify the
clustering pattern, where p-values of less than 0.05 identify statistically significant nodes
or group separations.

2.8 Conclusion
Pattern recognition tools such as PCA and OPLS-DA are valuable for interpreting
large data sets. This is important in systems biology as the metabolome for each organism
is very complex and quite dynamic. PCA and OPLS-DA are able to take advantage of
the complexity of the data and reduce them down to simple plots that are easy to
examine. Nevertheless, the number of application is small as metabolomics is a
relatively new field. However, the potential of pattern recognition tools have yet to reach
its full potential as new strategies continue to be developed. The advantage of these tools
is its relative simplicity; however, it can be easy to manipulate these plots to gain modest
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separation, which may provide incorrect results about perturbation of the system as a
whole. For example, relating systematic perturbation to only a few peaks and removing
all biologically relevant data should be prohibited as this does not relate to the whole
metabolomics system. Hence, much of the information is lost. Especially since metabolic
changes of one network may constitute passive alterations of other pathways to maintain
metabolic homeostasis [34]. Instead loading plots and S-plots should be used to identify
these metabolite perturbations. More importantly, every model should be validated to
give a statistical meaningful representation of the data. There are tools such as CVANOVA, permutation plots, PCAtoTree, and PCA/PLS-DA utilities that are able to
statistically validate cluster separations in a scores plot to yield a reliable interpretation of
the biological significance of the metabolome changes.
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CHAPTER 3
REVISITING PROTOCOLS FOR THE NMR ANALYSIS OF BACTERIAL
METABOLOMES§

3.1 Introduction
Metabolomics is the study of small molecules in a biological system that
participates in the metabolic reactions responsible for cell growth, survival, and other
normal cellular functions [1-3]. Additionally, the metabolome responds to transcriptional
and translational alterations associated with genotypical, epigenetic, or environmental
perturbations [4-7]. Thus, metabolomics provides an assessment of global perturbations
with respect to an altered genome, proteome, or environment [2, 8, 9]. The simultaneous
integration of genomic, transcriptomic and proteomic data has enabled an in-depth
analysis of the interplay, interaction, and regulation of DNA, RNA and proteins [10-12].
Along this line, monitoring the bacterial metabolome and integrating the results with
other “omics” data has provided valuable insights into bacterial adaptability [13],
biofilms [14], evolution [15], pathogenesis [16], and drug resistance [17].
Depending on the organism and growth state, the total number of metabolites
within a cell varies between several hundred to a few thousand, with a corresponding
diversity in physical and chemical properties, such as size, stability, and concentration
[18]. In addition to the challenge of the simultaneous study of all the metabolites within a
§
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given biological system [19], the selection of an analytical technique will influence which
metabolites are observed. NMR and MS are commonly employed for metabolomics,
where both instruments can be interfaced with LC, GC, and CE systems to select and
emphasize specific components of the metabolome [20-24]. NMR has a number of
advantages in analyzing the metabolome that includes minimal sample handling and that
it is not reliant on chromatography to purify or separate metabolites. In addition, multiple
resonances from a single molecule increase the accuracy of metabolite identification and
quantitation. This accuracy can be further enhanced by the application of 13C- and 15Nisotope labeling to enhance specific regions of the metabolome [25, 26]. Importantly, the
choice of 13C- or 15N-labeled metabolite determines the region of the metabolome
observed by NMR, providing significant flexibility in experimental design. In contrast to
MS, NMR is a relatively insensitive technique and only observes the most abundant (≥ 1
to 5 μM) metabolites. In addition, MS has the advantage of detecting a wider-range of the
metabolome. However, because of the relatively low molecular-weight range of the
metabolome, MS methods generally require chromatography to separate metabolites
before analysis [27]. Additionally, variations in ionization and the occurrence of ion
suppression in a complex mixture add uncertainty in detecting specific metabolites by
MS [28]. Finally, quantitation by MS is typically more challenging than NMR. Taken
together, NMR and MS each have strengths and weaknesses but should be viewed as
complementary techniques [29].
NMR-based metabolomics have been used to study a wide range of biological
systems such as tissues [30], biofluids [31], mammalian cell cultures [32], plants [33] and
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bacteria [34-36]. The overall procedure for an NMR-based metabolomics study includes
the following general steps: cell growth and harvesting, metabolite extraction, NMR data
collection and analysis, multivariate statistical analysis, metabolite identification and
quantification [37]. Typically, one-dimensional (1D) 1H NMR spectra are used for a
multivariate analysis such as principal component analysis (PCA) or orthogonal partial
least squares projections discriminant analysis (OPLS-DA) [38, 39]. Both PCA and
OPLS-DA provide global profiles of metabolome changes [40, 41]. Two-dimensional
(2D) 1H,13C Heteronuclear Single Quantum Coherence (HSQC) or 1H,1H TOtal
Correlated SpectroscopY (TOCSY) NMR experiments are used for the quantitative
assessment of metabolite changes resulting from genetic modification or external stimuli
[5, 14]. The ability to generate global profiles and quantitative differences coupled with
the ease of applying NMR-based metabolomics has contributed to the rapid growth of the
NMR metabolomics field. While NMR data acquisition and analysis methods are
improving, care must be taken to ensure that the methods are appropriate to the task at
hand and generate biologically relevant information. As an example, protocols to
efficiently extract metabolites without inducing cellular changes are essential for success
[32, 42]. In brief, the observed changes in the metabolome should reflect a change in the
state of the system instead of how the cells are handled and processed. Similarly,
variations in instrument performance, choice of procedures for data collection and
processing, and invalidated models from multivariate analysis may induce unintended
biases or incorrect interpretation of metabolomics data [43-46].
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Since NMR-based metabolomics is a relatively new and still developing
technology, improving and enhancing the experimental protocols is necessary to advance
the field and ensure continued success. Toward this end, we describe our recently
developed and optimized protocols for the application of NMR metabolomics to
microbial samples. We present our current methodology and also discuss the challenges
associated with each major step of the process: (i) sample preparation, (ii) NMR data
collection and processing, (iii) multivariate statistical analysis, (vi) metabolite
identification and network generation. Specifically, the overall methodology will be
discussed in detail, where a number of key features will also be highlighted, such as
automation, bioinformatics, experimental design, and harvesting the metabolome. The
focus of our efforts has been to identify and minimize procedural steps that negatively
influence the outcome of an NMR-based metabolomics experiment.
The development of the metabolomics protocol was a group effort where Steven
Halouska and Bo Zhang demonstrated significant and equal contributions to the project.
Steven Halouska was responsible for the development and applications for the overall
experimental design of the NMR metabolomics methods. This includes developing
methods for both metabolomics fingerprint analysis and metabolomics profiling. Bo
Zhang demonstrated significant contributions to the development and optimization of the
bacterial sample handling used for both fingerprint analysis and metabolomics profiling.
This includes optimizing the strategy for sample growth, cell quenching, and extraction.
Both Steven Halouska and Bo Zhang had equal contribution in the optimization in the
data analysis.

59
3.2 Experimental Design
A general protocol for the analysis of bacterial metabolomes using NMR is shown
in Figure 3.1. The flow diagram illustrates procedures for both a global analysis of
metabolome changes (metabolomics fingerprinting); and the identification and
quantitation of specific metabolites correlated with the biological process (metabolomics
profiling). The overall process consists of the following key steps: bacterial cultivation
and harvesting, metabolite extraction, NMR data collection and analysis, multivariate
statistical analysis, metabolite identification and quantification. Successful metabolomics
sample preparation involves three steps: The first step is the simultaneous growth of all of
the bacterial cultures or as many as is practical at a time. The bacteria are grown in a
standard medium for fingerprint analysis, whereas the medium is supplemented with a
13

C-labeled metabolite for metabolomics profiling [47, 48]. After the bacteria are grown

for a defined time or they have achieved a specified cell density, bacteria are harvested
and quenched to halt all enzymatic processes and washed to remove the medium. The
third sample preparation step involves lysing the cells and extracting the metabolome. A
variety of solvents are routinely employed depending on the solubility of the targeted
metabolites (cytosolic metabolites, lipids, etc.). The metabolomics samples are then used
to generate a series of NMR spectra, which are used for the multivariate statistical
analysis, metabolite identification and quantification. The individual steps of the NMRbased metabolomics protocol will be discussed in detail highlighting challenges
associated with each step.
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Figure 3.1. A flow chart of our protocol used for the NMR analysis of bacterial
metabolomes.
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3.2.1 Identification of an appropriate biological system for a metabolomics study
NMR-based metabolomics is an important tool in systems biology research. The
quantitative and qualitative measurement of metabolites from cytosolic extracts can be
extremely valuable for investigating cellular processes, pathogenesis, and the effects of
drugs or the environment on bacteria. Unfortunately, the bacterial metabolome is a
complex mixture of metabolites and numerous interconnected metabolic and signaling
pathways. This high interconnectivity may result in significant metabolite concentrations
changes far from the origin of the perturbation (inhibited, inactivated or down-regulated
protein). Correspondingly, it is easier to observe changes to the metabolome than deduce
the primary source of the perturbation after its impact has rippled throughout the
metabolome. As an illustration, treating a bacterial culture with a particular drug would
be expected to lead to a global change in the metabolome, but interpreting these changes
to identify the therapeutic target is extremely challenging. To address this challenge, the
in vivo mechanism of action of a potential drug lead may be determined by comparing
these metabolome changes to other drugs with known biological targets [49] or to a
mutant bacteria where a specific protein target is ablated or modified by genetic
inactivation [50, 51]. This example illustrates that the comparative analysis between two
or more metabolomes is an effective application of metabolomics. In order to obtain
reliable insights into the physiology of bacteria or any other organism, it is essential to
identify and establish at least two reference metabolomes (wild-type vs. mutant, drugresistant vs. drug susceptible, nutrient-rich vs. nutrient-limited, etc.) for a comparative
analysis. Once the reference conditions are established, bacteria can be exposed to any
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range of experimental variables such as a drug treatment, environmental stimuli (pH,
temperature, nutrient change), or gene knockout (mutants, RNAi, inhibitor) to determine
if similarities exists with the reference metabolome. The similarity between metabolomes
infers an overlap in the underlying physiological processes or responses that gave rise to
the metabolome changes. We have used this approach to demonstrate the similarity of
Staphylococcus epidermidis metabolomes resulting from exposure to divergent
environmental stressors that are known to facilitate biofilm formation [5, 14]. Our results
suggested that the tricarboxylic acid (TCA) cycle acts as a metabolic signaling network to
transduce external stresses into internal metabolic signals. This conclusion was only
possible because the experimental design was based on comparing the metabolomes of
the S. epidermidis wild-type strain 1457 and an aconitase mutant strain 1457-acnA::tetM
with and without the treatment of biofilm stressors. In summary, the successful outcome
of a metabolomics study hinges on the experimental design and the proper choice of the
cellular metabolomes to be compared.

3.2.2 Minimization of unintended bias and biologically irrelevant variations
In addition to the proper choice of bacterial strains to compare in a metabolomics
study, the experimental protocols must be optimized to reduce unwanted variation or bias
in the collection of cell-free lysates. It is essential to ensure that any metabolome changes
are limited to biologically relevant factors and are not caused by the handling or
processing of the samples. Thus, the key to metabolomics is establishing an efficient
methodology that closely captures the true state of the metabolome [52]. Fundamental to
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a successful metabolomics experiment is maximizing the uniformity of the preparation,
handling, processing, and analysis of each replicate sample [35, 45, 53-56]. In instances
where cultivation and/or processing variation is unavoidable (e.g., if multiple incubators
are required to accommodate all the replicates), then the cultures should be randomly
distributed between the incubators to minimize bias. Ideally, all of the metabolomics
samples should be handled by the same person because subtle differences in individual
techniques may influence the outcome. If multiple investigators are required to efficiently
handle the samples, each researcher should be assigned a specific set of tasks that are
consistently applied to each sample. For example, one investigator lyses all the bacterial
cells while another performs the metabolome extraction procedure on every sample.
As with sample cultivation and preparation methods, the NMR spectra generated
from metabolomics samples need to accurately represent the state of the system. In other
words, the NMR spectra must reflect the actual concentrations and identity of the
metabolites present in the biological sample at the time of harvest. If the sample
preparation and data acquisition represent the metabolic status at the time of harvest, then
multivariate statistical techniques, such as PCA and OPLS-DA, will enhance the
identification of similarities or differences in the NMR spectra, and, correspondingly,
between the bacterial metabolomes [39]. These multivariate statistical techniques
typically involve multiple replicates of 1D 1H NMR or 2D 1H,13C HSQC spectra for each
bacterial class or group (e.g. wild-type, mutant, drug treated, etc.). The exact number of
replicates is dependent on a number of factors: (i) the variance within a group, (ii) the
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variance between groups, (iii) the number of variables, and (iv) type of statistical analysis
performed [57, 58].
In most metabolomics experiments, the number of biological samples is
significantly smaller than the number of variables; in this case, the variables correspond
to peaks in the NMR spectra or the detectable metabolites [58]. For this reason, a larger
number of replicates (≥ 6) per class are required to obtain a statistically significant PCA
or OPLS-DA model. While greater numbers of replicates are desirable, there are practical
considerations to increasing the number of replicates, including increased experimental
time, availability of incubator space, and practical limits on the number of samples that
can be simultaneously prepared and processed within a reasonable time frame. The
increased time, larger number of samples, and added complexity may be detrimental to
maintaining consistency between samples, where metabolite stability may become more
of an issue [59]. So the potential benefit in improving the reliability of the PCA or OPLSDA models may be negated by too large of a sample size if sample consistency is
sacrificed. In general, 6 to 10 replicates per class can be routinely handled while
providing a statistically significant PCA or OPLS-DA model. Lastly, to increase the
sample consistency, the application of an automated sample changer or flow-probe can
minimize variability by eliminating human involvement and providing a uniform and
consistent protocol for NMR data collection. Nevertheless, instrument drift may still
occur during the high-throughput experiment so it is also important to randomize the
samples during data collection.
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3.3 Sample Preparation
3.3.1 Bacterial cultivation
Consistency is critical to metabolomics, where variations in a bacterial
metabolome may be introduced by cultivation protocols. To achieve the reproducible
cultivation of bacteria requires consideration of three variables: bacterial strain, culture
medium, and cultivation conditions. Strain selection is often driven by investigator
preference, availability, or cultivability. The choice of culture medium will largely
depend on which, if any, isotopically-labeled metabolite is being followed. For example,
when using 15N-arginine, it is impractical to add labeled arginine to a complex medium
containing an unknown concentration of unlabeled arginine. In this example, to achieve
maximal labeling of the bacteria, it would be best to use a chemically defined medium
lacking arginine. Importantly, the culture medium has to be consistently employed
throughout the metabolomics study. A different culture medium cannot be used for
metabolomics fingerprinting and profiling, it cannot vary based on the requirements of
the bacterial strain or to accommodate an experimental variable. Different culture media
will induce changes in the metabolome that will mask or complicate any analysis.
Bacterial cultures also need to be properly handled in order to avoid inducing biologically
irrelevant changes. For example, pre-warming the culture medium prevents temperature
shock and minimizes variation between biological replicates. Similarly, randomizing the
samples from each group and class also minimizes bias that may occur if all the samples
are processed in a predefined order. Importantly, different cell types may require special
care or different handling protocols. Cultivation conditions will also vary depending upon
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the experiment; however, consideration must be given to each of the following:
temperature, pH buffering (if used), % CO2 (if used), the flask-to-medium ratio, the
revolutions per minute of agitation (if used), the use of baffled or non-baffled flasks, and
the inoculum dose. In effect, one protocol does not necessarily “fit all” and a general
metabolomics protocol needs to be optimized for each experiment and cell type.
Deciding on the number of bacterial cultures needed for a metabolomics study
and identifying the optimal culture size are important next steps. The volume of the
bacterial culture should be large enough to provide a sufficient number of cells to
maximize the NMR signal-to-noise, but small enough to simplify the handling of
numerous replicate samples. An appropriate cell density must be determined empirically
for each species and bacterial strain, which will also limit the culture size. Similarly, the
growth phase chosen for harvesting bacteria will also contribute to defining the optimal
culture size since cell density changes drastically between the lag, exponential and postexponential phases. In our experience with staphylococcal and mycobacteria cultures,
media volumes between 15 to 50 mL are used to grow cells to an optical density at 600
nm (O.D.600) of 1-2 for bacterial cultures collected during the exponential phase.
Conversely, media volumes of between 3 to 5 mL are used to grow cells to an O.D.600 of
3 to 7 for bacterial cultures collected during the post-exponential phase (e.g., 6 to 7 for
Staphylococcus epidermidis, and 3 to 4 for Mycobacterium smegmatis). The overall goal
is to have an O.D.600 of 10 to 20 after the bacterial cells have been concentrated to a final
volume of 1 ml. This will ensure metabolite concentrations sufficient for detection by
NMR. These culture volumes and O.D.600 values should be viewed as guidelines and

67
targeted goals that may require further optimization for different bacterial strains or
species. As previously stated, the number of bacterial cultures determines the statistical
significance of class differentiation or metabolite changes. In our experience, ten
replicates are an optimal choice for metabolomics fingerprinting and only three replicates
are needed for metabolomics profiling.
Metabolomics profiling requires 13C- or 15N-labeled metabolites and defines the
choice of culture media. In our laboratories, we typically label staphylococci using 13Cglucose in the complex medium tryptic soy broth (TSB) that is devoid of unlabeled
glucose [6, 7]. This medium allows for maximal biomass generation, while assuring that
nearly all (~99%; 1.1% is due to naturally occurring 13C) of the 13C-labeled metabolites
in the metabolome were derived from glucose. Similarly, we have labeled mycobacteria
using 13C-glucose or 13C-glycerol in Middlebrook 7H9 Albumin Dextrose Complex
(MADC; Becton-Dickinson) media. We have also supplemented culture media with 13Calanine, 13C-aspartate, 13C-glutamate, 13C-proline and 13C-pyruvate as a more targeted
approach to the analysis of the metabolome. These metabolites are associated with a
limited number of metabolic pathways. The analysis of the metabolome can be further
focused by using a targeted metabolite where only one or a few specific carbons in the
metabolite are 13C labeled. Only the metabolic pathways involving the specific 13Clabeled carbon will be observable by NMR. The concentration of the 15N-, or 13C-labeled
metabolite needs to be high enough (≥ 1 to 5 μM) to be detected by NMR. In our
experience with staphylococcal and mycobacterial cultures, the volumes range from 25
mL to 100 mL and the culture media should be supplemented with approximately 2.5 to 4

68
g/L of 13C6-glucose or ~10-15 mg/L of a targeted metabolite like 13C-D-alanine in order
to acquire a 2D 1H-13C HSQC spectrum with acceptable signal-to-noise.
Ideally, each bacterial culture should contain the same number of cells and be at
the same growth phase when harvested. In reality, differences in cultivation conditions,
media, and/or bacterial strains may substantially affect growth rates and/or growth yields.
The two more common approaches to compensate for different bacterial growth rates are:
collect the bacteria when they have reached the same cell density, but at different times to
account for the different growth rates; and harvest the bacteria at the same time but
harvest equivalent cell numbers. As examples, in staphylococci, the exponential and postexponential growth phases were typically analyzed at the 2 h and 6 h time points,
respectively [5]. For our mycobacterial experiments, a consistent growth phase was
achieved by harvesting bacteria at a uniform O.D.600 of 1.2. In practice, it is extremely
difficult to harvest every bacterial culture with an identical O.D.600 value. To correct for
this variability, all the bacterial cultures are normalized to the same number of cells.
Simply, the cultures are suspended into a phosphate buffer until the O.D.600 values are
equal. Typically the cultures are concentrated to an O.D.600 of 10 to 20 into a final
volume of 1 mL prior to lysis. Alternatively, the bacterial cell cultures can be normalized
based on colony-forming units (CFU) or total protein concentration.
To ensure consistency, the experimental variable such as a drug treatment,
environmental stimuli, or gene knockout needs to be uniformly applied to the “treatment”
class. An additional consideration for treatment of cultures, is that the impact on the
metabolome should be strong enough to detect [49]. In other words, a particular drug
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dosage needs to be large enough to affect the cellular metabolome relative to untreated
cells, but should not induce cell death. In our experience, a drug concentration that
inhibits bacterial growth by 50% relative to untreated cultures is a desirable target [49,
50]. The availability from the literature of a minimal inhibitory concentration for the
strain (MIC), or otherwise for the population isolates (MIC50), provides a good starting
point for optimizing a drug dosage, but the actual dosage must be determined empirically
for each set of cultivation conditions. In our experience, literature MIC or MIC50 values
tend to be too low for cultivation conditions used for metabolomics. We typically test
drug concentration ranges at between 1 to 24 times the reported MIC or MIC50 values in
order to identify an optimal drug dosage. Importantly, this also implies that drugs with a
range of biological activity will require different drug concentrations in a metabolomics
study; hence, the use of the 50% inhibition of growth is used as a metric as opposed to
drug concentration. Typically, in our experiments the drug treatments are normally
administered during the exponential phase and the bacteria are allowed to grow for at
least one generation before harvesting. In our experience, this provides a sufficient
amount of time for the drug to affect cell physiology and induce a perturbation in the
metabolome. Administering a drug at an earlier time point can be problematic because of
the inability to harvest enough bacteria.

3.3.2 Quenching, washing and harvesting the bacterial cells
Speed is critical to harvesting bacteria without inducing a change to the
metabolome. Changes occur quickly because of different metabolite turnover-rates,
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varying stabilities, and the induction of stress responses, among other factors [59-61]. As
bacteria are being harvested, the environment is changing dramatically: (i) the bacteria
are either adhered to the surface of filter paper or at the bottom of a centrifuge tube under
anaerobic conditions, (ii) the temperature is changed from 37oC to ~ 0o C, and (iii) the
growth media is replaced with either double distilled water or a phosphate buffer. To
prevent perturbations to the metabolome caused by handling of the cell samples, the
bacteria need to be rapidly quenched in order to stop all cellular processes from
responding to these changes. Quenching efficiency has been widely discussed in the
literature [42, 62-64]. Importantly, the quenching technique employed also defines the
washing protocol and the order that quenching, washing and cell separation takes place.
Our quenching techniques consist of a filtered cells being quickly submerged into liquid
nitrogen or the cells and media being directly added to -60oC cold ethanol or methanol
solution while being vortexed. The media and ethanol/methanol volumes are at an equal
1:1 ratio. After centrifugation, the supernatant is decanted and disposed of, and the cell
pellet is ready for washing. Unfortunately, there is a possibility of cell leakage and loss of
metabolites when the cells are directly added to the cold ethanol or methanol solution.
Before intracellular metabolites can be analyzed, the bacteria need to be rapidly
separated from the culture media. Filtration and centrifugation are both routinely used in
our laboratory to separate bacterial cells from the media. Filtration has a definitive
advantage because it is significantly faster than centrifugation, but challenges in
removing and collecting intact cells from filter paper may lead to sample variability.
Conversely, the variability between metabolome replicates is expected to be reduced with
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centrifugation because of the ease in handling the cells. Nevertheless, our experience with
washing bacterial cells using either filtration or centrifugation has resulted in essentially
identical metabolomics fingerprints (Figure 3.2a); thus, any undesirable variation within a
group likely occurs during sample preparation. Metabolome differences between replicate
bacterial cultures likely arises from a combination of subtle variations in the number of
cells, culture conditions, length of bacterial cultivation time, and sample handling.
The use of centrifugation or filtration also determines the quenching protocol [36].
Harvesting bacteria using centrifugation requires quenching the bacteria using the direct
addition to -60oC cold ethanol or methanol. The bacteria, culture media, and quenching
solution are in a properly sized conical centrifuge tube that is centrifuged for 8 minutes at
4,284 g (bucket rotor). Following centrifugation, the culture media and quenching
solution are decanted and the bacteria are suspended in 30 mL of an ice cold wash. We
routinely wash bacteria with ice cold double distilled water, phosphate buffer (20 mM,
pH 7.2), or phosphate buffered saline (PBS; 6 mM phosphate buffer, pH 7.4, 137 mM
NaCl and 2.7 mM KCl) to remove residual media and avoid contamination of the
metabolome. The bacteria are centrifuged again, the wash is decanted off and the process
is repeated. After two washes, the cell pellet is suspended in 1 mL of the ice cold wash
and transferred to a 2 mL vial for cell lysing. Additional washings provide an
insignificant benefit in removing media contaminates, but results in an undesirable
increase in time. Also, the buffered wash eliminates any impact on the cells from a pH
change, but double distilled water eliminates the possibility of “salting-out” any
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Figure 3.2. Illustrations of the impact of a) filtration and centrifugation, b) number of
extraction steps, c) type of wash buffer, and d) lyophilization on the composition of the
metabolome.
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metabolites that may occur from concentrating the buffer in subsequent steps [65]. The
cells are kept on ice throughout this entire process.
Harvesting bacteria by vacuum filtration collects the bacteria on sterile filter
paper (0.45 μm pore size; Millipore), while simultaneously removing the media. The
number of bacteria that can be harvested onto a filter must be empirically determined to
prevent a filter blockage. Under proper conditions, removing the media should take less
than a minute, and should never exceed two minutes. If this cannot be achieved, then the
bacteria need to be harvested using centrifugation. After filtration, the filter paper
containing the cells is then quickly placed into a 50 mL conical centrifuge tube and
submerged into liquid nitrogen to freeze and quench the cells. The conical vial is then
warmed by placing it into a bucket of ice for ~1 to 2 minutes. This prevents freezing of
the 1 mL of wash that is added to the conical vial. The cells are gently removed from the
filter paper with the wash and then transferred to a 1.5 mL microcentrifuge tube. The
cells are centrifuged and washed twice (1 mL) as before.

3.3.3 Cell lysing and metabolite extraction
The cells need to be lysed in order to extract the cellular metabolome. Cells can
be lysed by chemical or physical means, but the use of chemicals runs the added risk of
contaminating the metabolome. Thus, the FAST-Prep bead beating method of lysing cells
is our preferred approach. Before lysing, the samples are normalized to an O.D.600 value
of between 10 to 20 units. This insures an equivalent number of cells, comparable
metabolite concentrations, and a detectable NMR spectrum. Each sample is placed into a
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2 mL micro-centrifuge tube with small glass beads (Lysinf Matrix B; MP Biomedical)
and 1 mL of extraction buffer. The cells are crushed by bead beating for 40 to 60 seconds
in the FAST-Prep instrument at a speed of 6.0 m/s. The sample is then centrifuged for 2
minutes at 17,000 g to pellet the cell debris. The supernatant with the extracted
metabolites is collected. The cell debris is washed 1 to 3 times with 1 mL of the
extraction buffer to maximize the metabolome yield (Figure 3.2b). Also, double distilled
water or a phosphate buffer are routinely used as the extraction buffer, since both
approaches provide similar results (Figure 3.2c). All extracts per sample are combined for
lyophilization, where the sample is then dissolved in 700 μL of a phosphate buffer in D2O
at pH 7.2 (uncorrected). Lyophilization may negatively impact some volatile metabolites,
but, in general, no effect is observed (Figure 3.2d). A major concern during the extraction
step is maximizing the overall yield while minimizing any perturbation to the
metabolome. In our experience, the cell lysing and metabolite extraction process will
require approximately 45 minutes for 30 cultures. The metabolomics samples can be
stored in a -80oC freezer or directly lyophilized overnight.

3.4 NMR Spectroscopy
3.4.1 One-dimensional 1H NMR methodology
One-dimensional (1D) 1H (proton) NMR is an unbiased, nonselective, and
nondestructive approach that requires no modification of the samples, where the data can
be collected in a high-throughput manner. A 1D 1H NMR spectrum contains numerous
proton signals generated from a complex metabolomics mixture, where the chemical shift
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of each signal describes the structural characteristic of a specific metabolite. Moreover,
the peak intensities or volumes are directly proportional to the concentration of each
metabolite. Quantification of metabolites can be achieved by using an internal standard
with a known concentration, where we routinely use 50 µM 3-(trimethylsilyl) propionic
acid-2,2,3,3-d4 (TMSP-d4, Sigma). Thus, 1D 1H NMR experiments combined with
multivariate statistics are commonly used for the global analysis of the metabolome.
Collecting 1D 1H NMR data for metabolomics is fast and simple, and provides
highly reproducible and accurate results. Importantly, the NMR experimental parameters
need to be identical for each metabolomics sample in order to collect reliable
metabolomics data. Any per sample variation will erroneously bias the resulting
clustering patterns in the PCA and OPLS-DA scores plot. To avoid this and maintain
sample consistency, we use a BACS-120 sample changer, Bruker ICON-NMR, an
automatic tuning and matching (ATM) unit, and autoshim to automate the NMR data
collection. Nevertheless, instrument drift may still occur during the high-throughput
metabolomics screen, so it is also important to randomize the samples during NMR data
collection. If an NMR spectrum is collected first for all the control samples followed
subsequently by each treatment class, there is a significant potential of inducing a
biologically irrelevant bias into the analysis. The clustering pattern in the PCA and
OPLS-DA scores plot may be dominated by the order of data collection instead of the
expected biological differences.
In our laboratory, a typical 1D 1H NMR spectrum is collected using 128 scans and
32k data points on a Bruker 500 MHz Avance DRX NMR spectrometer equipped with a
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triple-resonance, Z-axis gradient cryoprobe. The acquisition time is approximately 10
minutes per sample. The goal is to obtain optimal signal to noise while minimizing the
total experimental time. We previously demonstrated that spectral noise is detrimental to
the resulting PCA and OPLS-DA scores plot [53]. Random noise fluctuations results in
large and irrelevant variations in the scores clustering. To avoid this problem, spectral
noise needs to be removed prior to PCA and OPLS-DA. Correspondingly, the quality of
the within class clustering in PCA and OPLS-DA scores plot is directly dependent on the
spectral signal-to-noise (Figure 3.3). The within class variance decreases dramatically as
the number of scans (signal-to-noise) is increased from right to left in the scores plot.
Importantly, the spectral noise was still removed prior to PCA. Thus, the accuracy of
identifying similarities or differences between multiple classes is dramatically improved
by reducing within class variance, which is achieved by improving spectral sensitivity.
Also, correctly identifying class differences improves with the number of replicates
(Figure 3.4). The statistical significance of cluster separation as measured by p-values
[66] is shown to decrease as both a function of group variance and the number of
replicates. As a result, we prefer to use ten replicates per class and strive to achieve an
average signal-to-noise ratio of > 100 to 200. This is achieved by simply increasing the
number of scans or the number of cells, whichever is more practical. While signal-tonoise has a dramatic impact on scores clustering, PCA and OPLS-DA is indifferent to
changes in spectral resolution unless the number of data points is ≤ 2K.
A D2O phosphate buffer is the typical solvent of choice for aqueous metabolomics
samples in order to efficiently remove residual water signals and avoid interference from
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Figure 3.3. Illustration of the impact of the NMR signal-to-noise on within class
variation in a PCA scores plot. From right to left, the 1D 1H NMR spectra were collected
with an increasing number of scans (1, 2, 4, 8, 16, and 32) resulting in a proportional
increase in signal-to-noise. All other experimental parameters were kept constant.
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Figure 3.4. Illustration of the impact of within group variation and the number of
replicates on the p values calculated between clusters in a simulated PCA scores plot.
From top to bottom, p values from the simulated PCA scores plot were calculated with an
increasing number of replicates (6, 8, 10) resulting in a proportional decrease in p values.
Similarly, increasing the group variation by increasing the standard deviation () per
cluster resulted in a significant increase in p values.
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buffer signals. Water and buffer signals are problematic since they can distort the NMR
spectrum and may overlap and obscure important metabolite signals. Most NMR
processing software can automatically remove the residual water peak, but extra data
processing is required to correct for baseline distortions induced by the solvent.
Unfortunately, simply applying a baseline correction changes the PCA and OPLS-DA
clustering patterns [67]. Furthermore, different baseline correction protocols will induce
variable changes into the scores plot. Also, removing the residual water peak may result
in a potential loss of information by also removing metabolite peaks near the water
signal. Instead, a water suppression technique that experimentally removes the water
peak without inducing baseline distortions is the preferred alternative.
There are a variety of NMR pulse sequences for water suppression that are
available to the metabolomics community, such as WATERGATE, water pre-saturation,
WET, and PURGE [68-72]. Our preferred choice for a water suppression pulse sequence
is Solvent-Optimized Gradient-Gradient Spectroscopy (SOGGY). SOGGY does an
outstanding job in eliminating the water signal without inducing any base line distortions
(Figure 3.2) [72]. SOGGY is a variant of excitation sculpting that employs a pulsed field
gradient with a simple phase-alternating composite pulse. SOGGY offers the flexibility to
optimize the 180 degree hard pulse to achieve optimal excitation of the water signal, and
adjusting the 180 degree soft pulse to optimize the range of the water frequency to be
suppressed [72, 73]. As a result, SOGGY efficiently suppresses the water signal while
removing any phase cycle artifacts. A flat baseline is obtained while also maintaining
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metabolite signals near the water signal [72]. SOGGY completely eliminates the need to
apply any baseline correction.

3.4.2 Two-dimensional 1H-13C HSQC NMR methodology
The severe overlap of signals in a 1D 1H NMR spectrum is a challenge for
metabolite identification. The difficulty arises because hundreds to thousands of peaks
occupy a small chemical shift range (~10 ppm), where multiple metabolites share similar
chemical shifts. Thus, we typically do not use 1D 1H NMR spectra to assign metabolites.
Instead, we routinely use 2D 1H-13C HSQC experiments for metabolite assignments. The
2D 1H-13C HSQC experiment is a more reliable approach for metabolite identification
because of the significantly higher resolution and the correlation between 1H and 13C
chemical shifts for each C-H pair in a molecule [74, 75]. Also, the 2D 1H-13C HSQC
experiment simplifies the analysis of the metabolome because only compounds
containing a 13C-carbon derived from the 13C-labeled metabolite added to the media will
be detected.
In our laboratory, we use a standard 2D 1H-13C HSQC pulse sequence on Bruker
500 MHz Avance DRX NMR spectrometer equipped with a triple-resonance, Z-axis
gradient cryoprobe. An acceptable signal-to-noise is achievable using 64 scans. Similarly,
a reasonable digital resolution is achieved by collecting 2K and 128 data points in the
direct and indirect direction, respectively, with a corresponding spectral width of 10 ppm
and 140 ppm along the 1H and 13C axis, respectively. Since some aromatic C-H pairs
have a 13C chemical shift greater than 140 ppm, the spectrum will contain folded peaks,
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but the folded peaks will not interfere with or overlap with other metabolite peaks due to
their unique position along the 1H axis (~ 7.0 ppm). In general, the 2D 1H-13C HSQC
experiment requires approximately 4 hours per sample on our system.
A conventional 2D 1H-13C HSQC spectrum is useful for detecting metabolite
changes by overlaying multiple spectra to identify missing peaks or peaks with
significant intensity changes. Unlike 1D 1H NMR spectra, obtaining metabolite
concentrations is more difficult because peak intensities are dependent on J-couplings,
dynamics and relaxation, in addition to metabolite concentrations [76, 77]. To quantify
absolute metabolite concentrations, we use the Time-Zero HSQC (HSQC0) experiment
[76]. This approach requires collecting a series of three HSQCs spectra (HSQC1, HSQC2,
HSQC3) with an increased number of pulse sequence repetitions. A natural log plot of
peak areas or intensities versus the increment number (1,2,3) allows for an extrapolation
back to increment 0 or zero-time. The experimental parameters used in the HSQC0
experiment is similar to the conventional method, but with some minor variations. The
number of scans is increased to 128 due to the decrease in signal-to-noise in HSQC2 and
HSQC3. To partially compensate for the increase in experimental time, the number of
data points in the indirect dimension is reduced to 64. In general, the HSQC0 set of
experiment requires approximately 6 hours per sample on our system.
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3.5 Data analysis
3.5.1 Preprocessing of 1D 1H NMR data
The 1D 1H NMR spectra are minimally processed (Fourier transformed and phase
corrected) using ACD/1D NMR Manager (Advanced Chemistry Development). Each
NMR metabolomics sample contains 50 μM of TMSP-d4 as an internal standard, where
each NMR spectrum is referenced to the TMSP-d4 peak and uniformly aligned to 0.00
ppm. Also, all peak heights are normalized to the intensity of the TMSP-d4 peak.
Intelligent bucketing within the ACD/1D NMR Manager is then used to integrate each
spectral region with a bin size of 0.025 ppm. The spectra are normalized; noise regions
and residual solvent and buffer resonances are removed, and then the remaining bins are
scaled prior to PCA and OPLS-DA using SIMCA12.0+ (UMETRICS).
The need for data normalization and scaling prior to multivariate statistical
analysis has been extensively discussed in the literature [78, 79]. Normalization adjusts
for experimental variations between replicates, different number of cells, varying signalto-noise, etc., and minimizes these contributions to the clustering patterns in PCA and
OPLS-DA scores plot. We have encountered significant success in using a Z-score or
center averaging the spectrum,

Z

Xi  X



(3.1)

where X is the average signal intensity in a given spectrum,  is the standard deviation in
the signal intensity, and X i is the signal intensity within bin i (Figure 3.5a). After
normalization, all the noise bins are uniformly removed. This was initially accomplished
by manually identifying a “reference” noise region above 10 ppm and below 0 ppm; and
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Figure 3.5. Illustration of the impact of NMR preprocessing on within and between class
variations in a PCA scores plot. a) The 1D 1H NMR spectra was not properly
preprocessed. The spectra were not normalized and the noise was not removed. The
spectra were only Fourier transformed, phased corrected, and the residual H2O resonance
was removed. b) The 1D 1H NMR spectra were processed as in (a) with the addition of
normalization using center averaging, but without noise removal. c) The 1D 1H NMR
spectra were processed as in (b) with the addition of noise removal. Each spectrum was
binned using intelligent bucketing with a bin size of 0.025 ppm. The ellipses correspond
to the 95% confidence limits from a normal distribution for each cluster. The PCA scores
plots compare the metabolomes of S. aureus wild-type (wt) strain SA564 with an
aconitase mutant (acna) strain SA564-acnA::tetM at either two hours (2h) or six hours
(6h) of cell growth. Below each PCA scores plot is a corresponding dendrogram
generated from the scores using Mahalanobis distances, with p values for the null
hypothesis reported at each branch.
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calculating an average noise value. If a bin across all replicates had an integral value of
less than twice the average noise, it was also identified as noise and removed (Figure
3.5b). The protocol for identifying noise regions has been recently improved upon and
results in smaller within class variations (Figure 3.5c). This also results in an improved
separation between truly distinct classes and removed erroneous separations. For
example, the statistical significance between clusters 6hwt and 6hacna improved from a
p-value of 3.1x10-13 to 8.1x10-15, while the small, but biologically irrelevant, separation
between clusters 2hwt and 2hacna (p-value 2.5x10-3) was removed (Figure 3.5). Instead
of using an average minimal signal intensity to define noise, we now define noise based
on a relative standard deviation. This is based on the expectation that real NMR peaks
from metabolites will have a higher intrinsic variability compared to the noise because of
biological variations that naturally occur even between within class replicates.
Conversely, the variability of the noise should be effectively constant for a given
spectrometer operating within normal parameters. Simply, the standard deviation and
average is calculated for each bin, where the standard deviation is normalized by
theaverage peak intensity. This avoids eliminating weak peaks with a relatively small
standard deviation. The same is done for the reference noise region, which is then used to
define noise,
Noise:
Cutoff:

σi’≤σ0’

σ0’=avg(σn’)+2* sd(σn’)

(3.2)
(3.3)

where σi’,σn’ are the relative standard deviations (absolute standard deviation divided by
the mean) for the ith bin in the spectral region and nth bin in the reference noise region,
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respectively, and avg(σn’) and sd(σn’) are the mean and standard deviation of σn’
respectively. In effect, any peak that falls within the normal distribution of the reference
noise region is defined as a noise bin. This approach is better at defining noise peaks in
crowded and overlapping regions of the NMR spectra.
In addition to normalization, each bin or column in the data matrix also needs to
be scaled to account for the large dynamic range in peak intensities. PCA and OPLS-DA
emphasizes the absolute variation in bins between classes. Correspondingly, the relative
variation of an intense peak may be insignificant compared to a weak peak, but the
absolute changes in its intensity may completely mask biologically relevant changes in a
small peak. Scaling increases the weight of the low intensity peaks so strong peaks do not
dominate in PCA and OPLS-DA [78, 79]. In our experience, unit variance scaling, also
known as autoscaling or a Z-score (see eqn. 3.1), has been shown to be effective in
generating reliable clusters with the correct separation based on biologically relevant
class distinctions. Also, within class variance is reduced using autoscaling, which is our
default scaling method.

3.5.2 Multivariate statistical analysis of 1D 1H NMR data
We routinely apply PCA, a non-supervised technique, to determine if the 1D 1H
NMR data can easily distinguish between the various test classes. PCA provides an
unbiased view of group clustering in the resulting 2D scores plot. We only use a threedimensional (3D) scores plot if class separation in a 2D scores plot is insufficient and the
PC3 contribution is significant (> 5 to 10%). OPLS-DA is only used if class separation is
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observed in the PCA scores plot. OPLS-DA is a supervised technique and assesses a
relationship between the NMR data class designations. We limit OPLS-DA to only two
class designations that differentiate between the single control group (0) and the entire
treatment group (1). As a supervised technique, OPLS-DA maximizes a separation
between these two classified groups, while minimizing within class variations [39]. Thus,
OPLS-DA identifies the important spectral features (metabolites) that primarily
contribute to class separation. We routinely use an OPLS-DA S-plot or loading plot to
readily identify the key metabolites that contribute to class separation. Since OPLS-DA is
a supervised technique and can generate a class separation even for random data [80], it is
essential to verify the model [46]. But this is also an advantage of OPLS-DA over PCA;
the statistical significance of the model is quantified. We cross-validate OPLS-DA
models using a modified leave-one-out method [81, 82] and CV-ANOVA [83]. The
modified leave-one-out method provides a quality assessment score (Q2) and R2 values,
where CV-ANOVA provides a standard p-value. The theoretical maximum for Q2 is 1,
where a value of ≥ 0.4 is an empirically acceptable value for biological samples [84], but
Q2 does not have a critical value for inferring significance. It is still possible for an
invalid model to produce a large Q2 value. Similarly, the R2 values only provide a
measure of the fit of the data to the model. But large differences between Q2 and R2 (R2
>> Q2) does suggest an over-fit model. Conversely, a p-value << 0.05 from CV-ANOVA
provides clear validation of the OPLS-DA model.
In addition to validating the OPLS-DA model, it is also extremely important to
verify the statistical significance of the clustering patterns in the PCA and OPLS-DA
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scores plot. Is the between group difference larger than the within group variations? One
key factor is the number of replicate samples. We have previously shown that increasing
the number of replicates improves the statistical significance of cluster separation [85].
This finding is also supported by the increase in p-values seen with an increase in within
class variations (Figure 3.4). Again, increasing the number of replicates improves the
statistical significance of the class separation (lower p-value) even when within class
variation increases. Correspondingly, we routinely use 10 replicates per group in our
metabolomics study to improve the likelihood of observing statistical significant class
separations.
It is also important to visually define each group or class within the PCA and
OPLS-DA scores plot and to classify the statistical significance of the class separation.
We developed a PCA and OPLS-DA utilities software package [66] that draws ellipses or
ellipsoids around each group cluster in a scores plot, where the ellipse corresponds to the
95% confidence limits from a normal distribution for each cluster. Visual separation of
the ellipses infers a class separation. The same software package is also used to generate
a metabolomics tree diagram based on the group clusters in the scores plot [66, 85].
Simply, a centroid from each cluster is used to calculate a Mahalanobis distance between
clusters, where dendrograms are then generated from the resulting distance metric. The
significance of each node (cluster separation) is determined by using standard
bootstrapping techniques and returning a bootstrap number [86], where a value above 50
infers a significant separation; or from Hotelling’s T2 and F-distributions that returns a pvalue, where a number << 0.05 infers a statistically significant separation.
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Observing a statistically significant difference in the global metabolome between
two or more bacterial samples is typically the first objective of a metabolomics
investigation. While this difference may infer some biological significance, the ultimate
goal is to identify the underlying metabolites and associated pathways that are the
primary contributors to the observed class separation in the PCA and OPLS-DA scores
plot. One approach is to generate an S-plot (Figure 3.1) from the resulting OPLS-DA
analysis. The S-plot identifies the key bins or 1H chemical shifts that are correlated or
anti-correlated with the separation between the two classes in an OPLS-DA scores plot.
The 1H chemical shifts can then be compared against a number of online NMR
metabolomics databases [87-91] to assign the metabolites. Unfortunately, an
unambiguous assignment is rarely possible because of the low chemical shift dispersion
and the large number of potential metabolites. Instead, 2D NMR experiments combined
with the biological knowledge of the system under investigation are required to improve
the accuracy of metabolite identification.

3.5.3 Metabolite Identification
3.5.3.1 Automated peak picking of 2D NMR data
2D 1H,13C HSQC and 1H,1H TOCSY spectra are commonly used for metabolite
identification because of the increase in chemical shift resolution achieved by spreading
the information out into two-dimensions. Also, the correlation between 1H chemical
shifts for each J-coupled H pair; and the correlation between 1H and 13C chemical shifts
for each C-H pair significantly reduces the assignment ambiguity. This occurs because
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now both chemical shifts have to match a single metabolite in the database to make an
assignment. Despite the advantages, peak picking and organizing a table of intensities
from a 2D NMR experiment is a time consuming process, especially when multiple
spectra are involved. Numerous software packages are available to automate the peak
picking of 2D NMR spectra, however; it is extremely difficult, if not impossible, to align
and match multiple sets of spectra with different peak patterns due to unique
metabolomes.
For example, three different sets of cell cultures (different cell types, treatments or
environmental conditions, etc.) will each exhibit a distinct set of peaks in the NMR
spectrum due to the presence of unique metabolites. These unique peaks will be mixed
with other peaks common to all three groups, but the relative peak intensities are likely to
vary due to different metabolite concentrations. Thus, if the control group is designated
as the reference spectrum for automated peak picking, a peak list will be generated that
only contains peaks observed in the control spectrum that are above the designated noise
threshold. Correspondingly, peaks unique to the other two groups will be missed when
this peak list is used to peak pick their spectrum. In addition, weak peaks may also be
missed due to different noise levels between the spectra and a corresponding difference in
the threshold setting for peak picking. Instead, a composite reference spectrum for
automated peak picking needs to be generated that captures all the peaks present in the
three separate groups. We accomplish this task by using the addNMR function in the
NMRpipe software package [92]. As the name implies, addNMR mathematically sums
all spectra together from the three groups to make a single spectrum. This resulting
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“master spectrum” contains all the peaks observed throughout the set of 2D experiments
and is used to generate a peak list for automated peak picking of each individual
spectrum. Critically, the 2D NMR spectra need to be collected and processed using
identical experimental parameters (spectral width, data points, zero-filling, etc.) and
needs to be aligned to an internal reference (TMSP-d4). In our experience, all the peaks
from the complete set of NMR spectra are routinely matched to the reference list by using
a chemical shift error-tolerance of 0.04 ppm and 0.25 ppm in the 1H and 13C dimensions,
respectively. This approach has greatly simplified and increased the efficiency of a
previously laborious procedure. The addNMR command can also be used to generate a
difference spectrum that clearly highlights the major spectral changes between two
classes (Figure 3.6). cultures. Positive peaks, increased metabolite concentration, are
colored green and negative peaks, decreased metabolite concentration are colored red.

3.5.3.2 Assignment of an NMR peak to a metabolite
Metabolite identification is an extremely important component of the
metabolomics process because it enables the determination of the key metabolites
perturbed by the treatment or the metabolites primarily contributing to class distinction.
This includes the discovery of important biomarkers associated with drug efficacy or
drug resistance. Also, metabolite identification is important to the drug discovery process
by either identifying metabolic pathways affected by a drug to evaluate efficacy or
potential toxicity; or by identifying potentially new therapeutic targets. Nevertheless,
accurate metabolite identification is very difficult and labor-intensive. The success of
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Figure 3.6. a-c) Illustration of the procedure to generate a “master spectrum” and
facilitate automated peak picking by creating a complete peak list. (a-b) Representative
2D 1H-13C HSQC spectra obtained from two distinct bacterial cultures, where some
major spectral differences are highlighted. c) The two 2D 1H-13C HSQC spectra from (ab) were added to yield a master spectrum that contains all the observed NMR peaks. d-f)
Illustration of the procedure to generate a “difference spectrum” to facilitate metabolite
identification by creating a signed (+, -, null) peak list. (d-e) Representative 2D 1H-13C
HSQC spectra obtained from two distinct bacterial cultures. f) The two 2D 1H-13C HSQC
spectra from (d-e) were subtracted to yield a difference spectrum that identifies the NMR
peaks, and correspondingly metabolites, that differ between the two bacterial cell
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metabolite spectral assignment relies largely on the completeness of metabolomics
databases. We routinely use a combination of the following databases: Human
Metabolome Database [87], Madison Metabolomics Consortium Database [88], Platform
for RIKEN Metabolomics [89], BioMagResBank [90], and Metabominer [91], which
provide both redundant and complementary NMR spectral data. Importantly, the
reference NMR spectra in the various databases were obtained under different buffer
condition and use different internal standards. This results in a range of potential
chemical shifts for a given metabolite. Thus, the databases with sample conditions that
closely match our experimental conditions are used for chemical shift matching. The
overall goal is to identify a complete set of metabolites as quickly and accurately as
possible without any bias, by matching the experimental chemical shifts from the 2D
NMR spectra with the values in the database.
For a 2D 1H-13C HSQC experiment, it is important to realize that metabolites may
be heterogeneously labeled by the carbon-13 source present in the growth media.
Correspondingly, all the peaks for a specific metabolite may not be detectable in the 2D
1

H-13C HSQC experiment. Also, a reference spectrum for the metabolite may not be

present in any of the available databases. The assignment of a particular peak might still
be ambiguous because multiple metabolites may contain the same chemical shift or
contain an identical substructure (i.e., ATP, ADP, AMP or NAD, NADPH). Therefore, a
few automated filters are applied to overcome some of these ambiguities during the peak
assignment process.
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The first filter is to verify that the bacteria can actually produce the proposed
metabolite. This is routinely accomplished by searching the Biocyc [93] and KEGG [94]
database for metabolites known to exist in the bacteria under investigation. The second
filter is based on a differential peak list. All the NMR peaks potentially assigned to a
specific metabolite should have the same trend relative to the control. Obviously, the
metabolite can only have one concentration and all the NMR peaks need to be consistent
with this single concentration. Correspondingly, all the peaks have to be increased,
decreased or the same relative to the same peaks in the control spectrum. This is easily
and quickly visualized by subtracting the two sets of spectra and generating a signed (+, , null) peak list. Peaks assigned to the same metabolite have to have the same sign. The
third filter is based on a biological relationship with other metabolites. Simply, the
likelihood of a correct assignment increases if other metabolites in a specific metabolic
pathway have also been assigned. It is more likely to observe multiple metabolites from
the same pathway than various metabolites from unrelated pathways. Similarly, if there is
a direct metabolic path between two or more metabolites, then their assignments are more
likely to be correct. The final filter is the application of our biological knowledge of the
bacterial system under investigation. The pathways or metabolites that are expected to be
perturbed by the treatment would be given precedent in the assignment process. As a
simple example, a comparison between wild-type and mutant bacterial strains where
aconitase has been inactivated would reasonably be expected to lead to changes in
metabolites associate with the TCA cycle. Likewise, a comparison between untreated and
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drug-treated cells would be expected to lead to changes in metabolic pathways inhibited
by the drug.

3.5.3.3 Statistical analysis of the 2D 1H-13C HSQC data.
After assigning the 2D 1H-13C HSQC spectra to a set of metabolites, the next goal
is to determine metabolite concentration differences between the various bacterial culture
conditions under investigation. Unfortunately, peak intensities in a standard 2D 1H-13C
HSQC experiment are dependent on metabolite concentrations and J-couplings,
dynamics, and relaxation properties [76]. Therefore, only a relative percent change in a
metabolite concentration can be determined [5]. Alternatively, an absolute concentration
can be determined using HSQC0, which requires a set of three HSQC experiments per
sample. We routinely employ both approaches [76].
A relative difference in peak intensities is determined by using a triplicate set of a
conventional 2D 1H-13C HSQC experiment for each bacterial culture condition. Prior to
calculating a relative percent change in peak intensities, a detailed normalization process
is required, which was previously described in detail [5]. First, the peak intensities within
each spectrum are normalized by dividing each peak by the internal standard, the
intensity of the TMSP-d4 peak. Each peak pertaining to a specific chemical shift across
each triplicate data set is then normalized by the most intense peak in the set of three
peaks. Specifically, the maximal intensity for each peak across all data sets would be set
to 100 and all other intensities are scaled relative to this peak intensity. Then all the
normalized intensity for a given metabolite for each triplicate set is averaged together,
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and a relative percent error can be calculated between different cultures. A Student’s ttest or ANOVA is then used to determine if the relative change in peak intensities is
statistically significant at the 95% confidence limit. Calculating a relative difference in
metabolite concentrations can be beneficial to understanding broader changes to the
system, especially when a cluster of metabolites in a specific pathway exhibit a similar
trend in concentration changes inferring an important role for the metabolic pathway.
Nevertheless, this approach is rather cumbersome and does not allow for a direct
comparison between different metabolites.
Alternatively, we routinely use the HSQC0 experiment to determine absolute
metabolite concentrations. The overall protocol for the extrapolation of peak intensities to
time-zero and the determination of the associated concentration has been previously
described in detail [76, 77]. As an example, Figure 3.7 shows a linear regression plot of
the peak intensities for each carbon-hydrogen pair in fructose. This demonstrates that the
average peak height can be extrapolated. A distinct advantage of this method is that a
single calibration curve can be made using multiple compounds with known
concentrations to correlate the time-zero peak intensity with a concentration. Figure 3.8
illustrates such a calibration curve using 5 different mixtures, each consisting of 9
different 13C-labeled metabolites ranging in concentrations from 5 to 300 µM. Also, the
concentration for each metabolite was randomized in each mixture. For example the
concentration of 13C-D-alanine in the 5 mixtures is 300, 10, 25, 5, and 100 µM,
respectively. The data was fitted using a weighted linear least squares calculation.
Notably, the best-fit line (R2 0.997) has a y-intercept close to zero as expected for a
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Figure 3.7. Extrapolation of 2D HSQCi (i=1,2,3) peak intensities of fructose. Fructose
consists of multiple peaks in the 2D spectrum where each symbol represents a different
peak. The attenuation factors (spin dynamic properties) for each C-H pair represent the
slope of the line. The lines converge to the same general region at the y-intercept, where
the intensity is directly related to concentration.
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Figure 3.8. A strong correlation between NMR peak volumes and metabolite
concentrations (R2 0.997) is demonstrated by linear regression plot generated from
HSQC0 data. HSQC0 NMR spectra were collected for five different metabolite mixtures
containing nine 13C-labeled compounds with concentrations ranging from 5 µM to 300
µM. The relationship between peak volume and metabolite concentration is independent
of the metabolite.
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concentration of zero. Also, the correlation between peak volume and concentration is
independent of the metabolite. Importantly, the accurate application of the calibration
curve requires collecting and processing HSQC0 spectra identical to the parameters used
to obtain the original calibration curve. Critically, the receiver gain must be the same for
all samples, because any change in the receiver gain influences the slope of the
calibration curve. Also, the addition of 500 µM TMSP-d4 as an internal standard is
crucial, because both the calibration samples and experimental samples must both be
similarly normalized to the TMSP-d4 peak. As an example, if the TMSP-d4 peak
volumes for the calibration mixtures are 1000, 500, and 250 for each HSQCi (i = 1,2,3)
spectrum, respectively, then the experimental results for all in vivo metabolite extracts
must be normalized so that the internal standard (TMSP-d4) peak volumes are also 1000,
500, and 250. The concentrations are measured in triplicate, where a Student’s t-test or
ANOVA is used to determine if the concentration changes are statistically significant at
the 95% confidence limit.

3.5.4 Metabolomics Network Map
Metabolites are highly interconnected through numerous metabolic pathways that
form an extremely complex network [95]. Correspondingly, it is not uncommon to
observe correlated changes between distantly connected metabolites. In effect,
metabolomics depends on these complex interactions to understand the phenotype of a
bacterial cell. Thus, a metabolomics network map provides an efficient approach to
visualize and summarize the overall changes to the metabolome, to validate metabolite
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assignments based on clear connections to other metabolites, and the identification of key
metabolic pathways.
We have routinely used Cytoscape to easily and quickly generate metabolomics
network maps. Cytoscape is a user-friendly software package with plug-ins related to
metabolomics [96-99]. Cytoscape simply requires a list of the metabolites and their
associated concentration changes as input. The connections between nodes (metabolites)
in the map are based on metabolic pathways from the MetaCyc database [100]. An
example of a typical Cytoscape map summarizing the observed changes in the S.
epidermidis metabolome caused by environmental stimuli associated with biofilm
formation is shown in Figure 3.1. The metabolomics network map can be easily modified
to highlight specific features of the metabolome. Edges can be broadened to highlight
specific pathways; and the color and size of nodes can be adjusted to reflect the direction
and magnitude of the concentration changes, respectively [101]. Cytoscape also provides
a range of map design choices. Unfortunately, the resulting network maps (Figure 3.1) do
not resemble standard metabolic pathways. Thus, Cytoscape maps are simply used as a
template to manually draw more traditional looking metabolic pathways. Since
Cytoscape maps are so easily generated, we also use the software to assist in metabolite
assignments. Potential lists of metabolite assignments are input into Cytoscape to identify
metabolites that are isolated nodes excluded from the main network map. These
metabolites are likely missed assigned and are reevaluated. In addition to Cytoscape, we
also use the R statistics package to create heat maps from absolute metabolite
concentrations or percent relative concentration changes.
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3.6 Conclusion
NMR metabolomics is an invaluable tool for systems biology and its application
is rapidly expanding. Global changes in the metabolic state of bacterial cells occur as a
result of environmental stressors, genetic modifications, drug treatments, or numerous
other factors. A detailed analysis of the differences in the NMR spectra is commonly
used to identify the key metabolite changes that differentiate between these bacterial
classes (i.e., controls versus treated). In addition, metabolite identification by NMR
allows for the subsequent identification of the important metabolic pathways that are
affected by the treatment, providing further insight into the underlying biological process.
The appeal of NMR metabolomics is its simplicity, but unfortunately it is also easy to
obtain unreliable results. The observed changes in the metabolome should be biologically
relevant, but because the metabolome is so sensitive to any environmental change; it is
also easily perturbed by the experimental protocol. This is clearly an undesirable
outcome. To address this issue, we described in detail our optimized protocols for the
NMR analysis of bacterial metabolomes. We also highlighted common problems and
potential sources of mistakes. We discuss the entire process that includes growing and
harvesting bacterial cells, extracting the metabolome, NMR data collection, processing
and analysis, statistical analysis, metabolite and network identification. The protocols
described have been successfully applied to a number of systems biology projects.
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CHAPTER 4
PREDICTING THE IN VIVO MECHANISM OF ACTION FOR DRUG LEADS
USING NMR METABOLOMICS§

4.1 Introduction
Emerging and remerging infectious disease outbreaks from numerous gramnegative and gram positive pathogens have increased dramatically over the past decade
[1]. Further, we are facing the serious likelihood that these pathogens will soon become
resistant to all known antibacterial treatments, which may lead to worldwide pandemics
[2]. Unfortunately, the development and approval of antibiotics have not kept pace with
the growing emergence of resistant pathogens [3]. Instead, there has been a decline in the
approval of new antibiotics [4]. Twenty novel classes of marketable antibiotics were
produced between 1930 and 1962 [5]. These classes of antibiotics inhibit a short list of
cellular processes: cell wall biosynthesis, DNA supercoiling, transcription, translation
and folate biosynthesis. Since 1962, only two new antibiotic classes have received FDA
approval: oxazolidinones, which inhibits protein synthesis, and cyclic lipopeptides, which
destroys membrane potential. Both compounds are used in the treatment of gram positive
bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) [5]. However,
additional antibiotics are needed to combat the prevalence of other multidrug resistant
pathogens, such as Enterococcus faecium, Klebsiella pneumonia, Acinetobacter
§
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baumanii, Pseudomonas aeruginosa, and Enterobacter species that are infecting the
majority of U.S. hospitals [6]. Also extreme drug resistant strains of Mycobacterium
tuberculosis are a rising threat in the world.
The Infectious Diseases Society of America (IDSA) has proposed an initiative to
develop and approve 10 novel antibiotics by the year 2020 [7]. However, existing drug
discovery strategies may not be able to meet these challenges. Drug discovery programs
rely heavily on target based high throughput screening (HTS) of large chemical libraries
followed by lead optimization [8, 9]. Unfortunately, this approach has demonstrated an
extremely high rate of failure and erroneous leads. Even when a valid HTS hit is found,
it is uncertain if this chemical lead can penetrate into the bacterial cell while
demonstrating in vivo activity.
NMR Metabolomics is evolving as a significant component of the drug discovery
process and offers an inexpensive route to help overcome the multiple challenges faced
by researchers [10]. Metabolomics is a relatively new field and is based on the
identification and quantification of small molecules found in living cells or biofluids [11].
Since small molecules are downstream products of biomolecular process, the identity and
concentration of metabolites provide biochemical signatures for tracking the
physiological effects of antibiotic efficacy, selectivity, and toxicity. Characterizing these
biochemical signatures relies upon the global determination of numerous endogenous
small molecule followed by pattern recognition using multivariate analysis [12]. Such
comprehensive biochemical information can be readily obtained using 1H NMR
spectroscopy with minimal sample handling while providing highly reproducible data in
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an automated fashion [10]. Multivariate statistical analysis, such as orthogonal partial
least-squares discriminant analysis (OPLS-DA), is typically employed to extract
information from the large and complex NMR datasets [13]. Simply, OPLS-DA is used
to identify clustering patterns from the major variations between NMR spectra [10].
Herein, we describe a new method using 1H NMR and OPLS-DA to profile the in
vivo mechanism of action of known antibiotics used to treat M. tuberculosis. More
importantly, we aim to use the information to classify compounds with unknown
mechanisms of action, but demonstrated anti-tubercular activity. Our approach is
predicated on the hypothesis that drugs with similar modes of activity or therapeutic
targets will have a similar impact on the metabolome of M. smegmatis and will cluster
together in an OPLS-DA scores plot. Thus the mode of action of a novel chemical lead
can be inferred from its clustering in an OPLS-DA scores plot relative to drugs with
defined biological targets. Importantly, if the chemical lead is separated from known
drugs in the OPLS-DA scores plot, then this result would infer a new mechanism of
action and a potentially valuable, new antibiotic.

4.2 Methods
4.2.1 Determining Optimal Drug Dosage for NMR Metabolomics Experiments
M. smegmatis mc2155 cells were grown at 37 °C with shaking at 200 rpm in 50
mL of Middlebrook 7H9 media until an average optical density at 600 nm (O.D.600) of
0.6 was achieved. Each drug was titrated over a concentration range of 1 to 24 times the
literature MIC values and the cells were grown for an additional 2 hours. The optical
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density was recorded and the growth rate inhibition was calculated by comparing the
optical density of the treated cells to the untreated cells in the 2 hour time period. The
desired drug dosage was determined where a drug concentration inhibits cell growth by
approximately 50% of the growth rate of untreated cells.

4.2.2 Sample Preparation
A total of 190 M. smegmatis mc2155 cultures were grown in 50 mL of
Middlebrook 7H9 at 37 °C with shaking at 200 rpm until an O.D.600 of 0.6 was achieved.
A total of 40 untreated cultures were used as a control and 10 cultures were inoculated
with each antibiotics at the optimal dosage needed to inhibit cell growth by ~50% as
described in Table 3.1. The cells were then grown for an additional 2 hours. The used
media was removed and the cells were washed 3 times and re-suspended with 1 mL ice
cold double distilled water. The cells were lysed using a FastPrep-24 instrument for 60
seconds at 6 m/s, and the supernatant was extracted and frozen in a dry ice ethanol bath.
The samples were lyophilized and then re-suspended with 700 μL of 99.8% D2O solution
containing 50 mM phosphate buffer (pH 7.2, uncorrected) and 50 μM 3(trimethylsilyl)propionic acid-2,2,3,3-d4 (TMSP-d4) as an internal standard for chemical
shift referencing. The samples were then centrifuged for 5 minutes to remove any
insoluble material, and 600 μL of the supernatant was transferred to an NMR tube.
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Table 4.1. Description of Antimicrobial Compounds and Dosages Used in This Study
a

b

Compound

Class

Mechanism of Action

MIC
(ug/mL)

Ampicillin

Penillins

Inhibits transpeptidation and prevents cell wall formation

16.0

Cloramphenicol

Amphetamines

Inhibits protein synthesis by binding to the 50S ribosomal subunit

6.0

6.0

Ciprofloxacin

Fluoroquinolones

Inhibits DNA gyrase and prevents DNA supercoiling

0.2

2.0

D-cycloserine

Oxazolidinones

75.0

75.0

Ethambutol

Amino Alcohols

Inhibits alanine racemase and alanine ligase and prevents cell wall formation
(different from other oxazolidinones that inhibit protein synthesis)
Disrupts arabinogalactan formation by inhibiting arabinosyl transferase

10.0

100.0

Ethionamide

Pyridine
Derivatives
Aminoglycosides

Inhibits mycolic acid formation similar to isoniazid

20.0

160.0

Inhibits protein synthesis by binding to the 30S ribosomal protein S12 and 16S
rRNA
A prodrug that inhibits InhA and prevent mycolic acid synthesis

2.0

8.0

2.0

48.0

Inhibits protein synthesis by binding to the 30S ribosomal protein S12 and 16S
rRNA
Inhibits RNA polymerase and prevent RNA synthesis

4.0

4.0

30.0

60.0

0.25

1.5

50

450

Gentamicin
Isoniazid

c

Dosage
(ug/mL)
96.0

Kanamycin

Pyridine
Derivatives
Aminoglycosides

Rifampicin

Rifampicins

Streptomycin

Aminoglycosides

Vancomycin

Glycopeptides

Inhibits protein synthesis by binding to the 30S ribosomal protein S12 and 16S
rRNA
Binds to the D-alanyl-D-alanine dipeptide and prevents cell wall formation

Amiodarone

Benzofurans

Unknown

26.6

212.8

Clofazimine

Anilines

Unkown

0.32

3.84

Chlorprothixene

Thioxanthines

Unknown

36.0

216.0

a
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Literature values of minimum inhibitory concentrations against M. smegmatis used as a starting point to determine an optimal
dosage for the NMR metabolomics study. bActual dosage used to treat M. smegmatis cells to inhibit growth by ∼50% following drug
treatment. cReported for M. smegmatis β-lactamase and ribosomal protein S12 mutants.
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4.2.3 NMR Data Collection and Processing
The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer
equipped with a triple resonance and z axis gradient cryoprobe. A BACS-120 sample
changer was used for automated data collection. 1D 1H NMR spectra were collected
using excitation sculpting to remove the solvent signal and maintain a flat spectral
baseline [14]. A total of 32K data points with a spectral width of 5482.5 Hz, 16 dummy
scans and 128 scans were used to obtain each spectrum. The data was processed
automatically using ACD/1D NMR Manager (Advanced Chemistry Development).
Intelligent bucketing was used to integrate each spectral region with a bin size of 0.025
ppm. Each NMR spectrum was center averaged to minimize any experimental variations
between bacterial cultures as follows [15],
Z

Xi  X



(4.1)

where X is the average signal intensity, σ is the standard deviation in the signal intensity,
and Xi is the signal intensity within a bin. Noise regions of the spectra were omitted from
the PCA analysis by setting the corresponding bins to zero [16]. OPLS-DA and PCA was
performed using Simca-11.5+ (Umetrics), where each 1H NMR spectra was reduced to a
single point in the 2D OPLS-DA and PCA scores plot. The OPLSDA was calculated with
two classes, untreated versus drug treated cell cultures, for the Y matrix with the NMR
data incorporated into the X matrix. The OPLS-DA model was cross validated using a
modified version of the leave-one-out technique, where 1 out of every 7 samples (spectra)
were left out to calculate a model and predict the left out data [17]. The procedure was
sequentially repeated leaving out a different 1/7th of the data. The predicted data was
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then compared to the original data, where the quality assessment (Q2) score provides a
qualitative measure of the predictability of the model based on the consistency between
the predicted and original data. An ideal value for Q2 is one, where a typical value
for a biological model is ≥ 0.4.
Metabolomic Tree diagrams with corresponding bootstrap values were created
using our PCAtoTree program to interpret the OPLS-DA clustering pattern [18]. The
metabolomics tree diagram is based on the Euclidean distances between the cluster
centers from the 2D OPLS-DA scores plot. Standard bootstrapping techniques are used to
generate a set of 100 distance matrices by randomly re-sampling the cluster centers and
Euclidean distances. The set of 100 distance matrices are then used by PHYLIP
(http://www.phylip.com) [19], phylogenetic software package, to generate 100 tree
diagrams and a consensus tree diagram. The bootstrap numbers on the consensus tree
diagram indicates the number of times each node was present in the set of 100 tree
diagrams, where a bootstrap number below 50% indicates a generally insignificant node
or insignificant separation between the clusters.
Four additional OPLS-DA models were generated to identify specific metabolites
associated with drug activity: (i) inhibition of translation, transcription or DNA
supercoiling drug treated cells versus untreated cells, (ii) inhibition of mycolic acid
synthesis drug treated cells versus untreated cells, (iii) inhibition of cell wall synthesis
drug treated cells versus untreated cells, and (iv) the three TAACF compounds versus
untreated cells. S-plots and loading plots were generated from each OPLS-DA model.
Bins (chemical shift values) demonstrating a covariance of greater than 0.10 or less than
-0.10 were identified as major contributors to the class separation. Metabolites were
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identified from this list of chemical shifts using the Human Metabolome Database
(HMDB, http://www.hmdb.ca/) [20] with a chemical shift tolerance of 0.02 ppm.
Metabolic network maps were then generated using Cytoscape
(http://www.cytoscape.org/) [21] with the MetScape [22] plugin for the top 100
metabolite predicted by HMDB. Metabolites were excluded if not part of a network or
not present in M. smegmatis.

4.3 Results and Discussion
Our methodology was demonstrated using 12 antibiotics known to inhibit the
growth of M. tuberculosis and M. smegmatis (Table 4.1). The mechanism of action for
each antibiotic was identified from the Drug Bank Database [23], and the minimum
inhibitory concentrations (MIC) were obtained from the scientific literature [24-32]. In
addition three chemical leads were randomly selected from the Tuberculosis
Antimicrobial Acquisition and Coordinating Facility (TAACF) library of compounds
(http://www.TAACF.org). The compounds were screened against M. tuberculosis and
have comparable MICs to known TB drugs, but the biological target or mechanism of
action was not reported by TAACF. The non-pathogenic M. smegmatis was used as a
model system for the NMR metabolomics study.
In order to analyze changes in the M. smegmatis metabolome, the drug dosage
needs to be below lethal levels and only affect cell growth. Typically, a drug
concentration that inhibits cell growth by approximately 50% of the growth rate of
untreated cells is desirable. While MIC values are available from the literature, these
concentrations are based on standardized drug gradients, inoculum sizes, and readout
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endpoints. Additionally, the reported MIC’s were obtained with different bacterial
strains, at different growth stages or cell densities, and under a variety of experimental
conditions that includes either broth or agar methods. Further complicating the situation
is the diversity of MIC’s values reported for a single drug. Thus, the literature MIC
values listed in Table 4.1 were simply used as a starting point to determine an optimal
dosage for the NMR metabolomics study under our experimental conditions. Each drug
was titrated over a concentration range of 1 to 24 times the literature MIC values. The
individual drug concentrations needed to achieve ~50% growth inhibition are reported in
Table 4.1. An average growth inhibition of 43.1±10.5% was observed after the addition
of each of the 15 drugs. Preparation of the M. smegmatis cell cultures for metabolomics
analysis was then performed using the optimal dosage for each drug.
Due to the inherit variability of biological samples and to provide a robust
statistical analysis, 10 cultures inoculated with each antibiotic and 40 cultures of
untreated cells were prepared for the NMR metabolomics study. A 1D 1H NMR
spectrum was collected for each biological sample, which were normalized using center
averaging and analyzed using OPLS-DA. A representative 2D OPLS-DA scores plot
displaying a comparison between 6 antibiotics with known mechanisms of action is
shown in Figure 4.1. The OPLS-DA model was cross-validated using a modified leaveone-out method. A quality assessment score (Q2) of 0.82 was obtained, which is an
excellent result compared to an ideal score of 1.00. The, the cross-validation indicates a
highly reliable model. Each point in the 2D OPLS-DA scores plot represents a single 1D
1

H NMR spectrum of a specific drug treated or untreated cell culture. The 2D OPLS-DA
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Figure 4.1. 2D OPLS-DA scores plot demonstrating the clustering pattern obtained for
six different antibiotics with known and distinct biological targets: untreated M.
smegmatis cells, ciprofloxacin, streptomycin, ethambutol, isoniazid, D-cycloserine, and
vancomycin treated M. smegmatis cells. Symbols and labels are indicated on the plot. The
ellipses correspond to the 95% confidence limits from a normal distribution for each
cluster. The untreated M. smegmatis cells were designated the control class, and the
remainder of the cells was designated as treated. The OPLS-DA used one predictive
component and three orthogonal components to yield a R2X of 0.610, R2Y of 0.893, and
Q2 of 0.82.
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scores plot consists of 4 separate clustering patterns, which demonstrates that each group
has a considerably different impact on the metabolome of M. smegmatis.
Importantly, all the drug-treated M. smegmatis cell cultures form distinct and
separate clusters from the untreated cell cultures. This is consistent with all the drugs
being biologically active and inhibiting M. smegmatis cell growth. Antibiotics that share
a similar or identical biological target were observed to cluster together in the OPLS-DA
scores plot. For example, ethambutol and isoniazid inhibit mycolic acid biosynthesis that
prevents the formation of the arabinogalactan-mycolic acid matrix. Streptomycin and
ciprofloxacin form the second cluster. Streptomycin prevents protein synthesis and
ciprofloxacin inhibits DNA supercoiling that affects replication, transcription, and repair,
leading to a similar disruption in protein synthesis. Since these two antibiotics cluster
together, it implies that the inhibition of transcription or translation results in a similar
impact on the metabolome. Vancomycin and D-cycloserine both affect cell wall
formation and form the third cluster. In a principal component analysis (PCA) of the data
(Figure 4.2) there is a more pronounced separation between vancomycin and Dcycloserine along PC2. This reflects a fundamental difference between PCA and OPLSDA, where PCA is limited to a linear model and does not readily differentiate between
within-class and between-class variations [13, 33]. Correspondingly, OPLS-DA is
preferred as long as cross-validation verifies a reliable model.
The NMR metabolomics analysis was then expanded to include a total of 12
drugs with known biological targets and 3 compounds randomly chosen from the TAACF
library. Amiodorone, clofazamine and chlorprothixene are active against TB, but have
unknown mechanisms of action according to the TAACF database. Nevertheless, the
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Figure 4.2. PCA scores plot demonstrating the clustering pattern of 6 different classes of
known antibiotics: untreated M. smegmatis cells (■), ciprofloxacin (♦), streptomycin (♦),
ethambutol (▼), isoniazid (▼), D-cycloserine (▲), and vancomycin (▲) treated M.
smegmatis cells. The ellipses correspond to the 95% confidence limits from a normal
distribution for each cluster.
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three compounds are known drugs, where amiodorone is an antiarrhythmic agent that
affects potassium efflux, chlorprothixene is an antipsychotic drug that inhibits dopamine
receptors, and clofazamine is a 40 year-old leprosy treatment with an ill-defined
biological activity. The 2D OPLS-DA scores plot (Figure 4.3a) identified 4 distinct
clusters and yielded a highly reliable cross validation Q2 score of 0.671. As before, the
different clusters are correlated with distinct modes of action: inhibition of cell wall
formation, inhibition of mycolic acid biosynthesis, and inhibition of transcription,
translation or the overall effects of DNA supercoiling.
The accompanying metabolomics tree diagram (Figure 4.3b) clearly visualizes the
relative groupings of the three antibiotic classes [18]. The bootstrap numbers of 89 to 100
indicate a statistically significant separation between the five clusters and the reliability
of the general drug and TAACF classifications. The metabolic tree diagram also provides
a finer separation between the drugs within each cluster. These separations may reflect
actual differences in the specific drug targets. For example, D-cycloserine and
vancomycin are on separate branches in the cell wall node potentially because Dcycloserine inhibits alanine racemase and alanine ligase compared to vancomycin binding
the D-alanyl-D-alanine dipeptide. Alternatively, the separation may result from
differences in the relative activity of the drug. Streptomycin forms a separate branch in
the transcription, translation or DNA supercoiling drug cluster despite having a similar
target (binding to the 30S ribosomal protein S12 and 16S rRNA) relative to other
members within the cluster. But, streptomycin is one of the most active compounds
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Figure 4.3. a) 2D OPLS-DA scores plot demonstrating the clustering pattern for 12
antibiotics with known biological targets and three compounds of unknown in vivo
activity: untreated M. smegmatis cells, chloramphenicol, ciprofloxacin, gentamicin,
kanamycin, rifampicin, streptomycin, ethambutol, ethionamide, isoniazid, ampicillin, Dcycloserine, vancomycin, amiodorone, chlorprothixene, and clofazimine treated M.
smegmatis cells. The symbols correspond with the coloring scheme and labeled symbols
indicated on the tree diagram in (b). The ellipses correspond to the 95% confidence limits
from a normal distribution for each cluster. The untreated M. smegmatis cells (black
square) was designated the control class, and the remainder of the cells were designated
as treated. The OPLS-DA used one predictive component and six orthogonal components
to yield a R2X of 0.715, R2Y of 0.803, and Q2 of 0.671. b) Metabolomics tree diagram
determined from the OPLS-DA scores plot. The coloring scheme and associated symbol
for each compound in the tree diagram correlates with colored symbols in the OPLS-DA
scores plot. The bootstrap numbers for each node are indicated on the tree diagram.
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tested, requiring only a dosage of 1.5 μg/ml to inhibit M. smegmatis growth by
approximately 50%. Also, over-interpreting these subtle separations may be erroneous
since the within cluster differences may simply reflected experimental variability and
may not be biologically relevant. For instance, an average growth inhibition of 43.1 ±
10.5% was observed after the addition of each of the 15 drugs. This dosage variability
may lead to unintended separations in the 2D OPLS-DA scores plot. Essentially, the
reliability of these finer cluster differences is dependent on additional supportive
biological data.
Surprisingly, amiodorone, chlorprothixene, and clofazamine were found to cluster
together in the 2D OPLS-DA scores plot and metabolic tree diagram. This was an
unexpected result given that the three compounds were randomly selected from the large
TAACF library and have diverse therapeutic usages. But, it also implies the three
compounds share a similar mechanism of action in TB. Importantly, the three TAACF
compounds also cluster with the antibiotics that disrupt cell wall formation, ampicillin,
D-cycloserine and vancomycin. This infers a similar mode of action between the three
TAACF compounds and the antibiotics that are known to interfere with bacterial cell
walls. A subsequent literature search indicated that the three TAACF compounds have
been previously shown to disrupt bacterial membranes in organisms distinct from TB
[34-38]. Thus, the literature results are consistent with our NMR metabolomics analysis,
which support our general classification of the TAACF compounds as interfering with
bacterial cell walls. It is important to note that while ampicillin is a member of this class
of antibiotics, it is also skewed toward the untreated cells in the 2D OPLS-DA scores
plot. Presumably, this is because of M. smegmatis β-lactamase activity that provides
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resistance to ampicillin [32, 39]. The impact of ampicillin on the metabolome of M.
smegmatis is significantly diminished such that ampicillin M. smegmatis is similar to
untreated cells. As described previously, there are some differences between the OPLSDA and PCA scores plot (Figure 4.4). There is less discrimination between the untreated
and drug treated cells in the 2D PCA scores plot. This is not unexpected since PLS is
preferred over PCA for discrimination been classes [33]. Also, there is a separation
between the three TAACF compounds and the cell wall antibiotics in the PCA scores
plot, but the TAACF compounds are still closer to the cell wall antibiotics in the
associated metabolic tree diagram (Figure 4.4). In fact, the OPLS-DA and PCA
metabolomic tree diagrams are quite similar despite these visible differences in the scores
plots. Additionally, the quality of the OPLS-DA model is apparent from the fit to the
data, R2X > 0.610 and R2Y > 0.803, and the reliability of the model is apparent from the
cross-validation Q2 score > 0.617. Further validation of the OPLS-DA drug and TAACF
classifications comes from the analysis of the metabolites identified as the major
contributors to the OPLS-DA class separation (Figures 4.5-4.8 and Tables 4.2-4.5).
The S-plots and loading plots determined from the OPLS-DA models identify the
chemical shifts (and associated metabolites) that contribute to the observed separation
between the untreated and treated cells in the 2D OPLS-DA scores plot. The metabolites
and corresponding pathways predominately perturbed by the addition of each drug class
are listed in supplemental Tables 4.2-4.5. While there are some broad similarities in the
metabolites and pathways affected by the drugs because the comparisons are all made
relative to untreated cells, there are also some distinct differences. For example, proline,
cytidine, uridine and inosine (pyrimidine and purine pathways) are all uniquely decreased
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Figure 4.4. a) PCA scores plot demonstrating clustering patterns of 12 antibiotics with
known mechanisms and 3 compounds that are unknown: untreated M. smegmatis cells,
chloramphenicol, ciprofloxacin, gentamicin, kanamycin, rifampicin, streptomycin,
ethambutol, ethionamide, isoniazid, ampicillin, D-cycloserine, vancomycin, amiodorone,
chlorprothixene, and clofazimine treated M. smegmatis cells. The symbols correspond
with the coloring scheme and labeled symbols indicated on the tree diagram in (b). The
ellipses correspond to the 95% confidence limits from a normal distribution for each
cluster. b) Tree diagram of the PCA scores plot. The coloring scheme for each compound
in the tree diagram represents the data points in the scores plot. The bootstrap numbers
for each node are indicated on the tree diagram.
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Figure 4.5: a) OPLS-DA S-plot comparing the M. smegmatis treated with antibiotics
known to inhibit transcription or translation and untreated cell cultures. Each point in the
S-plot represents a specific bin containing a chemical shift range of about 0.25ppm, and
the range varied by 50% using intelligent binning in the ACD 1D NMR processor. b)
OPLS-DA loading plot comparing the M. smegmatis treated with antibiotics known to
inhibit transcription or translation and untreated cell cultures.
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Table 4.2. Metabolites perturbed from drugs affecting transcription, translation or DNA supercoiling.
Pathway
Metabolite
HMDB Scorea Relative Changeb
Glycolysis
Glucose-6-phosphate
19/50
+
Fructose-6-phosphate
15/37
+
Glycerol-3-phosphate
18/34
+
Lactate
2/2
Aminosugar
N-acetyl-D-glucosamine
23/50
+
N-acetyl-Neuraminate
12/37
+
Folate metabolism
Folate
10/33
+
Glycine,Serine,Threonine metabolism
Serine
5/12
+
Cysteine, Methionine metabolism
Methionine
18/22
+
TCA
Citrate
2/4
+
Isocitrate
6/16
+
Acetoacetate
1/2
+
Branched Chain Amino Acids
Isoleucine
7/42
Leucine
5/25
Alanine, Aspartate, Glutamate metabolism
Alanine
2/6
Glutamate
12/30
+
Glutamine
16/28
+
Lysine Biosynthesis
Lysine
5/41
Proline Metabolism
Proline
8/44
Pyrimidine
Cytidine
7/25
Uridine
5/26
Purine
Inosine
4/21
a
Number of peaks in query that matches the number of peaks in the Human Metabolome Database. Peaks
in the query can be matched multiple times. bRelative change of metabolite concentration in drug treated
cultures compared to untreated cultures.
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Figure 4.6. a) OPLS-DA S-plot comparing the M. smegmatis treated with antibiotics
known to inhibit mycolic acid pathways and untreated cell cultures. b) OPLS-DA loading
plot comparing the M.smegmatis treated with antibiotics known to inhibit mycolic acid
pathways and untreated cell cultures.
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Table 4.3. Metabolites perturbed from drugs affecting mycolic acid pathways
Pathway
Metabolite
HMDB Scorea
Glycolysis
Glucose-6-phosphate
16/50
Fructose-6-phosphate
15/37
Oxaloacetate
1/1
Lactate
2/6
TCA
Acetoacetate
1/2
2-Oxoglutarate
3/6
Isocitrate
6/16
Aminosugar
Arabinose
15/40
Alanine, Aspartate, Glutamate metabolism
GABA
6/11
Glutamate
12/30
Asparagine
5/12
Alanine
2/6
Glycine, Serine, Threonine metabolism
2-Ketobutyrate
3/7
Homoserine
12/44
Branched Chain metabolism
Valine
2/16
Leucine
3/25
Pyrimidine
Orotate
1/1
Ureidopropionate
6/7
Glycerophospholipid
Choline phosphate
8/15
Lysine Biosynthesis
Lysine
15/47
Arginine and Proline metabolism
Spermidine
7/21
Citrulline
16/44
Ascorbate metabolism
Ascorbate
6/16
Dehydroascorbate
10/35

Relative Changeb
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

a

Number of peaks in query that matches the number of peaks in the Human Metabolome Database. Peaks
in the query can be matched multiple times. bRelative change of metabolite concentration in drug treated
cultures compared to untreated cultures.
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Figure 4.7. a) OPLS-DA S-plot comparing the M. smegmatis treated with antibiotics
known to inhibit cell wall synthesis and untreated cell cultures. b) OPLS-DA loading plot
comparing the M. smegmatis treated with antibiotics known to inhibit cell wall formation
and untreated cell cultures.
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Table 4.4. Metabolites perturbed from drugs affecting cell wall.
Pathway
Metabolite
Glycolysis
Glucose-6-phosphate
Fructose-6-phosphate
Oxaloacetate
Aminosugar
N-acetyl-D-glucosamine
N-acetylneuraminate
Alanine, Aspartate, Glutamate metabolism
Alanine
GABA
Glutamine
Glutamate
Branched Chain Amino Acids
Valine
Isoleucine
Glycine, Serine, Threonine metabolism
Serine
2-ketobutyrate
Cysteine, Methionine metabolism
Methionine
Lysine Biosynthesis
Lysine
Folate metabolism
Folate

HMDB Scorea
19/50
20/37
1/1
25/50
12/37
2/6
8/11
18/28
18/30
10/16
31/42
7/12
3/7
15/22
15/47
13/33

Relative Changeb
+
+
+
+
+
+
+
+
+
+
+
+
+

a

Number of peaks in query that matches the number of peaks in the Human Metabolome Database. Peaks
in the query can be matched multiple times. bRelative change of metabolite concentration in drug treated
cultures compared to untreated cultures.
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Figure 4.8: a) OPLS-DA S-plot comparing the M. smegmatis treated with antibiotics with
unknown mechanism and untreated cell cultures. b) OPLS-DA loading plot comparing the M.
smegmatis treated with antibiotics with unknown mechanism and untreated cell cultures.
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Table 4.5. Metabolites perturbed from drugs of unknown mechanism.
Pathway
Metabolite
HMDB Scorea
Relative Changeb
Glycolysis
Oxaloacetate
1/1
Alanine, Aspartate, Glutamate metabolism
Glutamine
20/28
Glutamate
25/30
Branched Chain Amino Acids
Isoleucine
20/42
+
Cysteine, Methionine metabolism
Methionine
15/22
Folate metabolism
Folate
24/33
a
Number of peaks in query that matches the number of peaks in the Human Metabolome Database. Peaks
in the query can be matched multiple times. bRelative change of metabolite concentration in drug treated
cultures compared to untreated cultures.
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by drugs that affect transcription, translation or DNA supercoiling. Obviously,
nucleotides are essential metabolic precursors to DNA and RNA synthesis. Alternatively,
choline phosphate, lysine, spermidine, citrulline, ascorbate and dehydroascorbate
(glycerophospholipid, lysine biosynthesis, arginine and proline metabolism, and
ascorbate metabolism pathways) are decreased by drugs affecting the mycolic acid
pathway. Ascorbate metabolism is directly linked to the mycolic acid pathway, where
ascorbate leads to arabinose. Arabinose is the primary precursor for the arabinogalactanmycolic acid complex. Also, the inhibition of spermidine synthesis has been previously
observed for drugs targeting the mycolic acid pathway in mycobacteria [40].
Importantly, the set of metabolites affected by the TAACF compounds were identical to
metabolites perturbed by D-cycloserine and vancomycin. Both show a decrease in
oxaloacetate, glutamine, glutamate, methionine and folate and an increase in isoleucine.
Clearly, amino acids and their precursors are important components in peptidoglycan,
cell wall and cell membrane synthesis. There were some additional metabolites that are
increased by the addition of D-cycloserine and vancomycin that were not observed with
the TAACF compounds. These include other amino acids (alanine, lysine serine, valine)
and other precursors to peptidoglycan synthesis (N-acetyl-D-glucosamine, Nacetylneuraminate). Overall, the identity of the specific metabolites perturbed by each
drug class is consistent with the 2D OPLS-DA scores plot clustering pattern and drug
classifications.
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4.4 Conclusion
In conclusion, we have demonstrated that different classes of antibiotics uniquely
affect the metabolome of M. smegmatis. These metabolomic changes are directly
correlated with broad mechanisms of action that are associated with each TB class of
antibiotics, disruption of cell walls or membranes, inhibition of transcription, translation
or DNA supercoiling, or the inhibition of mycolic acid biosynthesis. Thus, NMR
metabolomics provides an efficient, simple and unbiased approach for providing rapid
classification of promising drugs leads that emerge from HTS. This is critical since HTS
does not provide any information on mechanisms of action; only relative activity with a
high-false positive rate. Instead, the in vivo biological activity of a novel lead can be
inferred by its relative clustering to existing drug classes in an OPLS-DA scores plot
derived from metabolomics data. Importantly, a chemical lead that forms a distinct
cluster from known drugs infers a potential new mechanism of action and a reason to
prioritize the chemical lead for a detailed follow-up investigation. Of course, the induced
metabolomic changes relative to untreated cells provide further confirmation of in vivo
efficacy, which was implied from the HTS results. While the technique was demonstrated
with M. smegmatis, it is generally applicable to bacterial pathogens and the effect of
therapeutic agents on human cell lines in addition to the analysis of biofluids.
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CHAPTER 5
TRICARBOXYLIC ACID CYCLE-DEPENDENT REGULATION OF
STAPHYLOCOCCUS EPIDERMIS POLYSACCHARIDE INTERCELLULAR
ADHESIN SYNTHESIS§

5.1 Introduction
Staphylococcus epidermidis is the most frequently isolated nosocomial pathogen
from the blood cultures of adult and pediatric intensive care unit patients in the United
States of America [1]. Frequently, S. epidermidis infections involve the formation of a
biofilm on the surfaces of biomaterials (e.g., catheters) [2]. A biofilm is a complex
aggregation of bacteria usually encapsulated by an adhesive exopolysaccharide matrix.
The exopolysaccharide matrix provides structural stability to the biofilm, enhanced
adhesion to surfaces, and protection from host defenses and antibiotics [3-5]. In S.
epidermidis, the exopolysaccharide facilitating bacterial adherence in a biofilm is
polysaccharide intercellular adhesin (PIA). PIA is an N-acetylglucosamine polymer [6] of
at least 130 residues [7] whose synthesis requires the enzymes encoded by genes in the
intercellular adhesin (ica) operon (icaADBC) [8]. The synthesis of PIA is required for the
maturation of biofilms [8], important for evasion of the host innate immune system [5, 9],
and critical in biomaterial-associated infections [10, 11].

§

Chapter 5 was adapted from Sadykov, M., et. al., Tricarboxylic Acid Cycle-Dependent Regulation of

Staphylococcus epidermidis Polysaccharide Intercellular Adhesin Synthesis, Journal of Bacteriology
(2008), 190 (23), 7621-7642. Reprinted with permission, copyright 2008 American Society for
Microbiology.
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Bacteria live in environments subject to rapid changes in the availability of the
nutrients necessary to provide energy and biosynthetic intermediates for the synthesis of
macromolecules. Consequently, bacterial survival depends on the ability to regulate
expression of genes coding for enzymes required for growth in the altered environment.
In pathogenic bacteria, adaptation to an altered environment often includes activating
transcription of virulence genes; hence, synthesis of many virulence determinants is
regulated by environmental/nutritional signals (e.g., nitrogen, iron, and calcium) [12].
Because PIA is the most important virulence determinant of S. epidermidis [3, 11, 13-16],
it is not surprising that PIA synthesis is regulated by environmental and nutritional
signals [17-21].
Regulation of the icaADBC operon is complex, involving at least two DNA
binding proteins (IcaR and SarA) and the alternative sigma factor σB
to the icaA transcriptional start site and represses transcription of the ica
operon [22, 23]. SarA is an essential positive effector of icaADBC transcription that binds
to the icaA promoter region [24, 25] σB affects PIA synthesis indirectly by regulating the
expression of icaR [26-28]. In addition, the luxS quorum-sensing system has a minimal
effect on PIA synthesis and biofilm formation; however, the mechanism remains to be
determined [29].
In Staphylococcus aureus, σB is activated during stress conditions and growth
phase transitions [30, 31]. Because S. epidermidis icaADBC transcription and PIA
synthesis are induced by environmental and nutritional stresses, stress-dependent
activation of σB has been a focal point of research into the environmental regulation of
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PIA synthesis and biofilm formation [24, 27, 32]. Importantly, σB does not respond
directly to environmental signals; therefore, a second area of research interest has focused
on identifying the regulatory network controlling σB activation, which is involved in
responding to environmental signals. The activation of σB involves an anti-sigma factor
(RsbW) and an anti-anti-sigma factor (RsbV) and resembles the process in the closely
related organism Bacillus subtilis [27]. In the absence of environmental stimuli, σB is
bound in a complex with RsbW. Stress-inducing stimuli are hypothesized to activate the
RsbU phosphatase to dephosphorylate (activate) the anti-anti-sigma factor RsbV, which
then binds RsbW in a competitive manner to increase the concentration of free σB [26,
27]. Based on several published studies, it seems likely that the σB posttranslational
regulatory network is responsible for responding to some environmental stresses (i.e.,
osmotic stress) but is only minimally involved in responding to nutritional signals (e.g.,
glucose), suggesting that there are other means for S. epidermidis o “

” nutritional

signals [19, 27, 28].
Previously, we observed the environmental and nutritional signals that enhance
PIA synthesis also repress tricarboxylic acid (TCA) cycle activity, leading us to
hypothesize that repression of TCA cycle activity would increase PIA accumulation [33].
To test this hypothesis, we incubated S. epidermidis strain 1457 with very low
concentrations of fluorocitrate, which minimally inhibited TCA cycle activity, and
determined the amount of cell-associated PIA. As the concentration of fluorocitrate in the
culture medium was increased, the amount of PIA produced increased proportionally
[33]. Fluorocitrate is a highly toxic compound when metabolized to 4-hydroxy-
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transaconitate by the TCA cycle enzyme aconitase, severely limiting the usable
concentration range [34, 35]. In the present study, we overcame this limitation by
genetically inactivating the aconitase gene in S. epidermidis strain 1457. The aconitase
mutant and complemented strains permitted a detailed analysis of the function of central
metabolism in PIA synthesis.

5.2 Materials and Methods
5.2.1 Bacterial strains, bacteriophage, plasmids, and growth conditions
Bacterial strains, bacteriophage, and plasmids used in this study are listed in Table
5.1. S. epidermidis strain 1457 [36] was used in these studies because it is a known PIA
and biofilm-producing strain. Escherichia coli strains were grown in 2x YT broth or on
2x YT agar [37]. S. aureus and S. epidermidis strains were grown in tryptic soy broth
without dextrose (TSB; BD Biosciences) supplemented with 0.25% glucose or on TSB
containing 1.5% (wt/vol) agar. S. epidermidis cultures were inoculated 1:200 from
overnight cultures (normalized for growth) into TSB, incubated at 37°C, and aerated at
225 rpm with a flask-to-medium ratio of 7:1. Bacterial growth was assessed by measuring
the optical density at 600 nm or by determining the number of CFU mL-1. Antibiotics
were purchased from Fisher Scientific or Sigma Chemical and were used at the following
concentrations: ampicillin (100 μg/mL for E. coli), chloramphenicol (8 μg/mL),
erythromycin (8 μg/mL), minocycline (2 μg/mL), and trimethoprim (10 μg/mL).
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Table 5.1. Bacterial strains, bacteriophage, and plasmids used in this study
Bacterial strain, bacteriophage,
or plasmid
Bacterial Strains
DH5α
RN4220
1457
1457-acnA

E.coli cloning host
S. aureus restriction-deficient strain 8325-4
S. epidermidis biofilm-forming strain
Strain 1457 acnA inactivated mutant; Minr

1457-citZC

Strain 1457 citCZ deletion mutant; Ermr

1457-∆ica
1457-icaR
1457-sigB
1457-sarA

Strain 1457 icaADBC deletion mutant; Tmpr
Strain 1457 icaR inactivated mutant; Minr
Strain 1457 sigB inactivated mutant; Tmpr
Strain 1457 sarA inactivated mutant; Minr

Invitrogen
[38]
[36]
This
study
This
study
[24]
[24]
[24]
[24]

Bacteriophage 71

S. epidermidis transducing phage

[39]

Expression vector; derivative of pSI-1; Camr
pBluescript II KS(+) with ermB inserted into ClaI site;
Ampr Ermr
Plasmid pCR2.1 containing tetM; Ampr Minr

Chia Lee
[40]

Plasmids
pCL15
pEC4
pJF12

pNF103

E. coli TA cloning vector; Ampr
pCL15 with acnA gene under the control of the Pspac
promoter; Camr
Derivative of pTS1-d with citZC::ermB fragment; Ampr
Camr Ermr
pUC19 with 1.7-kb internal fragment of acnA; Ampr

pNF117

pNF103 with tetM inserted into EcoRI site; Ampr Minr

pNF118

pRO6448::pNF117; Ampr Ermr Minr

pRO6448

pE194(ts) with AluI fragment (oriT) of pC221 cloned into
the unique ClaI site; Ermr
Shuttle vector; pE194orits; ColE1; Ampr Camr
o
o o
- o
region of ermC
E. coli cloning vector; Ampr

pGEM-T
pMRS2
pMRS5

pTS1
pTS1-d
a

Relevant propertiesa

pUC19

Source or
reference

J. Finan
and G.
Archer
Promega
This
study
This
study
This
study
This
study
This
study
[41]
[42]
This
study
[43]

Ampr, ampicillin resistant; Camr, chloramphenicol resistant; Ermr, erythromycin resistant;
Minr, minocycline resistant; Tmpr, trimethoprim resistant; ts, temperature-sensitive origin of
replication.
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Table 5.2. Oligonucleotide primers used in this study
o
663
o
664

……………………… GCGCGCGGCGCCGGGA A AAAATGGCTTCTA

……………………… GCGCGCC GCAGACCAGCAAGCGCATAAGCTA
SERP1762(glmM)- ……………… CACC GAA GGC
AAACTAGG
SERP1762(glmM)- ……………… CAACACGA A
G CAG CACTC
SERP1760(glmS)- ……………… G G GGAA G GG A A TGGC
SERP1760(glmS)- ……………… GCTTCACGTGATAATGTTGAACC
glmU- …………………………… CGATTATTCTGGCAGCAGGTAAG
glmU- …………………………… CGATTGATACGTTGTTGCAAAGC
o o
……………………GACAGTCGCTACGAAAAG
o
…………………… CCGAATAATTTGTAAATTTCC
icaR- ………………………………GGAGGCTCTAAAATACCAAGTCTC
pgi- ……………………………… GCATGAACTAGATCAGCAAAAGGATATTG
pgi- ……………………………… GCTGTAAGAACAGAATAACGACCTCC
sarA- ………………………………GGCTATTTCAAAAATCAATGACTGCTTTG
sarA- ………………………………GCTTCTGTGATACGGTTGTTTACTC
sigB- ………………………………CGAAAGAGTCGAAATCAGCTAGTG
sigB- ………………………………GTGAAACATGCATTTGACTAAGACC
SalI-SD-acnA-f……………………CTAAGTCGACAATATCAAGGGGGATATAAAA
TGGCTTC
SacI-acnA- ……………………… CAAGAGCTCATGACTG
CTTGTACTCAATAGTGAG
pCL15-f……………………………GTTCTACATCCAGAACAACCTCTGC
pCL15-r……………………………GAAATGATGACCTCGTTTCCACCG
citC-rB2………………………GACGTTCTGTACCTTCTTTAGGCGACTCATAGAAT
TATTTCCTCCC
citZ-fB…………………… …CACTTTGAGGAGTATGTGACGAAGGAGGGATTCG
TCATGTTG
phoP-B H ………………………GGAGGATCCACGTACAGTCTTTATCAATTTA
GGTTGC
ermB-citC2………………………GGAAATAATTCTATGAGTCGCCTAAAGAAGGTA
CAGAACGTCTAGTAAGAG
ansP………………………… GCAGAGCTCACTAAGTGTCGATGTAAATTTTA
TCGTGC
ermB-citZ…………………………GACGAATCCCTCCTTCGTCACATACTCCTCAAA
GTGCTTGTATAC
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5.2.2 Staphylococcus epidermidis mutant construction. Aconitase (acnA) mutant
A 1.7-kb internal PCR product of the acnA gene of S. epidermidis strain 1457 was
amplified using primers 663 forward (contains a KasI restriction site) and 664 reverse
(contains a PstI restriction site) (Table 5.2) and cloned into pGEM-T (Promega). The
1.7-kb PCR product was excised from pGEM-T by digestion with KasI and PstI and
ligated into the KasI and PstI sites of pUC19 [43] to generate the plasmid pNF103. The
tetM cassette from plasmid pJF12 (from J. Finan and G. Archer) was inserted into a
unique EcoRI site of pNF103 at nucleotide position 856 of the 2,702-bp acnA gene to
generate the pNF117 plasmid. The temperature-sensitive plasmid pROJ6448 [41] was
digested with PstI and ligated into the unique PstI site of pNF117. The resulting
temperature sensitive plasmid pNF118 was passaged through S. aureus strain RN4220
and introduced into S. epidermidis strain 1457 by electroporation [44]. Strain 1457
containing plasmid pNF118 was used to construct an acnA::tetM mutant as described
previously [45]. The resulting mutant was backcrossed into wild-type strain 1457 using
transducing phage 71 [39]. Inactivation of the acnA gene by tetM cassette was verified by
PCR, Southern blot analysis [46], and enzymatic assays [47].

5.2.3 Citrate synthase (citZ) and isocitrate dehydrogenase (citC) double mutant
The genes coding for citrate synthase and isocitrate dehydrogenase are present in
a two-gene operon and cotranscribed. To inactivate the citZC operon, a gene splicing by
overlap extension technique was used to replace a 2-kb internal DNA region of citZC by
the ermB gene. The ermB gene was amplified from pEC4 [40] using primers citC-r-
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ermB2 and citZ-f-ermB (Table 5.2), containing sequences homologous to the citC and
citZ genes. Genomic DNA from S. epidermidis strain 1457 was used as a template for
PCR amplification of the DNA flanking the internal citZC region. Primers ansP-SacI and
ermB-citZ-r (Table 5.2) were used for amplification of a 1.9-kb region of the citZ
upstream region. A 1.7-kb region of the citC downstream region was amplified using
phoP-BamHI and ermBcitC-f2 primers (Table 5.2). The resulting 4.6-kb PCR product
consisted of a 1-kb ermB gene with DNA flanking the internal citZC regions. The 4.6-kb
PCR product contained SacI and BamHI sites that were used for ligation into pTS1-d
digested with SacI and BamHI to generate pMRS5. The temperature-sensitive plasmid
pTS1-d is a derivative of pTS1 [42] with deletion of the plasmid-encoded

region of the

ermC gene. It was constructed by PCR amplification of pTS-1 DNA using primers
pTS1dErm-f and pTS1dErm-r, and the resulting PCR product was self-ligated as
described previously [48]. Plasmid pMRS5 was used to construct a strain 1457 citZC
double mutant (1457-citZC::ermB) [45]. Allelic replacement of the internal region of
citZC genes by the ermB cassette was verified by PCR and Southern blot analysis.

5.2.4 Construction of the complementation plasmid
Plasmid pCL15 (a kind gift of Chia Lee), containing a Pspac promoter, was used
for the construction of an acnA complementation plasmid. The pMRS2 complementation
plasmid was constructed by amplifying the 2.7-kb promoterless acnA gene from S.
epidermidis strain 1457 using SalI-SD-acnA-f and SacI-acnA-r primers, followed by
ligation of the PCR product into plasmid pCL15 digested with SalI and SacI. Plasmid
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pMRS2 was isolated from S. aureus strain RN4220 and electroporated into S. epidermidis
strain 1457 [44]. Plasmid pMRS2 was introduced into strain SE1457- acnA using
transducing phage 71 [38]. Induction of expression from the Pspac promoter was
performed by supplementing bacterial cultures with isopropyl-β-D-thiogalactopyranoside
(IPTG) (1 mM).
5.2.5 Measurement of acetic acid and glucose concentrations in culture medium
Aliquots of bacteria (2 mL) were centrifuged for 3 min at 14,000 rpm at 4°C, and
the supernatants were removed and stored at -20°C until use. Acetate and glucose
concentrations were determined with kits purchased from R-Biopharm and used
o

g o

’

oo o

5.2.6 Determination of NAD+, NADH, and ATP concentrations
Intracellular NAD+ and NADH concentrations were determined with an
enzymatic cycling assay kit (Biovision). Briefly, aliquots (5 to 20 mL) were harvested at
2, 3, 4, 5, and 6 h by centrifugation at 4°C for 10 min at 4,000 rpm. Bacterial pellets were
suspended in 1 mL of extraction buffer (Biovision) and lysed using lysing matrix B tubes
(Qbiogene) in a FastPrep instrument (Qbiogene). The lysate was centrifuged at 4°C for 5
min at 14,000 rpm. NAD+ and NADH concentrations were determined according to the
’

o ocol and normalized to the cell density. All assays were performed in

duplicate for two independent experiments.
Intracellular ATP concentrations were determined using the Enliten ATP assay
(Promega). Briefly, 2x107 bacteria were collected at 2, 3, 4, 5, and 6 h, washed three
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times with 1 mL of phosphate-buffered saline, and suspended in 100 μL of phosphatebuffered saline. Bacteria were lysed by the addition of 900 μL of dimethyl sulfoxide [49].
ATP concentrations were determined according to the manuf

’

oo o

normalized to the cell density. All assays were performed in duplicate for two
independent experiments.

5.2.7 Determination of aconitase activity
Cell-free lysates of S. epidermidis were prepared as follows: aliquots of bacteria
(2 mL) were harvested by centrifugation and suspended in 750 μL of lysis buffer
containing 90 mM Tris (pH 8.0) and 100 μM fluorocitrate. The samples were lysed using
lysing matrix B tubes (Qbiogene) in a FastPrep instrument (Qbiogene). The lysate was
centrifuged for 5 min at 14,000 rpm and 4°C. Aconitase activity was assayed in the
resulting cell-free lysate as previously described [50]. One unit of aconitase activity is
defined as the amount of enzyme necessary to give a ∆A240 min-1 of 0.0033 [51]. Protein
concentrations were determined by the method of Lowry [52].

5.2.8 PIA immunoblot assay
PIA accumulation was determined as described previously [33]. Briefly, TSB
medium containing 0.25% glucose was inoculated with equal numbers of bacteria from
overnight cultures. The cultures were grown at 37°C, with a flask-to-medium ratio of 7:1,
and aerated at 225 rpm. Every 2 h, equal numbers of bacteria (0.25 A600 unit) were
harvested by centrifugation, and the PIA was extracted in 0.5 M EDTA (pH 8.0) by
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boiling for 5 min. Aliquots of PIA were applied to a polyvinylidene difluoride membrane
(Immobilon-P; Millipore) and blocked with 5% skim milk overnight. The polyvinylidene
difluoride membrane was incubated for 2 h with PIA-specific antiserum (generously
provided by Michael Otto), which was followed by a 2 h incubation with an antirabbit
immunoglobulin G peroxidase conjugate. The presence of PIA was detected using Super
Signal West Pico chemiluminescent substrate (Pierce). The integrated density values of
bands on autoradiographs were determined with the TotalLab software (Nonlinear
Dynamics Ltd.)

5.2.9 Northern blot analysis
Northern blot analysis of transcripts was performed as described previously [37],
except that total RNA was isolated using the FastRNA Pro Blue kit (Qbiogene) and
purified using an RNeasy kit (Qiagen). Oligonucleotide primers (Table 5.2) used in
making DNA probes were designed using the S. epidermidis RP62A genome sequence
(GenBank accession number CP000029). Probes for Northern blotting were generated by
PCR amplification of unique internal regions of glmM, glmS, glmU, icaD, icaR, pgi,
sarA, and sigB genes and labeled using the North2South random prime labeling kit
(Pierce). Electrophoresis, transfer of the RNA to the Nytran SPC nylon membrane
(Whatman), and hybridization were done using the NorthernMax kit (Ambion). Detection
was performed using the chemiluminescent nucleic acid detection module (Pierce). When
necessary, reprobing of blots was done according to the

’

oo o
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5.2.10 NMR data collection, processing, and analysis
Nuclear magnetic resonance (NMR) samples were prepared from three
independent cultures (50 mL) of S. epidermidis strains 1457 and 1457-acnA during the
exponential growth phase (2 h) and post exponential growth phase (6 h) using
[13C6]glucose (Cambridge Isotope Laboratories) in place of glucose in the growth
medium. Bacteria were rapidly harvested, lysed using lysing matrix B tubes (Qbiogene)
in a FastPrep instrument (Qbiogene), and centrifuged to remove the cell debris. Samples
were lyophilized, suspended in a 99.8% D2O (Isotec) 50 mM phosphate buffer, and an
aliquot (500 μL) was transferred to an NMR tube for analysis.
The NMR spectra were collected on a Bruker 500-MHz Avance spectrometer
equipped with a triple-resonance, z-axis gradient cryoprobe. A BACS-120 sample
changer with Bruker Icon software was used to automate the NMR data collection. Twodimensional (2D) 1H-13C-heteronuclear single quantum coherence (1H-13C-HSQC)
spectra were collected with a Bruker pulse sequence (HSQCETGP), solvent
presaturation, and relaxation delay of 0.5 s. A total of 1,024 data points with a sweep
width of 4734.85 Hz and 64 data points with a sweep width of 13834.26 Hz were
collected in the 1H and 13C dimensions, respectively. A total of eight dummy scans and
128 scans were used to obtain each of the 2D 1H-13C HSQC NMR spectra. Spectra were
processed using the NMRPipe software package [53] and zero-filled with 2,048 and
1,024 points in the 1H and 13C dimensions, respectively. Additionally, the spectra were
Fourier transformed, manually phased, and baseline corrected.
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Spectra were analyzed using Primitive Interactive Peak Picker (PIPP) [54] to
determine chemical shifts and peak intensities. The chemical shifts were divided into
three groups (Tables 5.3 and 5.4) based on the intensities of similar peaks between the
wild-type and acnA mutant strains during the exponential and post exponential phases of
growth. Peak intensities were normalized for each spectrum by dividing by the average
peak intensity. The triplicate data sets were then used to calculate average peak intensities
for each peak observed in the 2D 1H-13C HSQC spectra for the wild-type and acnA
mutant. Similarly, a percent error was calculated for each peak by dividing the standard
deviation by the average peak intensity. The average peak intensities were then used to
calculate a percent difference between the wild-type and acnA mutant. Peaks with
calculated percent differences greater than five times the average percent error were
considered to have increased concentrations in the wild-type or acnA mutant strains.
Peaks with less than a fivefold deviation were considered similar. The peaks assigned to
the same metabolite were required to have the same relative change in intensity in order
to be classified as a metabolite with an increase in concentration.
NMR peaks were assigned to specific metabolites using the Madison
Metabolomics Consortium Database [55] using a tolerance of 0.05 ppm and 0.50 ppm for
1

H and 13C dimensions, respectively. The presence of metabolites and metabolic

pathways were verified with the KEGG [56] and Metacyc [57] databases. NMR reference
data available from the Madison Metabolomics Consortium Database is incomplete, so it
is currently not feasible to assign every NMR resonance observed in the 2D 1H-13C
HSQC NMR spectra to a S. epidermidis metabolite. It is also important to note that the
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Table 5.3. Summary of metabolic differences identified in
S. epidermidis strains by NMR after 2 h of growth
Increased intracellular
Similar intracellular conc. in
Increase intracellular conc.
conc. in the wild-type
wild-type and 1457-acnA
a
in strain 1457-acnA
a
strain 1457
strains
Lactic acid
Valine
Acetate
Succinate
Leucine
Glucose
Glutamate
Lysine
Glucosamine
Glutamine
Citrate
Ethanol
Asparagine
Serine
Glucose-6-phosphate
Aspartate
Arginine
Inosine
Fructose-6-phosphate
Adenosine
Glucono-1,5-lactone
Xanthosine
Acetaldehyde
N-Acetylglutamate
Isoleucine
NAD
Ornithine
Uridine
UDP-N-acetylglucosamine
Alanine
a
The intracellular concentration was considered to be increased when the percent
difference in the NMR peak intensities was fivefold greater than the percent error
observed in the peak intensities between the triplicate NMR spectra.

Table 5.4. Summary of metabolic differences identified in
S. epidermidis strains by NMR after 6 h of growth
Similar intracellular conc.
Increased intracellular conc. Increase intracellular conc.
in wild-type and 1457in the wild-type strain 1457a
in strain 1457-acnAa
acnA strains
Glutamine
Ethanol
Glucosamine-6-phosphate
Glutamate
Alanine
Glucose
Ornithine
Lactate
Ribose
Succinate
Acetaldehyde
Glucose-6-phosphate
Asparagine
Citrate
NAD
Aspartate
UDP-N-acetylglucosamine
UDP-glucuronate
γ-Aminobutanoate
Uridine
Ribose-5-phosphate
Isocitrate
Inosine
Fructose-6-phosphate
Adenosine
Xanthosine
a
The intracellular concentration was considered to be increased when the percent
difference in the NMR peak intensities was fivefold greater than the percent error
observed in the peak intensities between the triplicate NMR spectra.
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combination of 2D 1H-13C HSQC NMR spectra with isotopically enriched (e.g.,
[13C6]glucose) cellular extracts enables the measurement of accurate metabolite
concentration changes relative to one dimensional 1H NMR metabolomic methods alone.
Generally, only compounds that are metabolic products of [13C6]glucose were detected.

5.2.11 Statistical analysis
The statistical significance of changes between wild-type and mutant strains (e.g.,
A

o

o

’ t test. To determine whether a

correlation existed between two physiological parameters, a correlation coefficient (ρ)
was calculated.

5.3 Results
5.3.1 Construction and characterization of an S. epidermidis strain 1457 aconitase
mutant
Partial biochemical inhibition of TCA cycle activity in S. epidermidis increased
the accumulation of PIA [33]. Because fluorocitrate is very toxic, we were unable to
completely block TCA cycle activity without killing the bacteria. To overcome this
obstacle, we inactivated the TCA cycle in S. epidermidis strain 1457 by insertion of a
tetM cassette into the gene encoding aconitase (acnA; also known as citB) and then
assessed the effect on PIA synthesis. In S. epidermidis, aconitase is present as a sole copy
on the chromosome; hence, inactivation of aconitase results in a nonfunctional TCA
cycle. Inactivation of the aconitase gene in S. epidermidis strain 1457 by allelic
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replacement was genotypically verified by PCR and Southern blot analysis (data not
shown) and phenotypically by aconitase enzymatic activity assays (Figure 5.1a). In
addition, overall TCA cycle function was assessed by measuring the accumulation and
depletion of acetic acid from the culture medium of the wild-type, mutant, and
complemented strains (Figure 5.1d). (Acetic acid catabolism in staphylococci requires a
fully functional TCA cycle [47, 57].) As expected, aconitase inactivation inhibited the
post exponential oxidative catabolism of acetic acid (Figure 5.1d). Of importance, when
the concentration of acetic acid in the culture medium was plotted as a function of
growth, the exponential growth phase rates of acetic acid accumulation in strains 1457
and 1457-acnA were equivalent (data not shown), suggesting that carbon utilization in
both strains was proceeding through glycolysis and the acetate
kinase/phosphotransacetylase pathway at a similar rate. The equivalent rate of acetic acid
accumulation in strains 1457 and 1457-acnA was also supported by NMR metabolomic
analysis (Table 5.3). If carbon flow through glycolysis were equivalent, then it is
reasonable to predict that the growth rate of the wild-type and aconitase mutant strains
would also be equivalent.
Surprisingly, the growth rate of strain 1457-acnA was lower than the growth rate
of the isogenic wild-type strain, and this was reflected in the temporal depletion of
glucose (Figure 5.1c). This result was surprising because TCA cycle activity is repressed
during the exponential growth phase when nutrients are abundant; thus, inactivating a
repressed metabolic pathway should have minimal consequences. Restoration of the
growth rate and the ability to catabolize acetate was accomplished by complementation of
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Figure 5.1. Growth characteristics of the S. epidermidis strain 1457 aconitase mutant. a)
Aconitase activity of S. epidermidis strains 1457, 1457-acnA, and 1457-acnA containing
pMRS2 (1457-acnA _ pMRS2) was determined 6 h postinoculation. b) Growth curves of
wild-type strain 1457, aconitase mutant strain 1457-acnA, and strain 1457-acnA
containing the complementing plasmid pMRS2 grown in TSB containing 0.25% glucose.
At the indicated times, aliquots were removed, and the optical density at 600 nm
(O.D.600) was measured, and the pH of the culture medium was determined. c) Temporal
depletion of glucose from the culture medium of strains 1457, 1457-acnA, and 1457-acnA
containing pMRS2. d) Temporal accumulation and depletion of acetic acid in the culture
medium of strains 1457, 1457-acnA, and 1457-acnA containing pMRS2. The results are
representative of at least two independent experiments.
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the strain 1457-acnA mutation with a plasmid (pMRS2) containing the acnA gene under
the control of a Pspac promoter (Figure 5.1a to d). As a whole, these date demonstrate that
acnA was inactivated, and this resulted in a metabolic block in the TCA cycle.

5.3.2 TCA cycle inactivation redirects carbon from growth into UDP-Nacetylglucosamine biosynthesis
When grown in the presence of a rapidly catabolizable carbon source, grampositive bacteria repress the TCA cycle; hence, there is an accumulation of acidic
secondary metabolites (e.g., acetate) in the culture medium. Derepression of the TCA
cycle occurs upon depletion of the readily catabolizable carbon source(s) and coincides
with the depletion of acetate from the culture medium. The processing of glucose through
glycolysis and the resulting accumulation of acetate during substrate-level
phosphorylation were equivalent in S. epidermidis strains 1457 and 1457-acnA; hence,
the lower growth rate of strain 1457-acnA relative to the wild-type strain was likely due
to a redirection of carbon and energy from growth into other cellular processes or
metabolic pathways. If carbon and/or energy were diverted from growth to another
metabolic pathway or process, then the number of bacteria produced per unit of glucose
consumed should be lower in the aconitase mutant strain than in the wild-type strain.
Plotting the glucose concentrations in the culture medium as a function of optical density
at 600 nm for three independent experiments (Figure 5.2) confirmed that fewer bacteria
are produced per unit of glucose consumed by strain 1457-acnA than by strain 1457.
These data strongly suggest that carbon and/or energy were diverted from growth into
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Figure 5.2. TCA cycle inactivation redirects glucose carbons away from growth. The
concentrations of glucose in the culture medium of S. epidermidis strains 1457 and 1457acnA were plotted as a function of growth. The data are from three independent
experiments, and the line is a linear regression of these data generated using SigmaPlot
10.0. O.D.600, optical density at 600 nm.
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other cellular processes. To determine the metabolic pathways into which carbon might
be redirected, we utilized NMR metabolomics to assess the metabolic status of strains
1457 and 1457-acnA in the exponential growth phase (2 h) and the postexponential
growth phase (6 h) (Figure 5.3 and 5.4) (Tables 5.3 and 5.4). As expected, TCA cycle
inactivation decreased the intracellular concentration of amino acids derived from TCA
cycle intermediates (Asn, Asp, Gln, and Glu) and increased accumulation of the PIA
biosynthetic precursor UDP-N-acetylglucosamine. Interestingly, TCA cycle inactivation
resulted in an exponential-growth phase accumulation of branched-chain amino acids
relative to the wild-type strain (Figure 5.3) (Table 5.3). In addition to increasing the
carbon flow into branched-chain amino acid biosynthesis, the presence of a high
concentration of glucono-1,5-lactone in strain 1457-acnA suggests that inactivation of the
TCA cycle increased carbon flow into the pentose phosphate pathway.
NMR metabolomics indicated that TCA cycle inactivation redirected carbon into
UDP-N-acetylglucosamine biosynthesis (Tables 5.3 and 5.4). If carbon were being
redirected into UDP-N-acetylglucosamine biosynthesis, then it is likely that transcription
of genes coding for the UDP-N-acetylglucosamine biosynthetic enzymes would be
increased. To determine whether TCA cycle inactivation altered the transcription of
UDP-N-acetylglucosamine biosynthetic genes, we probed total RNA for pgi (glucose-6phosphate isomerase), glmS (glucosamine-6-phosphate synthase), glmM
(phosphoglucosamine mutase), and glmU (UDP-N-acetylglucosamine
pyrophosphorylase) (Figure 5.5). Consistent with metabolomic data indicating an
increased intracellular concentration of fructose-6-phosphate, transcription of pgi was
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Figure 5.3. NMR overlay spectra of S. epidermidis strain 1457 and strain 1457-acnA
grown for 2 hours. The spectrum for strain 1457 is displayed in red and the spectrum for
strain 1475-acnA is displayed in blue. Peaks of metabolites of interest are indicated
within the figure. The data are representative of spectra collected from three independent
cultures.

161

Figure 5.4. NMR overlay spectra of S. epidermidis strain 1457 and strain 1457-acnA
grown for 6 hours. The spectrum for strain 1457 is displayed in red and the spectrum for
strain 1475-acnA is displayed in blue. Peaks of metabolites of interest are indicated
within the figure. The data are representative of spectra collected from three independent
cultures.
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Figure 5.5. Northern blot analysis of UDP-N-acetylglucosamine biosynthetic genes in S.
epidermidis strains 1457 and 1457-acnA. At the indicated times during the growth cycle,
total RNA was isolated from strains 1457 and 1457-acnA, and Northern blot analysis was
performed using the indicated probes. To ensure that equivalent quantities of RNA were
loaded, 23S and 16S rRNA were visualized by ethidium bromide staining and used as
loading controls (bottom panel). The results are representative of at least two independent
experiments.
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slightly increased in S. epidermidis strain 1457-acnA relative to strain 1457 during the
exponential growth phase. (Glucose-6-phosphate isomerase catalyzes the second step in
glycolysis, specifically, the reversible isomerization of glucose-6-phosphate into fructose6-phosphate.) Fructose-6-phosphate is the biosynthetic precursor of UDP-Nacetylglucosamine, whose biosynthesis is encoded within the genes glmS, glmM, and
glmU. The exponential-growth-phase mRNA levels of glmS, glmM, and glmU were
increased in strain 1457-acnA relative to strain 1457. Taken together, these data
demonstrate that TCA cycle inactivation results in transcriptional changes that redirect
carbon into N-acetylglucosamine biosynthesis.
In addition to providing biosynthetic intermediates, the TCA cycle generates ATP
and reducing potential; therefore, a metabolic block in the TCA cycle will alter the
energy status of the bacterium. As an indicator of the energy status, the intracellular
concentrations of NAD+, NADH, and ATP were determined for S. epidermidis strains
1457 and 1457-acnA. The intracellular concentration of ATP was lower in the aconitase
mutant strain relative to the wild-type strain during both the exponential and post
exponential growth phases (Figure 5.6c). This decreased ATP concentration was likely
due to decreased oxidative phosphorylation, as the intracellular concentrations of NAD+
and NADH were significantly (P < 0.01) lower in the aconitase mutant strain than in the
wild-type strain (Figure 5.6a and b).
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Figure 5.6. Aconitase inactivation alters the redox and energy status of S. epidermidis.
a) At the indicated times during the growth cycle, intracellular concentrations of NAD
and NADH were determined in S. epidermidis strain 1457. b) Similarly, the
concentrations of reduced and oxidized NAD were determined for strain 1457-acnA. c)
ATP concentrations were determined for strains 1457 and 1457-acnA. The results are
presented as the means plus standard errors of the means (error bars) of duplicate
determinations for at least two independent experiments.
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5.3.3 TCA cycle inactivation increases PIA accumulation
To determine whether TCA cycle inactivation resulted in increased synthesis of
PIA, we assessed the relative amounts of cell associated PIA in the acnA mutant, the
complemented acnA mutant, and the wild-type strains using a PIA immunoblot assay
(Figure 5.7a and b). In addition, to facilitate comparison of the effect of TCA cycle
inactivation on PIA accumulation with the inactivation of well-established regulators
(i.e., IcaR, σB, and SarA), we determined the relative amounts of cell-associated PIA for
isogenic strains that had icaR, sarA, or sigB genetically inactivated. In agreement with
previous studies [22, 24, 25, 27, 32], we observed that mutations in the genes of positive
regulators sigB and sarA decreased PIA accumulation relative to the wild-type strain,
while inactivation of icaR increased PIA accumulation (Figure 5.7a and b). Surprisingly,
aconitase inactivation had a much greater effect on PIA synthesis than did inactivation of
the well-studied repressor IcaR (Figure 5.7a and b). Complementation of the acnA
mutation restores PIA accumulation to that seen in the parental strain (Figure 5.7a and b).
In B. subtilis, aconitase inactivation results in the accumulation of citric acid,
which is partially responsible for blocking sporulation and causing a slight decrease in
the growth rate [58]. NMR metabolomics revealed an accumulation of citric acid in the
aconitase mutant strain relative to the wild-type strain (Figure 5.3 and 5.4) (Tables 5.3
and 5.4), raising the possibility that the increased accumulation of PIA and the decreased
growth rate of S. epidermidis strain 1457-acnA relative to strain 1457 might be due to
citric acid-induced stress. To address these possibilities, we inactivated both citrate
synthase (citZ) and isocitrate dehydrogenase (citC) in S. epidermidis strain 1457 and
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Figure 5.7. TCA cycle inactivation increases PIA accumulation. a) Relative amounts of
cell-associated PIA were determined using a PIA immunoblot assay for S. epidermidis
strains 1457, 1457-acnA, 1457-sigB, 1457-sarA, 1457-icaR, and 1457-acnA containing
pMRS2 (1457-acnA + pMRS2). To determine the relative amounts of PIA, we defined
the amount of PIA produced by strain 1457 at 2 h in one experiment as 100% and
expressed all other amounts as relative to the amount at this 2-h point. The results are
presented as the means plus standard errors of the means (error bars) for three
independent experiments. b) Representative immunoblot used for determining spot
volumes. Strain 1457-∆ica, which does not synthesize PIA, was used to determine the
background density.
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assessed growth and assayed for PIA accumulation (data not shown). Similar to the
aconitase mutant strain, the citCZ double mutant dramatically increased PIA
accumulation. Additionally, the citCZ double mutant had a decreased growth rate relative
to the wild-type strain, but the growth rate was increased relative to strain 1457-acnA
(data not shown), suggesting that citric acid accumulation was partially responsible for
the slower growth of the aconitase mutant. Taken together, these data demonstrate that
TCA cycle activity represses S. epidermidis PIA accumulation and that this effect is
independent of citric acid.

5.3.4 TCA cycle activity represses icaADBC transcription
TCA cycle inactivation alters the metabolic status of S. epidermidis (Figure 5.1a
to d and 4.5 and Tables 5.3 and 5.4), raising the possibility that an icaADBC
transcriptional regulator could respond to the altered metabolic environment to increase
icaADBC transcription. To determine whether the increased accumulation of PIA by the
acnA mutant strain was due to altered icaADBC transcription, we examined icaADBC
mRNA levels in S. epidermidis strains 1457 and 1457-acnA. In addition, icaADBC
mRNA levels were determined for strain 1457 with mutations in sigB, sarA, or icaR.
Consistent with the PIA immunoblot data (Figure 5.7a and b), aconitase inactivation
resulted in a very large increase in icaADBC transcription, or mRNA stability, relative to
the isogenic wild-type strain (Figure 5.8a and b), demonstrating that TCA cycle activity
represses icaADBC transcription. In agreement with previous results, we observed that
sigB and sarA inactivation repressed icaADBC transcription and that icaR inactivation
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derepressed icaADBC transcription [22, 24, 59]. Interestingly, the extent of derepression
in the 1457-acnA mutant strain was dramatically higher than seen in an isogenic icaR
mutant (Figure 5.8a and b), suggesting TCA cycle activity has a greater role in regulating
icaADBC transcription than does IcaR. These data demonstrate that, like regulation of the
lac operon, icaADBC transcription is regulated by a catabolic process, specifically, the
TCA cycle.

5.3.5 TCA cycle inactivation alters transcription of icaR, sarA, and sigB
As stated, transcription of icaADBC requires at least two positive effectors, SarA
and σB, and one negative regulator, IcaR. The dramatic increase in icaADBC mRNA
levels in the aconitase mutant strain relative to the wild-type strain could be due to an
increased number of positive effectors or a decreased number of negative effectors. To
determine whether aconitase inactivation altered transcription of the known regulators of
icaADBC transcription, we probed total RNA isolated throughout the growth cycle for
changes in the transcription of sigB, sarA, and icaR (Figure 5.9).
Surprisingly, aconitase inactivation increased transcription or mRNA stability of
both positive regulators sigB and sarA and the negative regulator icaR. These data
suggest that TCA cycle inactivation can alter the mRNA levels of the known regulators
of PIA synthesis; however, they fail to establish that these regulators are involved in
TCA cyclemediated regulation of PIA synthesis. To determine whether IcaR, SarA, or σB
is regulating PIA synthesis in response to TCA cycle-associated metabolic changes, icaR,
sarA, and sigB regulatory mutants of strain 1457 were incubated with 400 μM of the
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Figure 5.8. TCA cycle inactivation derepresses icaADBC transcription. Total RNA was
isolated from S. epidermidis strains 1457 and 1457-acnA, 1457-sarA, 1457-icaR, and
1457-sigB, and Northern blot analysis was performed using an icaD-specific probe. To
make certain equivalent quantities of RNA were loaded, 23S and 16S rRNA were
visualized by ethidium bromide staining and used as loading controls (bottom blots). To
permit direct comparison of autoradiographs, total RNA from strains 1457-acnA and
1457 isolated at 6 h and 4 h postinoculation, respectively, were used to normalize the
exposure times. (To minimize variation, the same preparations of RNA were used as
exposure controls in all experiments.) The results are representative of at least two
independent experiments.
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Figure 5.9. Aconitase inactivation increases transcription of icaR, sarA, and sigB.
Northern blot analysis with icaR, sarA, and sigB with DNA probes generated using
primers shown in Table 5.2. To ensure that equivalent quantities of RNA were loaded,
23S and 16S rRNA were visualized by ethidium bromide staining and used as loading
controls (bottom blot). The results are representative of at least two independent
experiments.
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aconitase inhibitor fluorocitric acid, and PIA accumulation was assessed relative to the
parental strain 1457 (Figure 5.10) The addition of fluorocitric acid to the culture medium
of S. epidermidis strains 1457-sigB and 1457-icaR significantly (P < 0.01) increased the
accumulation of PIA relative to the untreated control cultures. In strain 1457-sarA, the
accumulation of PIA was similar irrespective of the presence of fluorocitric acid in the
culture medium (P > 0.05). Overall, these data suggest that TCA cycle-mediated
derepression of ica transcription and PIA synthesis occur independently of IcaR and σB.
Furthermore, these data confirm that PIA synthesis requires SarA (10, 74) and at least
one additional TCA cycle responsive negative regulator.

5.4 Discussion
5.4.1 Metabolic effect of TCA cycle activity on PIA biosynthesis
Glycolysis is the catabolic pathway that converts glucose into pyruvate, with the
catabolic fate of pyruvate being determined by the availability of oxygen. Interestingly,
the rate of glucose utilization by the wild-type S. epidermidis strain 1457 appears greater
than the rate by strain 1457-acnA (Figure 5.1c); however, these data fail to account for
the number of bacteria in the medium. When this is taken into account, glucose utilization
was greater in strain 1457-acnA than in strain 1457 (Figure 5.2 c), suggesting that carbon
flow through glycolysis might be greater in a TCA cycle mutant. If the amount of carbon
flowing through glycolysis were greater in a TCA cycle mutant than in the parental
strain, then the amount of acetate in the culture medium at the time when glucose was
depleted should be greater in the mutant. Glucose was depleted in the wild-type and
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Figure 5.10. Partial biochemical inhibition of aconitase increases PIA synthesis in sigB
and icaR mutants. Bacterial cultures were incubated with 400 μM fluorocitric acid and
grown for 2 h, and the relative amounts of cell-associated PIA were determined by a PIA
immunoblot assay. The data are presented as the means plus standard errors of the means
(error bars) from three independent experiments. Values that were significantly different
(P < 0.05) from the value for the isogenic untreated control (0 μM fluorocitrate) are
indicated by an asterisk.
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complemented strains after 5 h of growth; however, in strain 1457-acnA, glucose was
depleted after 7 h of growth (Figure 5.1c). Upon depletion of glucose, the concentrations
of acetate in the culture medium were similar (14 to 16 mM) for all strains (Figure 5.1d),
suggesting that carbon flow through glycolysis was similar in the aconitase mutant and
the wild-type strain. Additionally, because the concentrations of acetate were below 24
mM (if all glucose is processed through the glycolytic pathway, then a 2:1 stoichiometry
of acetate to glucose should be maintained), the data confirm that carbon are flowing into
other pathways. Consistent with these data, NMR metabolomics indicated that the
exponential-growth-phase concentrations of acetic acid in strains 1457 and 1457-acnA
were similar (Table 5.3). In addition to glycolysis, another major pathway staphylococci
use for glucose catabolism is the pentose phosphate pathway [60, 61]. The presence of
glucono-1,5- lactone in the NMR metabolomic data (Table 5.3) suggests that carbon flow
through the pentose phosphate pathway is increased in the TCA cycle mutant strain
relative to the wild-type strain. One function of the pentose phosphate pathway is to
provide the five-carbon intermediate for purine biosynthesis; hence, the increased carbon
flow through the pentose phosphate pathway is likely linked to the decreased intracellular
concentration of ATP in strain 1457-acnA relative to strain 1457 (Figure 5.5). (De novo
biosynthesis of ATP requires 5-phosphoribosyl-1-pyrophosphate. An important function
of the pentose phosphate pathway is to provide biosynthetic intermediates for purine
biosynthesis, namely, ribose-5-phosphate that is converted into 5-phosphoribosyl-1pyrophosphate.)
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NMR metabolomic data revealed an increased intracellular concentration of
fructose-6-phosphate in the TCA cycle mutant relative to the wild-type strain (Table 5.3).
Fructose-6-phosphate can undergo a transamination reaction to generate glucosamine-6phosphate, a reaction catalyzed by glucosamine-6-phosphate synthase (glmS; EC
2.6.1.16). Phosphoglucosamine mutase (glmM; EC 5.4.2.10) catalyzes the reversible
isomerization glucosamine-6-phosphate to glucosamine-1-phosphate. Glucosamine-1phophaste is the substrate for the bifunctional enzyme UDP-N-acetylglucosamine
pyrophosphorylase (glmU; EC 2.7.7.23 and EC 2.3.1.157) that catalyzes the acetylation
and UTP-dependent activation of glucosamine-1-phosphate to generate UDP-Nacetylglucosamine. NMR metabolomics confirmed that S. epidermidis strain 1457-acnA
has a greater intracellular concentration of UDP-N-acetylglucosamine than strain 1457
does. In addition, transcription of glmS, glmM, and glmU is increased more during the
exponential growth phase in the TCA cycle mutant than in the wildtype strain (Figure
5.5). In total, these data demonstrate that TCA cycle inactivation increased the
availability of the PIA monomer, UDP-activated N-acetylglucosamine and that this was
partially due to transcriptional derepression of N-acetylglucosamine biosynthetic genes.
In addition to PIA synthesis, UDP-N-acetylglucosamine is critical for biosynthesis
of the cell wall components teichoic acid and peptidoglycan. Inactivation of aconitase in
S. epidermidis decreased the growth rate (Figure 5.1b) and the number of bacteria
produced per unit of glucose (Figure 5.2), suggesting that UDP-N-acetylglucosamine was
redirected from cell wall biosynthesis to PIA synthesis (Figure 5.7a). Thus, the decreased
growth rate of the aconitase mutant strain was likely due to a combination of increased
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competition for substrate (i.e., UDP-N-acetylglucosamine) by PIA biosynthetic enzymes
and an accumulation of citric acid.

5.4.2 Regulatory effect of TCA cycle activity on PIA biosynthesis
Two common mechanisms by which bacteria control carbon flow are feedback
inhibition of enzyme activity and regulation of enzyme synthesis. Undoubtedly, some of
the metabolic changes arising from TCA cycle inactivation are the result of feedback
inhibition of enzyme activity; however, by definition, the derepression of icaADBC
transcription (Figure 5.8a and b) must be at the regulatory level. Although the prospect
that TCA cycle enzymes directly regulate icaADBC transcription is a possibility, it is
more likely that regulation is being mediated by regulatory proteins responding to
changes in the metabolic status of the bacteria. Metabolic regulation was one of the first
bacterial regulatory modalities identified, resulting in thousands of studies addressing all
aspects of regulation. This long history of research into metabolic regulation has
identified a large number of regulatory proteins capable of responding to changes in the
intracellular concentrations of molecules associated with TCA cycle activity, such as
NADH (e.g., Rex [62], NmrA [63], and CcpA [64]), citric acid (CcpC [65, 66]),
glutamate (GadX and GadW [67]), branched-chain amino acids (CodY [68]), and ATP
(KinA [69]). These observations lead us to hypothesize that a regulatory protein or
proteins respond to TCA cycle-associated metabolites and regulate icaADBC
transcription and PIA synthesis.
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TCA cycle inactivation increased the transcription or mRNA stability of the
known regulators of icaADBC transcription, specifically, sigB, sarA, and icaR (Figure
5.9). These data raise the possibility that TCA cycle-induced alterations in the metabolic
o

g

“

”

σB, SarA, or IcaR. Incubation of S.

epidermidis strain 1457-sigB with a low concentration of the TCA cycle inhibitor
fluorocitric acid restored PIA synthesis to wild-type levels (Figure 5.10). This
fluorocitrate- induced derepression of PIA synthesis in the sigB mutant strain is similar to
that observed in an S. epidermidis rsbU mutant strain (RsbU is an activator of σB) treated
with a PIA synthesis-stimulating concentration of ethanol [26]. In that study, the authors
found that ethanol could restore cell associated PIA accumulation in an rsbU mutant
strain to a level equivalent to that of the nonstimulated wild-type strain. Because ethanol
is an inhibitor of TCA cycle activity [70, 71], we hypothesize that the PIA synthesisstimulating properties of ethanol may be due to its TCA cycle inhibitory properties.
Inactivation of sarA in S. epidermidis dramatically decreases icaADBC
transcription [25] and PIA accumulation [24, 25] and results in a biofilm-negative
phenotype [32]. Because SarA is thought to be essential for PIA synthesis [25], the more
likely outcome of incubating S. epidermidis strain 1457-sarA with fluorocitric acid would
be equivalent PIA accumulation between the wild-type and sarA mutant strains. As
expected, the amount of PIA produced by strain 1457-sarA was similar irrespective of the
presence of fluorocitric acid (Fig. 8). These data are consistent with SarA being essential
for PIA synthesis and/or being required for responding to TCA cycle-associated signals.
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TCA cycle inactivation increased transcription or mRNA stability of icaR relative
to the wild-type strain (Figure 5.9). IcaR is a transcriptional repressor of icaADBC that
was originally hypothesized to be involved in environmental regulation of PIA synthesis
[22]. For these reasons, IcaR appeared to be a possible candidate for responding to TCA
cycle-induced metabolic changes. If IcaR were responding to TCA cycle-associated
metabolic changes, then in an icaR mutant background, the synthesis of PIA should be
unaffected by the presence of fluorocitric acid. Growth of strain 1457-icaR in the
presence of a low concentration of fluorocitric acid significantly increased the
accumulation of PIA (Figure 5.10), demonstrating that a second repressor is involved in
regulating PIA synthesis. It is likely that this second repressor is responding to TCA
cycle-associated metabolic signals.
NMR metabolomics (Table 5.3) indicated that the intracellular concentrations of
branched-chain amino acids were greater in the aconitase mutant strain than in the wildtype strain. In gram-positive bacteria, the intracellular concentrations of branched-chain
amino acids control the expression of numerous genes, a mechanism requiring the CodY
regulatory protein [68, 72, 73]. The affinity of CodY for its operator site is enhanced in
response to high intracellular concentrations of GTP and branched-chain amino acids [68,
74]. The more likely explanations for our data are that CodY is an activator of icaADBC
transcription, CodY-mediated repression is not functioning in S. epidermidis during the
exponential growth phase, or a positive effector, potentially SarA, can overcome CodY
mediated repression. We recently demonstrated that CodY is a repressor of PIA synthesis
in the closely related species S. aureus [48]; thus, it seems unlikely that CodY is an
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activator of icaADBC transcription in S. epidermidis. Investigations are under way to
determine the function of CodY in regulating S. epidermidis PIA synthesis.
In gram-positive bacteria, carbon catabolite repression is primarily mediated by
CcpA [75]. Recently, CcpA was shown to activate transcription of icaADBC and increase
the accumulation of PIA in S. aureus [76]. In B. subtilis, CcpA regulatory activity is
controlled by interactions with phosphorylated HPr or Crh and fructose-1,6-bisphosphate
or glucose-6-phosphate [77]. NMR analysis indicated that TCA cycle inactivation
increased the intracellular concentration of fructose-6-phosphate (Table 5.3). Fructose-6phosphate is the biosynthetic precursor of UDP-N-acetylglucosamine. In addition to its
importance in PIA biosynthesis, fructose-6-phosphate can be reversibly isomerized to
glucose-6-phosphate by glucose-6-phosphate isomerase, resulting in CcpA activation.
Taken together, these data lead us to hypothesize that TCA cycle inactivation increases
CcpA-mediated activation of icaADBC.

5.5 Conclusion
TCA cycle activity is repressed during the exponential growth phase; however, a
basal level of activity is present. As evidenced by the data in this study, disruption of this
basal activity can have pronounced metabolic consequences. TCA cycle activity is
regulated by the availability of nutrients, oxygen, and iron [60, 78-81] and by certain
stress-inducing stimuli, such as heat, ethanol, and antibiotics [70, 82, 83]; thus, numerous
external conditions can interfere with the basal TCA cycle activity and produce metabolic
changes. The linkage of TCA cycle activity and exopolysaccharide synthesis and the
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susceptibility of the TCA cycle to environmental inactivation lead us to speculate that
one mechanism by which staphylococci perceive external environmental change is
through alterations in TCA cycle activity. Thus, we hypothesize that the TCA cycle acts
as a novel signal transduction pathway to translate external stimuli/conditions into
intracellular signals that can stimulate or repress the activity of regulatory proteins like
CodY and CcpA.
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CHAPTER 6
USING NMR METABOLOMICS TO INVESTIGATE TRICARBOXYLIC
ACID CYCLE-DEPENDENT SIGNAL TRANSDUCTION IN
STAPHYLOCOCCUS EPIDERMIDIS§

6.1 Introduction
Staphylococcus epidermidis is a skin-resident, opportunistic pathogen that is the
leading cause of hospital-associated infections [1]. Although the type and severity of
diseases produced by this bacterium varies, its most common infectious manifestation is
associated with implanted biomaterials. The dramatic environmental changes that occur
during the transition from being skin-resident to residing on implanted biomaterials
necessitates the need for changes in the expression of genes coding for enzymes required
for growth in the new environment. This environmental adaptation often includes
activating transcription of virulence genes; hence, most virulence genes are regulated by
environmental and nutritional signals [2]. Accordingly, a major area of interest in
microbiology is determining how bacteria “sense” and respond to environmental signals.
Given the tremendous diversity of microbial life, it is not surprising that the mechanisms
bacteria employ are equally diverse. These mechanisms include two-component
regulatory systems, alternative σ factors, mechanosensors, small RNAs, riboswitches, and

§
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many others. Although remarkable advances have been made in identifying the response
regulators, our knowledge of signaling mechanisms has lagged behind, the exception
being cell-density signaling.
The tricarboxylic acid (TCA) cycle has been implicated as regulating or affecting
staphylococcal virulence and/or virulence determinant biosynthesis [3-9]. The TCA cycle
has three primary functions: (i) to provide biosynthetic intermediates, (ii) to generate
reducing potential, and (iii) to directly produce a small amount of ATP. The availability
of biosynthetic intermediates affects the availability of amino acids and nucleic acids.
Increasing the reducing potential alters the bacterial redox balance, necessitating
oxidation reactions via the electron transfer chain. The small amount of ATP produced
directly by the TCA cycle is amplified many times when the ATP generated by oxidative
phosphorylation is considered. In short, the TCA cycle has a central function in
maintaining the bacterial metabolic status. Importantly, the activity of TCA cycle
enzymes is affected by the availability of nutrients and a variety of stress inducing stimuli
[9-12]; thus, the availability of biosynthetic intermediates, the redox status, and the
energy status can be altered by nutritional and environmental stimuli. These observations
led us to propose a fourth function for the TCA cycle, the transduction of external signals
into intracellular metabolic signals that can be “sensed” by metabolite-responsive
regulatory proteins [2]. Fundamental to this hypothesis are the predictions that disparate
environmental stimuli will cause common metabolic changes and that these metabolic
changes will precede regulatory changes.
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Two of the more extensively studied environmental stimuli that influence S.
epidermidis virulence determinant biosynthesis are iron limitation [13, 14] and ethanol
stress [15, 16]. The effect of iron limitation on bacterial growth is primarily through
preventing the activity of enzymes that require iron as a cofactor and altering
transcription of iron-regulated genes [2]. As S. epidermidis has many iron-requiring
enzymes (e.g. aconitase, serine dehydratase, peptide deformylase, iron-containing alcohol
dehydrogenase, nitrate reductase, etc.), it is reasonable to expect that the metabolic
effects of iron-limited growth are diverse and not restricted to the TCA cycle. Ethanol
denatures proteins in the cytoplasmic membrane, causing changes in membrane
permeability, which can lead to the loss of membrane integrity [17]. With the exception
of the succinate dehydrogenase complex, most TCA cycle enzymes are not membraneassociated; hence, it is reasonable to predict that the deleterious effects of ethanol stress
are largely independent of the TCA cycle. Taken together, these observations suggest that
disparate environmental conditions will cause divergent metabolomic changes. In
contrast to this suggestion, our central hypothesis predicts that different stresses will
cause common metabolomic changes that are dependent on the TCA cycle. To test our
central hypothesis, we chose to induce environmental stress by growing bacteria in an
iron-limited medium or in a medium containing ethanol and assessing the metabolic
changes using NMR metabolomics.
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6.2 Experimental Procedures
6.2.1 Bacterial Strains, Media, and Growth Conditions
S. epidermidis wild-type strain 1457 [18] and the isogenic aconitase mutant strain
1457-acnA::tetM (tetM cassette inserted into position 856 of the 2,702-bp acnA gene) and
σB mutant strain 1457-sigB::dhfr [7, 19] have been described. Strains 1457-codY, 1457ccpA, 1457-acnA-codY, and 1457-acnA-ccpA were constructed using the gene splicing by
overlap extension (gene SOEing) technique [20] to replace the gene of interest with an
antibiotic resistance marker (i.e. ermB or tetM). Primers were designed to amplify ~1-kb
regions upstream and downstream of the gene of interest based on the genome sequence
of S. epidermidis strain RP62A. Gene knockouts were confirmed by PCR and Southern
blot hybridization. In addition, strains containing mutations in the single S. epidermidis
aconitase gene were assayed to ensure that no aconitase activity was detected (data not
shown). All strains were grown in tryptic soy broth without dextrose (TSB;4 BD
Biosciences) supplemented with 0.25% glucose (Sigma) or 0.25% 13C6-glucose
(Cambridge Isotope Laboratories). Deferrated TSB (DTSB) was prepared by adding 50 g
of Chelex 100 (Sigma) to ~1 liter of TSB and stirring at 4 °C for 20 h. After 20 h, the
Chelex resin was removed, 1mM MgSO4 was added, the volume was adjusted to 1 liter,
and the medium was filter-sterilized. To induce ethanol stress and minimize growth
defects, ethanol or deuterated ethanol (Isotec) was added to the medium at a final
concentration of 4% (v/v). All cultures were inoculated 1:200 from overnight cultures
(normalized for growth) into glucose supplemented TSB, incubated at 37 °C, and aerated
at 225 rpm with a flask-to-medium ratio of 7:1. Bacterial growth was assessed by
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measuring the optical density at 600 nm (A600). Antibiotics, when used, were purchased
from Fisher Scientific or Sigma and used at the following concentrations:
chloramphenicol (8 μg/mL), trimethoprim (10 μg/mL), and erythromycin (8 μg/mL).

6.2.2 Aconitase Activity Assay
Cell-free lysates of S. epidermidis were prepared as follows. Aliquots (3 mL)
were harvested by centrifugation (1 min at 20,800 x g) at the indicated times, suspended
in 1.5 mL of lysis buffer containing 90 mM Tris (pH 8.0) and 100 μM fluorocitrate. The
samples were lysed in 2-mL screw cap tubes containing lysing matrix B using a FastPrep
instrument (MP Biomedicals). The lysate was centrifuged for 5 min at 20,800 x g at 4 °C.
Aconitase activity in the resulting cell-free lysate was assayed by the method described
by Kennedy et al. [21]. One unit of aconitase activity is defined as the amount of enzyme
necessary to give a ∆A240 min-1 of 0.0033 [22]. Protein concentrations were determined
by the Lowry method [23].

6.2.3 Northern Blot Analysis
Northern blot analysis of transcripts was performed as described [7].
Oligonucleotide primers used in making DNA probes were designed using the S.
epidermidis RP62A genome sequence. Probes for Northern blotting were generated by
PCR amplification of unique internal regions of RNAIII and glnA (femC) genes using the
following primers: femC, orward

-
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GATGTTTGATGGTTCATCTATTGAAGGTTTCG-

em

GCAGTATCAGTCAATTGTAAATCACCTTCAG-

reverse

-

orward

-

- ; and RNAIII, reverse, - . DNA probes were labeled using the
North2South random prime labeling kit (Pierce). Electrophoresis, transfer of the RNA to
the Nytran SPC nylon membrane (Whatman), and hybridization were done using the
NorthernMax kit (Ambion). Detection was performed using the chemiluminescent
nucleic acid detection module (Pierce).

6.2.4 PIA Immunoblot Assay
PIA accumulation was determined as described [24].

6.2.5 NMR Sample Preparation
NMR samples for one-dimensional 1H spectra were prepared from 10
independent, 25mL S. epidermidis cultures. Two-dimensional 1H-13C HSQC [25, 26] and
two-dimensional 1H-1H TOCSY [27] spectra were prepared from three independent
50mL cultures. The TSB medium used in the two-dimensional 1H-13C HSQC analysis
contained 0.25% 13C6-glucose (Cambridge Isotope Laboratories). For two-dimensional
1

H-13C HSQC and two-dimensional 1H-1H TOCSY involving ethanol stress, deuterated

ethanol (Isotec) was used to minimize the contribution of exogenous ethanol to the NMR
spectra. For one-dimensional 1H NMR experiments, 2.74 A600 units were harvested at
each time point, and for the two-dimensional 1H-13C HSQC and two-dimensional 1H-1H
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TOCSY experiments, 5.48 A600 units were collected. Bacteria were harvested by
centrifugation (4,000 rpm for 5 min), suspended in 50 mM phosphate buffer in 100%
D2O at pH 7.2 (uncorrected), and lysed using lysing matrix B tubes and a FastPrep
instrument. The lysates were centrifuged to remove cell debris and glass beads and then
frozen in liquid nitrogen. All samples were kept at -80 °C until ready for analysis. At the
time of use, a 600 μL aliquot of the cell-free lysate was transferred to each NMR tube.

6.2.6 NMR Analysis
The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer
equipped with a triple resonance, z axis gradient cryoprobe. A BACS-120 sample changer
with Bruker Icon software was used to automate the NMR data collection. The onedimensional 1H NMR spectra collection and principal component analysis (PCA) were
performed as described with minor modifications [28-30]. Briefly, each multidimensional
NMR spectrum (chemical shifts and peak intensities) was converted to a single point in a
multidimensional Cartesian space. Conceptually, each axis corresponds to a specific
chemical shift, where the peak intensity is the value along the axis. PCA identifies a
principal component vector (P1) corresponding to the largest variation in the data set
within this multidimensional space. The second vector (P2) is orthogonal to the first and
represents the next largest variation in the data set. Each successive vector describes a
diminishing amount of the variability of the data set, where most of the variability is
described by the first two principal components. The PC1 and PC2 scores (unitless
values) are effectively the individual fit of each NMR spectrum to P1 and P2. The PC1
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and PC2 scores are usually presented in a two-dimensional plot, where similar NMR
spectra cluster together.
Solvent presaturation used excitation sculpting to efficiently remove the solvent
and maintain a flat baseline, eliminating any need for baseline collection that may induce
artifacts in the two-dimensional scores plot [31]. Each NMR spectrum was centeraveraged for PCA to minimize any experimental variations between cultures [32].
Two-dimensional 1H-13C HSQC spectra were collected and processed as
described previously [7]. Two-dimensional 1H-1H TOCSY spectra were collected with
WATERGATE solvent presaturation [33] and a relaxation delay of 2 s. A total of 1,024
data points with a sweep width of 5,000 Hz and 256 data points with a sweep width of
5,001.324 Hz were collected in the direct and indirect 1H dimensions, respectively. A
total of 16 dummy scans and 8 acquisition scans were used to obtain each of the twodimensional 1H-1H TOCSY NMR spectra. The two-dimensional 1H-1H TOCSY NMR
spectra were processed similar to the two-dimensional 1H-13C HSQC spectra, and both
spectra were analyzed using NMRView (One Moon Scientific [34]) and Sparky [35] to
identify chemical shifts and assign peak intensities.
The observed NMR peaks in the two-dimensional 1H-13C HSQC and 1H-1H
TOCSY spectra were assigned to specific metabolites using 1H and 13C chemical shift
tolerances of 0.05 and 0.50 ppm, respectively, and the Madison Metabolomics
Consortium Database (MMCD) [36], the BioMagResBank [37], and the Human
Metabolome Database [38]. The presence of metabolites and metabolic pathways were
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verified with the Kyoto Encyclopedia of Genes and Genomes (KEGG) [39] and the
MetaCyc [40] databases.
Peak intensities were normalized for each two-dimensional NMR spectrum by
dividing by the average peak intensity. The triplicate data sets were then used to calculate
average intensities for each peak observed in the two-dimensional spectra for strain 1457,
1457-acnA, ethanol stress, and iron limitation. A percentage of error was calculated for
each peak by dividing the standard deviation by the average peak intensity. The average
peak intensities were then used to calculate a percentage of difference relative to the
wild-type bacteria in TSB medium. Peaks with calculated percentage of differences
greater than five times the average percentage of error were considered to have either
decreased or increased concentrations relative to the wild-type strain 1457. Peaks with
less than a 5-fold deviation were considered similar. Secondary peaks assigned to the
same metabolite were required to have the same relative change in intensity to be
classified as a metabolite with an increase or decrease in concentration.

6.2.7 Metabolomic Dendrogram
The relative clustering patterns in the PCA two-dimensional scores plots were
quantitatively analyzed using a tree diagram and bootstrapping technique [41]. The PC1
and PC2 scores for each set of 10 duplicate NMR spectra representing a specific
metabolic state (iron limitation, ethanol treatment, etc.) were used to calculate an average
PC score and standard deviation. Any PC scores outside 2 standard deviations were
removed, and a new average was calculated. The average PC scores represent the center
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of a cluster of NMR spectra (metabolic state) in the two-dimensional scores plot. The
process is repeated for each set of 10 duplicate NMR spectra. Distances between the
average PC positions for each metabolic state are then calculated using the standard
equation for a Euclidean distance to create a distance matrix.
To assess the significance of the similarity (overlap) or difference (separation)
observed between pairs of clusters in the two dimensional scores plot, standard
bootstrapping methods were also applied [42, 43]. Briefly, the average PC scores were
recalculated by randomly selecting points from the data set. Distances were recalculated
between the clusters using the new average PC scores to create a new distance matrix.
The process was repeated until 100 different distance matrices were created and
transferred to version 3.68 of the PHYLIP [44] suite of software programs. PHYLIP
calculates a tree for each distance matrix and then determines a consensus tree. The
program calculates a bootstrap value for each node, which is simply the number of times
the node appears in all 100 trees. Bootstrap values below 50% imply a statistically
insignificant separation. Conversely, as the bootstrap number increases above 50%, the
confidence in the tree branch or separation increases.

6.3 Results
6.3.1 Disparate Environmental Stresses Create a Metabolic Block in the TCA Cycle
To determine whether ethanol stress and iron limitation alter TCA cycle activity,
the specific activity of aconitase in S. epidermidis strain 1457 at 2 (exponential growth)
and 6 h (post-exponential growth) after inoculation was assessed (Figure 6.1). As
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Figure 6.1. The temporal induction of aconitase-specific activity is inhibited by
dissimilar stressors. Aconitase activity was assessed during the exponential (2 and 4 h)
and post-exponential (6 h) growth phases during growth in DTSB or TSB containing 4%
ethanol. The data are presented as the mean and S.E. of two independent experiments
each determined in triplicate.
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expected, iron-limited growth and ethanol stress prevented the post-exponential growth
phase increase in the specific activity of the iron-requiring enzyme aconitase, creating a
metabolic block in the TCA cycle (Figure 6.1). Although ethanol-stressed bacteria are in
the post-exponential growth phase at 6 h after inoculation, their growth is slower, which
slows the consumption of glucose, and excess glucose can repress transcription of TCA
cycle genes. Irrespective of the mechanism by which ethanol repressed aconitase-specific
activity, the normal post-exponential growth phase increase in TCA cycle activity did not
occur. These data demonstrate that environmental stresses whose deleterious effects are
substantially different from one another have a similar effect on TCA cycle function.

6.3.2 Environmental Stimuli Elicit TCA Cycle-dependent Metabolic Changes
The TCA cycle provides biosynthetic intermediates, ATP, and reducing potential;
therefore, alteration of TCA cycle activity will alter the metabolic status of a bacterium.
To determine the metabolic changes associated with iron limitation, ethanol stress, and
TCA cycle inactivation, NMR metabolomic analysis (28, 29) was used to assess the
stressed and non-stressed metabolomes of strains 1457 and the TCA cycle inactive strain
1457-acnA. Specifically, S. epidermidis strains 1457 and 1457-acnA were grown for 2 or
6 h in TSB, TSB with 4% ethanol, or DTSB. Following acquisition of the NMR spectra,
the table of integrals was used for PCA (Figure 6.2a). As expected, during the
exponential growth phase, PCA revealed that the effects of ethanol stress and iron
limitation on the metabolome were largely independent of the TCA cycle (Figure 6.3).
This was expected due to the normal repression of TCA cycle activity during nutrient-
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Figure 6.2 Environmental stressors cause metabolomic perturbations similar to TCA
cycle inactivation. a) PCA two-dimensional scores plot comparing non-stressed, ethanolstressed, or iron-limited cultures of strains 1457, 1457-acnA, and 1457-sigB::dhfr grown
for 6 h. Symbols and colors are defined in the figure. The ovals are manually drawn to
identify clusters of related samples and to guide the reader. They are not statistically
relevant. The relative contribution of each principal component is indicated in the
parentheses. b) metabolic tree generated using the PCA scores plot data demonstrating
the relationship between stresses and strains. Bootstrap values are indicated on the
dendrogram branches. Bootstrap values below 50% imply a statistically insignificant
separation; conversely, as the bootstrap number increases above 50%, the confidence in
the tree branch or separation increases.
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Figure 6.3. PCA 2D scores plot comparing non-stressed, ethanol stressed, or iron-limited
cultures of strains 1457, 1457-acnA, and 1457-sigB::dhfr grown for 2h. Symbols and
colors are defined in the figure.
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Table 6.1. Metabolites that have increased or decreased concentrations relative to the
wild-type strain 1457 at 2 h after inoculation.
Strain 1457a
Strain 1457a
Strain 1457-acnAa
(DTSB)
(4% Ethanol)
(TSB)
Iron-limitation
Ethanol stress
TCA cycle inactivation
Metabolites whose concentration is increased relative to strain 1457 grown in TSB medium.

Acetyl-phosphate

Acetyl-phosphate

Acetaldehyde
Acetyl-phosphate
Citrate
Glyceraldehyde

Metabolites whose concentration is decreased relative to strain 1457 grown in TSB medium.

Acetyl-glutamateb
Asparagine
Glutamate
Lactate
Lactate
Glutamine
Glutamine
Glutamine
Succinate
Succinate
Succinate
a
The intracellular concentration was considered to be increased or decreased when the
percentage of difference in the NMR peak intensities was 5-fold greater than the
percentage of error observed in the peak intensities between triplicate NMR spectra.
b

Due to peak overlap, we are unable to determine whether the metabolite is
acetylglutamine or acetyl-glutamate; however, we note that acetyl-glutamine is
uncommon in prokaryotes.
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Table 6.2. Metabolites that have increased or decreased concentrations relative to the
wild-type strain 1457 at 6 h after inoculation.
Strain 1457a
Strain 1457a
Strain 1457-acnAa
(DTSB)
(4% Ethanol)
(TSB)
Iron-limitation
Ethanol stress
TCA cycle inactivation
Metabolites whose concentration is increased relative to strain 1457 grown in TSB medium

Acetaldehyde
Acetate
Acetylalanine
N-Acetyl-glucosamine

Acetaldehyde
Acetate

N-Acetyl-mannosamine
N-Acetyl-neuraminate
Acetyl-phosphate

N-Acetyl-glucosamine
Aceytl-glucosamine 6phosphate
N-Acetyl-mannosamine
N-Acetyl-neuraminate
Acetyl-phosphate

Ethanol
Glucosamine

Glucosaminec

GDP
Glucose
Glucose-1-phosphate
Glucose-6-phosphate
Glyceraldehyde
Lactate
c

Ribose

GDP
Glucose
Glucose-6-phosphate
Glyceraldehyde
Lactate
Myo-inositol
Ribose
UDP-N-acetyl-glucosamine

Acetaldehyde
Acetate

N-Acetyl-mannosamine
N-Acetyl-neuraminate
Acetyl-phosphate
Arginine
Citrate
Glucosamine
Galactose-1-phosphate
Glucose
Glucose-6-phosphate
Glyceraldehyde
Lactate
Proline
Ribose

Metabolites whose concentration is decreased relative to strain 1457 grown in TSB medium

α-ketoglutarate
γ-aminobutryate
Acetyl-glutamateb

α-ketoglutarate
γ-aminobutyrate
Acetyl-glutamateb

α-ketoglutarate
γ-aminobutyrate
Acetyl-glutamateb
Acetyl-ornithine
Alanine

Arginine
Asparagine

Asparagine

Asparagine
Aspartate
B-alanine
Citrulline
Ethanol
Fructose-6-phosphate
Glutamate

B-alanine
Citrulline
Fructose-6-phosphate
Glutamate

B-alanine
Citrulline
Ethanol
Fructose-6-phosphate
Glutamate
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Table 6.2. Continued
Glutamine
Isocitrate
Methionine
NAD+
Ornithine
O-succinyl-L-homoserine
Proline

Glutamine
Isocitrate
Methionine
NAD+
Ornithine
O-succinyl-L-homoserine
Proline

S-Adenosyl-L-methionine

S-Adenosyl-L-methionine

Glutamine
Isocitrate
Methionine
Ornithine
O-succinyl-L-homoserine
S-Adenosyl-Lmethionine

Sedheptulose
Selenomethionine
Selenomethionine
Selenomethionine
UDP-N-acetylglucosamine
a
The intracellular concentration was considered to be increased or decreased when the
percentage of difference in the NMR peak intensities was 5-fold greater than the
percentage of error observed in the peak intensities between triplicate NMR spectra.
b

Due to peak overlap, we are unable to determine whether the metabolite is
acetylglutamine or acetyl-glutamate; however, we note that acetyl-glutamine is
uncommon in prokaryotes.
c

The percentage of difference in the NMR peak intensities of these metabolites fell just
below the 5-fold cutoff in the percentage of error observed in the peak intensities
between the triplicate NMR spectra.
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rich growth (Figure 6.1) [8, 45]. Despite the TCA cycle being repressed during the
exponential growth phase, the different stresses induced common metabolomic changes
(Table 6.1). In contrast to the exponential growth phase, PCA of post-exponential growth
phase metabolomes revealed that ethanol stress and iron limitation induced metabolomic
changes very similar to TCA cycle inactivation (Figure 6.2a and Table 6.2). In addition,
these data highlight the relative insensitivity of the metabolome of strain 1457-acnA to
ethanol stress and iron-limited growth, confirming that the major effect of these stressors
is dependent upon the TCA cycle. That being said, the more diffuse clustering of ethanol
stressed metabolomes of both the wild-type and the aconitase mutant strains suggest that
ethanol stress had TCA cycle-independent metabolomic effects (Figure 6.2a). The TCA
cycle-independent effects are likely due to the denaturation of membrane proteins not
related to electron transport or the TCA cycle. Taken together, these data demonstrate
that diverse environmental stimuli elicit common metabolic changes that require the TCA
cycle.
The common metabolomic response to environmental stimuli can be more easily
observed by a recently developed method to visualize PCA data [41]. By calculating an
average position for each data set, such that each PC value (PC1, PC2, etc.) is treated as
an axis in a Cartesian coordinate system, a distance matrix can be generated.
Correspondingly, methods developed for representing genetic distances in phylogenetic
trees can be used to create a metabolomic dendrogram [44] (Figure 6.2b). Using this
approach, it becomes clear that stress-induced metabolomics responses are very similar to
the metabolome of the aconitase-deficient strain 1457-acnA. As with the two-dimensional
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scores plot (Figure 6.2a), the higher bootstrap values in the dendrogram for ethanolstressed cultures also indicate that ethanol has TCA cycle-independent effects on the
metabolome.
S. epidermidis grown in TSB under aerobic conditions have two distinct
metabolic states: the nutrient-rich exponential phase and the nutrient-limited postexponential phase. The transition from nutrient-rich conditions to nutrient-limited growth
coincides with the transition from generating ATP by substrate-level phosphorylation to
using oxidative phosphorylation. The reduced dinucleotides that drive oxidative
phosphorylation are primarily derived from the TCA cycle; thus, inhibiting TCA cycle
activity (Figure 6.1) hinders the transition to oxidative phosphorylation and the postexponential growth phase [8, 45]. Iron-limited growth of strain 1457 or aconitase
inactivation did not significantly alter the growth rate, although aconitase inactivation did
increase the lag phase (data not shown). Both aconitase inactivation and iron-limited
growth caused an early entry into the stationary phase; as such, the growth yield was
decreased. As stated, the addition of 4% ethanol decreased the growth rate; therefore, it
slowed the consumption of glucose. Based on these observations, it was reasonable to
hypothesize that post-exponential growth phase (6 h)-stressed metabolomes will be more
similar to an unstressed exponential growth phase (2 h) metabolome than to the
unstressed metabolome of post-exponential growth phase of cultures. As expected, PCAs
of unstressed strain 1457 cultures, grown for 2 or 6 h, form separate subsets in a threedimensional scores plot (Figure 6.4). Consistent with our hypothesis, PCAs of postexponential growth phase-stressed and acnA mutant cultures were more closely
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Figure 6.4. PCA three-dimensional scores plot comparing non-stressed, ethanol-stressed,
or iron-limited cultures of strains 1457 grown for 6 h with that of strain 1457 grown for
2h. Symbols and colors are defined in the figure. The ovals are manually drawn to
identify clusters of related samples and to guide the reader. They are not statistically
relevant. The relative contribution of each principal component is indicated within the
parentheses.
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associated with the unstressed exponential growth phase metabolome of strain 1457 than
with the strain 1457 post-exponential growth phase metabolome (Figure 6.4). These data
suggest that any stress that interferes with TCA cycle function results in a metabolome
similar to an unstressed exponential phase culture.

6.3.3 Metabolomic Changes Are Largely Independent of the σB-mediated General Stress
Response
In staphylococci, σB controls the general stress response and as such is activated
during stress conditions, growth phase transitions, and morphological changes [46, 47].
As stated previously, the regulation of many virulence determinants is affected by
environmental stresses; therefore, the stress-dependent activation of σB has been an
important area of research into the environmental regulation of staphylococcal virulence
determinants [48-50]. Interestingly, σB does not directly respond to most environmental
signals, suggesting another path to transduce stress signals that is independent of σB. To
test this possibility, an S. epidermidis sigB mutant strain (1457-sigB::dhfr) [19] was
grown for 2 or 6 h in TSB, TSB with 4% ethanol, or DTSB and the metabolomes were
analyzed by NMR spectroscopy. The PCA scores plot demonstrates that the majority of
metabolomics changes associated with iron limitation and ethanol stress occur largely
independent of σB (Figure 6.2a). Additionally, the metabolomic dendrogram confirms
that the stressor-induced metabolic changes observed in strain 1457-sigB::dhfr are most
closely associated with those in the TCA cycle mutant strain 1457-acnA (Figure 6.2b).
Taken together, these data demonstrate that environmental stresses can alter the
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staphylococcal metabolome by a largely σB-independent mechanism that requires the
TCA cycle.

6.3.4 Metabolomic Changes Precede Genetic Changes
Metabolomic data demonstrate that ethanol stress, iron limitation, and TCA cycle
inactivation decrease the intracellular concentration of Gln relative to the wild-type strain
grown in TSB medium (Tables 6.1 and 6.2). The two more likely explanations for the
decreased intracellular concentration of Gln are: (i) the stressors alter enzymatic activity,
causing a decrease in the concentration of Gln; or (ii) the stressors decrease transcription
of genes involved in the biosynthesis of Gln, resulting in a decreased concentration of
Gln. If the first possibility is correct, then stressors will cause an increase in the
transcription of Gln biosynthetic genes as bacteria attempt to compensate for the
decreased availability of Gln. If the second possibility is correct, then stressors will cause
a decrease in the transcription of Gln biosynthetic genes. To determine which of these
two possibilities was correct, we performed Northern blot analysis on glutamine
synthetase (femC; also known as glnA) (Figure 6.5). The data suggest that the first
possibility is the more correct one; specifically, bacteria are responding to metabolomics
changes by increasing transcription of genes necessary to counterbalance those changes.
Interestingly, in untreated wild-type cultures, the post-exponential growth phase
concentration of Glu and Gln increased between two and five times that of the
exponential growth phase concentration (data not shown), and this increase correlated
with a post-exponential growth phase decrease in glnA mRNA levels (Figure 6.5).

209

Figure 6.5. Northern blot analysis of RNAIII and glnA mRNA levels in the exponential
(2 h) and post-exponential (6 h) phases of growth. To ensure that equivalent quantities of
RNA were loaded in the gel, 23 S and 16 S rRNA were visualized by ethidium bromide
staining and used as loading controls (bottom panel). The results are representative of at
least two independent experiments.
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Similarly, Gln and Glu were not detected in the NMR spectra of the aconitase mutant
strain, and this correlated with a high level of glnA mRNA in both the exponential and
the post-exponential growth phases.
The correlation between Gln and Glu concentrations and glnA mRNA levels is
consistent with a GlnR-dependent regulation of glnA transcription [2]. This correlation
was maintained for Gln/Glu-sufficient or -insufficient conditions; however, the
intermediate concentrations of Gln and Glu found during ethanol stress and iron-limited
growth (data not shown) produce mixed glnA mRNA levels (Figure 6.5). These data
suggest that for the concentrations of Gln and Glu to affect glnA transcription, the stressinduced concentration change must be sufficiently large.

6.3.5 CcpA Responds to TCA Cycle-associated Metabolomic Changes
Ethanol stress, iron limitation, and TCA cycle inactivation increased the postexponential growth phase concentration of glucose-6-phosphate (Table 6.2). Glycolytic
intermediates such as glucose-6-phosphate and fructose-1,6-bisphosphate increase the
ATP-dependent phosphorylation of the histidine-containing protein (HPr) by enhancing
the activity of the HPr kinase [51]. The increase in phosphorylated HPr enhances its
interaction with the catabolite control protein A (CcpA) [52-54]. CcpA primarily
functions as a repressor; however, it also activates transcription of genes involved in
fermentation and overflow metabolism [53, 55]. In addition to the concentration of
glucose-6-phosphate being increased by TCA cycle stress, the concentrations of several
fermentation products or intermediates (i.e. lactate, acetate, and acetaldehyde) and the
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small phosphordonor acetyl phosphate (an indicator of overflow metabolism) were also
increased (Table 6.1), consistent with a change in CcpA-mediated regulation. The
repressor CodY also contributes to the regulation of overflow metabolism [55]; however,
CodY responds to the intracellular concentrations of branched chain amino acids [56].
TCA cycle stress did not alter the concentrations of branched chain amino acids beyond
the 5-fold threshold (Table 6.1), suggesting that the increase in overflow metabolism was
independent of CodY.
In Staphylococcus aureus, CcpA enhances biofilm formation and PIA
biosynthesis, whereas CodY represses PIA synthesis [57, 58]. In S. epidermidis, ethanol
stress, iron limitation, and TCA cycle inactivation enhance biofilm formation and PIA
synthesis [7, 13, 14, 16, 24, 59]. Based on the metabolomic data and published
observations, it was reasonable to hypothesize that PIA biosynthesis was regulated in
response to TCA cycle associated metabolomic changes by a CcpA-dependent and
CodY-independent mechanism. To test this hypothesis, ccpA and codY deletion mutants
were constructed in strains 1457 and 1457-acnA, and the amount of cell-associated PIA
was determined after 6 h of growth (Figure 6.6). Consistent with previous observations
(7), TCA cycle inactivation (strain 1457-acnA) dramatically increased the accumulation
of PIA, whereas neither CodY nor CcpA had a dramatic effect on the post-exponential
growth phase amount of PIA. When the codY mutation was introduced into an aconitase
mutant background, PIA accumulation resembled the response in strain 1457-acnA,
suggesting that TCA cycle-associated changes in PIA biosynthesis are independent of
CodY. In contrast to the codY-acnA double mutant, the ccpA-acnA double mutant failed
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Figure 6.6. CcpA is required for PIA synthesis during TCA cycle stress. PIA
immunoblot assay of strain 1457 and isogenic mutants of acnA, codY, ccpA, codY/acnA,
and ccpA/acnA grown for 6 h inTSB. The results are representative of three independent
experiments.
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to produce PIA, strongly suggesting that some TCA cycle-associated metabolomics
changes (i.e. glucose-6 phosphate) are sensed by CcpA, which in turn activates PIA
biosynthesis.

6.3.6 TCA Cycle Stress Decreases RNAIII Transcription
In S. aureus, inactivation of the TCA cycle increases the transcription or stability of the
riboregulator RNAIII of the accessory gene regulator (Agr) system [8, 9]. Conversely,
increasing TCA cycle activity decreases the transcription or stability of RNAIII [60]. The
causal relationship between TCA cycle activity and RNAIII transcript levels in S. aureus
led us to examine whether disparate environmental conditions would similarly affect
RNAIII transcription or message stability in S. epidermidis. In contrast to S. aureus, TCA
cycle inactivation decreased RNAIII transcription or stability during the exponential and
post-exponential growth phases in S. epidermidis (Figure 6.5). Importantly, ethanol stress
and iron limitation decreased RNAIII transcription or stability in a similar manner to
TCA cycle inactivation (Figure 6.5). In total, these data suggest that environmental
stresses act through the TCA cycle to elicit transcriptional changes to at least two of the
major staphylococcal virulence regulators (i.e. CcpA and RNAIII).

6.4 Discussion
In the life cycle of S. epidermidis, the transition from a skin resident, commensal
state to adhering on implanted biomaterials represents a dramatic environmental change.
In most pathogenic bacteria, environmental changes are accompanied by changes in the
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Figure 6.7. Summary of post-exponential growth phase metabolic changes associated
with TCA cycle stress. Metabolites in green represent an increased concentration relative
to the wild-type strain. Metabolites in red represent a decreased concentration relative to
the wild-type strain. Metabolites and pathways in black are inferred from the data, but
they are inconclusive. Glucose-6-P, glucose-6-phosphate; GlcN-6-P, GlcN-6-phosphate.
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transcription of virulence genes; thus, environmental signals (e.g. nutrient replete, ironlimiting, or oxygen-limiting growth conditions) commonly regulate virulence gene
transcription [2, 61-65]. Although S. epidermidis has relatively few virulence
determinants, one of its primary pathogenic effectors is the exopolysaccharide PIA [6669]. Previously, we demonstrated that PIA biosynthesis is regulated by TCA cycle
activity; specifically, repression of TCA cycle activity dramatically enhances
transcription of PIA biosynthetic genes (icaADBC) and PIA accumulation [7, 24, 60]. In
this study, we demonstrate that dissimilar environmental signals decrease TCA cycle
activity (Figure 6.1), resulting in common metabolomics changes (Figure 6.2 and Tables
6.1 and 6.2; summarized in Figure 6.7) that alter the activity of metabolite-responsive
regulators such as CcpA (Figure 6.6). These data lead us to propose that it is the TCA
cycle itsel that is “sensing” the environmental transition and transducing this in ormation
into metabolic signals that activate or repress the activity of metabolite responsive
regulators to modulate the expression of PIA and other virulence determinants.
As S. epidermidis transitions from residing on the skin to being implanted in a
host, it enters into an environment where free iron is present at a concentration of 10-18 M
[62], a condition antagonistic to TCA cycle activity (Figure 6.1) [9, 11]. Similarly, this
transition dramatically decreases the availability of free oxygen (the partial pressure of
atmospheric O2 is 159mmHg at sea level, and this decreases to an estimated 3–5 mm Hg
at the host cell level), a condition that is also antagonistic to TCA cycle activity. Taken
together, this type of environmental transition is accompanied by conditions that are
inhibitory to TCA cycle activity and stimulatory to PIA biosynthesis [7, 24]. In other
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words, the transition from an external environment to an internal environment represses
TCA cycle activity and primes S. epidermidis for PIA synthesis, which enhances biofilm
formation and increases the likelihood of establishing a biomaterial-associated infection.
The significance of the data presented here is 5-fold. First, it establishes a
mechanism by which well-established regulators (e.g. CcpA) participate in responding to
environmental stresses. Second, these data suggest how disparate environmental stimuli
can cause common phenotypic changes (e.g. iron limitation and ethanol stress both
increase PIA synthesis and biofilm formation [13, 70]). Third, these data suggest that a
difficulty in attributing the effects of an environmental stimulus, such as iron limitation,
to a specific regulator, such as the ferric uptake regulator (Fur) [71], is that many of the
effects are due to metabolite-responsive regulators reacting to changes in the
metabolome. Fourth, S. epidermidis has a second general stress response system that is
largely independent of the σB-controlled general stress response (Figure 6.2).
Finally, in bacteria, three metabolic pathways (Embden-Meyerhof-Parnas, pentose
phosphate, and TCA cycle) produce the 13 biosynthetic intermediates needed to
synthesize all macromolecules in a bacterial cell. Therefore, by linking virulence factor
synthesis to the TCA cycle, bacteria are connecting virulence to the availability of
biosynthetic intermediates needed to synthesize virulence determinants.

6.5 Conclusion
TCA cycle stress alters the intracellular concentrations of metabolites (Tables 6.1
and 5.2) relative to those of the wild-type strain 1457. If the change in the concentration
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of a metabolite is sufficiently large, then the activity of a regulator that can respond to
one of those metabolites may be altered. Therefore, these data present an exceptional
opportunity to identify regulators that coordinate metabolism and virulence in S.
epidermidis. Although a considerable amount of research needs to be done to determine
which metabolite-responsive regulators are involved in responding to TCA cycleassociated metabolomics changes, the work presented here sheds light on how
environmental signals alter the bacterial metabolic status to regulate adaptation to a new
environment.
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CHAPTER 7
NMR ANALYSIS OF A STRESS RESPONSE METABOLIC SIGNALING
NETWORK§

7.1 Introduction
In eukaryotic organisms, signaling pathways are essential to the life-cycle of cells
and are ubiquitous processes that regulate a variety of functions in response to both
extracellular and intracellular environmental changes [1-4]. These signaling systems are
spatially and temporarily organized, where the kinetic properties of these cycles depends
on the cellular distribution of the activator and deactivator proteins. Protein activity is
usually controlled through a variety of post-translational modifications (phosphorylation,
acetylation, ubiquitylation, etc.), through protein complex formation, through
transcription regulation, or any combination of these factors. A prototypical signaling
cascade includes a membrane-bound receptor that binds a signal molecule which in turn
activates a kinase proximal to the membrane. This activated kinase phosphorylates a
second kinase, where the cascade continues and perpetuates the signal away from the
membrane to the final target. Typically, the impact of a signaling network is the up- and
down-regulation of a set of genes or proteins associated with a specific response
(apoptosis, metabolic process, proliferation, stress responses, etc.). Correspondingly, the
cell commits a significant amount of energy and resources to undergo such a phenotype
change.
§

Chapter 7 was adapted from Zhang, B., et. al., NMR Analysis of a Stress Response Metabolic Signaling

Network, Journal of Proteome Research (2011), 10 (8), 3743-3754. Reprinted with permission, copyright
2011 American Chemical Society.
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In prokaryotes, signal transduction frequently involves two-component regulatory
systems that consist of a membrane-bound sensor histidine protein kinase and a response
regulator [5]. These two-component signal transduction systems are activated when an
external signaling molecule, peptide, metal ion, etc., is bound by the sensor kinase, which
undergoes autophosphorylation at a conserved histidine. Transfer of the phosphoryl
group to the receiver domain of a response regulator in the cytoplasm of a bacterium
completes the activation and the response regulator is then competent to activate
transcription of a limited set of genes. In staphylococci, there are numerous twocomponent regulatory systems [6], with the best studied being the agr quorum sensing
system [7]. In addition to two-component systems, bacteria use sigma factors as a means
to detect environmental conditions that induce heat stress, envelope stress, nitrogen
stress, etc [8]. In staphylococci, B is activated during stress conditions, growth phase
transitions, and morphological changes [9, 10]. Most recently, the hypothesis that central
metabolism can act as a signal transduction pathway to transduce external environmental
signals (e.g., iron-limitation) into intracellular metabolic signals by altering the activity of
the enzymes of central metabolism has been proposed [11].
The tricarboxylic acid (TCA) cycle is part of central metabolism and provides
reducing potential, energy and biosynthetic intermediates necessary for other
macromolecular synthesis [12]. Several studies have also shown that the TCA cycle is
involved in regulating or affecting virulence or virulent determinant biosynthesis [13-15].
One specific example is the production of the exopolysaccharide, polysaccharide
intercellular adhesion (PIA) [16], which is associated with virulence and biofilm
formation [17-20]. PIA synthesis is regulated by nutrient availability and external stress
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conditions [21, 22]. Importantly, TCA cycle activity has also been shown to be affected
by changes in environmental stress factors [16, 22, 23]. A number of environmental stress
factors have also been shown to influence biofilm formation: ethanol [24], oleic acid
[25], glucose [26], UDP-N-acetylglucosamine [27], sub-inhibitory concentrations of
some antibiotics [28], anaerobic conditions [29], Fe limitation [30-32], high osmolarity
[33], and high temperature [33]. The diversity of these external stimuli suggests a
versatile regulation system. Recently, we used NMR metabolomics to demonstrate that
Fe limitation and ethanol decrease TCA activity [23]. These stressors cause a common
metabolic change that can be sensed by metabolite responsive-regulators (e.g., catabolite
control protein A; CcpA) that affect PIA production. We proposed that the TCA cycle
plays a central role in a metabolic signaling network that senses disparate environmental
stress conditions and regulates PIA biosynthesis, virulence determinants and biofilm
formation (Figure 7.1). Herein, we report a further NMR analysis of the impact on the
metabolome of S. epidermidis resulting from a diverse range of environmental stress
factors associated with biofilm formation that include 5% NaCl [33], 2% glucose [26],
0.06 µg/mL tetracycline [28], and 400 nM autoinducer-2 (AI-2, furanosyl borate diester)
[34], in addition to our prior study [23] with 4% ethanol [24], and Fe limitation [30-32].
Our differential NMR metabolomics methodology has been applied to the study
of in vivo drug activity in Aspergillus nidulans [35] and Mycobacterium smegmatis [36]
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Figure 7.1. An illustration of the interrelationship of metabolic pathways associated with
the TCA cycle and biofilm formation.
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and is ideally suited to a systems biology analysis of the impact of environmental stress
factors on the S. epidermidis metabolome and the corresponding role of the TCA cycle
[23]. In the latter study, NMR was used to detect metabolic perturbations by following
changes to S. epidermidis (strain 1457) cultured under environmental stress conditions
that induce biofilm formation. These results were then compared to the metabolome of a
S. epidermidis mutant (aconitase mutant strain SE1457-acnA::tetM) with an inactivated
TCA cycle. If S. epidermidis senses environmental stress conditions by affecting TCA
cycle activity as previously observed, then the impact on the metabolome caused by the
aconitase mutant and the disparate external signals were expected to be equivalent. The
overlapping clusters in principal component analysis (PCA) and orthogonal partial least
squares discriminant analysis (OPLS-DA) two dimensional (2D) scores plot and the
branch similarity on a metabolic tree diagram [37] indicate that external biofilm signals
inactivate the TCA cycle. Furthermore, a detailed analysis of the relative concentration
changes of 55 different metabolites from 2D 1H-1H TOCSY and 2D 1H-13C HSQC
spectra implies the TCA cycle plays a central role in a metabolic signaling network [35,
36, 38, 39]. A metabolic network created with Cytoscape [40] illustrates this metabolic
signaling network and the interrelationship of the TCA cycle activity with alanine
metabolism, amino sugar metabolism, glycolysis/gluconeogenesis and the urea cycle.
The investigation of the NMR Analysis of a stress response metabolic signaling
method was a group effort where Steven Halouska and Bo Zhang demonstrated
significant and equal contribution to the project. Steven Halouska was involved in
developing protocols to identify and quantify carbon-13 labeled metabolites derived from
a 13C-Glucose. Bo Zhang performed a comparative analysis of metabolite fingerprints to
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show the relationships of the impact between different environmental stress factors. Both
Steven Halouska and Bo Zhang contributed equally in the analysis of the different stress
responses.

7.2 Methods and Materials
7.2.1 Bacterial growth and NMR sample preparation.
Staphylococcus epidermidis wild-type strain 1457 and the isogenic aconitase
mutant strain 1457-acnA::tetM were grown in tryptic soy broth (TSB; BD Biosciences)
without dextrose and supplemented with 0.25% glucose (Sigma Chemical) or 0.25%
13

C6-glucose (Cambridge Isotope Laboratories).
All bacterial cultures were inoculated to an optical density at 600 nm (O.D.600) of

0.06 and were grown for 2 hours or 6 hours at 37oC with 225 rpm aeration in TSB or TSB
supplemented with a stressor know to induce biofilm formation. Either 10 or 12 replicate
bacterial cultures were grown for each bacterial strain or environmental condition for the
one-dimensional (1D) 1H NMR experiments. 3 replicate bacterial cultures were grown for
each bacterial strain or environmental condition for both the two-dimensional (2D) 1H13

C HSQC and the 2D 1H-1H TOCSY experiments.
In general, four different bacterial cultures were harvested per experiment: (1)

wild-type S. epidermidis in TSB media, (2) wild-type S. epidermidis in TSB media with
an environmental stress condition, (3) aconitase mutant of S. epidermidis in TSB, and (4)
aconitase mutant of S. epidermidis in TSB with an environmental stress condition. The
environmental stress conditions used in this study were 5% NaCl [33], 2% glucose [26],
0.06 µg/mL tetracycline [28], 400 nM autoinducer-2 (AI-2, furanosyl borate diester) [34]
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in TSB media. To facilitate integrating this current work with our recent study [23]
control cultures containing 4% ethanol [24] in TSB or TSB medium depleted of iron
(DTSB, defferated TSB) [30-32] were included for comparison. DTSB was prepared as
described [23]. AI-2, furanosyl borate diester, was synthesized as previously described
[41, 42].
For the 1D 1H NMR experiments, 2.74 O.D.600 units were harvested for analysis
and for both the 2D 1H-13C HSQC and 2D 1H-1H TOCSY experiments 5.48 O.D.600 units
were harvested. Following harvest, the culture medium was removed and the bacteria
were suspended in 1 mL portions of 50 mM phosphate buffer (PBS) in 99.8% D2O
(Isotec) at pH 7.2 (uncorrected). The bacteria were lysed using a FAST-Prep instrument
(MP Biomedicals) for 40 seconds, centrifuged for 5 min to remove the bacterial debris
and glass beads, and frozen in liquid nitrogen.

7.2.2 NMR Data Collection.
The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer
equipped with a triple-resonance, Z-axis gradient cryoprobe. A BACS-120 sample
changer with Bruker Icon software was used to automate the NMR data collection. 1D 1H
NMR spectra were collected using excitation sculpting [43] to efficiently remove the
solvent and maintain a flat baseline, eliminating any need for baseline collection that may
induce artifacts in the PCA or OPLS-DA 2D or three-dimensional (3D) scores plot. 1D
1

H NMR spectra were collected at 298K with a spectrum width of 5482.5 Hz and 32K

data points. A total of 16 dummy scans and 64 scans were used to obtain each spectrum.
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2D 1H-13C HSQC spectra were collected with solvent pre-saturation and
relaxation delay of 0.5 seconds [44, 45]. A total of 1024 data points with a spectrum
width of 4734.85 Hz, and 64 data points with a spectrum width of 13834.26 Hz were
collected in the 1H and 13C dimensions, respectively. A total of 8 dummy scans and 128
scans were used to obtain each of the 2D 1H-13C HSQC NMR spectra. 2D 1H-1H TOCSY
spectra were collected with WATERGATE solvent pre-saturation, and a relaxation delay
of 2 seconds [46, 47]. A total of 1024 data points with a spectrum width of 5000 Hz, and
256 data points with a spectrum width of 5001.324 Hz were collected in the direct and
indirect 1H dimensions, respectively. A total of 16 dummy scans and 8 acquisition scans
were used to obtain each of the 2D 1H-1H TOCSY NMR spectra.

7.2.3 NMR Data Analysis.
1D 1H NMR spectra were processed in the ACD/1D NMR manager version 12.0
(Advanced Chemistry Development, Inc). The residual H2O NMR resonance was
removed. Intelligent bucketing was used to integrate each region with a bin size of 0.025
ppm. Each NMR spectrum was center averaged to minimize any experimental variations
between bacterial cultures as follows:

̅

(6.1)

where ̅ is the average signal intensity, σ is the standard deviation in the signal intensity,
and Xi is the signal intensity within a bin. Noise regions of the spectra were omitted from
the PCA analysis by setting the corresponding bins to zero [47]. The table of integrals
was imported into SIMCA11.0+ (UMETRICS) for PCA and OPLS-DA analysis using
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the program’s standard parameters. The identification of the control group and treated
group or groups for the OPLS-DA analysis was based on the PCA clustering pattern.
2D NMR Spectra were analyzed using NMRView [48] and Sparky (T. D.
Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco) to
identify chemical shifts and assign peak intensities. Peak intensities were normalized for
each 2D NMR spectrum by dividing by the average peak intensity for a given spectrum.
Each peak for each metabolite from each specific triplicate data set was averaged and the
intensity for each peak was further normalized across all data sets (i.e., wild-type,
aconitase mutant, and each bacterial growth condition). Specifically, the maximal
intensity for each peak across all data sets was set to 100. The peak intensities in the
remaining data sets were all scaled relative to this peak intensity. Then, a normalized
intensity for the metabolite within each data set was calculated by averaging the
normalized intensity for each of the metabolite’s assigned peaks. In this manner, the
relative percent difference in metabolite intensity (concentration) can be reported
between different bacterial strains or bacterial growth conditions. As an illustrative
example, consider a metabolite with thee assigned peaks (A, B, C) in a 2D 1H-13C HSQC
spectrum. The 2D 1H-13C HSQC spectrum is collected in triplicate under three different
bacterial growth conditions for a total of 9 spectra and 27 peak intensities, 3 peaks in
each spectrum for the metabolite. Peak A has average intensities of 0.05, 0.10, and 0.20 in
the three different bacterial growth conditions, respectively. The values would be
normalized to 25, 50, and 100. Similarly, peaks B and C are normalized against their
maximal peak intensities for values of 20, 60, 100 and 30, 65, 100, respectively. Thus, the
average relative concentrations of the metabolite under the three bacterial growth
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conditions would be the average of the three normalized peaks, yielding values of 25,
58.3 and 100, respectively. The bacterial growth condition with the highest relative
metabolite concentration (100) would have a corresponding concentration increase of 75
and 41.7 relative to the two other bacterial growth conditions.
The observed NMR peaks in the 2D 1H-13C HSQC and 2D 1H-1H TOCSY spectra
were assigned to specific metabolites using 1H and 13C chemical shift tolerances of 0.05
ppm and 0.50 ppm, respectively. Metabominer [49], Madison Metabolomics Consortium
Database (MMCD) [50], the BioMagResBank [51], and Human Metabolome Database
[52] were used to identify metabolites. The presence of metabolites and metabolic
pathways were verified with the KEGG [53] and Metacyc [54] databases. A metabolic
network map was generated using Cytoscape using a force directed layout [40].
Metabolites identified with a percent concentration difference of ≥ ±10% relative to wildtype S. epidermidis were manually color-coded to indicate either an up- or downregulated concentration change.

7.3 Results and Discussion
7.3.1 NMR metabolomics and principle component analysis.
The elimination of experimental factors that may inadvertently influence PCA or
OPLS-DA metabolomic data interpretation is essential. The observed variability in the
PCA or OPLS-DA data should result from differences in the biological samples as
opposed to changes in sample preparation, sample handling, data acquisitions, data
processing or any number of experimental parameters (temperature, pH, time,
concentration, etc.). In order to obtain accurate and reproducible metabolomic data, the
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following general protocols were employed: (i) bacterial cultures of wild-type S.
epidermidis were used as a reference metabolome and were prepared with all sets of
bacterial cultures, (ii) equivalent bacterial numbers were used, so metabolite
concentrations were independent of any bacterial growth variability, (iii) all NMR spectra
were normalized using center averaging [55], so variability in sample concentration was
minimized, (iv) noise regions [47] and solvents were removed from NMR spectra prior to
PCA or OPLS-DA, and (v) minimal processing (no baseline correction or apodization
functions) of the NMR spectra.

7.3.2 Harvesting of S. epidermidis cultures.
Bacteria grown in vitro undergo four different growth phases: (i) lag, (ii),
exponential, (iii) stationary, and (iv) death. Throughout a typical growth cycle, the state
of the bacteria and the environment are constantly changing. Clearly, there is a
fundamental difference between the exponential phase, when cell density is relatively
low, cells are rapidly dividing and the required nutrients are abundant; and the stationary
phase when these characteristics are effectively reversed. Correspondingly, the
metabolome is expected to reflect these differences. Therefore, exploring a biological
system by monitoring changes in the metabolome necessitates the appropriate choice of
the state of the system. In the case of S. epidermidis biofilm formation and the proposed
role of the TCA cycle in a metabolic signaling network, the proper choice of the state of
the system requires endogenous TCA cycle activity.

The TCA cycle is minimally active

during the exponential phase (2 h growth) when nutrients (i.e., glucose or other rapidly
catabolizable carbohydrates) are sufficient for bacteria to grow quickly [16, 56].
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Overflow metabolism results in an incomplete oxidation of glucose, leading to the
accumulation of acetate, lactate, and other incompletely oxidized metabolites in the
culture medium (Figure 7.2a). During the transition to the post-exponential growth phase
(6 hours), the TCA cycle is de-repressed as the carbohydrate(s) are depleted from the
culture medium. Concomitantly, the incompletely oxidized metabolites that accumulated
in the medium are catabolized through the TCA cycle resulting in the depletion of
secondary metabolites from the culture medium.
The growth phase-dependent activity of the TCA cycle in S. epidermidis is also
apparent from the PCA 2D scores plot generated from 1D 1H NMR spectra of S.
epidermidis cell lysate (Figure 7.2b). The 2D PCA scores plot indicates that PC1 and PC2
account for 20.6% and 10.7% of the variations in the NMR spectra, respectively. A 3D
PCA scores plot (Figure 7.3) did not improve cluster separations. Each 1D 1H NMR
spectrum obtained for each cell lysate is represented as a single point in the PCA 2D
scores plot, where the 10 replicates form four distinct clusters for the wild-type and
aconitase mutant strains grown for 2 hours and 6 hours, respectively. As expected and
consistent with our prior study [23], the metabolomes of the S. epidermidis wild-type and
aconitase mutant cells from the exponential growth phase (2 hours) were more similar to
each other than the 6 hour cultures. This is apparent from the close clustering in the 2D
scores plot for the 2 hour wild-type and aconitase mutant. This is consistent with the
minimal activity of the TCA cycle at 2 hours and the loss of TCA cycle activity for the
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Figure 7.2. a) A typical S. epidermidis growth curve superimposed on the cellular production of acetic acid. b) 2D PCA scores plot
and c) 2D OPLS-DA scores plot comparing 2 h growth of wild-type S. epidermidis 1457 ( ), 2 h growth of aconitase mutant strain
1457-acnA::tetM ( ), 6 h growth of wild-type S. epidermidis 1457 ( ), and 6 h growth of aconitase mutant strain 1457-acnA::tetM (
). The ellipses correspond to the 95% confidence limits from a normal distribution for each cluster. For the OPLS-DA scores plot, the 6 h
growth of wild-type S. epidermidis 1457 ( ) was designated the control class and the remainder of the cells were designated as
treated. The OPLS-DA used 1 predictive component and 3 orthogonal components to yield a R2X of 0.788, R2Y of 0.992 and Q2 of
0.992.
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Figure 7.3. Three dimensional versions of the 2D PCA scores presented in Figure 7.2b, Figure 7.5b, and Figure 7.7b, respectively. a)
3D PCA scores plot comparing S. epidermis 1457 strain (circles) and aconitase mutant (triangles) grown for 2 hours (grey) and 6
hours (black). The PCA model consists of 3 significant components where the contribution (R2) for each successive component is
20.6%, 10.7%, and 6.8%. The overall cross validation (Q2) is 15.9%, 7.58%, and 2.7%, respectively. b) 3D PCA scores plot
comparing wild-type S. epidermidis 1457 cells grown 6 h in standard TSB media ( ), with S. epidermidis 1457 cells grown 6 h in
iron-depleted media (DTSB) ( ), with the addition of 4% ethanol ( ),with the addition of 2% glucose ( ), with the addition of 0.06
µg/mL tetracycline ( ), with the addition of 5% NaCl ( ), and 6 h growth of aconitase mutant strain 1457-acnA::tetM in standard
TSB media ( ). The PCA model consists of 5 significant components where the contribution (R2) for each successive component is
12.5%, 7.5%, 6.0%, 3.8%, and 3.3%. The overall cross validation (Q2) is 15.9%, 7.58%, and 2.7%, respectively. c) 3D PCA scores
plot comparing wild-type S. epidermidis 1457 cells grown 6 h in standard TSB media ( ), 6 h growth of aconitase mutant strain 1457acnA::tetM in standard TSB media ( ), aconitase mutant strain 1457-acnA::tetM in iron-depleted media (DTSB) ( ), with the
addition of 4% ethanol ( ), with the addition of 2% glucose ( ), with the addition of 0.06 µg/mL tetracycline ( ), and with the
addition of 5% NaCl ( ). The PCA model consists of 5 significant components where the contribution (R2) for each successive
component is 12.3%, 8.1%, 6.7%, 3.8%, and 3.4%. The overall cross validation (Q2) is 10.1%, 6.8%, 6.0, 1.6%, and 2.3%,
respectively.
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aconitase mutant. Conversely, there is a large separation in the 2D scores plot along the
PC1 axis between the 6 hour wild-type and aconitase mutant. In fact, the 6 hour aconitase
mutant cluster is closer to the 2 hour wild-type cluster. Again, this is consistent with an
increase in TCA activity at 6 hours and the loss of TCA activity in the aconitase mutant.
Correspondingly, the separation along PC1 reflects TCA cycle activity. Since the TCA
cycle is minimally active during the exponential phase, the 2 hour wild-type cluster is
slightly closer to the 6 hour wild-type cluster along PC1, compared to the aconitase
mutants.
Alternatively, the separation along PC2 axis may reflect the variability in
nutrients available to the cells. Glucose is still present after 2 hours of bacterial growth,
but is being depleted while acetate is being accumulated. After 6 hours of growth, the
depletion of acetate is dependent on TCA cycle activity, resulting in the largest separation
along PC2 between the 6 hour aconitase mutant and the 2 hour wild-type samples. These
two samples correspond to the largest expected variation in glucose and acetate
concentrations. From the detailed 2D NMR analysis (please see below), acetate is
approximately twice as concentrated in the 6 hour wild-type sample compared to the 2
hour aconitase mutant. The glucose concentration is effectively reversed. Glucose is
twice as concentrated in the 2 hour aconitase mutant compared to the 6 hour wild type
sample.
The PCA results were used to guide a subsequent analysis using OPLS-DA
(Figure 7.2c). The OPLS-DA yielded a reliable model (R2X 0.788, R2Y 0.992, Q2 0.992).
The R2 and Q2 values represent the goodness of fit and predictability of the model,
respectively. The OPLS-DA scores plot is similar to the PCA scores plot, except for the
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limited separation between the 2 hour wild-type and aconitase mutant clusters. Again,
this is consistent with the minimal TCA activity expected for the 2 hour wild-type and
aconitase mutant. Also, OPLS-DA emphasizes the difference between the control group
(6 hour wild-type) and the treated classes, while minimizing contributions from within
group variations. Thus, OPLS-DA generates significantly tighter clusters than PCA.
More importantly, the S-plot (Figure 7.4) generated from the OPLS-DA provides
unambiguous identification of the major contributors to the class separation (i.e., 1H
NMR bins and associated metabolites). Specifically, comparing the 6 hour aconitase
mutant and the 6 hour wild-type samples, which had the largest separation along PC1 in
the PCA 2D scores plot, identified citrate, isocitrate, and other TCA related metabolites.
Similarly, comparing the 2 hour aconitase mutant and the 2 hour wild-type samples,
which had the largest separation along PC2 in the PCA 2D scores plot, identified glucose,
acetate and other nutrients required for cell growth. These results provide strong support
for our subjective analysis of the trends in the 2D PCA scores plot and demonstrate that
not only does PCA and OPLS-DA differentiate between metabolic profiles, but they also
provide information about specific enzymatic activity and environmental conditions.

7.3.3 Impact of environmental stress conditions on the S. epidermidis metabolome.
Numerous genes and protein complexes are involved in the transformation of
planktonic cells to a biofilm [57]. This process requires that S. epidermidis “sense”
changes in its environment and the availability of nutrients, such as changes in
temperature, O2 levels, osmorality, ethanol, glucose and iron [29, 31, 33, 58-62]. It is
reasonable to expect that different external factors would trigger distinct signaling
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Figure 7.4. a) OPLS-DA S-plots comparing the S. epidermidis 1457 and aconitase
mutant strain 1457-acnA::tetM where both cell cultures were grown for 6 hours. The two
cell cultures were shown be separated along the PC1 axis in Figure 7.2a. Each point in
the S-plot represents a specific bin containing a chemical shift range of 0.025 ppm, where
the points at the extreme ends of the S-plot are the major contributors to the class
distinction. Each point was identified to a specific metabolite using the Human
Metabolomics Database and Madison Metabolomics Database. All the identified
metabolites are associated with TCA cycle inactivation. b) OPLS-DA S-plot comparing
the mutant strain 1457-acnA::tetM grown for 2 hours and 6 hours. The two conditions are
shown to be separated along the PC2 axis in Figure 7.2a. The metabolites identified are
associated with variations in the utilization of glucose for cell growth. c) OPLS-DA
loading plot comparing S. epidermidis 1457 and aconitase mutant strain 1457-acnA::tetM
where both cell cultures were grown for 6 hours. Negative values indicate a decrease in
peak intensity when comparing the wild type to the mutant, while positive values indicate
an increase in peak intensity. These results are comparable to the bar graphs depicted in
figure 7.9 from the analysis of 2D NMR data. d) OPLS-DA loading plot comparing the
mutant strain 1457-acnA::tetM grown for 2 hours and 6 hours.
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pathways and mechanisms of biofilm regulation. Correspondingly, different biofilm
formation pathways would presumably induce dissimilar metabolomic profiles.
Alternatively, a versatile regulation system responsive to disparate signals would be
significantly more efficient. A metabolic signaling pathway is one potential mechanism
of rapidly responding to changing environmental stress conditions. Conceptually, the
environmental flux of essential nutrients and metabolites would direct the up- or downregulation of specific metabolic pathways in response to concentration changes (Le
Chatelier’s principle) to initially reestablish equilibrium without affecting protein
activity. Effectively, a limited or abundant metabolite would direct the metabolic flow
through a specific pathway causing a cascade affect due to the high interrelationship of
the metabolome. Eventually, gene and protein regulation processes would respond to the
perturbed metabolic activity leading to the up- or down- regulation of specific genes and
proteins.
We have previously demonstrated that both Fe limitation and 4% ethanol decrease
TCA cycle activity [23]. These environmental stress factors are known to induce S.
epidermidis biofilm formation [24, 30-32]. We have also demonstrated that Fe limitation
and 4% ethanol had a similar impact on the S. epidermidis metabolome and altered the
activity of CcpA, a metabolite-responsive regulator. An important role for the TCA cycle
in a staphylococcal biofilm metabolic signaling pathway seems apparent, especially since
the TCA cycle is a central metabolic pathway that interacts with numerous other
pathways (Figure 7.1). Thus, we proposed that the TCA cycle senses environmental
stressors and transduces this signal through the metabolome to activate or repress the
activity of metabolite-responsive regulators, which, in turn, modulates PIA production,
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virulence factor synthesis, and biofilm formation [23]. To further support our hypothesis
that the TCA cycle senses disparate environmental signals to regulate PIA synthesis and
biofilm formation, we analyzed changes in the S. epidermidis metabolome caused by
additional environmental stress factors also known to induce an S. epidermidis biofilm
[26, 28, 34, 63].
S. epidermidis cultures were treated with 5% NaCl, 2% glucose, 0.06 µg/mL
tetracycline, and 400 nM of autoinducer-2 (AI-2, furanosyl borate diester). Glucose and
NaCl were reported to induce biofilm formation by the regulation of the rbf gene [64],
which has been shown to be a regulator of icaR [65], a negative regulator of the
icaADBC operon that is required for PIA synthesis and biofilm formation [66].
Subinhibitory concentrations of antibiotics enhance icaADBC gene expression [28, 67]
by potentially inhibiting TcaR, a weak negative regulator of icaADBC gene expression
[68]. AI-2 is an intercellular signaling molecule that has a modest effect on
staphylococcal biofilms [63]. Conversely, if these additional environmental stress factors
impact the S. epidermidis metabolome in a manner similar to Fe limitation and 4%
ethanol, which is also correlated with TCA cycle inactivation, then these results would
further support the hypothesis that the TCA cycle acts as a signal transducer as a part of a
metabolic signaling network.
The PCA 2D scores plot (Figure 7.5a) and the associated metabolic tree (Figure
7.5c) indicates that S. epidermidis wild-type cultures grown with the addition of the
environmental stressors 4% ethanol, 0.06 µg/mL tetracycline or iron-limitation exhibited
essentially identical metabolomes as the aconitase mutant. Both the aconitase mutant and
wild-type cultures under these stress conditions formed a large cluster distinct from the
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Figure 7.5. a) 2D PCA scores plot and b) 2D OPLS-DA comparing wild-type S. epidermidis 1457 cells grown 6 h in standard TSB
media ( ), with S. epidermidis 1457 cells grown 6 h in iron-depleted media (DTSB) ( ), with the addition of 4% ethanol ( ),with the
addition of 2% glucose ( ), with the addition of 0.06 µg/mL tetracycline ( ), with the addition of 5% NaCl ( ), and 6 h growth of
aconitase mutant strain 1457-acnA::tetM in standard TSB media ( ). The ellipses correspond to the 95% confidence limits from a normal
distribution for each cluster. For the OPLS-DA scores plot, the 6 h growth of wild-type S. epidermidis 1457 ( ) was designated the control

class and the remainder of the cells were designated as treated. The OPLS-DA used 1 predictive component and 4 orthogonal
components to yield a R2X of 0.637, R2Y of 0.966 and Q2 of 0.941. Metabolomic tree diagram generated from the c) 2D PCA scores
plot depicted in (a) and (d) 2D OPLS-DA scores plot depicted in (b). The label colors match the symbol colors from the 2D scores
plot. Each node is labeled with the boot-strap number, where a value above 50 indicates a statistically significant separation.

246

247
cluster of wild-type cells in standard growth media. These results further support our
hypothesis that environmental stress factors influence biofilm formation by inactivating
the TCA cycle and re-directing key metabolites into PIA synthesis. Conversely, growing
S. epidermidis wild-type cells in the presence of 5% NaCl showed no significant effect on
the metabolome since the wild-type cells in the presence and absence of 5% NaCl cluster
together. Similarly, AI-2 did not affect the S. epidermidis metabolome since both the
wild-type and aconitase mutant cells in the presence and absence of 400 nM AI-2 cluster
together (Figure 7.6). Interestingly, S. epidermidis cells treated with 2% glucose were
separated from both the wild-type and aconitase mutant clusters, implying a different
impact on the metabolome and a unique mechanism of regulating biofilm formation.
Alternatively, the addition of 2% glucose may be viewed as an intermediary effect, where
the metabolome of the S. epidermidis cells grown with 2% glucose is moving toward the
aconitase mutant cells. Effectively, the amount of glucose added to the bacterial culture
was insufficient to completely inactivate the TCA cycle. It has been previously shown
that different strains have different glucose uptake rates and different sensitivities to
glucose-induced biofilm formation [69, 70].
The PCA results were used to guide a subsequent analysis using OPLS-DA
(Figure 7.5b) and the corresponding metabolomics tree diagram (Figure 7.5d). The
OPLS-DA analysis yielded a reliable model (R2X 0.637, R2Y 0.966, Q2 0.941), and
results identical to PCA. The wild-type cells in the presence and absence of 5% NaCl
were defined as the controls and, as expected, formed a single cluster in the 2D scores
plot. S. epidermidis wild-type cultures grown with the addition of the environmental
stressors 4% ethanol, 0.06 µg/mL tetracycline or iron-limitation again formed a single
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Figure 7.6. a) 2D PCA scores plot comparing wild-type S. epidermidis strain 1457 and aconitase mutant strain 1457-acnA::tetM with
and without the addition of 400 nM of AI-2. Cells were grown for 2 h or 6 h in standard TSB media, 2 h growth of wild-type S.
epidermidis strain 1457 with AI-2 ( ) and without AI-2 ( ); aconitase mutant strain 1457-acnA::tetM with AI-2 ( ) and without AI2 ( ); 6 h growth of wild-type S. epidermidis strain 1457 with AI-2 ( ) and without AI-2. ( ); and aconitase mutant strain 1457acnA::tetM with AI-2 ( ) and without AI-2 ( ). b) Metabolomic tree diagram generated from the 2D PCA scores plot depicted in (a).
The label colors match the symbol colors from the 2D PCA scores plot. Each node is labeled with the boot-strap number, where a
value above 50 indicates a statistically significant separation. c) 2D OPLS-DA scores plot comparing wild-type S. epidermidis strain
1457 and aconitase mutant strain 1457-acnA::tetM with and without the addition of 400 nM of AI-2. Each pair of cell cultures treated
with and without AI-2 were defined as a separate class for a total of four separate classes. The model consists of 1 predictive
component and 3 orthogonal components that yielded an R2X of 0.774, R2Y of 0.970, and a Q2 of 0.954.
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cluster with the aconitase mutant in the 2D OPLS-DA scores plot. Also similar to the
PCA results, the S. epidermidis cells grown with 2% glucose formed a unique cluster.
Thus, the corresponding metabolomics tree diagram identified three distinct clusters with
bootstrap values of 100. The OPLS-DA results further support our hypothesis that
environmental stress factors influence biofilm formation by inactivating the TCA cycle
and re-directing key metabolites into PIA synthesis.
To verify the observed effect on the S. epidermidis metabolome is due to
inactivating the TCA cycle as opposed to other potential factors, the S. epidermidis
aconitase mutant strain was also grown with the addition of 4% ethanol, 0.06 µg/mL
tetracycline, 2% glucose, 5% NaCl or under iron-limitation conditions. If the impact of
these stress conditions is primarily through the inactivation of the TCA cycle, then the
metabolome of the aconitase mutant strain should be unperturbed. Otherwise, if the stress
conditions induce additional or alternative responses, then changes in the metabolome
should be observed. The 2D PCA scores plot (Figure 7.7a) and metabolomic tree (Figure
7.7c) indicate the stress conditions did not affect the metabolome of the aconitase mutant.
The aconitase mutant with and without the stress conditions forms a large cluster distinct
from the wild-type cluster. Importantly, this includes the addition of 2% glucose. This
implies the addition of 2% glucose to wild-type S. epidermidis resulted in an incomplete
inactivation of the TCA cycle instead of a novel mechanism of biofilm regulation. Again,
the PCA results were used to guide a subsequent analysis using OPLS-DA (Figure 7.7b)
and the corresponding metabolomics tree diagram (Figure 7.7d). The OPLS-DA analysis
yielded an acceptable model (R2X 0.488, R2Y 0.976, Q2 0.961), and results very similar
to PCA. The lower R2X is consistent with the larger spread observed within the two
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Figure 7.7. a) 2D PCA scores plot and b) 2D OPLS-DA comparing wild-type S. epidermidis 1457 cells grown 6 h in standard TSB
media ( ), 6 h growth of aconitase mutant strain 1457-acnA::tetM in standard TSB media ( ), aconitase mutant strain 1457acnA::tetM in iron-depleted media (DTSB) ( ), with the addition of 4% ethanol ( ), with the addition of 2% glucose ( ), with the
addition of 0.06 µg/mL tetracycline ( ), and with the addition of 5% NaCl ( ). The ellipses correspond to the 95% confidence limits
from a normal distribution for each cluster. The four ellipses correspond to clusters formed by (i) wild-type S. epidermidis 1457 cells,
(ii) aconitase mutant strain 1457-acnA::tetM in standard TSB media, (iii) aconitase mutant strain 1457-acnA::tetM in DTSB or with
the addition of 4% ethanol, and (iv), aconitase mutant strain 1457-acnA::tetM with the addition of 2% glucose, 0.06 µg/mL
tetracycline, or 5% NaCl. For the OPLS-DA scores plot, the 6 h growth of wild-type S. epidermidis 1457 ( ) was designated the control
class and the remainder of the cells were designated as treated. The OPLS-DA used 1 predictive component and 2 orthogonal
components to yield a R2X of 0.488, R2Y of 0.976 and Q2 of 0.961. Metabolomic tree diagram generated from the c) 2D PCA scores
plot depicted in (a) and (d) 2D OPLS-DA scores plot depicted in (b). The label colors match the symbol colors from the 2D scores
plot. Each node is labeled with the boot-strap number, where a value above 50 indicates a statistically significant separation.
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primary clusters. The wild-type cells were defined as the controls and, as expected, the
aconitase mutant with and without the stress conditions formed a single large cluster.
Consistent with the PCA analysis, the single cluster also contained the addition of 2%
glucose. The OPLS-DA scores plot, along with the metabolomics tree diagram, suggests
sub-clusters are present within the large aconitase mutant cluster. But, the aconitase
mutant data is spread throughout this cluster, such that an ellipse that corresponds to the
95% confidence limit for the aconitase mutant data encompasses the two other apparent
sub-clusters. This result indicates that within the resolution of the PCA and OPLS-DA
model, no statistical difference is observed between the metabolomes of the aconitase
mutant with and without the stress conditions. Critically, the S-plot obtained from the
comparison between the wild-type cells and the aconitase mutant treated with the stress
conditions was identical to the S-plot generated from the comparison between the wildtype cells and the untreated aconitase mutant cells. Again, this supports the conclusion
that the addition of the stressors did not perturb the metabolome of the aconitase mutant
cells.

7.3.4 Detailed analysis of changes to the S. epidermidis metabolome caused by
environmental stress.
An overall correlation between the metabolomes of S. epidermidis under stress
and TCA cycle inactivation provides further support for our hypothesis that
environmental conditions induce biofilm formation though the regulation of the TCA
cycle [23]. Specifically, the disparate signals of 2% glucose, 4% ethanol, 0.06 µg/mL
tetracycline and iron-limitation are all sensed by the TCA cycle. To further support our
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hypothesis, a detailed analysis of changes to the S. epidermidis metabolome caused by
these environmental stress factors was necessary. We previously reported an analysis of
changes in the metabolome of S. epidermidis caused by TCA cycle inactivation that
resulted in an increase in PIA production [16]. Among other observed changes, aminoacids derived from TCA cycle intermediates (Asn, Asp, Gln, and Glu) exhibited a
decrease in concentration. Correspondingly, an increase in concentrations was observed
for the PIA biosynthetic precursors UDP-N-acetyl-glucosamine and fructose-6phosphate. A similar approach using 2D 1H-13C HSQC and 2D 1H-1H TOCSY NMR
spectra was applied to quantitate metabolite changes in the S. epidermidis metabolome
caused by Fe-limitation and 4% ethanol (Figure 7.8) [23]. 2D NMR spectra improve
metabolite identification by reducing the complexity and congestion of 1D 1H NMR
spectrum by spreading the information into two-dimensions. Additionally, the 2D 1H-13C
HSQC experiment allows for monitoring the flow of carbon-13 through the metabolome
from a specifically 13C-labeled metabolite. Alternatively, the 2D 1H-1H TOCSY spectrum
monitors all detectable metabolites with a bias to metabolites with the highest
concentration. This may include the carbon-13 labeled metabolites observed in the 2D
1

H-13C HSQC spectrum in addition to non-isotope labeled metabolites produced from

other carbon sources. Therefore, the 2D 1H-13C HSQC and 2D 1H-1H TOCSY NMR
spectra are complementary experiments for metabolomics and allow for a more complete
analysis of metabolite concentration changes. Specifically, S. epidermidis wild-type cells
and the aconitase mutant cells were grown with and without stress factors and harvested
during either the exponential or post-exponential phase with and without the addition of
13

C-glucose. A total of 12 different bacterial culture conditions were prepared in triplicate
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Figure 7.8. a) Overlay of 2D 1H-13C HSQC spectra comparing wild-type S. epidermidis strain 1457 (red) and aconitase mutant strain
1457-acnA::tetM (black) grown for 6 h in standard TSB media augmented with 0.25% 13C-glucose. NMR resonances corresponding to
specific metabolites are labeled, where citrate is circled. (b) Overlay of 2D 1H-1H TOCSY spectra comparing wild-type S. epidermidis
strain 1457 (red) and aconitase mutant strain 1457-acnA::tetM (black) grown for 6 h in standard TSB media.
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for both the 2D 1H-13C HSQC and 2D 1H-1H TOCSY NMR experiments for a minimum
of 72 bacterial cultures or NMR experiments. To maintain consistency, S. epidermidis
wild-type cells were used as a reference and prepared with each bacterial culture set.
Differences in metabolite concentrations between the stresses, the bacterial
growth phases, the aconitase mutant cells, and the wild-type cells was based strictly on
detecting changes in peak intensities in the 2D 1H-13C HSQC and 2D 1H-1H TOCSY
NMR experiments. To minimize contributions from experimental variability, three levels
of normalization were used. First, metabolite concentrations were normalized based on
the total number of cells grown for each culture. Second, the peak intensities in each
NMR spectrum were normalized by the spectrum’s average peak intensity. Third, each
individual peak was normalized by scaling by the largest intensity observed for that peak
across the set of NMR spectra. The intensity of peaks assigned to each metabolite within
a spectrum were averaged and then averaged across the triplicate NMR data set. Relative
changes in peak intensities (metabolite concentrations) were compared to the S.
epidermidis wild type metabolome and are displayed as bar graphs in Figure 7.9.
Importantly, the metabolites identified from the 2D NMR experiments were also
consistent with the metabolites identified as the major contributors to class distinction in
the 2D OPLS-DA plots (Figures 7.5, 7.7). The OPLS-DA S-plots (Figure 7.10) identifies
the relative contribution of each bin (1H NMR chemical shift) to the clustering in the
corresponding 2D scores plot. Each NMR bin with a high reliability (p(corr)[1] ~ 1 or -1)
and a high magnitude (p[1] > 0.1 or < -0.1) was assigned to a metabolite that was also
found to be present in the Figure 7.9 bar graph.
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Figure 7.9. Bar graphs showing the percent change in metabolite concentrations relative to wild-type S. epidermidis strain 1457
grown in standard TSB media. Metabolite concentration changes were measured after 2 h and 6 h bacterial growths for the aconitase
mutant strain 1457-acnA::tetM in TSB media (■), aconitase mutant strain 1457-acnA::tetM with iron-depletion (■), aconitase mutant
strain 1457-acnA::tetM with the addition of 4% ethanol (■), wild-type S. epidermidis strain 1457 with iron-depletion (■), and wildtype S. epidermidis strain 1457 with the addition of 4% ethanol (■) Positive values represent increased concentrations while negative
values represent decreased concentrations with respect to S. epidermidis strain 1457 grown in standard TSB media. The metabolite
names were abbreviated as follows: ACA (Acetaldehyde), ACE (Acetate), ACP (Acetyl-P), AKG (α-ketoglutarate), ALAAc (Acetylalanine), AMI (4-Aminobutanoate), ARG (Arginine), ASN (Asparagine), ASP (Aspartate), CIR (Citrulline), CIT (Citrate), ETH
(Ethanol), F6P (Fruc-6P), G1P (Gluc-1P), G6P (Gluc-6P), GAL (Galacturonic-acid), GAL1P (α-D-Gala-1P), GLN (Glutamine), GLR
(Glucuronate), GLS (D-glucosamine), GLS6P (Glucosamine-6P), GLSAc (N-Ac-D-glucosamine), GLSAc6P (Acetyl-glucosamine6P), GLU (Glutamate), GLUAc (Acetyl-glutamate), GLY (Glyceraldehyde), HIS (Histidine), ICI (Isocitrate), INO (Ino, Ade, Xan),
LAC (Lactate), ALA (alanine), LEU (Leucine), LYS (Lysine), MANAc (N-acetyl-D-mannosamine), MET (Methionine), MIN (myo
inositol), MSE (selenomethionine), NEUAc (N-Ac-neuraminate), ORN (Ornithine), ORNAc (Acetyl-ornithine), PEP
(Phosphoenolpyruvic acid), PRO (Proline), RIB (D-ribose), SAM(S-adenosyl-methionine), SER (Homoserine), SUCSER (OSuccinyl-L-homoserine), UDPGLR (UDP-glucoronate), UDPGLSAc (UDP-NAc-D-glucosamine), VAL (Valine)
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Figure 7.10. a) OPLS-DA S-plots comparing the S.epidermidis 1457 and the aconitase
mutant 1457-acnA::tetM under the different stress conditions described in Figure 4. b)
OPLS-DA loading plot showing the contribution of the identified metabolites from the Splot. These results are comparable to the bar graphs depicted in figure 7.9 from the
analysis of 2D NMR data.
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An inactivated TCA cycle caused concentration changes for 55 metabolites
involved in the amino sugar pathway, glycolytic pathway, several amino acid pathways,
and the TCA cycle. The NMR data shows the amount of cellular glucose in the 6 hour
post-exponential wild-type strain was reduced by 80% compared to the 2 hour
exponential phase. The amount of cellular acetate was increased by 25%. As expected,
the inactivation of the TCA cycle in the aconitase mutant resulted in the accumulation of
a large concentration of acetate. Acetate was the most intense peak in the 6 hour cultures
for the wild-type and aconitase mutant strains shown in Figure 7.8. There were also
noticeable differences in the aconitase mutant metabolome. Peaks corresponding to the
amino acids derived from the TCA cycle intermediates such as Asn, Asp, Gln, and Glu
were not present. Not surprisingly, a large amount of citrate was also seen, since the
inactivated aconitase prevents the conversion of citrate to isocitrate. Other metabolites
associated with the glycolytic pathway were up-regulated. Similarly, some amino sugar
and aromatic metabolites were up-regulated except for the significant down-regulation of
UDP-glucuronate.
As expected from the clustering pattern in the 2D PCA scores plot, the direction
of carbon flow in cells under stress were similar to the aconitase mutant cells, but
dramatically different from wild-type cells during post exponential growth. A decrease in
the concentration of amino acids derived from TCA cycle intermediates such as Asp,
Asn, Glu, and Gln shows that the TCA cycle is still repressed when the cells are under
stress. Instead the carbon flow is redirected back into the glycolytic pathway as indicated
by an increase in concentrations for phosphoenolpyruvate (PEP), acetaldehyde, and
fructose 6-phosphate. The carbon flow was also directed into the amino sugar pathway
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with an increase in concentrations for UDP-N-acetylglucosamine, N-acetyl-neuraminate,
and N-acetyl-D-mannosamine. UDP-N-acetylglucosamine is an important precursor to
PIA formation. Again, the detailed analysis of changes in the metabolome of S.
epidermidis provides additional support for the role of TCA cycle activity in a metabolic
signaling pathway that transduces disparate external stimuli into internal metabolic
signals that facilitate biofilm formation. Effectively, the observed changes in the
metabolome caused by disparate external stimuli are consistently suppressing TCA cycle
activity and inducing PIA synthesis required for biofilms.
Conversely, the change of the carbon flow in the 2 hour growth is minimal.
Again, this is consistent with the low TCA activity and the similar clustering in the 2D
PCA scores plot between the aconitase mutant and wild-type 2 hour growth (Figure
7.2b). Obviously, stress factors cannot suppress an already inactive TCA cycle. Instead,
the catabolic conversion of glucose into intermediates throughout the glycolytic pathway
proceeds as expected with a slight change since pyruvate is also produced. Much of the
carbon-13 from glucose was still directed to the production of acetate. The NMR data
indicates cellular acetate concentrations were similar across the 2 hour bacterial cultures,
but an increased amount of acetyl-phosphate was accumulated under stress conditions.
This confirms that when an abundant amount of glucose is present, it is processed by
glycolysis and pyruvate dehydrogenase into acetyl-CoA and converted into acetylphosphate for use in substrate level phosphorylation. The excretion of acetate into the
culture medium helps pH homeostasis due to the large flux of acetate [71]. Aside from
the glycolytic pathway, the NMR data indicates that wild-type bacteria tend to utilize
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glucose more efficiency based on small decreases in amino sugar and aromatic
metabolites.

7.3.5 Metabolic rearrangements during TCA cycle stress.
The metabolome of S. epidermidis is not a series of independent isolated
metabolic pathways, but instead is a complex inter-connected network. Thus, metabolic
pathways connected to the TCA cycle are also affected by changes in TCA cycle activity.
In order to visualize the cascade effect of inactivating the TCA cycle, a metabolic
network was constructed using Cytoscape [40]. The metabolic network (Figure 7.11) was
generated by manually associating each metabolite to its corresponding pathway from the
KEGG [53] database and then using the automated biological network modules
integrated into Cytoscape [72, 73]. The network connects the 37 metabolites identified by
NMR whose concentrations are either increased (red) or decreased (green) by an
inactivated TCA cycle. Only metabolites affected by a minimally active TCA cycle under
all circumstances (aconitase mutant and stress factors) are highlighted on the network
map. It is important to note that NMR is not able to identify every metabolite affected by
perturbing the metabolome. The concentrations or stabilities of some metabolites are
simply below the NMR detection limit. These intervening and undetected metabolites are
colored grey in the metabolic network. The network shows the TCA cycle as the central
pathway where common metabolites connect the urea cycle, alanine metabolism, and
glycolysis/gluconeogenesis that then leads to amino sugar metabolism and other
metabolites associated with PIA synthesis.
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Figure 7.11. Cytoscape [40] network depicting the metabolite concentration changes
caused by the inactivation of the TCA cycle. Nodes colored red correspond to metabolites
with an increase in concentration due to TCA inactivated. Nodes colored green
correspond to metabolites with a decrease in concentration due to TCA inactivated.
Nodes colored grey correspond to metabolites that are not observed in the NMR spectra,
do not have a reference NMR spectrum (or assignment), or did not exhibit a significant
concentration change. Metabolic pathways are labeled on the network. The metabolite
names were abbreviated as described in the legend to Figure 7.9.
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7.4 Conclusion
The systematic analysis of the S. epidermidis metabolome using NMR provides
further evidence for a metabolic signaling network for biofilm formation that involves the
TCA cycle. Inactivation of the TCA cycle enables metabolic precursors to flow into
pathways associated with PIA synthesis, an important component of S. epidermidis
biofilm formation. Disparate environmental stress conditions known to induce biofilm
formation were shown to perturb the metabolome of S. epidermidis in a manner similar to
an aconitase mutant. Effectively, iron-depletion, and the addition of ethanol, tetracycline,
and glucose resulted in the inactivation of the TCA cycle. Furthermore, a detailed
analysis of the specific changes to the S. epidermidis metabolome indicates that
essentially the same set of metabolites affected by TCA cycle inactivation are also
affected by environmental stress conditions. A network map identified the TCA cycle as
playing a central role in the proposed signaling pathway that also involves the urea cycle,
alanine metabolism, glycolysis/gluconeogenesis, amino sugar metabolism and other
metabolites associated with PIA synthesis. Interestingly, the addition of NaCl or
autoinducer-2 did not induce any effect on the S. epidermidis metabolome or effect TCA
cycle activity. Suggesting these factors must act through a distinct process from the other
environmental factors.
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CHAPTER 8
CCPA REGULATES ARGININE BIOSYNTHESIS IN STAPHYLOCOCCUS
AUREUS THROUGH REPRESSION OF PROLINE CATABOLISM§

8.1 Introduction
Staphylococcus aureus is a common cause of skin and soft tissue infections;
however more serious complications such as bacteremia, osteomyelitis, endocarditis, and
necrotizing pneumonia can occur [1]. During infection, S. aureus must catabolize diverse
carbon sources including carbohydrates, proteins and lipids; therefore, multiple global
regulators, including CcpA and CodY, subsequently regulate carbon flow [2-4]. Thus,
regulation of carbon flow through central metabolism and other metabolic pathways has a
direct link to expression and synthesis of virulence factors [5-7].
It has been known for over 70 years that S. aureus exhibits multiple amino acid
auxotrophies, including arginine, valine, proline, cysteine, and leucine [8, 9].
Complicating the picture, in 1937, Gladstone demonstrated that multiple strains of S.
aureus could be trained to grow in a chemically-defined broth lacking all twenty amino
acids through extended incubation [9]. These data suggested that S. aureus was indeed a
prototroph but repressed biosynthesis of certain amino acids. In support of this,
bioinformatics analyses of the S. aureus genome revealed an apparently complete
repertoire of biosynthetic operons needed to synthesize all 20 amino acids [10]. Included
§
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in these are the genes encoding the arginine biosynthetic pathway argJBCDFGH where
arginine is synthesized from glutamate [11]. This pathway is highly conserved among a
wide array of bacteria, including Escherichia coli, Salmonella enterica serotype
Typhimurium, Proteus mirabilis, Bacillus subtilis, and Streptomyces clavuligerus among
others [12-14].
Although B. subtilis synthesizes proline from glutamate [11, 15, 16], S. aureus
preferentially utilizes arginine rather than glutamate as a precursor for proline
biosynthesis via arginase (RocF), ornithine aminotransferase (RocD), and P5C reductase
(ProC) [17]. Furthermore, Li and colleagues recently reported that proline biosynthesis is
regulated through CcpA-mediated carbon catabolite repression at both rocF and rocD
[18]. Carbon catabolite repression allows bacteria to preferentially utilize preferred
carbon sources and therefore increase the organism’s fitness [19]. The trans-acting
carbon catabolite protein CcpA in a complex with Hpr binds to cis-acting DNA
sequences known as catabolite responsive elements (CRE) [20-23]. In the presence of a
preferred carbon source, HprK phosphorylates the Ser-46 position of Hpr and once
phosphorylated, Hpr binds to CcpA [23-25].
In this study, we utilized genetic and biochemical approaches to examine arginine
auxotrophy in S. aureus. bursa aurealis transposon mutagenesis identified CcpA as a
regulator of arginine biosynthesis. However, instead of de-repressing the conserved
arginine biosynthesis pathway (ArgJBCDFGH) via glutamate, S. aureus JE2 ccpA
synthesized arginine from proline via the urea cycle. To the best of our knowledge, this is
the first report of bacteria utilizing proline for arginine biosynthesis, which may indicate
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a predilection to degrade and utilize proteins rich in proline (i.e. collagen) during an S.
aureus infection for use in arginine biosynthesis. Utilization of proline to synthesize
arginine demonstrates the resourcefulness of S. aureus and its ability to rapidly evolve to
utilize nutrients that are readily available in the environment.

8.2 Materials and Methods
8.2.1 Ethics
The clinical S. aureus strains used in this study originated from the University of
Nebraska Medical Center. The Institutional Review Board at the University of Nebraska
Medical Center is charged with reviewing all research involving human subjects. The
clinical S. aureus strains utilized in the study were de-identified and analyzed
anonymously and were therefore exempt from human research committee approval.
Animal experimentation was performed under a University of Nebraska Medical Center
approved Institutional Animal Care and Use Committee (IACUC) Protocol to TK. The
University of Nebraska Medical Center is accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care International (AALAC). In addition, all
animals at the University of Nebraska Medical Center are maintained in accordance with
the Animal Welfare Act and the DHHS ‘‘Guide for the Care and Use of Laboratory
Animals.’’
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Table 8.1. Bacterial Strains and Plasmids used in study
Bacterial Strain or
Relevant Phenotype
Plasmid

Source

pFA545

Encodes pBursa transposase; Tetr

[26]

pBursa

Encodes bursa aurealis transposon; Ermr, Camr

[26]

pNF266

pCN51 (60) with ccpA cloned into the Sphl and
BamHI site using primers 2250 and 2251
removing cadA; Ampr, Ermr

This
study

pMRS44

Derivative of pTS1-d (58) with ccpA::ermB
Ampr, Camr, Ermr

This
study

S. aureus RN4220

Restriction deficient NCTC8325-4

[27]

S. aureus Newman

S. aureus ATCC 25904

[28]

S. aureus MST14

Newman containing an allelic replacement
mutation (tetL) in ccpA. Tetr

[2]

S. aureus LAC

USA300 PFGE type; ST8. Ermr, Camr, Tetr

[29]

S. aureus JE2 Cams, Tets

LAC cured of all 3 native plasmids; Erms

This
study

S. aureus JE2 ccpA::tetL

Allelic replacement mutation in ccpA; transduced
from MST14; Tetr

This
study

S. aureus SA564
ccpA::ermB

Allelic replacement mutation in ccpA Ermr

This
study

S. aureus JE2 ccpA::ermB

ccpA mutant; transduced from SA564
ccpA::ermB; Ermr

This
study

S. aureus RN4220
ccpA::tetL

Allelic replacement mutation in ccpA: transduced
from MST14; Tetr

This
study

JE2 ccpA::tetL/argJ::φNΣ

bursa aurealis argJ mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/argB::φNΣ

bursa aurealis argB mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/argC::φNΣ

bursa aurealis argC mutation in ccpA::tetL
background.

This
study

275

Table 8.1 (continued)
Bacterial Strain or
Plasmid

Relevant Phenotype

JE2
ccpA::tetL/argF::φNΣ

bursa aurealis argF mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/argG::φNΣ

bursa aurealis argG mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/argH::φNΣ

bursa aurealis argH mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/proC::φNΣ

bursa aurealis proC mutation in ccpA::tetL
background.

This
study

JE2 ccpA::tetL/putA::φNΣ

bursa aurealis putA mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/rocD::φNΣ

bursa aurealis rocD mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/arcB1::φNΣ

bursa aurealis arcB1 mutation in ccpA::tetL
background.

This
study

JE2
ccpA::tetL/arcB2::φNΣ

bursa aurealis arcB2 mutation in ccpA::tetL
background.

This
study

RN4220 argH::φNΣ

bursa aurealis argH mutation

This
study

RN4220 argF::φNΣ

bursa aurealis argF mutation

This
study

RN4220
ccpA::tetL/argG::φNΣ

bursa aurealis argG mutation in ccpA::tetL
background

This
study

RN4220
ccpA::tetL/argH::φNΣ

bursa aurealis argH mutation in ccpA::tetL
background

This
study

Newman
ccpA::tetL/argG::φNΣ

bursa aurealis argG mutation in ccpA::tetL
background

This
study

Newman
ccpA::tetL/argH::φNΣ

bursa aurealis argH mutation in ccpA::tetL
background

This
study

Source
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8.2.2 Bacterial Strains and Culture Conditions
For determination of arginine auxotrophy, eighty-two S. aureus isolates were
obtained from a previous collection testing the prevalence of heterogeneous vancomycin
intermediate susceptibility [30]. Other bacterial strains used in the study are shown in
Table 8.1. Defined bursa aurealis transposon mutants were acquired from the Nebraska
transposon mutant library via the Network on Antimicrobial Resistance in
Staphylococcus aureus (NARSA; http://www.narsa.net). Bacterial strains were grown in
either Tryptic Soy Broth (TSB; Becton Dickinson, Franklin Lakes, NJ) or Complete
Defined Medium (CDM) as previously described except containing 0.25% glucose [31].
Cultures were grown aerobically (1:10 volume to flask ratio) at 37oC, 250 rpm unless
otherwise stated. To train JE2 to grow on media lacking arginine, cultures were grown in
CDM-R broth for 6 days, at which point the bacteria were inoculated to CDM-R agar. To
study the reversion frequency of JE2, Newman and RN4220, the bacteria were grown for
20 hours in 3 mL of CDM. Cells were pelleted, resuspended in 0.9% NaCl, and diluted
onto CDM, CDM-R, or CDM-P. After 72 hours the colonies were counted and reversion
frequency was determined by taking the number of prototrophic revertants divided by
total number of colonies plated on CDM.
To determine the growth characteristics in CDM-R containing various alternative
carbon sources, JE2 was grown in 3 mL of CDM overnight, pelleted and resuspended in
0.9% NaCl. 3 mL of CDM and CDM-R supplemented with either 0.25% of glucose,
fructose, glycerol, sucrose, mannitol, maltose, salicin, gluconic acid, arabinose, sorbitol,
or ribose (all purchased from Sigma-Aldrich, St. Louis, MO) were inoculated in a 14 mL

277
polypropylene round-bottom tube (Becton Dickinson) to an OD600 of 0.05. Cultures were
grown for 18 h at 37oC to stationary phase.

8.2.3 Screening of Random bursa aurealis Transposon Mutant Library
Random bursa aurealis transposon mutants were generated using plasmids
pBursa and pFA545 and identified using inverse PCR as previously described [26].
Mutants were grown and collected in a 96 well format and pelleted and resuspended in 50
uL of 0.9% NaCl. 2 uL were plated on CDM and CDM-R and incubated at 37oC for 72
hours. Approximately 2700 mutants were screened; colonies that grew on CDM-R plates
were confirmed by growing in CDM-R broth.

8.2.4 Transduction, ccpA Mutant Construction and Complementation
bursa aurealis transposon mutations were moved to other strain backgrounds
through transduction using phage 80α or φ11 as previously described [32]. All primers
(Table 8.2) used for construction and confirmation of the ccpA mutation were generated
based on the sequence of S. aureus strain Mu50 (NC_002758.2). The ccpA mutant was
constructed by replacing a 0.6 kb internal region of the ccpA gene with an erythromycin
resistance cassette (ermB) using the gene splicing by overlap extension (gene SOEing)
technique [33]. ermB was amplified from pEC4 [34] using primers SAV1736-ermB-f and
SAV1736-ermB-r, which contain sequences homologous to the ccpA gene. Primers
BamHI-SAV1737-f and ermBSAV1736-r were used for amplification of a 1.3 kb region
upstream of the ccpA gene. Primers ermB-SAV1736-f and SacI-acuC-f were used to
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Table 8.2. Oligonucleotides used in study
Primer Name

Sequence

Relevant Characteristic

1868

TCTACAAGAACGCGATGTGC

Forward primer used to
amplify argF

1869

TTCACCCAATGTAGCAACCA

Reverse primer used to
amplify argF

1872

CAAAATCTATGGGGCAGAGC

Forward primer used to
amplify argG

1873

CCATGCAACATCGCATTTAC

Reverse primer used to
amplify argG

1874

TGCAACTATGCTTGCGAATC

Forward primer used to
amplify argH

1875

TGCTAGTTCCGTTGCATTTG

Reverse primer used to
amplify argH

1876

ACCCCCTACTTCAAGGCACT

Forward primer used to
amplify argD

1877

CGTCTTGAAAAGCTGCAACA

Reverse primer used to
amplify argD

1878

TAGGTATCGTTGGCGGTAGC

Forward primer used to
amplify argC

1879

CTCGATTTCCGGTTTGTGTT

Reverse primer used to
amplify argC

1880

ACACAAACATGGGTTGCTCA

Forward primer used to
amplify argJ

1881

GTTTCCCATTGTGGATGGTC

Reverse primer used to
amplify argJ

1882

AACACACGCTCATTGCAGAC

Forward primer used to
amplify argB

1883

AGGACAGCCATTTTCAATCG

Reverse primer used to
amplify argB

1929

TTGCAGCGCATGATCAAGGT

Forward qRT-PCR; argF

1930

TTCCACACTGGTACGCCTGAA

Reverse qRT-PCR; argF
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Table 8.2 (continued)
Primer Name

Sequence

Relevant Characteristic

1933

TGGGCATGGAGTCGTGAAGA

Forward qRT-PCR; argG

1934

CTCTGGTGGCGCAGCATAAG

Reverse qRT-PCR: argG

1935

ATCGAAGGCAGCATTGCACA

Forward qRT-PCR; argH

1936

CCACCAGCATCACCGATACG

Reverse qRT-PCR; argH

1937

TGGGAGCAAGTCGTTCCAGA

Forward qRT-PCR; argD

1938

CAAGCGCTGCCGTCGATATT

Reverse qRT-PCR; argD

1939

TCGTTGGCGGTAGCGGTTAT

Forward qRT-PCR; argC

1940

GGTGCTGGTGTCGCAAAGA

Reverse qRT-PCR; argC

1941

CATCGTCTTTGGCAAGTGCAG

Forward qRT-PCR; argJ

1942

CAGCTGTGCATCCAAACCACA

Reverse qRT-PCR; argJ

1943

TGGCGGTGGCCCATTTATTA

Forward qRT-PCR; argB

1944

CCCCAGTTGAAGCAACAGCA

Reverse qRT-PCR; argB

2250

CCCGGGGCATGCTGAATTCCA
AGCATTTTATGATGA

Forward ccpA; contains
SphI* restriction site

2251

CCCGGGGGATCCTGAATTTATT
TTGTAGTTCCTCGGTA

Reverse ccpA; contains
BamH1* restriction site

2186

TCGCTAAATTTTTCCAAACAAAA

Forward ccpA

2187

AAAGGCATTCTTCCAACACC

Reverse ccpA
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Table 8.2. (continued)
Primer Name

Sequence

Relevant Characteristic

1888

TTTGGGCATATGTTAACGACAG
AAAAACTAGTT

Forward hprK

1889

GGGGGATCCCTACTCCTCACTC
TTATGACTG

Reverse hprK

1886

AATGTACATATGGAACAAAATTC Forward ptsH
ATATGTAATC

1887

ACAGGATCCTTTAGTCAATCCTT
CTTTTGATAAGAC

Reverse ptsH

BamHI-SAV1737F

CCAGGATCCACGTATCACGTA
AGTTGAAACCTGAAG

ccpA SOEing

ermB-SAV1736R

CAACATGACGAATCCCTCCTTC
GCGCTTCTCTTGCTACATCATAT
ATAGTAAC
CTATATATGATGTAGCAAGAG
AAGCGCGAAGGAGGGATTCG
TCATGTTGG
CAATTCAATGTATCACCTAAT
CAATTCAATGTATCACCTAAT
ATTATTTCCTCCCG

ccpA SOEing

CGGGAGGAAATAATTCTATGA
GTCGCGGCCTTCAATTAGGTG
ATACATTGAATTG
GCAGAGCTCAGCAACAAGCGT
TTGATGATATTCG

ccpA SOEing

SAV1737F

GCAACAAAGGACCATTTAACGA
TAATAC

ccpA mutant confirmation

AcuC F

GGTGGACTTGAAATATTCGCTA
CAG

ccpA mutant confirmation

ermB F

GGGTCAATCGAGAATATCGTCA
ACTG

ccpA mutant confirmation

ermB R

GCCCTTTACCTGTTCCAATTTCG

ccpA mutant confirmation

SAV1736-ermBF
SAV1736-ermBR

ermB-SAV1736F
SacI-AcuC-F

*Restriction denotes in italics

ccpA SOEing
ccpA SOEing

ccpA SOEing
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amplify a 1.7 kb region downstream of the ccpA gene. The resulting 4.1-kb PCR product
contained BamHI and SacI sites that were used for cloning into pTS1-d [35] to generate
plasmid pMRS44. Plasmid pMRS44 was used to construct S. aureus SA564 ccpA::ermB
using the temperature shift protocol as previously described [36]. Allelic replacement of
the internal region of the ccpA gene by the ermB cassette was verified by PCR using
primers ermB-f, ermB-r, SAV1737-f and acuC-f. The ccpA::ermB mutation was
subsequently moved to JE2 through phage 80α transduction and confirmed using primers
noted above. For the ccpA complementation plasmid pNF266, ccpA was amplified from
JE2 using primers 2250 and 2251 (Table 8.2), digested with SphI and BamHI, and cloned
into pCN51 [37]. Note that two ccpA mutants were constructed in this study, JE2
ccpA::ermB and JE2 ccpA::tetL. JE2 ccpA::tetL was generated by phage 80α
transduction of the ccpA::tetL allele from MST14 [2] so double mutants could be
constructed using ermB as the second selectable marker.

8.2.5 NMR Data Collection
JE2 and JE2 ccpA::ermB were grown in 50 mL CDM to stationary phase. JE2 and
JE2 ccpA::ermB were subsequently inoculated to an OD600 of 0.05 in CDM containing
100 mM of either 13C5-glutamate or 13C5-proline (Isotec) and grown to stationary phase.
Cultures were normalized to an OD600 of 2.0 and pelleted by centrifugation (3000 rpm, 20
minutes, 4oC). Pellets were subsequently washed in 10 mL of cold sterile water and
resuspended in 1 mL cold sterile water. The pellet was lysed using a bead beater (MP
Biomedicals) and centrifuged for 15 minutes at 13,000 rpm at 4oC. This lysis step was
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repeated two more times and the pellet frozen in an ethanol/dry ice bath. The samples
were then lyophilized, suspended in 600 μL of 50 mM phosphate buffer (pH=7.2,
uncorrected) in 99.8% D2O (Isotec), and transferred to 5 mm NMR tubes for analysis.
The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer equipped
with a triple resonance, Z-axis gradient probe. A BACS-120 sample changer with Bruker
Icon software was used to automate the NMR data collection. The 2D 1H-13C HSQC
spectra were collected with a standard Bruker pulse sequence (HSQCETGP), solvent
presaturation and a relaxation delay of 1.5s. Each 2D 1H-13C HSQC spectrum was
collected with a spectrum width of 4734.85 Hz and 2048 data points in the direct (1H)
dimension; and a spectrum width of 13834.26 Hz and 64 data points in the indirect (13C)
dimension. A total of 16 dummy scans and 128 scans were used to obtain each 2D 1H-13C
HSQC spectra.
The spectra were processed using the NMRPipe software package [38]. The
spectra were Fourier transformed, manually phased, and baseline corrected. The
processed 2D 1H-13C HSQC spectra were then analyzed using NMRView [39] to assign
chemical shifts and intensities to each peak. The chemical shift list were assigned to
specific metabolites using the Human Metabalome Database [40], Madison
Metabolomics Database [41], and Platform for Riken Metabolomics [42] with a tolerance
level of 0.05 ppm and 0.40 ppm in the 1H and 13C chemical shifts respectively. The
presence of metabolites and metabolomics pathways was verified using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [43] and MetaCyc [44] databases. The
quantification of metabolomic peak intensities were performed in a similar manner as
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previously described [45]. The relative percent concentration difference was determined
by subtracting averages from the two cultures. A student T-test was performed to verify
the significance at a 95% confidence level, of the relative percent concentration
differences.

8.2.6 RNA Isolation and Northern Blot Analysis
Cultures of S. aureus JE2 and JE2 ccpA::ermB were grown overnight in CDM,
diluted to an OD600 of 0.05 into fresh CDM or CDM-R (1:10 volume to flask ratio, 250
rpm), and grown at 37oC to an OD600 of 1.5 (mid-exponential growth). Cells were
pelleted at 3000 x g for 20 minutes at 4oC and resuspended in RLT buffer with 1% bmercaptoethanol. Next, they were transferred to lysing matrix B tubes (MP Biomedicals)
and processed in a FP120 FastPrep cell disrupter (MP Biomedicals) for 24 seconds at a
setting of 6.0. The cells were pelleted at 13000 rpm at 4oC for 15 minutes; top-phase was
combined with 500 μL of ethanol. The samples were then processed using an RNeasy
mini kit, according to manufactures instructions (Qiagen, Inc.). Primers listed in Table
8.2 were used to make DNA probes that were subsequently labeled with digoxigeninlabeled dUTP (Roche). 5 μg of RNA was used for northern analysis that was performed
using DIG buffers and washes (Roche). Anti-Digoxigenin-AP Fab fragments (Roche)
was used with ECF substrate (GE Healthcare) for detection. Blots were visualized using
the Typhoon FLA 7000 imaging system (GE Healthcare).
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8.2.7 Amino Acid Analysis
JE2 and JE2 ccpA::ermB were grown overnight in 50 mL (500 mL flask) of
CDM. Cultures were inoculated to a starting OD600 of 0.05 in CDM (100 mL in 1 L flask,
250 rpm, 37oC) and grown for 5 hours. 500 μL of media was collected and pelleted for 5
minutes at maximum speed. Supernatant was collected and filtered through 3,000
MWCO Amicon Ultra centrifugal filters (Millipore) according to manufactures
instructions. Amino acid analysis was performed by the Protein Structure Core Facility,
UNMC, using a Hitachi L-8800.

8.2.8 Animal Models
Mouse subcutaneous abscess model. Subcutaneous abscesses were established in
C57BL/6 mice following the injection of 5 x 105 CFU of S. aureus JE2. Tissues were
collected at day 7 post infection and processed for immunofluorescence staining for
either type I collagen (Millipore, Billerica, MA), inducible nitric oxide synthase (Abcam,
Cambridge, MA), or arginase (Santa Cruz, San Diego, CA.) For type I collagen, tissues
were incubated with the nuclear stain DAPI to accentuate the abscess core. Mouse kidney
abscess model. C57BL/6 mice were anesthetized using ketamine and xylazine and 100
μL containing 107 CFU of S. aureus JE2, JE2 argH::φNΣ, or JE2 argF::φNΣ were
inoculated retro-orbitally. On day 20 following inoculation, the animals were sacrificed
and the kidneys were excised, homogenized, and subsequently plated for bacteriological
analysis (CFU/g of tissue) on Trypticase soy agar (TSA). Only those kidneys containing
greater than 100 CFU/g of tissue were statistically analyzed. Pairwise comparisons were
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conducted and differences were adjusted for multiple comparisons using the TukeyKramer method to maintain an overall alpha = .05 across all comparisons.

8.3 Results
8.3.1 Arginine Auxotrophy in Staphylococcus aureus
To examine arginine auxotrophy in S. aureus, eighty-two clinical S. aureus
isolates collected from positive blood cultures at the University of Nebraska Medical
Center were grown on Complete Defined Medium (CDM) with and without arginine.
Similar to observations by Emmett and Kloos, only one S. aureus isolate (SA2126) had
the ability to grow on CDM lacking arginine (CDM-R) following 48 h incubation,
whereas all isolates grew on CDM containing arginine further confirming the arginine
auxotrophic nature of S. aureus [8]. Furthermore, a community-associated S. aureus
USA300 strain JE2 (Table 8.1) was unable to grow on CDMR following 48 h incubation
at 37oC. To extend these observations, JE2 was grown to stationary phase in CDM broth
(5 x 109 CFU) and plated on CDM-R and CDM lacking proline (CDM-P). Similar to the
observations of Li and colleagues [18], S. aureus JE2 reverted to proline prototrophy at a
rate of 1 x 10-6; however, no colonies were isolated on CDM-R following five
experimental attempts. Nevertheless, similar to observations by Gladstone, slight growth
of JE2 was observed following five days of incubation in CDM-R broth [9]. These
observations suggest that S. aureus has the inherent ability to synthesize arginine upon
extended selection; however, the phenotype is not easily selected during growth in
medium replete with amino acids.
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8.3.2 Regulation of Arginine Biosynthesis by Carbon Catabolite Repression
Based on our observations that growth in CDM-R could be selected through
extended incubation, we hypothesized that arginine biosynthesis was under
transcriptional repression. Therefore, we screened a random bursa aurealis transposon
library to isolate JE2 mutants able to grow on CDM-R. Two mutants were isolated that
had the ability to grow on CDM-R; subsequent sequencing of the bursa aurealis
insertions found they had inserted in hprK and ccpA. Both HprK and CcpA function to
control carbon catabolite repression (CCR) in gram-positive bacteria [46]. Therefore, to
completely eliminate CCR, a ccpA allelic replacement mutant was generated in JE2
through 80α transduction of the ccpA::tetL allele from MST14 (kind gift of M. Bischoff).
As predicted, growth analysis in CDM-R demonstrated that JE2 ccpA::tetL enters
exponential phase between 7–12 h and reaches a maximum OD600 of 4.5 after 24 h,
whereas no growth was observed with wild type JE2 in CDM-R (Figure 8.1).
Importantly, introduction of the ccpA complementation plasmid pNF266 abrogated
growth of JE2 ccpA::tetL.
To further support the hypothesis that CCR functions to repress arginine
biosynthesis, JE2 was grown in CDM-R lacking glucose but containing other, nonpreferred carbon sources (Figure 8.2). Since CCR is alleviated when S. aureus is grown
in media containing a non-preferred carbon source, it was hypothesized that JE2 would
grow in CDM-R when glucose was replaced with a secondary carbon source. These
experiments demonstrated that arabinose, sorbitol and pyruvate were able to support
growth of JE2 when added to CDM-R (Figure 8.2). In contrast, glucose, fructose,
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Figure 8.1. Interruption of ccpA facilitates growth in CDM-R. Growth analysis of JE2,
JE2 ccpA::tetL, and JE2 ccpA::tetL/pNF266 (ccpA complement) in complete defined
medium lacking arginine (CDM-R). Isolates were grown aerobically using a 10:1 flask to
volume ratio. S. aureus strains containing a functional ccpA are unable to grow in CDMR. Data represent means 6 SEM of three independent experiments.
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Figure 8.2. Growth of JE2 in CDM containing non-preferred carbon sources. JE2 was
grown in CDM or CDM-R with the indicated carbon source at 37oC for 18 hours.
Significant growth in CDM-R was seen only when arabinose and sorbitol were used as
carbon sources. Data represent means 6 SEM of five independent experiments.
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glycerol, sucrose, mannitol, maltose, salicin, gluconic acid, and ribose were unable to
support growth in CDM-R suggesting these carbohydrates do not derepress CcpA in JE2.
In agreement with our results, Li and colleagues also determined that replacement of
glucose with arabinose or sorbitol abrogated CcpA-mediated repression in S. aureus
Newman and functioned to activate proline biosynthesis [18]. Overall, these data
demonstrate that CCR functions to repress arginine biosynthesis, suggesting that arginine
biosynthesis is linked to growth in niches where preferred carbon sources are limited.

8.3.3 Northern Analysis of argJBCDFGH in JE2 ccpA::ermB
Our preliminary data suggested that CCR functioned to repress an enzymatic step
in the conserved arginine biosynthetic pathway via glutamate [47] (Figure 8.3). To
further address this possibility, northern blot analysis was performed to address
transcriptional expression of argJBCDFGH in JE2 ccpA::ermB in comparison to
wildtype JE2. In S. aureus, argDCJB is arranged in an operon structure, whereas argF is
transcribed as a monocistronic unit and argGH are co-transcribed. JE2 and JE2
ccpA::ermB were grown in CDM and CDM-R, respectively, to mid-exponential phase
and mRNA was isolated. Utilizing DNA probes specific for each gene within the
conserved pathway, argDCJB and argF expression was not detected in either JE2 or JE2
ccpA::ermB (Figure 8.4). However, although argG and argH transcripts were not
detected in JE2, both transcripts were detected in JE2 ccpA::ermB (Figure 8.4).
Therefore, although JE2 ccpA::ermB has the ability to grow on media lacking arginine,
this strain does not appear to utilize the conserved arginine biosynthetic operon to
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Figure 8.3. Arginine biosynthetic pathway via glutamate and proline. Figure depicts
highly conserved arginine biosynthetic pathway via glutamate and the proposed pathway
from proline via PutA, RocD, ArcB1, ArgG and ArgH. Note the previously established
reverse pathway from arginine to proline via RocF, RocD and ProC.
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Figure 8.4. Northern analysis of arginine biosynthetic pathway in S. aureus JE2 and JE2
ccpA::ermB. JE2 and JE2 ccpA::ermB total RNA was isolated in mid-exponential phase
of growth in CDM and CDM-R, respectively. DNA probes specific for argJ, argB, argC,
argD, argF, argG, and argH were labeled with digoxygenin and detected using
antidigoxigenin-AP Fab fragments (a). (b) shows 16s and 23s rRNA depicting equal
RNA loading.
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synthesize arginine in CDM-R. These results suggested the existence of a novel arginine
biosynthetic pathway in S. aureus.

8.3.4 S. aureus Utilizes a Novel Proline Catabolic Pathway to Synthesize Arginine
Since our data indicated that glutamate was not the precursor for arginine
synthesis in JE2 ccpA::ermB, other potential pathways were examined in silico. Based on
the northern blot data demonstrating the expression of argGH in JE2 ccpA::ermB, we
hypothesized that arginine may be synthesized via the urea cycle (Figure 8.3). In silico
analysis predicted that either glutamate or proline have the potential to feed into the urea
cycle to serve as substrates for arginine biosynthesis. To address this hypothesis, we
examined amino acid consumption by JE2 and JE2 ccpA::ermB grown in CDM and
CDM-R, respectively (Figure 8.5). These results demonstrated that both JE2 and JE2
ccpA::ermB consumed similar amounts of glutamate from the culture media following 24
h of growth. In contrast, JE2 ccpA::ermB consumed all available free proline from the
culture medium, whereas only approximately 50% of the available free proline was
consumed by JE2. Taken together, these observations allowed us to speculate that JE2
ccpA::ermB utilized proline via the urea cycle for arginine synthesis.
To further investigate this hypothesis, φ11 transducing lysates were prepared from
defined JE2 bursa aurealis mutants with insertions in the following genes: putA, proC,
rocD, arcB1, arcB2, argF, argG, argH, argC, argB and argJ. These bursa aurealis
mutations (conferring erythromycin resistance) were transduced into JE2 ccpA::tetL and
subsequently grown in CDM-R (Figure 8.6). Mutations in argG, argH, putA, rocD, and
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Figure 8.5. Amino acid analysis of JE2 and JE2 ccpA::ermB following growth in
CDM. JE2 and JE2 ccpA::ermB were grown in CDM for 18 hours and supernatant was
collected and analyzed for amino acid content. Percent of proline and arginine remaining
is shown suggesting more efficient utilization of proline by JE2 ccpA::ermB in
comparison to JE2.
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Figure 8.6. Determination of arginine biosynthesis-dependent genes in S. aureus JE2
ccpA::tetL. Defined bursa aurealis transposon mutants in argJ, argB, argC, argF, argG,
argH, proC, putA, rocD, arcB1, and arcB2 were transduced into JE2 ccpA::tetL and
assessed for growth in CDM-R for 18 hours. Data represent means 6 SEM of three
independent experiments.
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arcB1 abrogated growth of JE2 ccpA::tetL in CDM-R. However, mutations in argJ,
argB, argC, argF, arcB2, or proC had no effect on growth consistent with the prediction
that arginine is synthesized from proline and not glutamate (Figure 8.6).
Two-dimensional (2D) 1H-13C heteronuclear single quantum coherence (HSQC)
nuclear magnetic resonance (NMR) experiments were performed to confirm these data.
JE2 and JE2 ccpA::ermB were grown in the presence of 13C5-glutamate or 13C5-proline in
CDM and CDM-R, respectively. Based on our genetic studies, it was predicted that 13Clabeled arginine would only be detected when JE2 ccpA::ermB was grown in CDM-R
containing 13C5-proline. As expected, 13C-labeled arginine was detected when JE2
ccpA::ermB was propagated in the presence of 13C5-proline but not with 13C5-glutamate
(Figure 8.7). Collectively, these results provide strong evidence that proline is the
substrate for arginine biosynthesis in a ccpA genetic background. Furthermore, it is
demonstrated that the highly conserved arginine biosynthetic pathway via glutamate is
inactive under the growth conditions utilized in the study.

8.3.5 Arginine Auxotrophy in Other Staphylococcus aureus Strains
To determine whether our data regarding arginine biosynthesis were specific to
the JE2 background, φ11 transducing lysates were prepared from JE2 bursa aurealis
argF and argH mutants and introduced into RN4220 and Newman ccpA backgrounds. As
previously noted with JE2 ccpA::tetL, an argH mutation abolished the ability of both
RN4220 ccpA::tetL and Newman ccpA::tetL to grow in CDM-R, whereas a mutation in
argF had no effect (Figure 8.8). Interestingly, RN4220 has the ability to grow in CDM-R
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Figure 8.7. Two-dimensional (2D) 1H-13C heteronuclear single quantum coherence
(HSQC) nuclear magnetic resonance (NMR) analysis of JE2 and JE2 ccpA::ermB. JE2
and JE2 ccpA::ermB were grown in the presence of 13C5-glutamate or 13C5-proline in
CDM and CDM-R, respectively, and assayed using 2D 13C HSQC NMR. The differences
in 13C-arginine relative intensity were determined by subtracting the average intensities
between JE2 and JE2 ccpA::ermB, and a student’s t-test was utilized to determine
significance. A positive relative intensity value is indicative of a greater intensity of 13Carginine in JE2 ccpA::ermB in comparison to JE2. JE2 ccpA::ermB accumulated
significantly greater amounts of 13C-arginine when grown in CDM containing 13C5proline in comparison to JE2. Note that there was no significant difference in 13Carginine accumulation between JE2 and JE2 ccpA::ermB when grown in CDM and
CDM-R, respectively, containing 13C5-glutamate.
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Figure 8.8. Determination of arginine biosynthesis-dependent genes in S. aureus
Newman and RN4220. Defined bursa aurealis transposon mutants in argF and argH
were transduced into Newman ccpA::tetL and RN4220 ccpA::tetL and assessed for
growth in CDM-R for 18 hours. Data represent means 6 SEM of three independent
experiments.
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broth. Subsequent studies demonstrated that RN4220 reverted to arginine prototrophy at a
frequency of 1.6 x 10-5; however, sequence analysis of these mutants indicated they did
not have mutations in ccpA, hprK or ptsH suggesting weak carbon catabolite repression
in the RN4220 strain background. In addition, RN4220 argH::φNΣ was unable to grow
in CDM-R broth whereas a bursa aurealis mutation in argF had no effect on growth
suggesting RN4420 synthesizes arginine from proline but not from glutamate.
Collectively, these data suggest that as a species, S. aureus has evolved to synthesize
arginine via proline when growing in conditions lacking a preferred carbon source.

8.3.6 Virulence in a mouse kidney abscess model
C57BL/6 mice were inoculated retro-orbitally with 106 CFU of JE2, JE2
argH::φNΣ, JE2 argC::φNΣ, JE2 putA::φNΣ, or JE2 argF::φNΣ. The mice were
harvested at 20 days and the kidneys were homogenized and CFU/gram of tissue
determined (Figure 8.9). No statistical difference was determined between JE2 and JE2
argF::φNΣ, JE2 argC::φNΣ, or JE2 putA::φNΣ. However, a significant difference was
noted between JE2 (mean log10 CFU of 5.31) and JE2 argH::φNΣ (mean log10 CFU of
4.21) indicating a potential function of argH and arginine biosynthesis in abscess
development and persistence.

8.4 Discussion
The study of arginine biosynthesis has served as a paradigm for the regulon
concept, originally coined by Maas and Clark, where the same transcriptional repressor
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Figure 8.9. Mouse kidney abscess model. C57BL/6 mice were infected with 106 CFU of
JE2 (n = 16 mice), JE2 argF::φNΣ (n = 14 mice), JE2 argH::φNΣ (n = 15 mice), JE2
argC::φNΣ (n = 13 mice), or JE2 putA::φNΣ (n = 18 mice). Kidneys were homogenized
after 20 days and bacterial burden determined through viable count (CFU/gram tissue).
Horizontal line represents median log10 CFU/gram; significant differences in bacterial
burden were noted between JE2 and JE2 argH::φNΣ (**p<.01). Data were analyzed
using two-way ANOVA.
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regulates unlinked loci, ArgR [48]. Based on these studies and over 60 years of research,
there are three established biochemical pathways, all utilizing glutamate as a substrate,
that synthesize arginine in bacteria [47]. These three pathways primarily differ in the
enzymes used to generate L-citrulline from N-acetyl-L-ornithine [47, 49]. All sequenced
staphylococcal species analyzed to date encode the highly conserved ArgJBCDFGH on
three separate unlinked transcriptional units; two operons (argDCJB and argGH) and one
monocistronic gene (argF). Within the S. aureus USA300 FPR_3757 genome
(NC_007793), the genes predicted to encode the arginine biosynthetic pathway are as
follows: argJ (bifunctional ornithine acetyltransferase/glutamate N-acetyltransferase),
SAUSA300_0185, EC 2.3.1.35/2.3.1.1; argB (acetylglutamate kinase),
SAUSA300_0184, EC 2.7.2.8; argC (N-acetyl-gammaglutamyl-phosphate-reductase),
SAUSA300_0186, EC 1.2.1.38; argD (acetylornithine transaminase), SAUSA300_0187,
EC 2.6.1.11; argF (ornithine carbamoyl transferase), SAUSA300_1062, EC 2.1.3.3;
argG (argininosuccinate synthase), SAUSA300_0864, EC 6.3.4.5; and argH
(argininosuccinate lyase), SAUSA300_0863, EC 4.3.2.1. However, as previously
reported and confirmed in this study, S. aureus is a functional arginine auxotroph when
grown on complex laboratory media [8, 9]. In addition, no nonsense mutations or
insertions were detected within the argJBCDFGH genes of the USA300 FPR_3757
genome or any other sequenced staphylococcal genome, suggesting that arginine
biosynthesis is not a decaying pathway in the staphylococci. As discussed by Somerville
and Proctor, in some cases, amino acid auxotrophies in S. aureus may be linked to TCA
cycle inactivity or feedback inhibition due to growth in amino acid and glucose replete
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media [50]. Our results are in agreement with this hypothesis where inactivation of ccpA,
which represses the TCA cycle [51] and other genes that function to metabolize
secondary carbon sources, was linked to arginine biosynthesis in S. aureus. In the
presence of a preferred carbon source, the CcpA/Hpr complex represses a multitude of
genes linked to central metabolism, amino acid metabolism and virulence [2, 52-54].
Therefore, based on previous studies, bioinformatic analyses of the S. aureus genome,
and the work by Li and colleagues demonstrating that proline biosynthesis was linked to
ccpA regulation, it was not unexpected to discover that arginine biosynthesis was linked
to carbon catabolite repression [5, 18, 50, 55]. However, it was remarkable to discover
that S. aureus does not use the conserved argJBCDFGH pathway to synthesize arginine
via glutamate. Rather, we provide both genetic and biochemical evidence in support of a
novel biosynthetic pathway, whereby S. aureus utilizes proline as a substrate via the urea
cycle. First, mutations within putA, rocD, arcB1, argG, and argH, but not argJ, argB,
argC, or argF, abolished growth of a ccpA mutant on CDM-R, providing genetic
evidence that proline serves as a precursor for arginine synthesis (Figure 8.6). It is
important to note that inactivation of arcB1 abrogated growth of JE2 ccpA::tetL whereas
a mutation in arcB2 did not. arcB1 (SAUSA300_2569) encodes the native ornithine
carbamoyltransferase within the arginine deiminase operon whereas arcB2
(SAUSA300_0062; ornithine carbamoyltransferase) is within the ACME pathogenicity
island encoded arginine deiminase operon [56]. These data suggest that ArcB1 and ArcB2
are not functionally redundant or are not expressed under the same growth conditions.
arcB2 transcript is not detected using northern analysis (data not shown) under in vitro
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growth conditions used in this study (CDM or CDM-R broth), however, it is unknown
whether it is induced under other in vivo or in vitro growth conditions. Second, 2D 1H13

C HSQC NMR experiments provided compelling evidence that arginine is synthesized

via proline and the urea cycle in a S. aureus ccpA mutant. Although there have been two
reports demonstrating that proline is synthesized from arginine in S. aureus [17, 18], we
are unaware of any reports demonstrating that arginine can be synthesized from proline.
Li and colleagues demonstrated that CcpA binds to a cre site just upstream of rocD.
Using the cre site from pckA as a consensus sequence [18], we identified potential cre
sites upstream of putA, arcB1, and argGH (Figure 8.10). However, the function of these
cre sites in regards to CcpA regulation has yet to be defined.
Previous studies have demonstrated that a S. aureus ccpA mutant also synthesizes
proline from arginine via RocF (arginase), RocD (ornithine aminotransferase), and ProC
(P5C reductase) [17, 18]. Collectively, these data and our observations suggest that
under carbon-limiting conditions (in vivo environment), S. aureus can synthesize proline
from arginine and arginine from proline depending on which amino acid is limited. Based
on our findings and the existing literature, we propose a hypothetical model whereby free
arginine is limited in the host during infection causing competition between the host and
bacteria for arginine. In humans, L-arginine is a non-essential amino acid under
homeostatic conditions. However, arginine becomes a ‘‘conditionally essential’’ [57]
amino acid during sepsis or trauma due to its use as a substrate for inducible nitric oxide
synthase [58] and function in cell-mediated immunity [59], protein synthesis [60] and
wound healing [61, 62]. Indeed, recent studies have shown significant iNOS and arginase
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Figure 8.10. Putative cre sites in arginine biosynthesis-dependent genes. Using
the cre site from pckA as a consensus sequence, putative cre sites were identified
in rocD, arcB1, putA, and argGH. cre site from pckA is the top sequence whereas the
putative cre site from the identified gene is the bottom sequence.
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expression during S. aureus infection [63] (Figure 8.11), providing further support that a
staphylococcal abscess may be an arginine-depleted environment based on the
requirement of arginine for these host enzymes to function. In addition, low levels of Larginine have been reported in plasma during sepsis [57], causing some investigators to
suggest the use of L-arginine as a treatment modality [64]. Furthermore, arginine can
serve as a substrate for arginine deiminase and subsequent direct ATP generation in the
staphylococci [47].
Although little information is available regarding the concentration of free proline
in a staphylococcal abscess, proline is the predominant amino acid found in collagen.
Collagen is the most abundant protein in animals and type I collagen is a major
constituent of the fibrotic wall surrounding staphylococcal abscesses [65] (Figure 8.11).
Furthermore, S. aureus encodes two proteases, SspB and ScpA, which possess the ability
to degrade collagen [66-68]. Therefore, our model predicts that S. aureus utilizes specific
proteases to degrade collagen, resulting in the liberation of free proline or prolinecontaining peptides that are utilized to synthesize arginine via the urea cycle.
Strengthening this argument, earlier work demonstrated that mutants lacking the
high affinity proline permease PutP are less virulent in animal models of infection [69,
70]. This proposed framework was initially tested using a mouse kidney abscess model
previously utilized by Cheng and colleagues [71]. In this model, staphylococcal abscesses
within the kidney are contained within a pseudocapsule-like structure; we hypothesized
an argH and putA mutant would be attenuated in abscess persistence in comparison to
wild type JE2, JE2 argC::φNΣ and JE2 argF::φNΣ due to the inability to utilize proline
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Figure 8.11. Mouse subcutaneous abscess model. C57BL/6 flank abscesses caused by
subcutaneous injection of 5 x 105 CFU of S. aureus JE2. Tissues were processed for
immunofluorescence staining for either type I collagen (red), inducible nitric oxide
synthase (iNOS, red), or arginase (green). In addition to type I collagen, tissues were
processed with the DAPI nuclear stain (blue) to accentuate the abscess core.
Representative confocal microscopy images are presented for type I collagen (10 x
magnification) and iNOS/arginase (20 x magnification).
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from the pseudocapsule as a substrate for arginine synthesis. Supporting our model, in
those kidneys containing staphylococcal abscesses, a significant 1 log10 difference was
observed between JE2 and JE2 argH::φNΣ demonstrating the importance of arginine
biosynthesis via the urea cycle in an in vivo infection model. As predicted, based on our
in vitro data, no significant difference was observed between JE2, JE2 argC::φNΣ, and
JE2 argF::φNΣ in the mouse kidney abscess model. However, in contrast to our predicted
results, no significant difference in bacterial persistence was detected between JE2 and
JE2 putA::φNΣ; PutA converts proline into pyrolline-5-carboxylate (Figure 8.3). It is
known that the addition of either citrulline or ornithine to CDM-R can complement JE2
ccpA::tetL putA::φNΣ allowing growth. Therefore, it is possible that generation of
citrulline or ornithine by arginine deiminase and ornithine carbamoyltransferase [47],
respectively, circumvents and complements the proline requirement and facilitates the
synthesis of arginine. In addition, since argGH is common to both the glutamate and
proline pathways leading to the synthesis of arginine, an alternative interpretation of the
data is that both pathways are active in vivo and have the ability to complement each
other.
Finally, we have demonstrated that other S. aureus strains synthesize arginine
from proline when CcpA activity is abolished, suggesting conservation of this pathway
within the species. However, based on the conserved sequence analysis of the
ArgJBCDFGH pathway within sequenced S. aureus isolates, we predict that this arginine
biosynthetic pathway is active under growth conditions or niches that remain to be
identified. Further work is required to dissect the evolving dogma regarding arginine
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metabolism and the relationship between the host and S. aureus in the ‘‘war for arginine’’
during infection.
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CHAPTER 9
DISPENSABILITY OF D-ALANINE RACEMASE IN MYCOBACTERIUM
SMEGMATIS AND MYCOBACTERIUM TUBERCULOSIS UNDERLIES A
NOVEL PATHWAY OF D-ALANINE BIOSYNTHESIS

9.1 Introduction
Tuberculosis (TB) is a major global health problem and still the second
worldwide cause of death from an infectious disease. Critical challenges to achieve the
global targets for TB control and elimination include drug resistant TB, the co-epidemics
of TB and HIV and the lack of more effective tools to prevent, diagnose and treat the
disease [1]. The cell wall of Mycobacterium tuberculosis, the main etiological agent of
human TB, plays an important role in mycobacterial pathogenesis and is a major source
of targets for design of antimicrobial agents and attenuated mutants [2-4]. As in other
bacteria, peptidoglycan strands and their crosslinks are critical components and
stabilizers of the mycobacterial cell wall backbone. D-alanine is an essential building
block of mycobacterial peptidoglycan and other eubacteria as it is involved in
peptidoglycan crosslink formation [4-9].
The main source of D-alanine is the conversion of L-alanine by D-alanine
racemase (Alr), an enzyme encoded by the alr gene [4, 7, 9]. The critical role of Dalanine in the cell wall peptidoglycan highlights the importance of its biosynthetic
pathway(s) as targets for generation of new antimicrobial agents and attenuated mutants.
Core to that design is the determination of alr essentiality and its role in the context of
mycobacterial pathogenesis. Studies on alr in the fast growing species Mycobacterium
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smegmatis, rendered apparently contradictory results. In our initial report, we found that
the M. smegmatis alr gene was not required in the absence of D-alanine in the
recommended Middlebrook 7H9 mycobacterial medium [10]. Our data also supported the
existence of an alternative pathway of D-alanine biosynthesis in this species.
Contradictory results were reported as M. smegmatis growth was assessed in LuriaBertani or Middlebrook 7H11 media [11] since alr mutants were found to be auxotrophic
for D-alanine. Moreover, recent reports in M. tuberculosis H37Rv suggest that alr
mutants are also auxotrophic for D-alanine in both Middlebrook 7H9 and 7H11 [12].
Thus, according to these two reports, the alr gene is required in the absence of D-alanine
in both M. smegmatis and M. tuberculosis. In that context, these latter results negate the
existence of an alternative endogenous pathway of D-alanine biosynthesis in both
species, as D-alanine would be an absolute requirement for growth of alr mutant strains.
Resolution of the controversy surrounding alr essentiality in mycobacteria is
important, not only in the context of the role of Alr in mycobacteria, but also for its
implications in the design of more effective drugs and vaccines targeting the endogenous
synthesis of D-alanine in M. tuberculosis strains found in clinical settings. Moreover,
evidence of horizontal gene transfer in mycobacteria [13, 14], highlights the impact that
the potential transfer of genes involved in an alternative pathway of D-alanine
biosynthesis might have in TB epidemiology and management. Herein, we describe the
results of our studies aiming at determining alr essentiality in M. smegmatis and M.
tuberculosis and possible implications for future in vivo studies.
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9.2 Materials and Methods
9.2.1 Bacterial strains, plasmids, phages, culture conditions and nucleic acid
manipulation.
Bacterial strains, plasmids and phages used in this study are listed in Table 9.1.
E. coli and, in some cases M. smegmatis strains, were grown at 37ºC in broth or agar
(1.5%, Difco Laboratories, Detroit, Mich.) using LB broth base, containing Tryptone, a
pancreatic digest of casein (BD, Franklin Lakes, NJ). For M. smegmatis strains, LBT
medium was LB broth or agar supplemented with 0.05% Tween 80 (Fisher Scientific,
Pittsburgh, PA). For routine growth, M. smegmatis strains were cultured at 37ºC in
Middlebrook 7H9 base broth (BD) or agar (Fisher Scientific) supplemented with ADC
(0.5% bovine serum albumin fraction V (Fisher Scientific), 0.01 M glucose, 0.015 M
sodium chloride, 0.2% glycerol, and for broth media only 0.05% Tween-80 ; MADC). M.
tuberculosis strains were grown in MADC broth or 7H9 based agar media supplemented
with ADC or OADC (ADC plus 0.6 mg/mL oleic acid). In some experiments, the
following supplements (Sigma Chemical Co., St. Louis, MO) were individually added at
specified concentrations: L-serine, D-serine, L-glutamic acid, D-glutamic acid, Larginine, L-tryptophan, L-asparagine, L-aspartic acid and L-lysine, D-alanine, and
pyruvate. Antimicrobial agents used were ampicillin (0.05 mg/mL); kanamycin A
monosulfate (0.025 mg/mL), hygromycin B (0.075 to 0.1 mg/mL; Roche Molecular
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Table 9.1. Bacterial strains, plasmids and phages used in this study.
Bacterial strains and
vectors
E. coli DH5α
M. smegmatis mc2155
M. smegmatis
TAM23
M. smegmatis
TAM23-12
M. smegmatis GPM
292- GPM295
E. coli DH5α
pBUN307
M. tuberculosis
H37Rv
M. tuberculosis
H37Rv (pBUN307)
TBcol1
pBUN73
pBUN82
pMV262
pBUN201
pBUN205
pCR2.1
pET15b
pBUN307
pBUN369
pBUN373
pBUN381
pTAMU3
pYUB412

Description
-

F lacZDM15 endA1 hsdR17 supE44 gyrA96 relA1
Alr+; M. smegmatis ATCC 607 mutant, high transformation
efficiency
Alr-; Kanr; M. smegmatis alr insertion mutant derived from
M. smegmatis mc2155
Alr-; Kanr; Higr; M. smegmatis alr and murI double mutant
derived from M. smegmatis TAM23, D-alanine auxotroph
Alr--; Kanr; M. smegmatis alr deletion mutant derived from
M. smegmatis mc2155
Kanr. E. coli DH5α transformed with pBUN307

Reference
Invitrogen Life
Technologies
[15]
[10]
This study
This study
This study

Laboratory reference strain.

ATCC 25,618

Kanr. alr merodiploid strain. M. tuberculosis H37Rv
transformed with pBUN307
Kanr, Hygr alr chromosomal mutant of M. tuberculosis
H37Rv transformed with pBUN307
Kanr Tetr. pMV203 derivative

This study

Kanr. M. smegmatis wild type alr gene cloned into
pMV262
Replicating E. coli-Mycobacterium shuttle plasmid; carries
Phsp60 promoter upstream
from polylinker site
pCR2.1 derivative carrying M. tuberculosis alr gene
pET15b derivative carrying M. tuberculosis alr gene
Original TA cloning vector
Standard Expression vector
Kanr. Replicative shuttle plasmid carrying M. tuberculosis
H37Rv alr transcribed under the control of its own
promoter
Tetr Replicative shuttle plasmid. pBUN73 derivative.
Tetr Replicative shuttle plasmid, pBUN369 derivative
carrying the M. smegmatis alr gene from pBUN82
pBlueScript KS+ derivative carrying. M. tuberculosis alr
gene flanking regions in a 3.8 kb fragment
Ampr Hygr; pYUB412 derivative carrying M. smegmatis
alr gene
Ampr Hygr; E. coli-Mycobacterium integration-proficient
vector

Barletta lab.
Unpublished
[16]
[17]
This study
This study
Invitrogen Life
Technologies
Novagen
This study
This study
This study
This study
[10]
[18]
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Table 9.1. (Continued)
Bacterial strains and
vectors
phAE159(Tn5371)

phAE87
pYUB854
pBUN287
pBUN288
phBUN1

Description

Reference
r

Derivative of phAE159 carrying transposon Tn5371 with a Hyg
marker

[19]

Thermosensitive phasmid. PH101 derivative carrying cosmid
pYUB328
Hygr Cosmid. Designed for phasmid construction and directional
cloning of homologous recombination substrates
Hygr. pYUB854 derivative. Carries the 5’end of alr gene from M.
tuberculosis H37Rv
Hygr. pBUN287 derivative. Carries the 5’and 3’ends of alr gene
from M. tuberculosis H37Rv and its adjacent regions
Hygr phasmid. phAE87 derivative with pYUB328 replaced by
pBUN288

[20]
[21]
This study
This study
This study
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Biochemicals, Indianapolis, Ind.); D-cycloserine (0.00117 to 0.150 mg/mL); and
tetracycline (0.0125 mg/mL).
M. smegmatis growth curves were determined in minimal broth medium as
previously described [10]. M. smegmatis and E. coli broth cultures were incubated with
shaking at 200 rpm in an Innova 4300 rotary incubator (New Brunswick Scientific Co.
Inc., Edison, N.J.). M. tuberculosis broth cultures were incubated horizontally in
standing flasks. Phage stocks were prepared following standard procedures and stored in
MP buffer made with 50 mM Tris-HCl pH 7.5 (MP Biomedicals, LLC. Aurora, OH,
USA), 150 mM NaCl (Merck KGaA, Danmstadt, Germany), 2 mM CaCl2 (SigmaAldrich, CO. St. Louis, MO, USA), and 10 mM MgSO4-7H2O (MP Biomedicals, LLC.
Aurora, OH, USA), following standard procedures [22]. Specific protocols are further
described.
Standard procedures were followed for nucleic acid purification, enzyme
restriction digestions, ligations, and agarose gel electrophoreses [23]. Bacterial
transformations and transfections were performed as described [22].

9.2.2 Construction, verification and complementation of M. smegmatis alr deletion
mutant.
The alr flanking regions were amplified from 50 ng of M. smegmatis mc2155
DNA using primer sets AlrK01/AlrK02 and AlrK03/AlrK04, as described [11] (Table
9.2). The resulting fragments (1.2 kb and 1.3 kb respectively) were subcloned into
pBluescript KS+ to generate pBUN381. A 3.8 kb fragment from pBUN381, carrying the
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pUC18K aphA-3 kanamycin resistance marker outflanked by the alr uspstream and
downstream regions, was used to transform M. smegmatis mc2155. Transformants GPM
292, GPM293, GPM294 and GPM295 were selected on LBT supplemented with 5.0 mM
D,L-alanine. Deletion of alr was verified by PCR and Southern blotting analysis.
For PCR verification, M. smegmatis genomic DNA was amplified with the
following primer sets: AlrInt1F/AlrInt1R and AlrIntF /AlrIntR, targeting the deleted alr
region, as well as with primers 5alr2 and 3alr2, targeting the wild alr gene flanking
sequences. For Southern blotting analysis, approximately 3.0 µg of SmaI digested M.
smegmatis wild type and mutant genomic DNA were transferred to nylon membranes and
hybridized with a radiolabelled DNA fragment amplified from wild type mc2155 DNA
using primers AlrK01 and AlrK02. Prehybridization, hybridization and high-stringency
washes were done at 65ºC.
To complement the alr deletion mutant strain GPM292, cells were grown to midexponential phase in LBT supplemented with 5.0 mM D,L-alanine. Cells were
transformed by electroporation with pTAMU3 as previously described [10].
Transformants were selected on LBT agar supplemented with 5.0 mM D,L-alanine and
0.1 mg/ml hygromycin B (A.G. Scientific, San Diego, CA) until normal sized colonies
were visually observed at 37ºC. Individual transformant colonies were grown in 1.0 mL
of LBT supplemented with 5.0 mM D,L-alanine and 0.1 mg/mL hygromycin B, and cells
from 0.001 mL growing cultures were directly lysed in the thermocycler and subjected to
PCR amplification to verify the presence of the hygromycin resistance gene from
pTAMU3. Amplification was carried out under standard conditions with primers Hygro-

321
2F and Hygro-2R, using the following settings: 95°C for 5 minutes, followed by 30
cycles of 95°C for 30 sec, 55°C for 30 seconds, 72°C for 30 sec, and a final extension at
72°C for 7 minutes.

9.2.3 D-Alanine racemase enzymatic activity assays.
M. smegmatis mc2155, TAM23 and GPM292 cells were grown to midexponential phase (OD600nm ca. 0.6-0.7) in 200 mL LBT supplemented with 1.0 mM Dalanine, harvested, and concentrated 20-fold in 50 mM Tris-HCl (pH 8.0). Cell extracts
were prepared as described [16], except that a Centriprep YM10 (Millipore, Billerica,
MA) concentration step was added prior to final filtration and dialysis. Protein
concentrations were determined by a modified Lowry protein assay
(http://www.ruf.rice.edu/~bioslabs/methods/protein/lowry.html).
Alr reactions were performed in triplicate in a final volume of 50 μL containing
50 mM Tris-HCl (pH 8.0), 0.1 mM pyridoxal phosphate, 15 mM D-alanine, 0.5 μCi 14C
D-alanine, and approximately 100 μg of each cell extract. Reactions were incubated at
37ºC and in a water bath for 15 min, and stopped by adding SDS to a final concentration
of 0.25%. Parallel negative controls were performed with heat inactivated extracts
otherwise processed in identical manner. Standards for 14C-D-alanine, 14C-L-alanine, and
a 50% D, L-alanine mixture were prepared with the same reaction components, heat
inactivated mc2155 extract, and 0.5 μCi of total 14C-alanine. Chiral plates (MachereyNagel, Bethlehem, PA; 10 x 20 cm) were baked for 30 minutes at 100 ºC prior to sample
loading. Reaction mixtures (5 μL) were spotted on the plate, 2.5 μL at a time, allowing
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the spots to dry between applications. Plates were developed by ascending
chromatography in a chamber saturated with vapors of the running solvent
(acetone:methanol:water 10:2:2) until the solvent front reached 0.5 cm from the top of the
plate.
Plates were dried, wrapped in plastic, and exposed to a Kodak Imaging Screen-K
for 4 h, and analyzed using a Biorad Molecular Imager PharosFX and Quantity One
Software. To quantify spots, the rectangular volume analysis tool was used. For
overlapping oval spots (e.g., Alr activity in mc2155), the rectangular box for a particular
spot was extended up to the inflection point in the spot images. Global subtraction was
used to reduce background.

9.2.4 Growth of M. smegmatis alr mutants in liquid media.
Minimal concentrations of D-alanine required for the mutant strains to yield
significant growth were determined in both LBT and MADC broth, supplemented with
0.1 mM – 1.0 mM D-alanine, to an initial OD600 ca. 0.01. The small inoculum was to
mimic the conditions previously used in other alr deletion mutant study [11]. OD600
values were taken at 48h after inoculation.
To test D-alanine requirements in minimal media, M. smegmatis mc2155, TAM23
and GPM292 were grown to an OD600 c.a. 1.0 in MADC supplemented with 50 mM Dalanine, washed twice with PBS-Tween and inoculated into pre-warmed minimal media
(5 mM ammonium chloride, 22 mM dibasic potassium phosphate, 16 mM monobasic
potassium phosphate, 25 pM ferric chloride, 8.6 nM zinc sulfate, 0.84 nM cobalt
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chloride, 10.1 nM manganese chloride, 68 nM calcium chloride, 2.4 mM magnesium
sulfate, 4.9 nM pyridoxal hydrochloride, 21mM glycerol, and 0.05 % Tween 80) at an
initial concentration of approximately 1.2 x 106 c.f.u. /ml. Cultures were grown at 37oC
with shaking at 200 rpm in an Innova 4300 rotary incubator (New Brunswick Scientific
Co.) and optical densities (OD600nm) were monitored for approximately 200 h.
Generation and lag times were determined following described conceptual
definitions [24]. To calculate generation times, logOD for each independent growth curve
was plotted versus time during exponential growth. Linear regression lines were
determined and from the slopes, generation times were calculated using the formula: G
(min) = [1/(3.33 * slope)] * 60. Mean generation times with SEMs (n=3) were obtained
from independent growth curves for each strain and condition. For growth curves
displaying a plateau followed by resumption of exponential growth resembling diauxic
growth, additional generation times were determined for each exponential growth phase.
Curves were compared by fitting individual nonlinear growth curves to each of
the samples, followed by a MANOVA of the estimated growth curve parameters. Data
analysis was carried out using the NLIN and GLM procedures (SAS Institute Inc. 2009.
SAS OnlineDoc® 9.2. Cary, NC: SAS Institute Inc.). Pair-wise comparisons of
generation times were performed using the Mixed Procedure in SAS version 9.1.3 (SAS
Institute). P values were determined using least squares means and applying the Tukey
adjustment. The two lag times were compared using the two-tailed unpaired t-test SAS
procedure. Graphs were constructed using DeltaGraph version 5.6.2 (Red Rock
Software).
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9.2.5 Growth of M. smegmatis alr mutants in solid media.
To determine the effect of D-alanine on growth in solid media, M. smegmatis
strains were streaked on agar media with and without 5.0 mM D, L-alanine (LBT), or
with and without 50 mM D-alanine (MADC). A 1 μL disposable loop was used to streak
cells taken from 50% glycerol stocks prepared from cultures grown in original stocking
media (MADC for M. smegmatis wild type mc2155 and TAM23(pTAMU3); MADC with
50 mM D-alanine for insertion mutant TAM23 and LBT with 5.0 mM D,L alanine for
deletion mutant GPM292 and its complemented derivative GPM345. Plates were
incubated for seven days at 37ºC and then imaged.
To determine the overall effect of solid media components on growth, glycerol stocks of
M. smegmatis wild type and M. smegmatis TAM23 and GPM292 alr mutants were
streaked on LBT, MADC and MADC agar plates supplemented with: 1mg/mL tryptone
(Difco); a mixture of 20 aminoacids (0.25 mM each); a mixture of glucogenic aminoacids
including L-alanine, L-asparagine, L-aspartate, L-glutamic acid and L-glutamine (1mM
each); a mixture of branched chain aminoacids including L-isoleucine, L-leucine and Lvaline (1.67 mM each); Middlebrook 7H10 and Midddlebrook 7H11. Growth patterns
were determined after incubating for 7 days at 37ºC. Further testing was carried out
streaking glycerol stocks of wild type mc2155, complemented strain GPM345, and alr
mutants TAM23 and GPM292 on MADC agar with or without D-alanine, D-glutamate,
L-glutamate, D-serine or L-serine (5.0 mM each), or a mixture of 5.0 mM D-glutamate
with 18 mM pyruvate. Plates were incubated for 7 days at 37ºC, imaged and scored.
Scores were generated for growth coverage and colony size, as shown in Figure 9.1.
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Figure 9.1. Scoring growth of M. smegmatis strains on agar media. To compare growth
on solid agar media, the following scoring scheme was used, based on the following
models: 1) GPM292 on LBT, -; 2) TAM23 on MADC,+; 3) GPM292 on LBT with 5.0
mM D/L-alanine,++; and 4) GPM292 on MADC 50 mM D-alanine, +++.
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9.2.6 NMR Data Collection.
The NMR spectra were collected on a Bruker 500 MHz Avance spectrometer
equipped with a triple-resonance, Z-axis gradient probe. A BACS-120 sample changer
with Bruker Icon software was used to automate the NMR data collection. For the
comparison between wild-type cells and the racemase mutants without D-alanine
supplementation, one-dimensional (1D) 1H NMR spectra were collected with a standard
solvent presaturation sequence and a spectral width of 5482.5 Hz and 32k data points at
298K. A total of 16 dummy scans and 128 scans were used. For the comparison between
wild-type cells and the racemase mutants supplemented with 50 mM D-alanine, 1D 1H
NMR spectra were collected using excitation sculpting to remove the solvent [25] with a
sweep width of 5482.5 Hz and 32k data points at 298K. A total of 16 dummy scans and
128 scans were used.
The series of three time-zero two-dimensional (2D) 1H-13C HSQC spectra
(HSQC0) were collected using the pulse sequence described by Hu et al. [26]. The spectra
were collected with 2048 data points and a spectral width of 5000.0 Hz in the 1H
dimension, and 64 data points and a spectral width of 17605.6 Hz in the 13C dimension. A
total of 16 dummy scans and 64 scans with a relaxation delay of 1.5 s were used to obtain
each 2D 1H-13C HSQC0 spectrum.

9.2.7 1D NMR Data Analysis.
All 1D 1H NMR spectra were processed as previously described [27]. Data were
processed automatically using ACD/1D NMR manager version 12.0 (Advanced
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Chemistry Development, Inc). Intelligent bucketing was used to integrate each region
with a bin size of 0.025 ppm and a looseness of 50%. The table of integrals was centered
average and imported into SIMCA version 12.0 (Umetrics) for principal component
analysis (PCA) or orthogonal partial least-squares discriminant analysis (OPLS-DA).
Supervised classification for each group was arranged by cell type, with M. smegmatis
mc2155 defined as the control (or assigned a value of 0), and M. smegmatis TAM23 and
GPM292 defined as the mutant strains (or assigned a value of 1). Ellipses for each group
or class in the PCA or OPLS-DA scores plot depict the 95% confidence level from a
normal distribution.

9.2.8 2D NMR Data Analysis.
2D 1H-13C HSQC spectra were processed using the NMRPipe software package
[28]. The spectra were Fourier transformed, manually phased, and baseline corrected.
The processed 2D 1H-13C HSQC spectra were then analyzed using NMRView [29] to
assign chemical shifts, intensities, and volumes to each peak. Chemical shift lists were
assigned to specific metabolites using the Human Metabalome Database [30], Madison
Metabolomics Database [31], and the Platform for Riken Metabolomics [32]. A chemical
shift error-tolerance of 0.05 ppm and 0.40 ppm was used for 1H and 13C chemical shifts,
respectively. The identification of metabolites and metabolomics pathways from the
NMR metabolomics data were further verified using the Kyoto Encyclopedia of Genes
and Genomes (KEGG) [33] and MetaCyc [34] databases.
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Metabolomic peak volumes from the HSQC0 experiment was calculated as
previously described [26, 35]. The calibration of metabolite peak volumes from the
HSQC0 experiments with an absolute concentration was performed using a series of 5
external standards, each consisting of 9 13C-labeled compounds with concentrations
ranging from 5 M to 300 M. All standard samples also included 500 M of TMSP as
an internal standard for spectral referencing and normalization. A linear regression line
was created to correlate the absolute concentrations with the average time-zero peak
volume for each metabolite standard in order to create a standard calibration curve. The
M. smegmatis mc2155, TAM23 and GPM292 metabolite concentrations were then
calculated from the time-zero peak volumes obtained from the HSQC0 experiment and
from this standard calibration curve. The HSQC0 experiment was obtained for a triplicate
set of cultures for each M. smegmatis strain. The triplicate HSQC0 experiments were used
to calculate averages and standard deviations for each metabolite concentration.

9.2.9 Construction of TAM23 mutant library and isolation of D-alanine Dependent
Mutants.
Transposon mutagenesis was carried out as described [36]. 5 mL of MADC broth
supplemented with 50 mM D-alanine and kanamycin (20 µg/mL) were inoculated with
50 µL of a frozen stock of M. smegmatis TAM23. The culture was grown to an optical
density OD620nm of c.a. 1.0 and centrifuged at room temperature for 10 minutes at 3,700 x
g (Sorvall LegendTM RT Kendro Laboratory products. Thermo Fisher Scientific Inc.
Waltham, MA. USA). The pellet was washed twice in an equal volume of MP buffer and
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resuspended in 5 mL of MP. This cell suspension was incubated at 37°C, standing, for 30
minutes before phage infection, and 100 µL were used to make ten-fold dilutions (10-1 10-6) in MADC. Titration was carried out plating in MADC agar supplemented with 50
mM D-alanine and 20 g/mL kanamycin. For transfection, 2.0 mL of undiluted M.
smegmatis TAM23 were transferred to 50-mL screw cap tubes and mixed with 2.0 mL of
a high titer lysate of phAE87 (Tn5371) (Table 9.1), (1x109 pfu/mL), to achieve a
multiplicity of infection of 10:1. The mixture was incubated at 37°C, standing for 3
hours. Two milliliters of M. smegmatis TAM23 were incubated with the same quantity of
MP buffer as negative controls. After incubation, cells were centrifuged for 10 minutes at
3,700 x g at room temperature (Sorvall LegendTM RT Kendro Laboratory products.
Thermo Fisher Scientific Inc. Waltham, MA. USA). The pellet was resuspended in 2.0
mL of MADC broth and plated in MADC agar supplemented with 50mM D-alanine, 20
g/mL kanamycin and 75 g/mL hygromycin. Negative controls were plated in MADC
agar with and without antibiotics. Plates were incubated at 37°C for 48 - 72 hours and
individual transductants were isolated.
Individual transductant colonies were checked for D-alanine dependence through
a two-step process. For the first step, each isolated colony was replica plated in MADC
agar media with 20 g/mL kanamycin and 75 g/mL hygromycin in the presence or
absence of 50 mM D-alanine. Wild type M. smegmatis mc2155 and M. smegmatis
TAM23 were used as controls in each inoculated plate. Plates were incubated for 7 days
at 37°C before being replica plated once more in identical manner, to reconfirm Dalanine auxotrophy. An individual auxotroph (TAM23-12) was further characterized.
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Table 9.2. Primers used for gene cloning experiments
Primer
Sequence (5’-3’)
AlrKO1
AAATTTGGATCCGACAAGAACATGATCGACAA
AlrKO2
AAATTTGGTACCGGTCTGCATCGTCATAATCT
AlrKO3
AAATTTAAGCTTGGCAGGACAACAAGATTGAG
AlrKO4
AAATTTTCTAGAGCCCTCGACATCCATTGCTT
AlrInt1F
ATGACCTTGAAATGCCCGGTGG
AlrInt1R
ACCACGAACTGGTCCATGCAGAT
AlrIntF
CGGTCTGATGAGCCACCT
AlrIntR
CCTTGATCAGCACGTCGATA
5alr2
AAATTTCCATGGTGGGGCAGTACTACAACTTC
3alr2
AAATTTAAGCTTGTAGGGGTCTTCCTTGCTCA
Hygro-2F
AACACCTCGAAGTCGTGCAGGAAG
Hygro-2R
CTACCTGGTGATGAGCCGGATGAC
Tn-Mar-Hyg-1
AGTGCCACCTAAATTGTAAGCGT
RS6-4
GTAATACGACTCACTATAGGGCNNNNCATG
Tn-Mar-Hyg-2
GACCGAGATAGGGTTGAGTGTTGT
T7
TAATACGACTCACTATAGGG
Tn-MAR-Hyg-2b
CGAGATAGGGTTGAGTGTT
MURISMEGF
CCGGCCATATCTGACCTCATG
MURISMEGR
TGGCGACACAGATCATCT
TBALRUF
ACGGTACCGGCCTCATCCCTATTCGAC
TBALRUR
CGCTCTAGATGGCTTTCCGACATTCTCC
TBALRDF
GGCAAGCTTGAGGACGTATCACCAGGAC
TBALRDR
ATGCTCGAGCATGACGCCGCACGATAC
EXTBALRF
GTTAACGTGAAACGGTTCTGG
TBALRR
GGATACCCTCACGGCTCA
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9.2.10 Identification of the Himar1 transposon insertion site and target gene in M.
smegmatis TAM23-12.
M. smegmatis TAM23-12 cells (approx. 1-5 x 106 from a concentrated 50% glycerol
stock) were directly lysed in a thermocycler (Eppendorf Mastercycler Gradient,
Eppendorf, Hauppauge, NY). Samples were subjected to a nested PCR method adapted
from published procedures [37, 38] using two rounds of amplification. The first
amplification round was carried out with an annealing temperature of 52°C, using the
transposon specific primer Tn-Mar-Hyg-1 and the degenerate primer RS6-4 (Table 9.2).
Reactions were carried out in a total volume of 50 L with 10 mM Tris-HCl (pH 8.3), 50
mM KCl, 5% (v/v) dimethylsulfoxide (DMSO), 2 mM MgCl2, 0.2 mM deoxynucleoside
triphosphates, 0.1 µM Tn-Mar-Hyg-1, 1.0 µM RS6-4, and 2.5 units of Promega GoTAQ
DNA polymerase (Promega Corporation. Madison, WI). For the second round, 1 L of
the first round PCR mixture was amplified using primers Tn-Mar-Hyg-2 and T7 (Table
9.2) under the same conditions as for the first round, except that primers were used at 0.5
µM. The mixture from the second nested PCR reaction was purified and concentrated
using a batch column purification method (Promega Wizard PCR Preps) and run onto a
1.5% agarose gel. DNA bands were excised and purified using a Qbiogene Geneclean III
kit (MP Biomedicals, LLC. Aurora, OH) and corresponding DNA sequences were
determined at the University of Nebraska-Lincoln sequencing facility by the Sanger
method using the sequencing primer Tn-MAR-Hyg-2b (Table 9.2). The information from
this sequence was combined with the himar1 transposon sequence and the Blastn suite
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(http://blast.ncbi.nlm.nih.gov/) analysis to determine the exact location of the transposon
insertion site within the target gene.
To confirm the identity of the target gene, PCR was carried out using primers
specific to the target genes outflanking each transposon insertion site. Cells were lysed as
described above. The Himar1 insertion within the gene of interest should yield in the
mutant strain a fragment 2,217 bp longer than in the wild type strain mc2155.
Amplification was carried out using a standard procedure in a 50 L reaction mixture
containing 25 ng of each specific primer pair in the presence of 1x NH4-based Reaction
Buffer (Bioline USA Inc., Taunton, MA), 2 mM MgCl2, 5% (v/v) DMSO, 0.3 mM
deoxynucleoside triphosphates, and 2.5 units of Biolase™ DNA Polymerase (Bioline).
M. smegmatis genomic DNA was amplified using primers MURISMEGF and
MURISMEGR (Table 9.2), spanning the region external to the identified target gene. The
reaction was carried out with thermocycler settings of 94°C for 5 minutes, followed by 30
cycles of 94°C for 1 min, 50°C for 30 sec, 72°C for 1 min, and a final extension at 72°C
for 7 min.

9.2.11 Complementation and phenotypic characterization of M. smegmatis D-alanine
auxotrophic strain TAM23-12.
To construct the complementing vector pBUN373, the tetracycline resistance
gene from pBR322 [39] was released by digestion with BsgI and EcoRI and ligated into
the HpaI and EcoRI sites of the E. coli-Mycobacterium multi-copy shuttle plasmid
pMV203 [16]. The corresponding recombinant clone (pBUN73) was digested with SpeI
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and then partially digested with NheI to remove the kanamycin resistance gene, resulting
in the 4,496 bp tetracycline resistant shuttle plasmid pBUN369. A 2,361 bp fragment
containing the M. smegmatis alr gene was released from pBUN82 [16] by EcoRI and
Acc65I digestion and the final step in pBUN373 construction was to ligate the fragment
into EcoRI - Acc65I digested pBUN369 (Table 9.1). After transformation with pBUN373
the recombinants were incubated at 37°C for 2-3 days on MADC agar supplemented with
50 mM D-alanine and 12.5 µg/mL tetracycline as a mycobacterial selection marker [40].
Non-transformed M. smegmatis parent strains were used as controls. Tetracycline
resistance was confirmed by culturing individual colonies in 5.0 mL of MADC broth
supplemented with 50 mM D-alanine and 12.5 µg/mL tetracycline at 37°C in a shaker at
250 r.p.m. (Unimax 1010. Heidolph Instruments GmbH&Co. KG. Schwabach. Germany)
until the culture reached an OD620nm of c.a. 1.0. The cultures were mixed with seven 4
mm glass beads (Paul Marienfeld GmbH & Co. KG, Am) before the optical densities
were measured. Cells were concentrated by centrifugation at room temperature for 10
minutes at 3,700 x g (Sorvall LegendTM RT Kendro Laboratory products. Thermo Fisher
Scientific Inc. Waltham, MA. USA). The supernatant was discarded and the pellet was
washed twice in equal volume of MADC. The final pellet was resuspended in 4 mL of
MADC and the OD600 was measured again in order to inoculate the same amount of cells
in each culture. 100 µL of dilutions 10-5 and 10-6 were inoculated by triplicate in MADC
agar supplemented with 50 mM D-alanine and 12,5 µg/mL tetracycline and in MADC
agar supplemented only with 12,5 µg/mL tetracycline. Plates were incubated at 37°C for
7 days and examined visually at day 3, 5 and 7.
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Phenotypic characterization included growth in media with and without Dalanine, as well as macro and microscopic visualization of colonies. Strains were grown
to an O.D.600nm c.a. 1.0 in MADC broth (M. smegmatis mc2155), MADC broth
supplemented with 50 mM D-alanine and 10 µg/mL kanamycin (M. smegmatis TAM23),
and MADC broth supplemented with 50 mM D-alanine, 10 µg/mL kanamycin and 75
µg/mL hygromycin (M. smegmatis TAM23-12). Strains were sub-cultured in 5.0 mL of
the same media as above and incubated at 37°C in shaker at 250 r.p.m. (Unimax 1010.
Heidolph Instruments GmbH&Co. KG. Schwabach. Germany) until the culture reached
an OD600nm c.a. 1.0. The cultures were mixed using seven 4 mm glass beads (Paul
Marienfeld GmbH & Co. KG, Am) before the OD600nm was measured. Cells were
concentrated by centrifugation at room temperature for 10 minutes at 3,700 x g (Sorvall
LegendTM RT Kendro Laboratory Products, Thermo Fisher Scientific Inc., Waltham,
MA. USA). The supernatant was discarded and the pellet washed twice in equal volume
of MADC. The final pellet was resuspended in 4.0 ml of MADC and the OD600nm was
measured again in order to inoculate the same amount of cells in each culture. 100 µL of
dilutions 10-5 and 10-6 were inoculated by triplicate in the follow media: MADC agar,
MADC agar supplemented with D-alanine, MADC agar supplemented with kanamycin,
MADC agar supplemented with D-alanine and kanamycin, MADC agar supplemented
with hygromycin, MADC agar supplemented with D-alanine and hygromycin, MADC
agar supplemented with kanamycin and hygromycin and MADC agar supplemented with
D-alanine, kanamycin and hygromycin as above. Plates were incubated at 37°C for 7
days and examined visually and microscopically at days 3, 5 and 7.
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9.2.12 Vectors for M. tuberculosis alr inactivation and merodiploid constructions.
To construct the vector for chromosomal alr inactivation, M. tuberculosis H37Rv
genomic DNA was amplified with primer pairs TBALRUF / TBALRUR and TBALRDF
/ TBALRDR (Table 9.2). The purified 613 bp PCR product, corresponding to the
upstream region and 33 bp at the 5’ end of the alr gene, was digested with KpnI and
XbaI. The fragment was cloned into pYUB854 digested with the same enzymes,
generating plasmid pBUN287. The purified 625 bp PCR product, corresponding to the
downstream region and 43 bp at the 3’ end of the alr gene, was digested with HindIII and
XhoI and ligated to pBUN287 digested with the same enzymes. The resulting plasmid,
pBUN288, was digested with PacI and ligated with phAE87 digested with the same
enzyme. The resulting phasmid phBUN1, carrying the upstream and downstream regions
of the M. tuberculosis alr gene flanking a hygromycin resistant marker, was used to
inactivate the chromosomal copy of the alr gene in M. tuberculosis, as described [22].
For the construction of recombinant plasmid pBUN307, the complete coding
region of alr from M. tuberculosis H37Rv was amplified using the Expand High Fidelity
PCR System (Roche). The 1,227 bp M. tuberculosis alr was amplified from genomic
DNA as a 1248 bp fragment using primers EXTBALRF and TBALRR (Table 9.2). After
purification with the Wizard PCR Prep Kit (Promega), the PCR fragment was cloned into
the Original TA Cloning Kit vector pCR2.1 (Invitrogen). The corresponding recombinant
clone (pBUN201) was digested with MseI and BamHI and ligated into the NdeI-BamHI
sites of the vector pET15b (Novagen). The recombinant clone (pBUN205) was verified
by restriction endonuclease digestion and DNA sequencing. For the construction of
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pBUN307, pBUN205 was linearized with XbaI and polished with Pfu polymerase. This
blunt ended linear fragment containing the H37Rv alr was further digested with EcoRI
and ligated into the PvuII and EcoRI sites of the E. coli-Mycobacterium multi-copy
shuttle plasmid pMV203 [16]. In this construct, major recombinant plasmid transcripts
are expressed in the same direction.

9.2.13 Construction, verification and characterization of M. tuberculosis alr mutant
strains.
Standard procedures were used to transform wild type M. tuberculosis H37Rv
with pBUN307, the multicopy plasmid carrying the M. tuberculosis wild type alr gene
[22]. The resulting merodiploid strain H37Rv (pBUN307) was selected in media with 10
g/mL kanamycin and the presence of the extrachromosmal alr copies was verified by
PCR. Plasmid DNA isolation was used to confirm the generation of a M. tuberculosis
H37Rv recombinant carrying the plasmid pBUN307. Inactivation of the alr gene in wild
type and merodiploid M. tuberculosis strains was carried out by transduction with
phBUN1 at M.O.I. 1:10, following standard procedures [22]. Transfectants were selected
by incubating for 6 weeks at 37°C in the presence of 50, 125 or 225 mM D-alanine
(Sigma-Aldrich, CO. St. Louis, MO, USA) and 75 µg/mL hygromycin (Alexis
Biochemicals, San Diego, CA, USA).
Inactivation of the chromosomal alr gene was confirmed by Southern blotting
analysis. To this end, approximately 3.0 µg of SacII (New England Biolabs, Ipswich,
MA) digested chromosomal M. tuberculosis H37Rv wild type and mutant genomic DNA
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was transferred to a nylon membrane (Hybond-N+. Amersham Pharmacia Biotech,
Buckinghamshire, England UK), prehibridized and hybridized at 56 ºC, following
standard procedures [23, 41]. The 0.6 kb PCR fragment generated by pBUN288 DNA
amplification with primers TBALRDF and TBALRDR (Table 9.2) was used as
hybridization probe. The fragment was radio labeled with [32P] dCTP (Easy Tides 32P
dCTP 3000 Ci/mMol; Waltham, MA) using a commercial kit (Rediprime II Kit,
Amersham Pharmacia Biotech, Buckinghamshire, England), following the
manufacturer’s instructions. Washes were done under high-stringency conditions at 65ºC.
The membrane was exposed for two hours at room temperature on a phosphor screen
(Bio-Rad Laboratories; Hercules, CA). Radioactivity detection was carried out in a
Molecular Imager PharosFX Plus system (BioRad Laboratories; Hercules, CA),
following manufacturer’s instructions.
Phenotypic studies included determination of acid-alcohol resistance by the
Kinyoun stain [42] and, macro and microscopic visualization of colonies (Nikon
Instruments, Inc.). Wild type M. tuberculosis H37Rv, merodiploid M. tuberculosis
H37Rv pBUN307 and M. tuberculosis H37Rv TBcol-1 alr mutant were initially grown in
MOADC broth, with or without supplements, to an OD620 nm of approximately 1.0. 10 µL
(approximately 3x106 cells) of each culture were inoculated in 7 mL MGIT® tubes
(Becton, Dickinson and Company, Sparks, MD, USA) supplemented with OADC (for
wild type M. tuberculosis H37Rv), OADC and kanamycin 10 µg/mL (for recombinant M.
tuberculosis H37Rv pBUN307 strains) and OADC with or without 50 mM D-alanine and
hygromycin 75 µg/mL (for M. tuberculosis H37Rv TBcol-1 alr mutant strain). The tubes
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were incubated in MGIT® 960 System (Becton, Dickinson and Company, Sparks, MD)
at 37°C until mycobacterial growth was detected. Positive tubes were centrifuged for 15
minutes at 4000 r.p.m. at 4°C, 10 µL of sediment were plated in MADC agar plates with
or without supplements, and incubated for 3 weeks at 37°C. Macro and microscopic
examination were carried out weekly in these plates. Additionally, 20 µL of sediment
were used to determine acid-alcohol resistance following standard methods [42].

9.3 Results
9.3.1 Construction, verification and complementation of M. smegmatis alr deletion
mutant.
To solve the controversy surrounding the requirement for the M. smegmatis alr
gene in the absence of D-alanine, we generated alr deletion mutants GPM292, GPM293,
GPM294 and GPM295. After conducting a preliminary characterization by Southern blot
analysis (see below), one representative deletion mutant, M. smegmatis GPM292, was
selected for further analysis. Deletion of 99% of the alr gene coding sequence was
accomplished using an approach that was similar to that previously described for the
construction of other M. smegmatis alr deletion mutant strains [11]. To that end, we
transformed the wild type strain mc2155 with a pBUN381 (Table 9.2) fragment carrying
the non-polar pUC18K aphA-3 kanamycin resistance marker outflanked by the M.
smegmatis alr upstream and downstream regions. The inactivation was accomplished
using a one-step strategy, since the lack of illegitimate recombination in this species
makes this direct selection for a double cross-over feasible [40].
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Our alr deletion mutants are in principle identical, except for polylinker site
sequences introduced at the drug marker region, to the alr deletion mutants previously
described, including the same non-polar aphA-3 marker [11]. A new deletion mutant was
made to assure that both the deletion and insertion mutants to be analyzed were derived
from the same parental strain, a low-passage isolate of mc2155 that was directly received
from the original source [15]. Thus, any potential source of variability due to mc2155
isolates kept at different laboratories was eliminated for the comparison of insertion and
deletion alr mutant strains. Mutant strains were verified by PCR (data not shown) and
Southern blotting analysis. The schematic display of M. smegmatis wild type and alr
mutant patterns in Southern blotting analysis with a left flank probe upon SmaI digestion
predicts the following approximate sizes for the band patterns: 1.63 kb and 1.56 kb for
wild type mc2155; 1.97 kb and 1.6 kb for TAM23 and 1.56 kb and 0.6 kb for the deletion
mutants (Figure 9.2a). M. smegmatis GPM 292 - 295 yielded the expected patterns and
were confirmed to be true alr deletion mutants (Figure 9.2b). The complemented strain
GPM345 was generated by transformation of M. smegmatis GPM292 with pTAMU3
(Table 9.1) and verified by the presence of a 0.56 kb signature band corresponding to the
amplification of the pTAMU3 hygromycin resistance gene (data not shown).

9.3.2 Enzymatic activity of M. smegmatis alr mutants.
Alr enzymatic activity was determined using a 1-step chiral plate assay, designed
to directly measure the conversion of 14C-D-alanine into 14C-L-alanine without the need
for further coupling steps that could diminish the sensitivity of the assay (Figure 9.3). The

340

a)

b)
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Figure 9.2. a) Genomic comparison of M. smegmatis wild type and mutant alr loci.
Location of left flank probe complementary sequences in relevant SmaI fragments for
WT, TAM23, and GPM292 alr chromosomal loci. Displayed features are: alr upstream
and downstream sequences adjacent to the original chromosomal locus (open arrows), alr
gene (filled arrows), probe sequences (striped boxes), and the kan markers aph2
(checkered) and aphA-3 (dotted) arrows. b) Southern blotting analysis of M. smegmatis
wild type and alr mutants. Genomic DNA was digested with SmaI (lanes 2 to 7). Lane 1
contains the non-labeled 1,237 bp probe homologous to the alr upstream flanking
sequence defined by amplification with primers AlrKO1 and AlrKO2. Lane 2, mc2155;
lane 3, TAM23; lanes 4-7, alr deletion mutants GPM292-GPM295.
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Figure 9.3. Alr enzymatic assay using chiral separation of alanine enantiomers. Protein
extracts were incubated at 37ºC for 15 min in the presence of 50 mM Tris HCl pH 8.0,
15 mM D-alanine, 0.1 mM pyridoxal phosphate, and 14C-D-alanine (lower spot). Control
reactions were performed under the same conditions using WT-heat inactivated extracts
with 14C-L-alanine, 14C-D-alanine or both radioactive alanine compounds present at a 1:1
ratio. Chiral plates were baked at 100ºC for 30 min, spotted with 5 μl of reaction
mixture, air dried and developed in a saturated chamber with acetone, methanol and
ddH2O in a ratio of 10:2:2. Lane 1, 1:1 mixture of 14C-D and 14C-L-alanine; Lane 2,
14

C-D-alanine; Lane 3, 14C-L-alanine; Lane 4, WT alr; Lane 5, TAM23; Lane 6,

GPM292 & Lane 7, 1:1 mixture of 14C-D and 14C-L-alanine. Assays were performed in
triplicate. Image was captured in BioRad Quantity One version 4.4.6, Contrast was
adjusted uniformly and image cropped to remove excess space only.
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test was able to resolve an equimolar mixture of D- and L-alanine (lanes 1 and 7), with
each enantiomer generating a unique spot (lanes 2 and 3). In contrast to the wild type
strain, able to convert D-alanine into an approximately equimolar mixture (44.4 ± 1.8 %)
of both enantiomers upon 15 min incubation (lane 4), both alr insertion (lane 5) and
deletion (lane 6) mutants were unable to convert D-alanine into L-alanine. Overnight
incubation resulted in enantiomeric equimolar equilibrium (50.7 ± 1.6 %) in the wild type
strain, as expected from the predicted thermodynamic parameters [43], but was unable to
detect any enzymatic activity in the alr mutant strains (data not shown). Alr specific
activity in wild type M. smegmatis was 0.2 µmol min-1 per µg of protein, consistent with
previous data [10].

9.3.3 Growth of M. smegmatis alr mutants in different media.
The pair of isogenic insertion (TAM23) and deletion (GPM292) alr mutants was
tested under various conditions. As expected, the composition of the media played a
significant role in the ability of both mutant strains to grow with or without D-alanine.
Minimal concentrations of D-alanine required for the mutant strains to yield significant
growth were determined in duplicate using both LBT and MADC broth, with or without
D-alanine supplementation. Upon incubation for 48 h., both alr mutants failed to grow in
either media in the absence of D-alanine, supplementation with 0.1 mM D-alanine was
sufficient for alr mutants to display some growth on MADC, and 0.3 mM D-alanine was
required for growth in LBT (Figure 9.4). The results on LBT are basically identical to
those previously reported for other alr deletion mutant [11]. In one experiment, CFUs
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Figure 9.4. Growth of M. smegmatis alr mutants in MADC-Tween and LBT at varying
D-alanine concentrations. Mycobacterium smegmatis alr deletion mutant GPM292
insertion mutant TAM23, and wild type mc2155 were grown in both MADC-Tween a)
and LBT b) media with varying concentrations of D-alanine. Cultures were inoculated to
an initial OD600 ca. 0.01, and OD600 values were taken at 24h (not shown) and 48h
(shown) after inoculation. Plotted data are means of two independent experiments (n=2).
In one experiments, CFU were also determined and the results followed closely the data
from the OD600nm measurements depicted in this figure. Complemented strains TAM23
(pTAMU3) and GPM345 exhibited the same growth as mc2155 (data not shown, n=1).
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were also determined and the results followed closely the OD600nm measurements.
Complemented strains TAM23 pTAMU3 and GPM345 exhibited the same growth as
mc2155 (data not shown).
Growth curves of both M. smegmatis alr mutants TAM23 and GPM292 in
minimal media with and without D-alanine exhibited similar patterns to those we
reported before for TAM23 [10], including a long lag time in the absence of D-alanine.
The wild type growth pattern was restored by addition of 50 mM D-alanine. Statistical
analysis indicated that each strain and condition resulted in a characteristic growth curve
(P < 0.03 or lower), except for mc2155 and TAM23 grown in the presence of D-alanine
that yielded similar growth patterns (P < 0.61). Most importantly, in medium without Dalanine, both alr mutant strains were able to grow, but displayed a long lag time (Figure
9.5).Thus, both M. smegmatis alr insertion and deletion mutants are not dependent on Dalanine for growth.
Observations in solid media confirmed similar growth patterns for M. smegmatis
insertion (TAM23) and deletion (GPM292) mutants. Growth of the wild type and mutant
strains was initially assessed on MADC and LBT agar with and without D-alanine. M.
smegmatis mc2155 and the alr+ complemented strains displayed abundant growth on
MADC and LBT agar both with and without D-alanine. Both TAM23 and GPM292 alr
mutants were able to grow in MADC in the presence (more growth) or absence (poor
growth) of D-alanine, while they grew on LBT only if supplemented with D-alanine, as it
had been reported for other M. smegmatis alr deletion mutants [11]. Thus, these
experiments conclusively demonstrate that D-alanine auxotrophy is conditional on the

346

Fig. 9.5. Growth of M. smegmatis Alr mutant strains in minimal media with and without
2

D-alanine. Strains mc 155, TAM23, and GPM292 were grown in MADC-Tween with
50mM D-alanine to an OD600nm of 0.8 – 1.2. Cells were harvested, washed twice with
phosphate-buffered saline (PBS)–0.05% Tween 80, and three independent cultures per
strain were inoculated 1:50 (initial OD600nm ca. 0.02) into minimal media (Chacon et al.
2002) with 21 mM glycerol as the carbon source, 5.0 mM ammonium chloride,
supplemented with or without 50 mM D-alanine. Growth was recorded for 200 h by
monitoring the OD600nm. SEM (n=3) are indicated by the corresponding error bars.
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growth medium (Figure 9.6).
Plating on non-supplemented and supplemented LBT and MADC agar, revealed
that the growth of alr mutants was inhibited by addition of Tryptone (LBT component
absent in MADC), an equimolar mixture of 20 aminoacids or a mixture of glucogenic
aminoacids (L-alanine, L-glutamic acid, L-glutamine, L-aspartate and L-asparagine).
Mutant growth was also inhibited in Middlebrook 7H11 but not in Middlebrook 7H10
(Table 9.3). Further testing, using the plating score described in Figure 9.1, revealed
abundant growth of M. smegmatis wild type mc2155 and the complemented strain
GPM345 in all media. M. smegmatis TAM23 and GPM292 exhibited wild type growth
levels in the presence of 5 mM D-alanine, as well as in the presence of a combination of
5 mM D-glutamate and 18 mM pyruvate. Growth was observed with no D-alanine or any
other supplementation, and with D-glutamate, L –glutamate, D-serine (Table 9.4), or 18
mM pyruvate (see Supplemental material). Addition of L-alanine, L-asparagine, L-serine
or L-glutamine did not affect the growth of the wild type strain while totally inhibited the
growth of both alr mutants (data not shown).

9.3.4 Global changes in the metabolome of alanine racemase mutants.
The principal component analysis (PCA) 2D scores plot (Figure 9.7a) illustrates a
comparison between the metabolomes of M. smegmatis wild-type mc2155 cells, and the
alanine racemase insertion (TAM23) and deletion (GPM292) mutants grown in MADC
without D-alanine. The 2D scores plot reduces the complex 1D 1H NMR spectrum that
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Fig. 9.6. Growth of M. smegmatis Alr mutant strains in minimal media with pyruvate as
carbon source, supplemented with D-alanine or D-glutamate. Strains mc2155, TAM23,
and GPM292 were grown in MADC-Tween with 50 mM D-alanine to an OD600nm of 0.8
– 1.2. Cells were harvested, washed twice with PBS–0.05% Tween-80, and inoculated
1:50 (initial OD600nm ca. 0.02) into minimal media (Chacon et al. 2002) with 18 mM
pyruvate replacing 21 mM glycerol as carbon source, 5.0 mM ammonium chloride, and
50 mM D-alanine (solid lines) or 5.0 mM D-glutamate (dotted lines). Growth was
recorded for 200 h by monitoring the OD600nm. SEM (n=3) are indicated by the
corresponding error bars.
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Table 9.3. Growth of alr mutants on selected agar media supplemented with various
nutrients.

a

Media (Supplements)a

WT

TAM23

GPM292

LBT

+

-

-

MADC

+

+

+

+ Tryptone

+

-

-

+ 20 AA

+

-

-

+ Glucogenic AA

+

-

-

Middlebrook 7H10

+

+

+

Middlebrook 7H11

+

-

-

MADC agar plates (regular and supplemented with 5mM of the listed amino acid) were
streaked from glycerol stocks with 1 μl loops in four directions (S->E->N->W) on duplicate
plates. Plates were incubated at 37 ºC and checked at day 7 for growth. ). Results were recorded
as growth (+) or no growth (-). Media tested were LBT, MADC, Middlebrook 7H10,
Middlebrook 7H11, and MADC with and without supplementation of 1g/L Tryptone (Difco);
mixture of 20 individual amino acids (0.25 mM each), and glucogenic aminoacids (1.0 mM
each), as described in the text.

350

Table 9.4. Growth of M. smegmatis wild type and alr mutant strains on supplemented
solid media.
Media (Supplements)a
mc2155 GPM292 TAM23 GPM345

a

MADC

+++

++

++

+++

MADC + 5.0 mM D-alanine

+++

+++

+++

+++

MADC + 5.0 mM D-glutamate

+++

++

++

+++

MADC + 5.0 mM D-serine

+++

++

++

+++

MADC + 5.0 mM D-glutamate + 18.1
mM pyruvate

+++

+++

+++

+++

MADC agar plates were streaked from glycerol stocks (S->E->N->W) on duplicate plates. Plates
were incubated at 37 ºC and checked after 5 and 7 days. Results reported are from day 7. Scores
were assigned following the scheme described in Figure 9.1.
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Figure 9.7. a) PCA 2D scores plot and a) OPLS-DA 2D scores plot. Comparison of the
1D 1H NMR spectra obtained from M. smegmatis TAM23, GPM292, and mc2155 cell
lysates. The wild-type M. smegmatis mc2155 cells were designated the control class in
the OPLS-DA, and the remainder of the cells was designated as the mutant class. The
OPLS-DA used one predictive component and one orthogonal component to yield a R2X
of 0.517, R2Y of 0.822, and a Q2 of 0.746. Cross validation using CV-Anova yielded a pvalue of 1.38e-6. The ellipses correspond to the 95% confidence limits from a normal
distribution for each cluster.
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captures the state of the cellular metabolome into a single point in principal component
space (PC1, PC2, etc.). Correspondingly, the principal components represent the largest
variations between the individual 1D 1H NMR spectra. The 2D scores plot indicates that
PC1 and PC2 account for 18.1% and 11.5% of the variation in the NMR
spectra,respectively. A total of 10 replicates for each of the mc2155, TAM23, and
GPM292 strains formed three distinct clusters in the PCA 2D scores plot. It is interesting
to note, that despite the fact that both TAM23 and GPM292 lack alanine racemase
activity, the two M. smegmatis strains formed separate clusters in the PCA 2D scores plot
indicating different changes in the metabolome. More specifically, the GPM292 cluster
was primarily separated from the mc2155 and TAM23 clusters along PC1, the largest
variation between the 1D 1H NMR spectra.
The unsupervised PCA model effectively demonstrated class separation between
the three M. smegmatis strains, which is generated based on the highest variations in the
NMR data. To gather information about the discriminatory variations that maximize class
separation, OPLS-DA was performed [44]. The OPLS-DA 2D scores plot exhibited a
similar class separation between M. smegmatis mc2155 wild-type cells and the two
alanine racemase mutants (Figure 9.7b). The OPLS-DA model yielded a reliable fit as
evident by an R2X of 0.517, R2Y of 0.822, and a Q2 of 0.746. Importantly, cross
validation using CV-Anova [45] yielded a statistically significant p-value of 1.38e-6,
validating the class separation between the two alanine racemase mutants and the mc2155
wild-type cells. More importantly, the alanine racemase mutant strains clustered at
different locations along the orthogonal component of the 2D scores plot, demonstrating
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a statistically significant class separation between the deletion and insertion alanine
racemase mutants. This is consistent with the PCA 2D scores plot where three distinct
clusters were formed, indicating differences between the three M. smegmatis strains.
Furthermore, the S-plot generated by OPLS-DA identified the NMR spectral differences
and, correspondingly the major metabolomic changes contributing to the class
separations (Figure 9.8). The significant variables (chemical shifts) labeled on the S-plot
had contributions of 0.1 or greater (correlated) or -0.1 or less (anti-correlated). The
metabolites identified from TAM23 and GPM292 as major contributors to class
separation are summarized (Table 9.5). Specifically, a pair wise comparison between the
alanine racemase insertion mutant (TAM23) and the wild-type mc2155 cells identified an
increase in TAM23 for serine, glycolate, phosphoserine, alanine, lysine, UDP, and ATP.
Conversely, a decrease was observed for glutamate, isoleucine, lactate and TCA cycle
intermediates in TAM23. The S-plot resulting from the pair wise comparison between the
alanine racemase deletion mutant (GPM292) and the wild-type mc2155 cells identified a
larger number of bins significantly contributing to the class separation. However, as in
TAM23, serine, glycolate, phosphoserine, lysine, alanine and UDP were increased in
GPM292. Similarly, TCA cycle intermediates and glutamate were also decreased in
GPM292. Despite the general similarity between TAM23 and GPM292, there were some
differences in specific metabolites (Table 9.5). For example, acetate was increased in
TAM23, but decreased in GPM292. Conversely, lactate increased in GPM292, but
decreased in TAM23.
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Figure 9.8. OPLS-DA S-plots comparing the 1D 1H NMR spectra obtained from M.
smegmatis a) TAM23 and mc2155, b) GPM292 and mc2155 cell lysates. Each point in
the S-plot represents a specific bin of integrals for a chemical shift range of 0.025 ppm,
where the points at the extreme ends of the S-plot are labeled and are major contributors
to the class distinction.
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Table 9.5. M. smegmatis alr mutants and wild type metabolites in absence of Dalanine
Increase
Decrease
TAM23

GPM292

TAM23

GPM292

Acetate

Alanine

Alphaketoisovalerate

Acetate

Alanine

Aspartate

Ethanol

Ethanol

ATP

ATP

Fatty Acid

Fatty Acid

GABA

Glycolate

Glutamate

Glutamate

Glucarate

Glucarate

Glycerol

Glycerol

Glycolate

Lactate

Isoleucine

Isoluecine

Lysine

Lysine

Lactate

NAc-glucosamine-6phosphate

Phosphoserine

Phosphoserine

NAc-glucosamine6-phosphate

Oxaloacetate

Serine

Serine

Oxaloacetate

Succinate

Succinate

Succinate

Succinate

Valerate

Threonine

Threonine

Valerate

UDP

UDP
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The global NMR metabolomics experiment was repeated using M. smegmatis
mc2155, TAM23, and GPM292 cells grown in MADC supplemented with 50 mM Dalanine. Again, the PCA 2D scores plot contained three distinct clusters indicating a
different metabolome between the M. smegmatis wild-type and alanine racemase mutant
strains supplemented with D-alanine (Figure 9.9a). The scores plot indicated that PC1
and PC2 corresponded to 26.1% and 14.7% of the variation in the data, respectively.
More importantly the three clusters were primarily separated along PC1 suggesting the
separation was dominated by the inactivation of alanine racemase, while inherent
variations within each group contributed to the variations in PC2.
Similarly, the OPLS-DA 2D scores plot exhibited a similar class separation
between M. smegmatis mc2155 wild-type cells and the two alanine racemase mutants
(Figure 9.9b). The OPLS-DA yielded a reliable fit as evident by R2X of 0.559, R2Y of
0.926, and a Q2 of 0.862. Importantly, cross validation using CV-Anova yielded a
statistically significant p-value of 2.05e-10, validating the class separation between the
two alanine racemase mutants and the mc2155 wild-type cells. Again, TAM23 and
GPM292 formed distinct clusters along the orthogonal component, indicating a different
metabolome between the two strains in presence of D-alanine. The S-plot from OPLSDA was used to identify the bins (chemical shifts) that significantly contributed (0.1 or 0.1) to the class separation (Figure 9.10). The assigned metabolites are summarized
(Table 9.6). The pairwise comparison between the alanine racemase insertion (TAM23)
and deletion (GPM292) mutants to wild-type mc2155 cells showed some remarkable
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Figure 9.9. a) PCA 2D scores plot and b) OPLS-DA 2D scores plot comparing the 1D 1H
NMR spectra obtained from lysates of M. smegmatis mc2155, TAM23, and GPM292cells
grown in MADC media supplemented with 50 mM D-alanine. The wild-type M.
smegmatis mc2155 cells were designated the control class in the OPLS-DA, and the
remainder of the cells was designated as the mutant class. The OPLS-DA used one
predictive component and one orthogonal component to yield a R2X of of 0.559, R2Y of
0.926, and a Q2 of 0.862. Cross validation using CV-Anova yielded a p-value of 1.205e10

. The ellipses correspond to the 95% confidence limits from a normal distribution for

each cluster.

358

Figure 9.10. OPLS-DA S-plots comparing the 1D 1H NMR spectra obtained from M.
smegmatis cell lysates a) TAM23 and mc2155 b) GPM292 and mc2155. All cells were
grown in MADC supplemented with 50 mM D-alanine.
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Table 9.6. M. smegmatis alr mutants and wild type metabolites in presence of 50
mM D-alanine.
Increase

Decrease

TAM23

GPM292

TAM23

GPM292

Citrulline

Alanine

Alanine

Alpha-ketoglutarate

Fatty Acid

Citrulline

Alphaketoglutarate

Glucose

Glutamate

Fatty Acid

GABA

GABA

Isoleucine

Glutamate

Lysine

Lysine

Oxaloacetate

Isoleucine

Ornithine

Ornithine

Succinate

Lactate

Trehalose

Trehalose

Threonine

Oxaloacetate

Valine

Valine

Succinate
Threonine
Ureidopropionate
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similarities. Metabolites that were increased in TAM23 and GPM292 included glutamate,
TCA cycle intermediates, isoleucine, threonine, and compounds with fatty acyl side
chains. These metabolites were also identified in the absence of D-alanine (Table 9.5).
Metabolites that were decreased in TAM23 and GPM292 included trehalose, lysine and
valine. Importantly, the changes in alanine and glucose were different between the
alanine racemase mutant strains, where alanine was increased in GPM292, but decreased
in TAM23. Conversely, glucose was decreased in GPM292, but did not appear to change
significantly in TAM23. Additionally, lactate and ureidopropionate were increased in
GPM292, but unaffected in TAM23.

9.3.5 Quantitative analysis of metabolite changes in alanine racemase mutants
The NMR metabolomics experiment was repeated using M. smegmatis mc2155,
TAM23, and GPM292 cells grown in MADC supplemented with 100 M of 13C-labeled
D-alanine. 13C-labeled metabolite extracts from three sets of each strain, mc2155,
TAM23, and GPM292 were analyzed using time-zero 1H-13C HSQC (HSQC0)
experiments [35, 46]. The 2D 1H-13C HSQC NMR spectra allows for easier identification
of metabolites because of the reduced complexity and spectral overlap compared to the
1D 1H NMR spectra. Also, the coupled 1H and 13C chemical shifts obtained for each C-H
pair in the 2D 1H-13C HSQC spectra increases the accuracy in metabolite assignments.
The 2D 1H-13C HSQC experiment was performed to monitor the flow of carbon-13
throughout the M. smegmatis metabolome, where only metabolites that originate from the
supplemental 13C-D-alanine are observed (Figure 9.11). Each peak in the 2D 1H-13C
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Figure 9.11. Overlay of 2D 1H-13C HSQC spectra. Comparison of cell lysates of M.
smegmatis TAM23 (black) and GPM292 (red) supplemented with 100 µM 13C-D-alanine.
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HSQC spectra represents a 13C-H pair for a specific metabolite that is labeled by
matching the chemical shifts against NMR metabolomic databases. A total of 38
metabolites were identified from the three M. smegmatis strains. Importantly, the
distribution of carbon-13 throughout the M. smegmatis metabolome in the two alanine
racemase mutants suggested that there is an alternate metabolic pathway involving Dalanine. The metabolite concentrations derived from 13C-D-alanine were compared
between the M. smegmatis mc2155 wilt-type cells and the two alanine racemase mutants.
A concentration for each metabolite was determined by extrapolating peak volumes and
intensities from a series of three 2D 1H-13C HSQC spectra at different time points to
interpolate a time-zero peak volume or intensity. The spectra were collected in triplicate
to determine the average and standard deviation. The average extrapolated peak volume
for each metabolite is directly proportional to a concentration based on a calibration
curve using 9 13C-labeled compounds of known concentration. These results permit a
direct comparison of metabolite concentration changes between the three M. smegmatis
strains (Figure 9.12). For example, an 8-fold increase in alanine was observed for
GPM292 compared to mc2155, substantially larger than the increase observed in TAM23
compared to the wild type strain. Peptidoglycan precursors such as glutamate, lysine, Nacetyl-glucosamine all decreased significantly in the alanine racemase mutants, as well as
the concentration of trehalose, an essential precursor for trehalose-containing glycolipids,
which allows the attachment of glycolipids to arabinogalactan in the cell wall [47].
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Figure 9.12. Metabolite concentrations. Bar graphs showing the concentrations of
metabolites identified in cell lysates from M. smegmatis mc2155 (black), TAM23 (red),
and GPM292 (blue) using the time-zero 2D 1H-13C HSQC experiment.
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9.3.6 Construction, verification and characterization of a M. smegmatis D-alanine
auxotroph.
A total of 12,744 mutants were selected after 17 independent transductions of M.
smegmatis TAM23 with mycobacteriophage phAE159::Tn53711 (Table 9.2). Initial Dalanine dependence tests, carried out in 3,723 colonies, identified one colony absolutely
dependent on D-alanine for growth: M. smegmatis TAM23-12. Growth of M. smegmatis
mc2155, TAM23 and TAM23-12 in MADC agar with 50 mM D-alanine was detectable
after 3 days of incubation. As expected, M. smegmatis mc2155 was able to grow in
absence of D-alanine at day 3 of incubation. Similarly, M. smegmatis TAM23 was also
able to grow in absence of D-alanine although at day 5 of incubation colonies were
smaller when compared with the wild type strain (Figure 9.13). M. smegmatis TAM23-12
was not able to grow in the absence of D-alanine. Bioinformatic analysis of the
transposition insertion identified murI as the target gene in TAM23-12 (Figure 9.14).
Identity of the gene in TAM23-12 was confirmed by PCR amplification using specific
primers outflanking murI. As expected, TAM23-12 yielded a 3.9 kb fragment that was
2.2 kb longer than the 1.7 kb wild type mc2155 product. Complementation using
pBUN373 restored M. smegmatis TAM23-12 growth in media without D-alanine (data
not shown).
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Figure 9.13. D-alanine dependency of M. smegmatis alr murI double mutant strain. M.
smegmatis wild type mc2155 (1), alr mutant TAM23 (2) and double alr murI mutant
TAM23-12 (3), grown in MADC agar in absence (A) or presence (B) of 50mM Dalanine.
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Figure 9.14. Strategy to determine transposon insertion sites. Insertion of Tn5371
within the murI gene is depicted (Panel A) with the corresponding transposon elements:
inverted repeats (triangles), R6K origin of replication (open rectangle), and the
hygromycin resistant gene (hyg). Binding sites for the primers of the first round
amplification are shown as vertical dashed (corresponding to various potential locations
of the degenerate primer binding sites) or solid lines. Panel B illustrates the location of
the insertion site of Tn5371 identified in TAM23-12.
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9.3.7 Construction, verification and characterization of M. tuberculosis strains with
inactivation of the chromosomal alr gene.
Our numerous attempts to inactivate the alr gene in M. tuberculosis H37Rv were
unsuccessful. A different strategy was then implemented and extra copies of the alr were
introduced in M. tuberculosis H37Rv before re-attempting the inactivation. The
recombinant M. tuberculosis H37Rv(pBUN307) strain was confirmed by verifying the
presence of pBUN307 plasmid DNA (data not shown), and transfected with phBUN1.
Successful inactivation of the chromosomal alr gene was confirmed by Southern blot
analysis comparing the expected bands (Figure 9.15a) with the observed patterns (Figure
9.15b). The chromosomal alr mutant strain with extra copies of alr in pBUN307 was
named TBcol1. The wild type strain M. tuberculosis H37Rv displayed a pattern of 2
bands of 0.675 kb (also present in TBcol1) and 1,682 kb. Besides the 0.675 kb band, the
pattern in TBcol1 included two more bands of 0.9 kb (also observed in pBUN288) and
1.522 kb (also found, as a unique band, in pBUN307). The pattern in pBUN288 included
another band of 2.634 kb.
Kinyoun staining for acid-alcohol resistant bacilli revealed no differences
between wild type, wild type merodiploid or alr merodiploid mutant bacilli. After two
weeks incubation at 37°C, microscopic examination revealed more dense microcolonies
in TBcol1 than in the wild type strains. Macroscopic morphology revealed that wild type
colonies were irregular, raised and wrinkled with more dense growth at the center
forming a classic cord and less dense and flat borders. In contrast, TBcol1 colonies were
irregular, raised, wrinkled and compact (Figure 9.16).

368

Figure 9.15 . Southern blot analysis of M. tuberculosis (Mtb) alr mutant for strain
H37Rv. a) Relevant SacII fragments for plasmid pBUN288, wild type Mtb H37Rv alr
chromosomal locus, pBUN307, and Mtb alr deletion mutant chromosomal locus.
Relevant features are alr downstream sequences adjacent to the alr chromosomal locus
(open boxes), alr gene (black boxes), 624 bp MTBalrdown probe sequences (striped
boxes), and the hyg marker (dotted boxes). Different diagrams are not necessarily drawn
to scale. b): Southern blot. DNA was digested with SacII. MTBalrdown (624 bp) was
radiolabelled and used as a probe. Lane 1, pBUN288; Lane 2, pBUN307; Lane 3, Mtb
H37Rv; and Lane 4, Mtb H37Rvalr::hyg-pBUN307(alr+) (Tbcol1). Fragment sizes
(bp) are indicated. Bands of 2,634 and 900 were present in pBUN288 (Lane 1). Plasmid
pBUN307 displayed a band of 1,522 (Lane 2). Wild type Mtb H37Rv displays a pattern
of two bands of 675 bp and 1,682 bp (Lane 3). Mtb H37Rv merodiploid strain infected
with phBUN1 displays a pattern of three bands, the 1,522 bp band from pBUN307 and
the 900 bp and 675 bp bands corresponding to the mutated chromosomal alr gene. (Lane
4).
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Figure 9.16. Colony morphology of M. tuberculosis alr wild type, alr merodiploid, and
chromosomal alr mutant strains. M. tuberculosis H37Rv (1), H37Rv(pBUN307)
merodiploid (2) and alr mutant TBcol1 (3) strains were plated in MADC agar plates
supplemented with 50mM D-alanine and incubated at 37ºC.. Individual colonies were
compared by microscopy at two weeks (A) and macroscopically at 4 weeks (B and C).
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9.4 Discussion
As expected, modifications of the mycobacterial cell wall have been associated
with attenuation and increased vulnerability to external agents and conditions [9, 48].
Through the study of mutant strains, this structure has been recognized as an excellent
target for antimicrobial agents and a rich source of potential vaccine strains. However,
when designing mutant studies related to cell wall biosynthesis, care must be taken to
avoid experimental conditions that may lead to inaccurate interpretations. It is known, for
example, that in vitro conditions not always mimic the in vivo environment and that
certain media components, such as Malachite Green, may have antimicrobial effects in
the presence of an altered cell wall [48].
Given the importance of D-alanine in peptidoglycan biosynthesis [9], the unique
alr gene in the M. smegmatis and M tuberculosis genomes was expected to be required in
both species for growth in media devoid of D-alanine. However, our previous studies
indicated that the M. smegmatis alr gene was not required in absence of D-alanine,
supporting the existence of an alternative pathway of D-alanine biosynthesis in that
species [10, 49]. Our findings were further supported by metabolomics analysis
confirming significant differences between the wild type and the alr mutant metabolomes
[50]. Controversy appeared when alr auxotrophy for D-alanine was reported by Milligan
et al [11] in DM22, a cleverly designed M. smegmatis alr deletion mutant. We generated
our own deletion mutant, M. smegmatis GPM292, in a similar fashion and found that, as
our M. smegmatis insertional mutant (TAM23), exhibited D-alanine auxotrophy in LBT,
but did not require D-alanine in MADC agar. These results indicate that the auxotrophy
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conferred by the alr mutation depends on the testing media. The growth patterns
observed in different solid media identified casein hydrolysate as the responsible
component for growth inhibition in LBT and Middlebrook 7H11. Previous reports have
associated susceptibility to Malachite Green, a synthetic dye and component of 7H10 and
7H11, to cell wall defects [48]. However, Malachite Green did not inhibit growth of M.
smegmatis alr mutants as both M. smegmatis TAM23 and GPM292 grew well in 7H10, a
medium that contains the dye but lacks casein hydrolysate. Therefore, we concluded that
the lack of growth observed in M. smegmatis alr mutants in 7H11 or LBT was likely due
to the presence of free amino acids provided by the casein hydrolysate. Further testing
attributed the inhibitory effect to the presence of L-alanine, L-serine, L-asparagine, or Lglutamine. Additional studies are warranted to identify the role of these metabolites in
growth inhibition.
D-alanine can be synthesized in bacteria through a transamination reaction of the
general type: D-amino acid + pyruvate  α-keto-acid + D-alanine, catalyzed by D-amino
acid aminotransferase, encoded by the dat gene. In the case of the intracellular pathogen
Listeria monocytogenes, inactivation of both alr and dat genes is required to achieve Dalanine auxotrophy [51]. Unfortunately, a dat homologue has not been identified in
mycobacteria. However, the existence of an unknown transaminase in M. smegmatis is
supported by the growth of both M. smegmatis alr mutants to levels similar to the wild
type strain in media with D-glutamic acid and pyruvate, but without D-alanine. Likewise,
identification of the glutamate recemase (murI) mutation as responsible for complete Dalanine auxotrophy in TAM23-12 further supports the involvement of D-glutamate in the
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alternative pathway of D-alanine biosynthesis in M. smegmatis. Our NMR studies
revealing decreased glutamate levels in absence of D-alanine and increased levels in its
presence, compared to the wild type glutamate levels, further strengthens the case for this
alternative D-alanine biosynthetic route. In summary, the M. smegmatis alr gene is nonessential and its inactivation confers conditional D-alanine auxotrophy. Otherwise, the alr
gene is dispensable in absence of D-alanine. Thus, a regulated pathway of D-alanine
biosynthesis, dependent on MurI and a novel but still unknown D-amino acid
aminotransferase, underlies this phenotype.
For M. tuberculosis H37Rv, our study indicates that Alr is an essential function in
H37Rv, as gene inactivation requires extra wild type copies of the alr gene in either the
presence or absence of D-alanine in MADC media. These results differ from those of
Awasthy et al. [12] that were able to obtain H37Rv alr mutants without providing extra
copies of the gene, by selecting mutants on MADC media supplemented with D-alanine.
Their results indicate that Alr is not essential in M. tuberculosis since its inactivation
leads to auxotrophy that can be compensated by a low concentration of D-alanine (e. g.,
10 µg/ml, approx 0.1 mM). There are several possibilities that could explain these
seemingly contradictory results. The mutants isolated by Awasthy et al could have
acquired, during the lengthy selection process in the sucrose selection media, a
compensatory mutation that partially activates the putative alternative pathway of Dalanine biosynthesis that we discovered in M. smegmatis. In that case, this activation
would not be sufficient to allow for growth in complete absence of D-alanine, but allow
the alr mutants to grow with very little D-alanine. Otherwise, this low requirement would
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be counterintuitive as mycobacteria incorporate D-alanine in both peptidoglycan and
glycolipids [49]. In that case, it could be further argued that additional compensatory
mutations may occur both in vitro and in vivo that could lead to activation of the
alternative pathway at sufficient levels so as to allow growth in complete absence of Dalanine. Compensatory mutations leading to increased virulence in vivo have been
reported for isoniazid resistant strains. Moreover, Aswasthy et al., noted that alr mutants
were able to persist at low levels in mice.
Alternatively, the corresponding H37Rv laboratory strains used in the two studies
may differ in genetic regions relevant to D-alanine biosynthesis and uptake. In this
context, these isolates correspond to different American Type Culture Collection
Catalogue numbers (ATCC 25,698 in our study versus ATCC 27,294 in Awasthy et al.).
It is to be noted that genomic differences have been reported in H37Rv laboratory strains
even among isolates derived from the same ATCC substrain. Lastly, it is also possible
that the stringent selection used in our shuttle plasmid gene inactivation procedure, to
select directly for double cross over events, inhibits the growth of any potential alr
mutant strains at a critical time. Discovery of all genes involved in the alternative
pathway of D-alanine biosynthesis in M. smegmatis and the presence or absence of
homologues in M. tuberculosis may help to sort out these alternative hypotheses.
Regarding the lethal target(s) of DCS in mycobacteria, our studies suggest that
Alr is not the lethal target in M. smegmatis, as alr mutants can grow in absence of Dalanine. The inhibitory effect of DCS on M. smegmatis is likely due to another target
such as D-alanine ligase [52]. Alternatively, DCS may be able to also inhibit the
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alternative pathway of D-alanine biosynthesis and thus determine a complete shut-down
of this biosynthetic process. A similar situation may or may not occur in M. tuberculosis,
depending upon how these possibilities described above are sorted out. In that case, if
the genes required for the alternative pathway are partially or fully absent from M.
tuberculosis, then Alr is likely to be the primary target of DCS.
Our long term goal is to apply our studies to design novel therapeutic agents
and/or attenuated vaccine strains that can be used to control human TB. Thus, our
findings should be interpreted in the context of the in vivo interaction between the
pathogen and its human host environment. The ability to survive inside human
macrophages constitutes a major factor in M. tuberculosis pathogenesis. Therefore,
understanding the dynamic interaction between M. tuberculosis and the host cell is of
paramount importance in the development of new, more effective tools to prevent and
control TB. Although this issue has been addressed using cleverly designed in vitro and
in vivo models of infection, a major drawback is the lack of an appropriate matrix that
permits their interpretation in the context of pathogen-cell interactomes. Fortunately,
completion of the M. tuberculosis and human genomes and recent bioinformatics
advances have enabled the development of promising genome-wide metabolic
reconstructions [30, 53-56] that represent important tools to achieve a comprehensive
understanding of the dynamic interactions between M. tuberculosis and the host cell(s).
In the context of our study, D-alanine has been identified in human tissues and a
potential role in neurotransmission has been suggested [57-60]. Free D-alanine (9.52
nmol/g) has been detected in the brain of normal subjects while higher levels (20.8
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nmol/g) were detected in Alzheimer’s patients [60]. Moreover, D-alanine is the substrate
for a human D-amino acid oxidase, an enzyme that has been associated with increased
susceptibility to schizophrenia. The affinity of the enzyme for D-alanine is higher than
for its putative substrate, D-serine (Km, approx.1.3 mM and 7.5 mM, respectively) [61].
Furthermore, oral administration of D-alanine (100 mg/kg/day) to schizophrenic patients
resulted in significant clinical improvement without major side effects, making this
amino acid a promising candidate for schizophrenia pharmacotherapy [62]. The high
affinity of a human enzyme for D-alanine, coupled with the side effects of the D-alanine
analog D-cycloserine on the nervous system, indicate that D-alanine may play an
important role in normal subjects and in patients with certain neurological conditions
[63]. Therefore, further studies on the specific role of D-alanine in humans are warranted
in order to maximize the efficacy and safety of novel antimicobacterial tools based on alr
inactivation. The use of those tools might be contraindicated in the presence of certain
medical conditions or pharmacotherapy agents. Thus, the success of any application that
is dependent on the inhibition of D-alanine biosynthesis in M. tuberculosis must be
evaluated with the assumption that low concentrations of D-alanine are found in human
tissues. In that context, the results of Awasthy et al. indicate that M. tuberculosis alr
mutants may be inappropriate as TB vaccine candidates as they could grow to a
considerable extent in human tissue regardless of the presence or absence of an
alternative pathway of D-alanine biosynthesis in M. tuberculosis. Likewise, Alr inhibitors
would not be effective to treat TB as the low concentrations of D-alanine could
compensate for alr gene inactivation. In summary, this study indicates that several
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factors ranging from experimental design to result interpretation, and comprehensive
knowledge and understanding of the specific interaction between the Mycobacterium and
the host cell, are extremely important for a successful use of alr mutants in the design of
novel tools urgently needed to control TB.
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CHAPTER 10
METABOLOMICS ANALYSIS IDENTIFIES D-ALANINE-D-ALANINE LIGASE
AS THE PRIMARY LETHAL TARGET OF D-CYCLOSERINE IN
MYCOBACTERIA

10.1 Introduction
Tuberculosis (TB) remains one of the leading causes of morbidity and mortality
from a single infectious disease on a global perspective [1]. In 2011, 8.7 million people
were infected with TB with over 1.8 million deaths world-wide. Moreover, the
emergence of multiple- (MDR-TB) and extensively drug-resistant- (XDR-TB)
Mycobacterium tuberculosis strains threaten to curtail efforts in disease control.
Currently, about 3.7% of new TB patients are infected with MDR-TB. To achieve the
WHO targeted goal of a successful treatment rate of 75% by 2015, a better understanding
of the molecular mechanisms of action and resistance to existing antibiotics and the
development of novel drugs that are more potent and safer is urgently needed.
D-Cycloserine (DCS) is a second line drug that is currently used as a last resort
on MDR- and XDR-TB. DCS has been used to treat TB for over fifty years despite a lack
of knowledge regarding the identity of its lethal target [2]. Although DCS inhibits
bacterial cell growth, it has serious neurological side effects [3-5]. DCS treatment results
in psychosis, depression, and convulsions, among other issues. In this context, DCS has
also been tested in neurological studies and has been shown to act as a partial agonist of
N-methyl-D-aspartate (NMDA) and glycine receptors [6]. Thus, understanding the source

383
of DCS antimicrobial activity would enable the development of next-generation
antibiotics for TB that avoids these CNS side effects. DCS is a cyclic analogue of Dalanine and has been shown to competitively inhibit Alanine racemase (Alr, EC 5.1.1.1)
and D-alanine-D-alanine ligase (Ddl, 6.3.2.4) [7, 8]. Correspondingly, the current
understanding of DCS activity against mycobacteria is through the inhibition of Alr
and/or Ddl that halts the synthesis of peptidoglycan precursors. However, we previously
demonstrated that Alr is not the lethal target of DCS, suggesting Ddl is the primary target
in live mycobacteria [9]. This is also consistent with the observation by Takayama et al.
that the UDP-MurNAc-tripeptide accumulates in M. tuberculosis upon treatment with
DCS.[10] UDP-MurNAc-tripeptide is the product of the MurE meso-diaminopimelateadding enzyme (EC 6.3.2.13) in the peptidoglycan biosynthesis pathway, while the next
step involves the MurF D-alanyl-D-alanine adding enzyme (EC 6.3.2.10) ligating the
UDP-MurNAc-tripeptide with D-alanyl-D-alanine, the product of Ddl [11]. Clearly, the
inhibition of Ddl by DCS would decrease the production of D-alanyl-D-alanine and lead
to the observed accumulation of the UDP-MurNAc-tripeptide, as the co-substrate of the
MurF reaction is decreased.
Peptidoglycan biosynthesis is an ideal target for drug design because the pathway
is not present in mammalian cells [11]. Also, the resulting peptidoglycan-arabinogalactan
complex gives the cell its structural integrity [11-13]. The peptidoglycan layer consists of
an alternating N-acetylglucosamine and N-glycolated or N-acetylated muramic acid.
Each N-glycolated or N-acetylated muramic acid is bound to a tetrapeptide consisting of
an L-alanyl–D-isoglutaminyl–meso-diaminopimelyl–D-alanine (L-Ala–D-Glu–A2pm–D-
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Ala) moiety. The tetrapeptide forms a crosslink between adjacent alternating aminosugars
where the side chain of meso-diaminopimelate of one group forms a peptide bond with a
D-alanine or meso-diaminopimelate residue from the adjacent group. This large mycolylarabinogalactan-peptidoglycan complex creates an impermeable barrier that is essential
for the viability of the cell [14]. This metabolic route includes the D-alanine branch
pathway consisting of three enzymes that contribute to the synthesis of the glycomuramyl
pentapeptide involved in the crosslinking of mature peptidoglycan. Alr is a pyridoxal
phosphate dependent enzyme that interconverts L-alanine and D-alanine [15, 16]. The
ATP Ddl catalyzes the subsequent peptide bond between two D-alanine moieties [17].
The final step is the addition of this dipeptide to the glycomuramyl tripeptide cytoplasmic
precursor by the ATP-dependent MurF adding enzyme to form the pentapeptide complex
[18]. As a result, numerous enzymes within the peptidoglycan biosynthesis machinery
recognize or bind a D-alanine moiety and are potentially inhibited by DCS. Herein, we
describe our application of Nuclear Magnetic Resonance (NMR) based metabolomics and
bioinformatics to determine the lethal target of DCS in mycobacteria and to investigate
the effects of this drug on central metabolic pathways related to peptidoglycan
biosynthesis. Our analysis indicates that DCS is a promiscuous inhibitor targeting
multiple enzymes within the peptidoglycan biosynthesis pathway, but Ddl is the primary
target. Our results also support the prior observation by Caceres et al. [19] that D-alanine
is a competitive inhibitor of DCS and its over-production is a primary mechanism of
resistance.
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10.2 Method and Materials
10.2.1 Preparation of M. tuberculosis NMR metabolomics samples
General procedures for the handling and preparation of M. tuberculosis NMR
samples for metabolomic analysis have been described elsewhere [20]. Six (3 for 13C-Dalanine and 3 for 13C-D-alanine DCS) M. tuberculosis H37Rv 110 mL MADC broth
(Middlebrook 7H9 complete media) cultures from glycerol stock were grown shaking at
100 rpm at 37ºC for approximately 7 days (OD600 0.6-0.8). A 500 L sample was
removed and kept at 4ºC for CFU determinations. 13C-D-alanine (0.1 mM final
concentration; e.g.,100 μL of a 100 mM stock) was added to all cultures. DCS (50 μg/mL
final concentration (500 μL of a 10 mg/mL stock)) was added to only 3 flasks. All
cultures were incubated for an additional 18 hours, taking another OD600 reading and
removing a 500 μL sample from each flask. Cultures were placed on ice for 5 minutes
and left on ice throughout the rest of the processing. Cultures were harvested by spinning
them down at 2000 g at 4ºC for 15 minutes in 50 mL tubes. The samples were washed
two times (~25-30 mL) with ice-cold double distilled water (ddH2O). The cell pellets
were re-suspended with 1 mL of ddH2O and transferred to a 2 mL vial consisting of 0.1
mm silica beads (Lysing Matrix B). The cells were then lysed using a FastPrep-24
instrument for 60 seconds at 6 m/s. The cellular mixture was centrifuged at 15,000 g at
4ºC for 10 minutes and the supernatant was extracted to a 1.5 mL tube. 700 μL of ddH2O
was added to the tube containing the lysing matrix B and briefly vortexed, followed by
centrifugation, and then transferring and combining the supernatants in a 1.5 mL tube.
The supernatant was syringe filtered (0.2 µm) into a sterile tube. A 100 µl of the sample
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(10%) was plated on MADC to verify that there are no live cells. Samples were frozen in
an EtOH-dry ice bath and stored at -80ºC for 2 months. After verification that the plates
contained no viable cells (CFUs), the metabolomic samples were taken out of BSL3
containment, lyophilized and prepared for analysis by NMR. 10 μL of the supernatant
was used to determine protein concentration as described below for the M. smegmatis
samples.

10.2.2 Preparation of M. smegmatis NMR metabolomics samples
NMR samples for 2D 1H-13C HSQC experiments were prepared from 6 groups of
triplicate and independent M. smegmatis mc2155 cultures using 100 μM 13C2-D-alanine
(13C and 13C labeled) or 13C3-pyruvate as a carbon-13 source. The following groups
using 13C2-D-alanine are mc2155 as a control and mc2155 treated with 75, 300, or 1200
μg/mL of DCS. The groups using 13C3-pyruvate are untreated mc2155 and mc2155 treated
with 75 μg/mL DCS. The replicate cultures were grown at 37°C with shaking at 200 rpm
in 110 mL of MADC (250 mL flask) until an OD600 of 0.6 was met. 13C2-D-alanine or
13

C3-pyruvate was inoculated to the designated cultures for a final concentration of 100

μM. The cultures were allowed to grow for 10 minutes and then were treated with DCS to
a final concentration of 75, 300, or 1200 μg/mL. The cultures were then grown for an
additional 2 hours before harvesting. Each culture was placed on ice for 5 minutes and
then centrifuged for 10 minutes at 1500 g and 4ºC. The cell pellets were washed twice
with 30 mL of ice-cold ddH2O. The cell pellets were re-suspended with 1 mL of ddH2O
and transferred to a 2 mL vial consisting of 0.1 mm silica beads. The cells were then
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lysed using a FastPrep-24 instrument for 40 seconds at 6 m/s. The cellular mixture was
centrifuged for 10 minutes at 12,400 g and 4ºC and the supernatant was extracted. 10 μL
of the supernatant was used to determine the protein concentration in the extracted
metabolomics sample. Bio-Rad DC Protein Assay was used to obtain the total protein
concentration for each sample using bovine serum albumin as standard. The supernatant
was frozen in a dry ice ethanol bath and stored at -80oC until analyzed by NMR.
Two groups of triplicate and independent M. smegmatis mc2155 cultures were
also grown using 13C6-glucose as the carbon-13 source. The two groups are untreated
mc2155 and mc2155 treated with 75 μg/mL DCS. The cell cultures were grown in 50 mL
of minimal media containing 22 mM 13C6-glucose, 500 mM ammonium chloride, and
essential salts. The pH of the minimal media was adjusted to 7.2. The cultures were
grown as described above until an OD600 of 0.6 was achieved. DCS was then added to the
selected cultures to a concentration of 75 μg/mL and the bacteria were allowed to grow
for 2 more hours. The metabolome was extracted as described above.
Prior to collecting the 2D 1H-13C HSQC spectra, all metabolomics samples are
lyophilized and re-suspended in a 500 mM potassium phosphate buffer in 99.8% D2O at a
pH of 7.2 (uncorrected) containing 500 μM of unlabeled 3-(trimethylsilyl)-propionic2,2,3,3-d4 acid sodium salt (TMSP) as an internal standard. The volume used for each
sample was normalized based on the relative protein concentration determined for each
sample. The sample with the lowest protein concentration was dissolved in 650 μL of the
NMR buffer, where the other samples were dissolved in a proportionally larger buffer
volume based on the relative protein concentrations. In this manner, the final
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metabolomics sample concentrations were equivalent and directly comparable. 600 μL of
the reconstituted metabolomics sample was then placed into a 5 mm NMR tube for data
collection.

10.2.3 2D 1H-13C HSQC NMR Data Collection
The 2D 1H-13C HSQC NMR spectra were collected on a Bruker 500 MHz Avance
DRX spectrometer equipped with a triple-resonance, Z-axis gradient cryoprobe. A
BACS-120 sample changer with Bruker Icon software was used to automate the NMR
data collection. All spectra were collected using the HSQC0 pulse sequence and followed
the experimental protocol as previously described [21]. The 2D 1H-13C HSQC NMR
spectra were collected with a total of 2048 data points and a spectrum width of 5000.0
Hz, and 64 data points with a spectrum width of 17607.23 Hz in the 1H and 13C
dimensions, respectively. A total of 16 dummy scans, 128 scans, a receiver gain of
9195.2, and a relaxation delay of 1.5 seconds was used to obtain all spectra.

10.2.4 2D 1H-13C HSQC NMR Data Analysis
All 2D NMR spectra were processed using the NMRpipe software package [22].
A reference spectrum for peak picking was created by adding all spectra together. All
spectra including the reference spectra was automatically peak picked and the peak
intensities were organize by their chemical shifts using NMRviewJ [23]. The observed
NMR peaks were assigned to specific metabolites using 1H and 13C chemical shift
tolerances of 0.05 and 0.40 ppm respectively. Metabominer [24], Madison Metabolomics
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Consortium Database (MMCD) [25], Human Metabolome Database (HMDB) [26], and
Platform for Riken Metabolomics (PRIME) [27, 28] were used to identify all metabolites.
All identified metabolites were verified using KEGG [29] and MetaCyc [30] databases.
The concentrations of all metabolites were calculated using an extrapolation
procedure that has been previously described [21]. The concentration for each metabolite
from the triplicate datasets are then averaged, standard deviation was calculated, and
Student’s t-tests were used to test for statistical significant (p < 0.05) differences between
each group.

10.2.5 NMR ligand binding assay for D-alanyl-D-alanine Ligase
M. tuberculosis D-alanyl-D-alanine ligase was obtained using protocols described
previously [17]. Ligand binding assays were performed to determine if alanine, ATP, and
DCS can bind to the ligase individually or in combination. Six combinations of each
ligand were used: 1) ATP, 2) D-alanine 3) DCS, 4) ATP and D-alanine 5) ATP and DCS,
and 6) ATP, D-alanine, and DCS. The final concentration for each ligand is 100 μM. A
second set of the six combinations of ligands were prepared identically, but with the
addition of 25 μM of D-alanyl-D-alanine ligase. NMR inhibition studies of the Dalanyl-D-alanine ligase were performed using multiple concentrations of D-alanine and
DCS. A total of 4 mixtures were prepared using 100 μM D-alanine with 0, 250, 500, or
1000 μM DCS. ATP was kept at a high concentration of 6 mM to prevent any
competitive inhibition by low ATP:ADP ratios. D-alanyl-D-alanine ligase was titrated
into the solution for a final concentration of 25 μM.
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Each of the NMR samples was dissolved in 600 μL of 50 mM Tris buffer (pH 8.0,
uncorrected) consisting of 10 mM magnesium chloride, 11.1 μM TMSP, and 2% DMSO.
1D 1H NMR spectra were collected using excitation sculpting to efficiently remove the
solvent signal [31]. A total of 16k data points with a spectrum width of 5482.5 Hz were
collected using 32 scans and 8 dummy scans. The 1D 1H NMR spectra were processed
using ACD 1D NMR manager version 12.0. The peak area for D-alanine and D-alanyl-Dalanine was determined and the concentration was calculated based on the TMSP peak.

10.3 Results
10.3.1 Overall Impact of DCS on Mycobacterium smegmatis and Mycobacterium
tuberculosis Metabolomes
In our previous studies, we found that M. smegmatis alr null mutants were able to
grow on Middlebrook 7H9 medium without D-alanine supplementation [32, 33].
Furthermore, principal component analysis (PCA) of NMR metabolomics data revealed
that M. smegmatis alr null mutants had different clustering patterns in PCA scores plots
than the wild type and resistant strains indicating that Alr inactivation had a major impact
on the metabolome [9]. However, the wild type and alr mutant cells treated with DCS
cluster together in the PCA scores plot, but separate from untreated alr mutant cells,
indicating that DCS acts on a common target different from Alr. Also, the onedimensional (1D) 1H NMR metabolomics data showed that glutamate and pyruvate may
be a source for D-alanine synthesis, suggesting that a transaminase may convert D-(L)glutamate into D-alanine. This heterologous racemization of amino acids by a bacterial
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transaminase has been previously observed [34]. Thus, Alr is not an essential function of
mycobacteria and is not the lethal target of DCS. We hypothesized that the inhibition of a
secondary target, possibly Ddl, may negatively impact cell survival and function as the
lethal target.
To analyze in depth the mechanism of action of DCS in both M. smegmatis and
M. tuberculosis, a comparison of the impact of DCS on both microorganisms was
performed using NMR metabolomics (Figure 10.1). Typically, metabolites from cell
extracts are detectable by 1H-NMR where the intensities of each peak correlate with the
concentrations of the metabolites. Therefore, any differences in peak intensity between
organisms indicate a difference in the metabolomes. A spectral comparison between these
two species indicates that there are few differences in the metabolomes (Figure 10.1a).
More noticeable, the M. tuberculosis metabolome shows a higher concentration of
carbohydrates and aminosugars (3.5-4.5 ppm). However, the impact of DCS is similar for
both M. smegmatis and M. tuberculosis suggesting the mechanism of DCS inhibition is
similar in both species. The 1D 1H-NMR spectrum indicates that alanine (1.43-1.45 ppm)
showed a large increase while glutamate (2.00-2.45 ppm) had a dramatic decrease in
concentration when both M. smegmatis and M. tuberculosis were treated with DCS
(highlighted by blue boxes). In M. tuberculosis, there is an increase in the concentration
of UDP, acetate, -ketoglutarate while there is a decrease in AMP, glutamine, and
methionine (Figure. 10.1b). An increase in UDP would be expected because it is an
important precursor for peptidoglycan synthesis by providing N-acetyl(glycolyl)glucosamine and the corresponding muramate UDP-derivatives.
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Figure 10.1. a) 1D 1H NMR spectra comparing the metabolome of M. tuberculosis and
M. smegmatis with (top) and without (bottom) treatment with DCS. The highlighted
regions show the major differences between the extracted metabolomes when treated
with DCS. b) The 1D 1H NMR spectra of M. tuberculosis with (top) and without
(bottom) treatment with DCS. Key metabolite changes are labeled. Overlay of 2D 1H-13C
HSQC spectra comparing metabolite extracts from c) M. tuberculosis (black) and M.
tuberculosis treated with 50 μg/mL DCS (red), d) M. smegmatis (black) and M.
smegmatis treated with 75 μg/mL DCS (red). The circled region highlights the major
differences between the untreated and treated cultures. e) Highlighted region of the 2D
1

H-13C HSQC spectra comparing M. tuberculosis (red) and M. smegmatis (blue) treated

with DCS, with a reference spectrum of D-alanyl-D-alanine (black).
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To further quantify metabolite changes resulting from DCS treatment, we
collected 2D 1H-13C HSQC spectra after supplementing the bacterial growth medium
with a carbon-13 source. This procedure allows for monitoring the carbon-13 flow
through the metabolome. Since the natural abundance of carbon-13 is 1.1%, only
compounds derived from the 13C-labeled metabolite through enzymatic turnover will
bedetected in the 2D 1H-13C HSQC spectrum. As the D-alanine pathway is the primary
focus of our study, both M. smegmatis and M. tuberculosis cells were pulse labeled with
13

C-D-alanine and treated with DCS shortly thereafter. Cells were further grown for

approximately half to one generation and harvested. Not surprisingly, the resulting 2D
1

H-13C HSQC spectrum of the metabolomes obtained from the two untreated

mycobacterial species cells differed (Figure 10.1 c,d). As observed in the 1D spectra, the
M. tuberculosis peaks in the 2D 1H-13C HSQC spectrum appear to be more congested in
the carbohydrate and aminosugar region (13C = 60-80 ppm, 1H = 3.0-4.5 ppm). Therefore,
the carbon-13 flow for M. tuberculosis appears to be directed towards gluconeogenesis.
This differs from M. smegmatis, where the peaks are well dispersed throughout the 2D
1

H-13C HSQC HSQC spectrum and correspondingly in the metabolome.
Again, the impact of DCS appears to be similar for both M. smegmatis and M.

tuberculosis as three additional peaks clearly appeared in both 2D 1H-13C HSQC spectra
upon drug treatment (circled region in Figure 10.1c,d). Using metabolomics databases
containing reference NMR spectra, we were able to identify one of the peaks as alanine
(13C 56.0 ppm, 1H 3.54 ppm). This is consistent with the inhibitory effect of DCS on
Ddl that may lead to an accumulation of 13C-D-alanine. However, the two nearby peaks
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were not identified from the NMR databases. Based on the peak intensities and chemical
shifts, it was suspected to be a close derivative of D-alanine. To test this hypothesis, we
collected the natural abundance spectrum of a solution of D-alanyl-D-alanine as a
reference. The two unknown peaks were a perfect match to this D-alanyl-D-alanine
reference spectrum (Figure 10.1e) indicating that D-alanyl-D-alanine is accumulated
upon DCS treatment with supplemental 13C-D-alanine. This result was expected from Alr
inhibition by DCS and the flow of the 13C label into D-alanyl-D-alanine [35] as Ddl
activity is maintained because the supplemented 13C-D-alanine effectively competes with
DCS for the Ddl active site [19]. Further inspection of cell growth curves confirmed that
the DCS treated cultures when supplemented with 13C-D-alanine were growing similarly
to untreated cells. Thus, 13C-D-alanine appears to compete very effectively with DCS and
promote cell viability in the presence of DCS. This effect would readily explain the wellknown reversal of DCS inhibition by D-alanine [36].

10.3.2 Impact of DCS on the Central Metabolism and Peptidoglycan Synthesis
To study the impact of DCS on M. smegmatis, a detailed analysis of changes to
the metabolome was performed by measuring the 13C metabolite concentrations using 2D
time-zero 1H-13C HSQC (HSQC0) experiments [21]. Two sets of triplicate cultures were
grown in minimal media with 13C-glucose as the primary carbon source. Cells were
grown to exponential phase, treated with 75 μg/mL of DCS and grown for one additional
generation. Analysis of the corresponding cell extracts (Figure 10.2a) indicated that the
variations in the metabolites identified from the HSQC0 experiment were similar to those
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Figure 10.2. Bar graphs generated from the average of triplicate 2D 1H-13C HSQC
spectra comparing the differences between untreated (black) and DCS treated (white) M.
smegmatis cultures using a) 22 mM 13C-glucose or b) 100 μM 13C-pyruvate as the sole
carbon-13 source. Metabolites having statistically significant perturbations (p < 0.05)
upon treatment with DCS are displayed in the bar graph.
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identified from the 1D 1H-NMR spectra (Figure 10.1a,b). This further confirms that
carbohydrate precursors leading towards the biosynthesis of trehalose, glycogen, rhamose
and UDP-galactose were significantly decreased upon DCS treatment. Moreover, the
increase in fructose-1,6-bisphosphate highlights the switch to the catabolic route
suggesting up-regulation of the glycolytic pathway. Glutamate is an important metabolite
for energy generation, purine synthesis, peptidoglycan synthesis, and transfer of amino
groups. Consistent with these roles, glutamate was greatly decreased in the presence of
DCS suggesting the metabolite was catabolized. This same catabolic effect was observed
on the pools of nucleotide precursors such as dUMP, dCMP, dTDP, and thymidine,
which were all decreased significantly upon DCS treatment. There is also a significant
decrease in the concentration of precursors in the oxidative branch of the pentose
phosphate pathway such as D-glucono-1,5-lactone and 6-phosphogluconate. But, there is
also an increase in the concentration of D-ribose-5-phosphate and D-ribose, suggesting a
switch to the non-oxidative branch of the pentose phosphate pathway.
-alanine is the precursor of important vitamins such as panthotenate via the
conversion of aspartate to -alanine by the PanD enzyme. Moreover, pantothenate is a
precursor of Coenzyme A, which is essential for the production of fatty acids and
peptidoglycan. A significant decrease in the pool of -alanine was also observed,
potentially suggesting DCS may inhibit the PanD enzyme. Instead, the carbon flow is
rerouted towards the production of methionine and lysine, the terminal product of the
pantothenate pathway immediately downstream from meso-2-6-diaminopimelate, a
component of the peptidoglycan bridge. However, the increase in concentration of N-
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alpha-acetyl-lysine suggests that lysine is also being catabolized. Other peptidoglycan
precursors such as alanine, UDP-N-acetyl-glucosamine, UDP, D-ribose, D-ribose-5phosphate, and carbamoyl-L-aspartate are all significantly increased, consistent with the
inhibition of peptidoglycan biosynthesis.
These results were confirmed by a second metabolomics study using 13C-pyruvate
as a carbon-13 source (Figure 10.2b). Carbon flow was initially directed toward
gluconeogenesis and glutamate production. However, trehalose, myoinositol, glucose-1phosphate and glutamate decreased significantly upon DCS treatment. Consistent with
the inhibition of peptidoglycan synthesis, the carbon flow was also directed towards
purine and lysine biosynthesis, as observed by the significant increase in UDP, Ncarbamoyl-L-aspartate, and N-alpha-acetyl-lysine. There was also a significant increase
in proline concentration as the metabolism of this amino acid plays an important role in
the detoxification of methylglyoxal, a toxic aldehyde generated from the cleavage of the
phosphate group of dihydroxyactenone phosphate by the enzyme methylglyoxal synthase
[37]. The over production of methylglyoxal has been associated with the imbalance in
the anabolic and catabolic processes in the cell [38]. Although we were unable to identify
methylglyoxal, the increase in proline levels suggests the existence of a mechanism to
compensate for excessive activity in the catabolic pathways.

10.3.3 The effect of D-alanine on DCS inhibitory activity
To determine the effect of DCS on the D-alanine pathway, M. smegmatis cultures
were grown in Middlebrook 7H9 media supplemented with 100 μM 13C-D-alanine at

398
mid-exponential phase. After 10 min incubation, cultures were treated with either 75,
300, or 1200 μg/mL of DCS. To determine the uptake of 13C-D-alanine, the total area
under the peaks observed in the 2D 1H-13C HSQC spectra was compared between treated
and untreated samples. This is possible because all of the peaks in the 2D 1H-13C HSQC
spectrum are derived from 13C-D-alanine. We observed that D-alanine was able to
effectively compete with DCS for uptake. At 75 and 300 μg/mL the total carbon-13
concentration was approximately 35% higher in the DCS-treated cultures. This indicated
that D-alanine uptake was increased as needed to produce peptidoglycan precursors and
increase the internal D-alanine pools to out-compete DCS from internal targets such as
Alr and Ddl. However, a 15% decrease in D-alanine uptake was observed at 1200 μg/mL
DCS, which represents a 100-fold molar excess of DCS.
D-alanine readily reversed cell growth inhibition by DCS. For example, cell
growth was inhibited when cultures were grown with 13C-pyruvate and 13C-glucose using
75 μg/mL DCS. Upon addition of 100 μM 13C-D-alanine to the culture medium, growth
inhibition was not observed even with 300 μg/mL DCS. Consistent cell growth inhibition
only occurred when the DCS dosage was raised to 1200 μg/mL, a 100-fold molar excess
of DCS to D-alanine (Figure 10.3a). Comparison between non-inhibitory and inhibitory
conditions was important to assess the transient effect of DCS on the metabolome (Figure
10.3b). At 75 or 300 μg/mL DCS, the overall impact on the metabolome was minimal, as
indicated by the corresponding heat maps of metabolite concentrations derived from 13CD-alanine (Figure 10.3a). However, major changes were observed in cultures treated with
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Figure 10.3. a) Heat map generated from the average of triplicate HSQC0 spectra
comparing the relative difference in metabolite concentrations between M. smegmatis and
M. smegmatis treated with 75, 300, or 1200 μg/mL DCS using 100 μM 13C-D-alanine as
the carbon-13 source. The relative differences between the untreated and treated cultures
are plotted on a color scale from -100% to -25% (red), -25% to 25% (black), and 25% to
1,200% (green). b) M. smegmatis growth curve comparing untreated (black) cultures to
cultures treated with 75 (magenta), 300 (blue), 1200 μg/mL (red) DCS. O.D values were
determined after the treatment of DCS with an initial O.D.600 of ~0.6.

400
1200 μg/mL DCS, a concentration resulting in inhibition of both D-alanine uptake and
cell growth.
Increasing the DCS concentration had a major impact on the pool of 13C-labeled
metabolites originating from 13C-D-alanine (Figure 10.4). At 75 μg/mL DCS, the internal
pool of D-alanine increased 12-fold with respect to untreated culture. Similarly, a 4-fold
increase in D-alanyl-D-alanine and a slight 10% increase in glutamate were also
observed. At 300 μg/mL DCS, the D-alanine concentration increased 4-fold compared to
untreated cultures, while the D-alanyl-D-alanine and glutamate concentrations increased
further by 5.5-fold and 50%, respectively. At 1200 μg/mL, both the D-alanine and Dalanyl-D-alanine concentrations were similar in both treated and untreated cultures, while
the glutamate concentration decreased by 50%. Treatment with increasing DCS
concentrations also leads to similar changes in other metabolite pools. For example, an
increase in DCS concentration results in an increase in peptidoglycan precursors such as
lysine and UDP. These results are consistent with the hypothesis that D-alanine can be
metabolized by three pathways: i) direct stereospecific conversion into L-alanine by Alr,
ii) dimerization into the peptidoglycan precursor D-alanyl-D-alanine by Ddl, and iii)
transamination into pyruvate with concomitant formation of glutamate from ketoglutarate (Figure 10.5). As pyruvate turnover is extremely fast (Figure 10.2b), the
rapid incorporation of the 13C-label into glutamate may proceed in three steps: i)
conversion of D-alanine into pyruvate, ii) pyruvate turnover into -ketoglutarate, and
finally iii) the incorporation of the 13C-label into glutamate by iteration of the first step as
required by the principle of microscopic reversibility. Thus, in absence of DCS, D-
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Figure 10.4. Bar graphs depicting relative concentration differences in metabolite
precursors a) alanine, b) D-alanyl-D-alanine, UDP, c) glutamate, d)UDP, and e) lysine
that are involved in the biosynthesis of peptidoglycan. The observed metabolite
concentration changes result from treating M. smegmatis and M. smegmatis with DCS. A
positive value indicates an increase in the concentration of the metabolites when the
cultures are treated with DCS, and a negative value indicates a decrease in the
concentration of the metabolites when the cultures are treated with DCS.
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Figure 10.5. Schematic representation of pathways that may synthesize D-alanine. Alr
(red path) is inhibited at a dose of 75 μg/mL of DCS, which inhibits the primary pathway
of D-alanine production. However, inhibiting Alr is non-lethal as the transaminase
pathway (green path) is hypothesized to remain unaffected upon DCS treatment. This
reaction may lead to an alternative mechanism of D-alanine biosynthesis that antagonizes
DCS activity through a competition for Ddl. Ddl (pink path) is inhibited at a dose of 1200
μg/mL of DCS, inhibition of peptidoglycan biosynthesis initiates a cascade of events
leading to cell death [39] TCA, tricarboxylic acid.
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alanine is rapidly converted into L-alanine by Alr as well as other metabolites such as Dalanyl-D-alanine and glutamate. As the concentration of DCS is increased, Alr inhibition
leads to label accumulation in the alanine pool, while the D-alanyl-D-alanine pool
remains constant only decreasing at the higher DCS concentrations (1200 μg/mL)
reflecting the inhibition of Ddl. Moreover, though the conversion of D-alanine into Lalanine is inhibited, the results indicate that part of this label is still converted into
glutamate. These results suggest that DCS first inhibits Alr, but cell growth inhibition
parallels the inhibitory effect of DCS on Ddl. Moreover, there is a conversion of Dalanine into glutamate at all DCS concentrations, suggesting that a DCS-insensitive Dalanine transaminase converts D-alanine into glutamate by steps described above. By the
principle of microscopic reversibility, this enzyme may also convert glutamate into Dalanine. Nonetheless, the major conversion of alanine into glutamate depends on Lalanine transaminase, as the 13C-label incorporated into glutamate decreases significantly
upon Alr inhibition. Therefore, Ddl rather than Alr, is the main lethal target of DCS,
while D-alanine transaminase is responsible for the alternative pathway of D-alanine
biosynthesis (Figure 10.5). It is important to note that other enzymatic reactions that
produce D-alanine are possible alternative explanations, such as the Strickland reaction in
the ornithine fermentation pathway [40] or the decarboxylation of D-(L-)-aspartate by a
D-amino transaminase [41]. Correspondingly, the observed PanD inhibition and decrease
in -alanine caused by DCS may result from an increase in the production of CoA for the
Strickland reaction. Of course, the ornithine fermentation pathway that is composed of
nine enzymes has not been identified in mycobacteria. Alternatively, the observed
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increase in aspartate upon DCS treatment may suggest D-aspartate is being converted
into D-alanine through the activity of a D-amino transaminase. Nevertheless, this still
requires invoking the activity of a transaminase to explain the production of D-alanine
when Alr is inhibited by DCS.

10.3.4 Impact of DCS on D-alanyl-D-alanine Ligase
To further investigate the interaction of DCS and the Ddl lethal target, the binding
of relevant potential ligands with Ddl were followed by NMR. Moreover, the influence of
a given ligand on the simultaneous or consecutive binding of another ligand was followed
as well. Previous studies have yielded dissimilar results regarding the dependency of Dalanine binding on the presence of ATP in solution [8, 17]. To resolve this issue, purified
Ddl was incubated with ATP, D-alanine, or both ATP and D-alanine and binding was
analyzed by NMR (Figure 10.6-10.8). The observed NMR peak broadening for ATP
upon the addition of Ddl indicates that ATP binds strongly to Ddl in the absence of Dalanine. Conversely, the D-alanine NMR peaked is unaffected by the addition of Ddl in
the absence of ATP, indicating that D-alanine cannot bind to Ddl without ATP. The
addition of ATP induces the binding of D-alanine to Ddl and the conversion of D-alanine
to D-alanyl-D-alanine and ATP to ADP (Figure 10.9). These results are consistent with
the mechanism of ordered binding and the binding assays reported by Prosser [8]. Ddl
NMR line-broadening binding assays were also carried out with DCS, DCS and ATP,
and DCS with both ATP and D-alanine. The DCS NMR peaks broaden and incurred a
chemical shift change in all three cases indicating that, in contrast to D-alanine, DCS can
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Figure 10.6. Ligand binding assays comparing the intensities of the ATP peaks (8.28 and
8.54ppm) in mixtures consisting of: a) 100 μM ATP, D-alanine, DCS and 25 μM Ddl; b)
100 μM ATP and D-alanine and 25 μM Ddl; c) 100 μM ATP and 25 μM Ddl; and d) 100
μM ATP as a control.
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Figure 10.7. Ligand binding assays comparing the intensities of the D-alanine peaks
(1.45-1.50) in mixtures consisting of: a) 100 μM ATP, D-alanine, DCS and 25 μM Ddl;
b) 100 μM ATP and D-alanine and 25 μM Ddl; c) 100 μM D-alanine and 25 μM Ddl; and
d) 100 μM D-alanine as a control. Formation of D-alanyl-D-alanine (1.33-1.38ppm) is
formed when ATP, D-alanine, and Ddl are in the same mixture.
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Figure 10.8. Ligand binding assays comparing the intensities of the DCS peaks (3.954.10 ppm) in mixtures consisting of: a) 100 μM ATP, D-alanine, DCS and 25 μM Ddl; b)
100 μM ATP, DCS and 25 μM Ddl; c) 100 μM DCS and 25 μM Ddl; and d) 100 μM
DCS as a control.
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bind Ddl independently of ATP. Nonetheless, DCS is a weak binding ligand as evident
by the modest changes in line-width and chemical shifts consistent with reported Ki
values of 14 M[8] to 0.9 mM.[42]. Furthermore, no additional peaks were observed
suggesting that there was no chemical modification to DCS. This suggests DCS is a
competive inhibitor that binds to Ddl with no chemical modification. This observation is
unique compared to inhibition to Alr and D-alanine transaminase. Alr and D-alanine
transaminase are pyridoxal-phosphate (PLP) dependent enzymes that are also inhibited
by DCS. Unexpectedly, DCS and PLP forms a complex stable aromatic tautomer which
then inhibits the PLP dependent enzymes [43].
To confirm these results, we followed the progression of the Ddl (25 μM) reaction
at varying DCS concentrations and fixed amounts of D-alanine (100 μM) and ATP (100
μM). Using NMR, the concentrations of the substrates (ATP and D-alanine) and two of
the products (ADP and D-alanyl-D-alanine) were determined over time (Figure 10.9). In
the absence of DCS, the conversion of ATP and D-alanine into ADP and D-alanyl-Dalanine was stoichiometric, but followed a very slow kinetics, reaching a maximum
conversion in the forward reaction at approximately 4 h (Figure 10.10a). Thereafter, the
reaction was inhibited by accumulation of the ADP and D-alanyl-D-alanine products. To
analyze the inhibitory effect of DCS, the reaction conditions were modified by adding
saturating amounts of ATP at 6.0 mM. Under these conditions, the reaction proceeds to
completion until D-alanine is exhausted (Figure 10.10b). At increasing DCS
concentrations, the reaction is progressively inhibited, but never reaches full inhibition.
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a)

a)

Figure 10.9. 1D 1H NMR was used to monitor the conversion of a) ATP (blue) to ADP (red) and b) D-alanine (red) to D-alanyl-Dalanine (blue) by Ddl. The initial concentrations were fixed at Ddl (25 μM), D-alanine (100 μM), and ATP (100 μM).
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Figure 10.10. NMR kinetic analysis of a) ADP and b) D-alanyl-D-alanine formation by
Ddl. The 1D 1H spectrum were collected at one hour intervals after the addition of 25 M
of Ddl into a mixture containing 100 μM D-alanine and 100 μM ATP. c) Plot of Dalanyl-D-alanine formation as monitored by 1D 1H NMR that demonstrates a decrease in
Ddl activity as a function of increasing DCS concentration: 0 (black), 250 (red), 500
(blue), 1000 (green) μM of DCS.
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This is as expected given that DCS binds weakly to Ddl and D-alanine is a competitor of
DCS.

10.4 Discussion
DCS is known to inhibit peptidoglycan biosynthesis, but its primary target has
been a point of controversy and extensive investigation for over fifty years. The effect of
DCS has been attributed to the inhibition of Alr, Ddl or both [32, 33, 44, 45]. Both Alr
and Ddl are known binding targets in mycobacteria and their enzymatic activities are
inhibited by DCS in a concentration dependent manner [19, 35]. Alr is the only known
enzyme to produce D-alanine in M. smegmatis and M. tuberuculosis. In addition,previous
studies have shown that the overexpression of alr confers resistance to DCS while alr
mutant strains are more susceptible [19, 33]. However, overexpression of ddl also leads
to DCS resistance, but to lower levels [35]. Similarly, contradictory genetic studies have
been presented that seem to indicate that Alr is required in the absence of D-alanine [44,
45]. Nonetheless, as we have previously observed [19] these seemingly contradictory
results may occur because of the different experimental conditions employed by these
various studies to analyze Alr conditional essentiality. Critically, alr mutants are still able
to grow in the absence of D-alanine [32, 33]. Also, the NMR metabolomic profiles of alr
mutants do not match the metabolome of wild type M. smegmatis treated with DCS,
which indicates that Alr is not the main inhibitory target of DCS [9]. Thus, these studies
taken together conclusively rule out Alr as the lethal target of DCS in mycobacteria.
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Figure 10.11. Peptidoglycan biosynthesis pathway depicting the metabolites that were
identified by 2D 1H-13C HSQC analysis or from literature results.[46, 47] The arrows
correspond to metabolites with statistically significant (p < 0.05) concentration increases
(up) or decreases (down) when comparing DCS treated cells to untreated cells. Circles
indicate the metabolite concentration is similar (p > 0.05). The p values were calculated
using the Student’s t-test. Hyphens indicate the metabolites were not identified for the
specific carbon-13 source. Cells were incubated with 13C-glucose and treated with 75
g/mL of DCS (black arrow), 13C-pyruvate and treated with 75 g/mL of DCS (red
arrow), 13C-alanine and treated with 75 g/mL of DCS (grey arrow), 13C-alanine and
treated with 300 g/mL of DCS (blue arrow), 13C-alanine and treated with 1200 g/mL
of DCS (dark blue arrow), and literature data (pink arrows)
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In this study, we found that DCS does not only inhibit peptidoglycan synthesis,
but it also caused a cascade of effects on the central metabolism of the cell (Figure
10.11). Our NMR metabolomics results using both 13C-glucose and 13C-pyruvate as
carbon-13 sources showed a large increase in the accumulation of peptidoglycan
precursors, as would be expected from DCS inhibition of peptidoglycan biosynthesis.
Furthermore, DCS treatment of both M. smegmatis and M. tuberculosis resulted in a
metabolic shift towards a catabolic state. We hypothesize that this catabolic shift occurs
to compensate for the need to increase the synthesis of peptidoglycan precursors used to
construct the cell wall. The shift towards the non-oxidative branch of the pentose
phosphate pathway was evidenced by a decrease in oxidative branch metabolites with a
concomitant increase in ribose-5-phosphate. This effect is most likely associated with the
inhibition of peptidoglycan synthesis as ribose-5-phosphate is used in the synthesis of
UTP needed to generate UDP-N-acetyl-glucosamine, which is the initial precursor in this
biosynthetic step. This metabolic shift is also likely to result in a decrease in mycolic acid
formation since the pentose phosphate oxidative branch is a major source of NADPH,
which is required for the synthesis of mycolic and fatty acids. This would be expected to
further weaken the cell wall and contribute to the bactericidal action of DCS.
The demonstration that a decrease in the biosynthesis of D-alanyl-D-alanine
occurs simultaneously with cell growth inhibition shows that Ddl is the primary target of
DCS. However, inhibition of Alr may contribute indirectly to the effect of DCS by
simply lowering the pools of D-alanine produced [32]. The lower levels of D-alanine
glutamate as we report here and elsewhere [9, 19, 32, 33]. Other investigators proposed
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that Alr, rather than Ddl, is the main target of DCS based on the reversal of growth
inhibition by externally added D-alanine and the weak reversal activity of D-alanyl-Dalanine [44]. However, our results clearly show that D-alanine and DCS are both
competitors for Ddl binding, where a significant increase in D-alanine concentration can
mitigate DCS activity by the intracellular protection of Ddl. Ddl is simply a kinetically
alternative pathway by transamination from pyruvate with concomitant production of
inefficient enzyme and, correspondingly, a bottle neck in peptidoglycan biosynthesis. The
externally added D-alanine is simply increasing Ddl activity by outcompeting DCS.upon
Alr inactivation may allow DCS to outcompete D-alanine for Ddl binding. However the
inactivation of Alr would not prevent the cells from obtaining D-alanine from an Thus,
increasing the intracellular pool of D-alanine is an effective mechanism of increasing
DCS resistance. In conclusion, our combined analysis in this and previous studies
indicate that DCS acts primarily on Ddl, an alternative pathway provides a source of Dalanine when Alr activity is inhibited or deleted, and Alr plays an indirect role in
protecting Ddl by maintaining a higher internal pool of D-alanine.
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